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Abstract 
Ubiquitous computing technologies offer opportunities to improve treatments for chronic health 
conditions. Type 1 diabetes is a compelling use-case for such approaches, given its severity, and 
need for individuals to make frequent care decisions, informed by complex data. However, current 
apps, typically based on effortful reflection on collected data, generally show poor adoption, lack 
vital cognitive and emotional support, and are poorly tailored to users’ actual diabetes decision 
making processes. This thesis investigates how diabetes apps can be improved from a user-centered 
perspective. An initial questionnaire-based study investigated how well existing diabetes apps meet 
user needs. Perceived benefits, limitations, and reasons for low adoption rates were identified. A 
talk-aloud study of detailed user interactions with diabetes logging apps was conducted to 
characterize the benefits and limitations of diverse UI elements for T1 diabetes management, and to 
more precisely identify wider problems with current interaction designs. This led to positing a 
refined version of Mamykina et al.’s model for diabetes self-management, to account for observed 
practices, whereby the previously accepted habitual and sensemaking cognitive states are 
augmented by a posited ‘fluid contextual reasoning’ (FCR) mode, which allows multiple contextual 
factors to be balanced for dynamic course correction when navigating complex situations, using 
previously learned knowledge. To investigate user perceptions of the levels and kinds of 
monitoring anticipated in next generation diabetes decision support systems, a 4-week technology 
probe, in which participants used multiple networked devices and external data aggregation, was 
used to frame requirements for user-centered development of such future systems. Integrating all of 
the above work, an iterative design process was undertaken to create DUETS, a card-based system 
to facilitate reflection by designers, users, and other stakeholders on diabetes support management 
systems.  The resulting tool and method were then implemented and evaluated through structured 
sessions with stakeholder focus groups.  
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Chapter 1: On Balance 
 
“Unnecessarily complex tasks can be restructured, usually by using technological innovation.”  
— D. Norman, The Design of Everyday Things 
1.1 Introduction 
Type 1 diabetes is an auto-immune condition whereby the beta cells in the pancreas are unable to 
produce the hormone insulin.  This is problematic as without insulin, the body is unable to properly 
transport glucose from the blood stream, causing blood glucose levels to rise to dangerous levels.  
This causes a cascade of metabolic disfunction which can be fatal within days. The discovery and 
commercial production of insulin meant that T1 diabetes was no longer a fatal diagnosis; however, 
insulin is just one component of a sensitive biological control loop which continuously adjusts 
blood glucose levels so as to stay within certain thresholds. Therefore, to preserve health it is not 
enough to just inject insulin, the amount of insulin in the body must be continuously in balance 
with needs. Too much insulin and the blood glucose level can become dangerously low 
(hypoglycemia), which can in extreme cases cause seizure, coma, brain damage, and even death. 
Alternately, elevated blood glucose levels (hyperglycemia) can over time cause serious 
complications such as kidney failure or blindness. Therefore, it is essential that people with 
diabetes maintain their blood glucose levels within certain tolerances to minimize short- and long-
term risks.  
The goal for diabetes treatment is straightforward: balance insulin in the body with insulin 
requirements to keep blood glucose levels within certain parameters. Many of the mechanisms that 
can influence this balance are easily explained. For example, carbohydrates are sugars, so their 
intake will raise blood glucose levels. Insulin helps transport glucose out of the blood stream, so 
injecting insulin lowers blood glucose levels. Exercise requires calories, so exercise reduces blood 
glucose levels. Yet, there are also many other factors which must be taken into account to maintain 
a near normal glycemic state. For example, carbohydrate absorption can be delayed when mixed 
with fiber or fat, causing a delayed increase in glycemic levels. Or strenuous exercise can lead to an 
unpredictable rise in blood glucose levels rather than a decrease. There are also diverse other and 
often individually variable factors which can all influence blood glucose levels in hard to predict 
ways. Examples might include emotional stress, sickness, variable insulin absorption rates, alcohol 
consumption, weather, and many others. A clinician can inform about these factors and recommend 
a daily regimen of insulin dosages, meals, and exercise. However, strict adherence to a structured 
plan is not only hard to maintain given the demands of everyday life, it is also often sub-optimal 
due to the great number of variables and contexts which can influence glycemic state. In practice, 
achieving relatively stable glycemic levels while maintaining a reasonable quality of life demands a 
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dynamic approach requiring frequent problem solving, coping with challenges, re-adjusting 
medication, lifestyle, and periodic correcting of out of range blood glucose levels. As many of 
these care decisions are best made in real-time, it is often impractical to depend on a clinician or 
3rd party. Generally long-term diabetes care is most successful when the person with diabetes 
assumes a high level of personal engagement and responsibility in their own care. This continual 
and life-long process of learning, predicting, and integrating multiple factors into daily choices is 
commonly referred to as diabetes self-management. However, as noted the factors that can 
influence blood glucose levels are many and their effects can be both interdependent and hard to 
predict. For the person without diabetes this regulatory process is continuous and entirely 
unconscious, managed by a highly responsive metabolic control loop which can quickly release 
hormones to raise and lower blood glucose levels in response to subtle stimuli. In contrast, the 
person with diabetes must make conscious decisions and engage in deliberate actions. Given that 
these responses are less finely calibrated, more periodic, and take longer to take effect, even the 
most dedicated and experienced person with diabetes can face periods of unwanted glycemic 
variability. Hence diabetes management is not only cognitively and behaviorally demanding, but 
can be frustrating as well.  
Given these many challenges, technology has long been an essential aspect of diabetes care. For 
example, insulin pumps can better simulate pancreatic function than periodic injections through 
continuous insulin infusion. And blood glucose meters provide real-time measurements to inform 
appropriate insulin titration. However, for all the clinical benefits of these technologies, such 
systems are still limited in their ability to help the individual make sense of the complex and inter-
related factors which can affect management decisions. The first generation of diabetes smartphone 
logging apps were one attempt to address this need, offering an affordable and portable update to a 
paper diary, which could help to collect, visualize, and reflect on diverse personal data. Continuing 
advances in ubiquitous computing technologies are suggesting new opportunities to support 
diabetes decision making in more active ways. For example, a diabetes support system might, in 
addition to blood glucose, also collect data on other factors such as exercise, and location. Such 
data might with correct processing and delivery help users to locate correlations or outliers which 
could help inform more beneficial decisions. However, given the challenges of diabetes 
management, any intervention must be carefully considered to minimize risk to the user. From a 
practical as well as ethical perspective, it is essential that designers of new technologies seek in-
depth understanding of the users, their opinions, their practices, and their needs so that the care 
practices are supported and enhanced rather than accidently impaired or undermined. 
Towards the goal of improving the life of people with diabetes, this thesis seeks to contribute 
practical and theoretical knowledge which can be applied to improve supportive technologies, and 
in particular approaches that help individuals make better informed decisions in manner that 
respects user autonomy. The remainder of this introductory chapter will give a general overview of 
this thesis in order frame the approach and scope. This will include: outline of the challenges that 
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will be addressed, scope of the problem, my motivations and perspective, initial research question, 
and primary strategies. This is followed by a brief outline of the chapters within the thesis and the 
limitations of its scope. 
1.1.1 Challenges 
Despite the promise and excitement surrounding new technologies, there are significant challenges 
in designing systems that meet the multiple requirements posed by real-world Type 1 diabetes self-
management. This thesis, while optimistic about future technologies, maintains that especially 
within the medical realm it is essential to retain a critical viewpoint. For example, an analysis of 
current diabetes apps (Chapter 4) discusses the failure of implicit design assumptions that require 
persistent manual logging. Chapter 5 presents evidence that continuing the trend of automating data 
collection is insufficient to solve diabetes app deficiencies without improving interaction design to 
better support user needs for situated decision-making and emotional sensitivity. In addition, 
current approaches often fail to support the cognitive processes used for diabetes self-management 
(Chapter 6). And while the aforementioned technical innovation could better meet such user needs, 
such systems could also introduce increased concerns about privacy, trust, and personal safety 
which must be carefully addressed (Chapter 7).  
1.1.2 What is needed  
In order to overcome such limitations, it is essential to design systems that solve actual user needs 
and augment user abilities, ideally forming a collaborative relationship which helps users to meet 
their personal goals. To accomplish this, designers must come to terms with how users interact with 
their data, their decision-making processes, their concerns about using such systems, and finally 
method of helping designers to create systems that meet those needs (Chapter 8). 
1.1.3 Scope and importance of the problem 
Diabetes is one of the most common major health conditions. It afflicts over 400 million people 
worldwide, and its prevalence is increasing (International Diabetes Federation, 2017). It is also 
costly both in terms of human suffering, with side effects such as kidney failure and blindness, and 
economically, with the International Diabetes Federation estimating that in 2017 world spending 
for diabetes, and related complications for adults, exceeded 850 billion USD.  Effective treatment 
is challenging, depending not only on medications, but also continual patient engagement with 
factors such as emotional coping, exercise, diet, and problem solving; therefore, seeking means to 
support diabetes management is not constrained to clinical research, but a multi-disciplinary effort 
to support diverse aspects of care.  
1.1.4 Personal motivation 
Throughout the research presented in this thesis all attempts have been made to remain neutral in 
collecting data and reporting resulting conclusions from this data. However, it is important to note 
that I have a personal investment in diabetes beyond academic interest, and that I entered my 
research with pre-conceptions informed through many years of personal experience. I have lived 
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with T1 diabetes and depended on related technologies since the age of 13. It is possible that this 
has shaped my beliefs about certain aspects of diabetes management while giving a motivation to 
my research which would have otherwise not existed. Likewise, this research has motivated 
changes in own diabetes management as I have read emerging evidence, attended presentations at 
medical conferences, and adopted new technology. I see this first-hand experience as a valuable 
tool that has assisted in my reaching out and empathizing with people with diabetes, who are often 
saturated with requests to engage in research and at times sensitive about this auto-immune 
condition. Therefore, to claim complete impartiality would be dishonest. However, I would also 
argue that supporting diabetes self-management can be well served by addressing both objective 
and subjective research approaches. While blood glucose measurements and their influence on 
physical health are objective, there are subjective and contextual aspects which must be taken into 
account to determine appropriate goals, as an optimal goal blood glucose level can be dependent on 
shifting contexts and emotional requirements which are not always easily quantified. For example, 
an individual might temporarily need to maintain a higher than recommended blood glucose level 
in certain situations, such as to feel safe drinking alcohol, working with heavy machinery, or to 
reduce a family member’s fear of hypoglycemia. In addition, given the importance of the affective 
aspects of diabetes self-management such as motivation and emotional coping, it is counter-
productive to exclude the importance of subjective approaches. This thesis aligns ideologically 
with the growing movement asserting that it is critical that these technologies support the needs and 
rights of the users, rather than being exclusively means of achieving adherence to clinical metrics. 
It therefore follows that there is an explicit bias and assumption of the author that such tools should 
enhance independence and autonomy to the extent desired by the user. This calls for a balanced 
approach that recognizes that as well as helping to meet evidence based goals for glycemic 
management, users of diabetes technologies have a right to live their lives as they see fit, that 
diabetes management should not overly dominate lives, and that systems must be carefully 
considered as to their impact on user self-determination. Therefore, automation and other methods 
that help attain clinical targets and reduce the burden of diabetes management must be carefully 
balanced with the user maintaining conscious engagement and personal awareness when designing 
personal informatics tools. 
1.1.5 Voice and research 
To avoid confusion, it is important to discuss the pronouns used within this thesis. I have 
personally conducted all the interviews, surveys, user-interaction studies, focus groups, and 
processing of data presented within this thesis unless otherwise noted. That being said, the 
questions asked and interpretations of collected data have been influenced by the many hundreds of 
people I have talked to and worked with. This includes not only my thesis supervisors, but also all 
the patients, participants, clinicians, academics, conference attendees, and others, who have 
impacted my research process. Therefore, while I will use the first person singular when I am 
presenting a personal thought, I will at times defer to the first-person plural ‘we’ to refer to either 
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actions in which the reader is included, or to credit the collaborative processes which helped form 
concepts, interpretations, and ideas, though I take full responsibility for any errors or shortcomings 
in the findings presented.  
1.1.6 The roots of the research 
The initial research in this thesis was inspired by my own experiences using diabetes apps as well 
anecdotal observations from within the diabetes community that while many people with diabetes 
were excited about smartphone apps in general, diabetes apps were often failing to provide 
sufficient benefits to enter into daily care routines. This lack of adoption was intriguing as diabetes 
management is challenging and requires interaction with complex data and therefore seemed an 
ideal application for mobile computing technology. While in 2009 when I purchased my first 
iPhone there were already many diabetes apps available, by the time I started this thesis the number 
was in the hundreds. Some of these apps had been released by major pharmaceutical companies 
with significant expenditure and presumably made use of current best design practices. Yet it 
appeared that in contrast to social networking and other ‘sticky’ apps as well as devices such as 
continuous glucose monitors, diabetes apps consistently ‘failed’ to gain widespread long-term 
adoption by the T1 community. This discrepancy between the number of available diabetes apps, 
the similarity of their approach, and lack of user adoption suggested there might be something 
missing in the current knowledge about the interaction design of diabetes self-management apps, 
and that there might be important differences deserving of further investigation between designing 
an engaging social media or fitness apps as opposed to an engaging chronic disease management 
app. It was these gaps that this thesis began to explore so as to improve the design of future 
systems.   
1.1.7 Preliminary research question  
To the end of understanding if diabetes apps needed further development and if so, in which ways, 
this thesis set out to determine: what people with T1 diabetes thought about current products and to 
what extent popular interfaces supported or failed to support their needs; how such interfaces could 
better support decision-making process; and finally recognizing the challenges of effective clinical 
testing of digital health products within iterative development processes, how these findings could 
be brought together in a manner that could inform and support developers as they design new 
systems.  Consequently, in the context of diabetes self-management, ubiquitous computing 
technologies, and in reflecting the growing movements in patient’s choice, the preliminary 
research question for the thesis can be stated as follows:  
“How can we improve the practical utility of diabetes self-management apps from a user-
centered perspective?”  
The research question will be revisited and refined in Chapter 3. More generally the thesis seeks to 
understand the challenges and concerns people face when having to make frequent and potentially 
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life-threatening decisions and how tools can be designed to assist in this process. However, at the 
same time as addressing a research question, this thesis can be seen as having a practical goal: 
 
 This thesis is specific in its goal of helping individuals self-manage the chronic health 
condition, Type 1 Diabetes (T1D).  
 
Through a series of in-depth user studies, interviews, survey, and focus groups, this research aims 
to contribute to a better understanding of the requirements and mental processes of users of 
diabetes self-management systems and draw attention to questions that should be asked in order to 
help avoid future development of products that neither meet user needs nor respect user concerns. It 
is therefore the goal of this thesis to provide insights, observations, questions, and frameworks that 
can be practically applied to the design and development of future systems that will directly benefit 
those who must live everyday with diabetes. In addition, given that diabetes management requires 
attention to fundamental behaviors such as diet and exercise, I hope that aspects of this research 
might also be applicable for other chronic conditions and health in general. 
1.1.8 Strategic approach to support of diabetes 
While there is much to be agreed with in the move towards helping clinicians to adopt more 
patient-centered medicine (Berwick, 2009), given the practical and highly personalized demands of 
diabetes management, this thesis agrees with the principles and practical requirements of patient 
empowerment (Funnell and Anderson, 2004), e.g. helping people to be capable of making their own 
routine treatment decisions and thereby to take care of themselves. With this approach, clinicians 
still have a valuable supportive role, but the patient assumes much of the medication and lifestyle 
adjustment that might be otherwise be accomplished by trained medical personal. Given that a 
person with managed diabetes is not necessarily sick in the common sense of the term, it is perhaps 
more useful to think of those who rely on these tools not as patients, but as users. Therefore, it is 
the user-centered approach (Norman, 2016) with its methods of understanding users, their 
requirements, and integration into the development process (Gulliksen et al., 2003) which form the 
primary research approach of this thesis. In a broader sense, while T1 diabetes may have certain 
distinct requirements and form a relatively small part of the global population, many aspects of 
diabetes management, such as attention to diet, mitigating stress, and physical exercise (Educators, 
2009), are generalizable to the greater population. Therefore, through careful examination of this 
specific use-case, I hope that insights will emerge that have relevance not only to diabetes, but 
other chronic health conditions, more general wellness, and even perhaps to other tasks that depend 
on complex data and acquired knowledge to inform frequent critical decisions.  
 7 
1.2 Outline of the Thesis  
In order to provide a map for reading and understanding the course of this thesis, the 
following section gives a brief description of the research undertaken within each chapter, 
and the emergent themes which have guided the following research.  
1.2.1 Chapter 2: Review of the literature  
In order to set the context for the approach of this thesis, the literature review begins by discussing 
selected papers which have been foundational for this thesis. These papers are for the most part 
concerned with the relationship between users, ubiquitous computing devices, and personal data, as 
well as how acquired knowledge can support informed decision making in a personally 
empowering manner. Therefore, while much of this literature is not necessarily diabetes specific, 
there is considerable overlap with the direction of my research. Most, though not all, of these 
papers emphasize the human-centered approach of computer science research, rather than more 
technical priorities. This is to say research which specifically seeks to understand the relationships 
or interactions between humans, information, and computing devices. This will be referred to 
within this thesis as the field of Human Computer Interaction (HCI), though there are other terms 
which might be equally suitable. After using this discussion to orient this thesis, it is necessary to 
discuss diabetes in greater detail to set a basis for further discussion. This section includes a general 
overview of diabetes and its treatment, which is followed by a review of commonly used diabetes 
technologies with an emphasis on diabetes apps. Essential aspects of more general decision support 
systems are then discussed, followed by a review of ethical implications of such systems, and 
methods of design and assessment of such systems. At the conclusion of this review is a discussion 
of the relation of the literature to the thesis, and conclusions drawn from this review. 
1.2.2 Chapter 3: Outlines of methods and methodology  
This section provides an overview of the methods which were used to gather and analyze the 
information gathered for this thesis. These include: questionnaires, user-interaction studies, semi-
structured interviews, technology probes, and guided focus groups. For purposes of sign posting, 
these approaches will be briefly reviewed within this chapter and then explored in greater detail 
within the following chapters. 
1.2.3 Chapter 4: Adoption of Diabetes Apps Pilot Study   
The chapter reviews a pilot study (Katz et al., 2015) which set out to explore objectively the 
perhaps counterintuitive notion that many people with T1 diabetes who use smartphones and 
depend on technology everyday are not adopting diabetes smartphone apps.  In order to investigate 
the user perspective, a pilot survey of 26 individuals with T1 diabetes was conducted. Through a 
questionnaire and in-person interviews, it was established that it was indeed common for users to 
abandon functioning diabetes apps, suggesting that for a majority of participants,  these apps were 
failing to adequately meet needs. Findings related to the lack of support for affective and cognitive 
requirements are discussed, as well technical barriers to adoption such as the need to manually log 
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data, and concluding with a general discussion of these difficencies. This chapter reports on this 
survey, presents study data, and proposes hypotheses that served as the foundation for later 
research.  
1.2.4 Chapter 5: Data, Data Everywhere, and Still Too Hard to Link 
As the previous chapter found that manual data entry was a barrier to diabetes app adoption, this 
chapter investigates the utility of typical diabetes app interfaces in a possible future where all data 
entry could be automated. To this end, this chapter reports on a talk-aloud user interaction study 
(n=16) undertaken to identify and characterize the benefits and limitations of common interfaces of 
diabetes logging apps when used for reflecting on pre-entered diabetes relevant data (Katz et al., 
2018a). By providing examples of a range of participant observations, the first part of this chapter 
presents evidence suggesting that, while providing certain specific benefits, these interfaces could 
be too cognitively demanding, potentially emotionally insensitive, and did not fully take advantage 
of participant’s already acquired knowledge. In addition, these sessions suggested insights into 
participant’s cognitive processes which are explored in the following chapter. 
1.2.5 Chapter 6: Fluid Contextual Reasoning  
In this chapter, existing dual-process cognitive models were applied to analyze participant’s 
responses from the user-interaction study in the previous chapter. This process suggested that some 
participant described thought processes did not fit well within these existing models. An expanded 
cognitive model is introduced to better represent an apparent hybrid mode, which appears to enable 
decisions based on complex data in a relatively-low cognitive demanding manner. This proposed 
mode Fluid Contextual Reasoning (FCR) and its defining characteristics are outlined. The results 
of this analysis and the resultant expanded cognitive model motivated an online survey of people 
with T1 diabetes (n=192) to further investigate this hypothesis. The expanded model was used to 
formulate questions, which according to the model should initiate different responses when 
considering different diabetes scenarios (Katz et al., 2018b). These responses and their implications 
for the proposed extended model are discussed. The chapter concludes with a discussion of the 
expanded model as a framework for assessing diabetes decision support interfaces, as well as 
suggesting how this model could offer guidance for future design. To contribute towards the goal 
of real-world implementation of this approach, the following chapter investigated user concerns 
and potential barriers to the monitoring infrastructure that would form the data gathering structure 
for such an approach. 
1.2.6 Chapter 7: User Concerns for Multi-Device Diabetes Monitoring 
This thesis will present evidence that current diabetes logging apps have an inherent flaw in 
demanding significant manual data entry while delivering insufficient benefits. This chapter looks 
forward to a ‘next generation’ diabetes support system capable of providing the data needed for 
implementing the model in Chapter 6. This approach would make use of multiple sensors to 
eliminate the need for manual data entry while aggregating this data to allow for analysis and 
integration with other services. This chapter discusses the results of a 4-week technology probe 
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(n=8) in which participants were outfitted with multiple networked devices in order to learn more 
about user perception and willingness to adopt such multi-device monitoring. Through detailed 
analysis of their interview responses both before and after the study period, this chapter reports on 
user concerns related to sharing their medical and behavioral data with different stakeholders, 
changes in sentiment during the study period, software solutions that could increase user 
acceptance, and finally emergent questions for designers of such systems.   
1.2.7 Chapter 8: DUETS: A Card-Based Tool for Stakeholder Reflection 
The preceding chapters draw attention to user concerns and requirements related to app-based 
diabetes decision support systems. However, industrial partners might find academic research 
challenging to apply within actual design processes and these challenges could become even more 
pronounced given the increasing complexity of IoT-based systems. With the goal of bringing about 
real-world impact, this chapter proposes a card-based methodology for integrating and organizing 
such findings in a manner that can facilitate stakeholder reflection and critical discussion. This 
chapter suggests five criteria for assessing user requirements, which are then implemented through 
a described iterative development process, with a resulting card-based method for product 
assessment. This tool is then implemented and evaluated through three focus group sessions, the 
first and third with a team of developers from a diabetes analytics startup (n=3), and the second 
with an early adopter patient group (n=6). The strengths and weaknesses of this approach are then 
discussed, with suggestions for future development. 
1.2.8 Chapter 9: Conclusions 
This chapter reviews the research question and sub-questions, summarizes the principle findings, 
outputs, and contributions of the thesis, and suggests specific key questions for designers of 
diabetes apps. This is then followed by limitations, future work and concluding remarks. 
1.3 Thesis Scope 
Diabetes management is a complex topic and the knowledge from diverse fields could be 
applicable (and have been applied) to the development of new or improved interventions. While 
this thesis is situated within the computer science literature which focuses primarily on interaction 
design considerations between humans and computing systems, the research within this thesis has 
required the consideration of a variety of sources. Reviewed literature includes work conducted 
within the domains of clinical care, cognitive psychology, computer science, design, and others. 
Due to the vastness of potential sources and approaches, it has been necessary to limit or even 
exclude many important areas. The following section details a few of these limitations: 
Not about onboarding: The focus has been almost entirely on assisting with long-term self-
management, which neglects the onboarding and initial learning that takes place as the newly 
diagnosed learn how to manage life with diabetes (Blondon et al., 2013). While the initial phase is 
extremely important, this decision has been justified by the relatively short period of this first phase 
as opposed to the life-long aspects of living with a chronic health condition. 
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Not clinician-centered: This thesis emphasizes the user-perspective of the person with diabetes and 
has largely neglected the needs and perspectives of the clinician or many others who could also be 
considered users of such systems (Forlizzi, 2018). While the clinician and other diabetes 
professionals can play an important role in diabetes management, the majority of daily care must be 
carried out by those living with diabetes (Funnell and Anderson, 2004). However, this thesis in no 
way means to diminish the importance of these other viewpoints, which should be integrated into 
the development process of future systems.  
Not Closed loop: And finally, this thesis has the limitation that it explores a quickly moving 
technology, and that over the period of the research there have been significant advances in 
diabetes technologies. The closed loop artificial pancreas is a prominent example, driven forward 
by the DIY/maker community, which has in a short time progressed far beyond commercially 
available options. At the start of this thesis, such systems were still being prototyped in controlled 
clinical settings, and the literature foresaw years of controlled studies (Peyser et al., 2014). Just a 
few years later, such self-built un-regulated systems are now being worn by an ever expanding 
early adopter community (Barnard et al., 2018). However, while closed loop systems are 
potentially revolutionary for insulin dependent diabetes management, such innovation need not 
invalidate the broader contributions of this thesis in areas such as medical/lifestyle decision 
support, user-interaction with complex data, UI design, user concerns regarding monitoring 
systems and devices, and supporting more general user-centered development practices. 
1.4 Summary  
While much progress has been made with diabetes related technologies, it is in the ability to fit into 
the complex ecology of the individual user’s life and lifestyle that these technologies will truly 
succeed. In order to improve these technologies, we need to recognize in which ways existing 
products are succeeding or failing to meet user needs, understand what the unmet needs are, and 
then develop processes that better support the integration of these needs into the next generation of 
systems. In a broader sense, people with T1 diabetes form an engaging research focus, already 
depending on and having widely adopted sensor driven technologies. In addition, the extreme 
variability and responsiveness of blood glucose levels to behavioral decisions, and the ability to 
easily monitor these responses, forms an edge case for ubiquitous computing and self-tracking. 
Therefore, while this thesis is diabetes specific, it potentially provides insights into human 
computer interaction which will likely become increasingly relevant as the use of real-time bio-
markers for personalized health-oriented decision making enters the mainstream. 
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Chapter 2: Related Work 
This chapter contains broadly two elements – a critical review of the literature in the context of 
the preliminary research question, and a more practical outline of diabetes related background 
knowledge including a brief account of relevant technologies. These elements are interwoven to 
first orient the reader within the primary body of literature that this thesis builds upon, then to 
offer sufficient background on diabetes to support more in depth discussion, and finally the 
principal literature review. As noted previously, this chapter draws from several domains 
including research on interactions between humans and computing systems which is foundational 
to this thesis, as well as aspects of medicine, informatics, and psychology, which all offer valuable 
perspectives. The following paragraph gives a brief overview of the sub-sections of the literature 
review and a brief description of the reasoning behind their inclusion: 
Situating thesis within the literature: Chapter 2.1 critically reflects on ways in which ubiquitous 
computing technologies have in the past been applied to supporting interactions with personal 
data in the pursuit of supporting healthier behaviors. This section will also identify and discuss 
examples where theory has directly informed the design of digital interventions. The work in this 
section has been most directly influential on my thinking and research, especially for chapter 6. 
There will also be a brief introduction of bio-ethical principles, as these values guide the 
approaches and assumptions made throughout this thesis. Ethics and computing systems will be 
explored in greater detail in chapter 2.5.  
Diabetes general knowledge and supporting technologies: Chapter 2.2 and 2.3 presents the basics 
of diabetes care and the current technologies associated with diabetes management. These 
sections are primarily informational in nature and could be skipped by those who already have 
sufficient knowledge of subjects such as the normal range of blood glucose levels, details of 
diabetes self-management, and the characteristics of continuous glucose monitoring.  
Candidate directions for next generation diabetes apps: Section 2.4 returns to the process of 
critical literature review to discuss potential components of next generation diabetes app-based 
interventions.  
Ethical implications of more active approaches: Section 2.5 reviews ethical concerns for 
computing systems, relevant considering the potential harm caused by the more active and 
intelligent systems advocated by this thesis.  
Methods of design and assessment: Section 2.6 reviews methods for designing and validating 
user-centered health systems for practical consideration of how to implement real-world future 
systems. 
2.1 Situating this Thesis within Literature 
As outlined above, this section begins by discussing selected papers from within the human 
computer interaction literature which have been especially relevant in informing the direction of 
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this thesis. While many of these papers are not diabetes specific, they are for the most part 
concerned with the relationship between users, ubiquitous computing devices, and their personal 
data as well as how such interactions can influence healthful behaviors. In addition, by setting this 
more general context it is hoped that the reader might be able to see the connections between 
diabetes care and a broader health agenda, and therefore that this thesis might provide 
contributions which could be applied beyond the diabetes domain. 
2.1.1 Fish’n’Steps 
Later chapters will discuss barriers to adoption resulting from diabetes apps which are dependent 
on manual logging to gather data and offer in return standard graphs and charts of this collected 
data. Fish’n’Steps (Lin et al., 2006) was influential for this thesis as an early example of 
combining automated sensor-based tracking combined with methods of visualizing data in an 
intuitively understandable manner. It also directly relevant for the goals of influencing user 
behaviors as well critical investigation of the potential affective impact of visualized personal 
data. In this study, the authors linked virtual fish on public and private monitors to pedometer step 
counts to encourage increased physical activity. Animated fish responded to the user’s logged 
steps by growing in size, transitioning through stages of development, and changing facial 
expressions. The fish’s environment also reflected user activity through cleanliness and added 
virtual features. The researchers hypothesized that a visual representation of real-world behaviors 
and the ability to influence an avatar through deliberate actions could help to build a sense of 
empowerment and thereby further support positive behaviors beyond the virtual environment. 
Two versions of the game were implemented, one with a solo fish, and a second with a shared 
tank, where fish could also be viewed in comparison to other fish, which served as a social 
motivator. While the positive facial expressions were noted as motivating, in some cases the 
‘unhappy’ fish could be demotivating, leading to reduced engagement. This counter-productive 
aspect of negative reinforcement, and the implications for interface design will be discussed 
further in Chapter 5 in relation to diabetes apps, where I found that the viewing of out of range 
data could be discouraging for some users. Similarly, the authors reported that the social aspect 
could be motivating or demotivating depending on context, a finding which is potentially relevant 
to medical applications where ‘do no harm’ is especially important. The authors also noted that 
the game was not successful at maintaining long-term engagement, although causality was 
inconclusive. This study provides evidence that there are considerable challenges to integrating 
gamification as an intervention within the health context. At the time of this thesis, more than ten 
years later, there are still relatively few examples of successful implementation of game elements 
within diabetes apps. Therefore, it remains unknown to what extent introducing competition and 
virtual rewards systems is suitable for the long-term requirements of diabetes management. I will, 
in a limited manner, discuss findings related to gamification elements in Chapter 5. 
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2.1.2 Adoption of behaviour change theory into interaction design 
Fish’n’Steps was also notable for adopting aspects of behavior change theory from cognitive 
psychology into digital interventions, which will be further explored in Chapter 6 when I propose 
an expanded cognitive model for analyzing and designing diabetes decision support systems. In 
this study, the authors attempted to apply the Transtheoretical Model (TTM) to validate the 
positive long-term effects of their approach. TTM proposes that individuals progress through a 
series of six progressive stages from not being ready or aware of a problem (pre-contemplation) to 
having the new habit so ingrained that there is no longer danger of relapse (termination). 
Interventions can therefore be tailored for the specific needs of each individual stage. The 
individual’s confidence that they can handle a specific situation (self-efficacy) also plays an 
important role in this model. The authors proposed that digital interventions might allow the use 
of such techniques without the extensive clinical resources traditionally needed for a TTM based 
intervention. Additional concepts were also taken from behavior theory literature, including 
building a sense of control through the care of the virtual pet (internal locus of control), goal 
setting, and social influence through sharing the ‘fish tank’ with other participants. At the 
beginning of the Fish’n’Steps study, each participant was interviewed to assess stage along the 
TTM. Lin et al.  reported that those in the middle stages of TTM were most likely to have the 
greatest change in behavior. The authors claimed that 14/19 participants either advanced stages in 
the TTM or increased step counts, therefore validating the approach. Those assessed in the lower 
stages at the beginning were most likely to progress in their willingness to change, but not their 
step counts. Those in the middle stages were most likely to change behavior and actions, and 
those with habitual exercise patterns were least likely change in either respect. Although the 
sample size could be too low to validate the conclusions, this study helped to support the use of 
theory in designing and assessing digital behavior change interventions. Such stage-based theories 
might be especially relevant in designing adaptive systems that personalize interactions, 
determining the most appropriate intervention to bring about a desired outcome. For example, 
interventions for those in pre-contemplation level might focus on education and awareness of 
state, while those in more motivated stages might be more actively encouraged by the UI to 
engage in specific behaviors. While not disputing the validity of such stage-based approaches and 
recognizing the importance of their inclusion in comprehensive interventions, this thesis and in 
particular Chapter 6 build upon the more cyclical approaches discussed in 2.1.6 and 2.1.7. 
2.1.3 UbiFit Garden: Positive rewards and activity recognition in a mobile context 
Similar to the previous study, UbiFit Garden is relevant to this thesis for its early use of mobile 
technologies for systems of automated data collection and situated and intuitive data presentation. 
UbiFit Garden (Consolvo et al., 2008) used a garden metaphor to motivate healthier behaviors. 
This study used a mobile phone with color display, linked to a prototype wearable for automated 
tracking and activity classification. There was a companion app that while automatically 
collecting data from the wearable, also allowed manual journaling, reviewing, and editing of 
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collected personal data. This app also placed a glanceable display on the home screen, with 
flowers that rewarded the user by growing in response to physical activities and butterflies to 
indicate goal attainment. The system made use exclusively of positive reinforcement, visually 
rewarding for behaviors such as exercise or journal entries, while avoiding the potentially 
discouraging negative reinforcement noted in the previous study. The flowers were also 
responsive to varied user actions, with different flowers being achieved for various encouraged 
activities, such as aerobic exercise or walking. While this study was only conducted for a 
relatively short period, users were positive about the interface and reported the virtual rewards as 
motivational. Users were also positive about automated activity sensing, although some users 
were irritated by the systems inability to record and reward exercise that the system could not 
classify. The study noted that the ability to manually correct activity logs was therefore an 
important feature. This study draws attention to an important challenge for health management 
systems in finding the right balance between automation and user engagement as well as how the 
display of information in non-traditional ways could encourage behavior change. 
2.1.4 UbiFit Garden: Goal setting and motivation 
A second UbiFit Garden study (Consolvo et al., 2009) demonstrated how theory taken from 
psychology literature can form the foundation for a mobile app-based intervention, an approach 
which offers guidance for future application of the model proposed in Chapter 6. Using the 
previously discussed Ubifit mobile app, the authors explored the potential for goal-setting in a 
persuasive technology context.  Adopting Locke and Latham’s Goal Setting Theory (Locke, 
1968), the studied focused on two aspects of the intervention: who should set the goal (goal 
sources), and the time-period to achieve the goal (goal timeframes). This theory describes the 
ways in which different types of goal setting can affect performance, asserting: specific goals 
outperform overly general goals; goals should be ambitious, but not too difficult to attain; and that 
incentives should not be too closely linked to achievement, as this can be de-motivating when not 
viewed as attainable. It was reported that participants overwhelmingly chose to self-set goals, as 
opposed to externally set options, although customized goals from a qualified expert appealed to 
many. While this paper did not report how different goal-setting strategies directly affected 
performance, by exploring user preferences and willingness to engage in different methods of 
goal-setting it contributed useful guidance to implementing such strategies in future systems. 
While this thesis does not directly engage with this theory, these findings are relevant to the 
reoccurring research themes related to motivation and user autonomy. 
2.1.5 Increasing  awareness through data interaction: The Quantified Self  
While not necessarily diabetes specific, another body of literature relevant to this thesis emerges 
from the Quantified Self (QS) movement, as this early adopter community has often been at the 
forefront of the use of emerging technologies to record, collect, integrate, and analyze diverse 
personal data. The Quantified Self movement’s goals are often related to optimizing lifestyle 
behaviors such as diet, sleep, and exercise which are all directly relevant to diabetes management 
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(see 2.2.2.2). In addition, the early adopter and technology proficient aspects of this group 
generate knowledge on emerging technologies which could inform the design of more 
comprehensive diabetes-oriented systems. The Quantified Self movement often operates under the 
premise that the process of collecting and reflecting on personal data will lead to increased self-
knowledge and thereby lead to the formation of more desired habits (Li et al., 2011). QS also 
promotes methodical recording, as it allows greater opportunities to discover important 
correlations than when relying on biological memory. In addition, Li et al. also emphasized the 
value of manually recording such data to increase awareness and engagement; however, as will be 
discussed later in Chapter 2.4 this aspect of QS can be problematic within certain requirements of 
diabetes management such as the non-elective and continuing nature of care, the non-
predictability of outcomes, and the emotional impacts associated with disease complications.  
2.1.6 QS and models of understanding how people make use of personal data 
One of the principal paths of inquiry of this thesis is how diabetes apps can increase the utility of 
personal data. Relevant to this need, Li et al. (Li et al., 2011) provided frameworks that describe 
how people interact with their personal data and their use of supporting technologies. Li et al. 
proposed two modes: discovery and maintenance, noting that people transition back and forth 
between these states. In the former, people were actively asking questions, trying to establish 
cause-and-effect relationships, and goals. In contrast, in the latter they were primarily trying to 
maintain behaviors, or the steps needed to achieve established goals. Discovery phases are marked 
by an increased willingness to engage in effortful reflection on personal data, and thus require 
tools that assist in the collection and merging of data. In contrast, in maintenance phases the tools 
should primarily be for alerting the user when goals are not being met, and to assist in finding 
factors that could assist with goal achievement.  The authors also note that in the case of long-
term conditions many of the goals, such as maintaining glycemic stability, become clear over 
time, leading users towards more maintenance, and decreased discovery phases. This proposed 
dual process model is quite similar in structure to the following section, though the Mamykina et 
al. framework has been more explicitly tailored to the diabetes use case. 
2.1.7 A theoretical framework of sensemaking in diabetes self-management  
Mamykina et al. (Mamykina et al., 2015) proposed a sensemaking framework for diabetes self-
management which forms the foundation of inquiry for Chapter 6. Mamykina et al. propose a 
framework for how individuals use and understand self-monitoring data for assisting in chronic 
condition management. Similar to Li et al. (Li et al., 2011), this framework emphasizes the 
cycling between two modes, habitual and sensemaking, (the first term being similar to what Li et 
al. referred to as maintenance and the second discovery). This framework also defines three 
sensemaking activities: perceiving new information related to condition, understanding this 
information, and actions based on this information. The authors note problem-solving as an 
essential aspect of diabetes self-management, drawing attention to how such skills allow 
individuals to understand and overcome barriers to better self-management practices. It is also 
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asserted that many of the most popular cognitive and behavioral theories used for designing 
digital interventions for self-management focus on motivating and controlling behaviors; 
Mamykina et al. in contrast, suggest how individuals can grow to understand their own condition 
and construct personally significant self-care mental ‘models’ that explain how a given behavior 
leads to a specific outcome. For example, such a mental model might involve that a particular 
breakfast cereal leads to a predictable and dramatic rise in blood glucose levels, and therefore 
should only be eaten before exercise. Once enough of these self-care models have been validated 
and learned, they can be used to guide future actions in a reflexive manner. As this knowledge is 
personally relevant, validated, and internalized through a learning process, this aligns well with 
this thesis’ perspective of supporting user autonomy. This framework also addresses the dynamic 
nature of diabetes self-management, and in contrast to more stage-based models, there is no end 
stage of accomplishment. This reflects that individuals must constantly assimilate new 
information and must continually find new solutions to situations that do not fit within previously 
constructed mental models. As the sensemaking mode is analytic in nature, it is inherently 
effortful as individuals seek to create mental models that explain situations. In contrast, the 
habitual mode accesses these pre-existing models, and is therefore of low-cognitive effort. Both 
sensemaking and habitual mode make use of three activities: Perception, the acquisition of new 
information; Inference, creating or using a model; Action, the carrying out of a response.  The 
following figure (Figure 2-1) visually represents these interactions: 
 
FIGURE 2-1 REPRESENTATION OF MAMYKINA ET AL’S (MAMYKINA ET AL., 2015) SENSEMAKING FRAMEWORK  
 
The sensemaking/habitual framework in Figure 2.1 is also similar to Kahnemann’s (Kahneman, 
2011) proposal of System 1 and System 2 thinking, with the former being fast, instinctual, and 
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low effort, while the latter is effortful as it cannot draw upon an existing model or solutions, and 
must create new ones. Kahneman sees both systems as essential, as System 2 requires too much 
time and energy to be in continuous use, however System 1 is prone to common errors or biases. 
This is reflected in Mamykina’s framework as well, as continual application of the sensemaking 
mode would be incompatible with the demands of everyday life. Similar to Li et al., Mamykina et 
al. also emphasize the value of recorded data to correctly formulate new mental models; as 
memory is prone to errors, individuals might have difficulties remembering the correct 
information to create accurate new mental models. However, this binary approach does not offer 
guidance for how an intervention might keep users engaged enough to overcome cognitive biases 
while still decreasing cognitive load sufficiently for frequent interaction. Chapter 6 suggests an 
expanded non-binary model which I term Fluid Contextual Reasoning. This expanded framework 
proposes that in certain diabetes care situations, many people make use of a reasoning process that 
allows them to engage with complex data and situations through application and adjustment of 
previously learned self-care heuristics, thereby reducing the cognitive load demanded by System 2 
(sensemaking) processes. This chapter also suggests how this research could be applied to analyze 
existing approaches and suggests a path forward for the development of more user-centered 
approaches.  
2.1.8 Moving beyond reliance on reflection with next generation approaches 
While the approaches proposed by Li et al. and Mamykina et al. in the previous section have 
relied heavily on the user engaging in active reflection of personal data to establish internalized 
models, section 2.4 will discuss certain limitations to this approach for diabetes management, 
implying the need for systems that can provide additional cognitive support. Intille (Intille, 2004) 
suggested an alternate and more active approach using sensors and mobile technologies to provide 
‘just-in-time’ reminders to promote healthier behaviors. This paper focused on how such 
technologies could assist in preventative medicine with text messages. Despite evolution in 
technology such as more graphic UI design, the essential concepts expressed are still relevant to 
current system design. This paper proposed that a system capable of monitoring everyday 
activities could offer suggestions to assist the user in key situations, thereby influencing actions. 
Intille offered four components for motivating behavior change:  
1. Present a simple message that is easy to understand. 
2. At just the right time. 
3. At just the right place. 
4. In a non-annoying way. 
Interestingly, this work predates much of the more reflection-based research (see section 2.4) and 
offered over a decade ago a recipe for more active integration of computing systems into the 
decision-making process. However, Ohlin and Olsson (Ohlin and Olsson, 2015), recently noted 
that while personal data collection and visualization is easily accessible with current generations 
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of wearables and apps, next-generation systems with decision support are still largely lacking 
from the consumer space. The authors note that the model of personal informatics advanced by Li 
et al. depends on users acting as rational actors, which is often not the case. In order to assist users 
in daily life, the authors suggested a series of relationships between users and intelligent 
computing systems: cooperative, in which humans and computers work together, combining the 
best skills of each; augmented, in which computers enhance human abilities in realms such as 
memory, motivation, and decision making; and ambient, where the system senses and acts 
independently. The authors suggested building a sense of shared purpose between the system and 
the user, and then tailoring these relationships to given situations. Other key features suggested 
for such systems include:  
• Real-time contextually aware feedback grounded in past performance. 
• Exploring ways of including the user in automatic data collection to increase engagement. 
• Allowing users to give feedback to the system to allow the system to adapt to user desire. 
• Mutual establishment of goals. 
This more active integration of ubiquitous computing capabilities into disease management, 
especially concerning the reduction of cognitive stresses associated with frequent decision making 
is a major concern of this thesis. Methods of advancing such approaches inform the approach of 
Chapters 6-8 which discuss the previously mentioned cognitive model, user concerns related to 
use of such systems, and a card-based method for working with stakeholders to reflect on 
ubiquitous computing systems. 
2.1.9 Ethical values  
Despite the limitations (discussed in 2.4) of reflection-based approaches to supporting chronic 
disease management, there are distinct benefits in seeking to empower the user to engage in 
independent learning and decision-making. A more active decision support system, as suggested 
by Intille and Ohlin and Olsson could require the use of automated monitoring and an overt 
intervention into the decision process, which can introduce a range of ethical issues. Meredith and 
Arnott (Meredith and Arnott, 2003) proposed that the work of Beauchamp & Childress 
(Beauchamp and Childress, 2001) on bio-ethical principles form a reasonable foundation for 
decision support systems. These include: 
• Autonomy: respecting right of the individual to make independent decisions regarding 
their own welfare.  
• Non-maleficence: avoiding within one’s capabilities causing harm to others.  
• Beneficence: maximizing benefits to others while balancing costs and risks.  
• Justice: equitable distribution of costs, risks, and benefits.  
Meredith and Arnott asserted that as a system becomes more capable of learning through 
experience, responsibility of action becomes more difficult to assess, and that as these systems 
replace human decision makers, ethical responsibility becomes difficult to assign. Maintaining 
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user autonomy with such technologies is also concerning, and such systems raise critical concerns 
respecting the right of an individual or group to self-determination. Given the user-centered 
perspective of this thesis, these concerns will be explored further in 2.5, as well as forming an 
important framework for continued investigations. 
2.2 Diabetes General Knowledge  
The previous section discussed literature which, while foundational to this thesis, had often 
focused on more general support of healthy behaviors such as increased daily exercise. While 
such behavior change interventions are generally beneficial to supporting diabetes care there are 
research issues whose relevance to T1 diabetes is difficult to appreciate without basic knowledge 
of the essentials of diabetes management. Therefore, to provide a foundation for understanding 
the context for the research, the following sections will present a general overview of: diabetes, 
diabetes self-management practices, and relevant diabetes technologies. Those already familiar 
with these topics may wish to skip to section 2.4. 
2.2.1 Type 1 and Type 2 Diabetes 
Type 1 diabetes (T1D), the primary focus of this thesis, is a popular and prevalent ubiquitous 
computing target as the estimates of people in need of assistance are in the tens of millions 
(Aguiree et al., 2013). It is also a compelling test case for mobile health interventions as blood 
glucose levels are responsive to individual decisions, allowing the effectiveness of a given 
intervention to be quickly measured at relatively-low cost. In addition, while the diabetes 
treatment regime of multiple daily insulin injections and blood glucose (BG) tests are disease 
specific, the essential lifestyle guidelines are highly generalizable for general health even for 
those not affected by diabetes.  
It is important to note that there are several forms of diabetes, with Type 2 diabetes (T2D) being 
the most common. It is often related to lifestyle, and especially in early stages, can often be 
treated with changes in diet and exercise (Force, 2006). Nonetheless, many do not manage to 
adjust, and the majority of T2D patients will eventually require insulin to control blood glucose 
levels (Home et al., 2014).  In contrast to T1 diabetes, generally T2 patients continue to be 
capable of some insulin production, though they either produce insufficient quantities, or become 
resistant to the insulin they produce. Therefore, T2D patients can, in some cases, be treated 
through lifestyle alterations such as increasing exercise, altering diet, or losing weight. In contrast, 
Type 1 diabetes, which afflicts 5-10% of people with diabetes is caused by the body’s immune 
system rejecting the beta cells in the pancreas which produce the hormone insulin. While lifestyle 
alterations are important for management, and can reduce insulin requirements, diet and exercise 
cannot cause insulin to be produced, which must therefore be administered. Despite years of 
research and multiple approaches into biological cures for T1 diabetes, cell implantation remains 
costly and problematic as it still requires the use of immunosuppression medication (Pellegrini et 
al., 2016).  Therefore, daily use of insulin is required to stabilize BG levels. Before the 
identification of insulin in 1921, type 1 diabetes was invariably a fatal condition, and even with 
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advances in treatment, side effects can still be severe. Long-term complications related to 
habitually elevated BG (hyperglycemia), can include blindness, kidney failure, nerve damage, and 
death, while short-term complications caused by severely low blood glucose levels 
(hypoglycemia), can include shaking, sweating, unconsciousness, seizure, coma, and in rare cases 
death (McGill and Ahmann, 2017). However, unlike some chronic health conditions, diabetes can 
be successfully managed, blood glucose levels stabilized, and complications minimized with a 
carefully controlled lifestyle and the correct use of medications (Aguiree et al., 2013).  
While there are certain important overlaps between T1 and T2 treatment as both are concerned 
with stabilizing blood glucose levels, there are also important distinctions. Given the broadness of 
the domain and for purposes of specificity, I found it expedient to limit this thesis to T1 diabetes. 
Therefore, while many of the findings within this thesis might be applicable to T2 individuals, 
such an assertion could not be made without additional research. 
2.2.2 Diabetes Management 
Diabetes management is the process whereby appropriate behaviors, medications, and 
technologies are used together with specific strategies and problem solving to control glycemic 
levels (Educators, 2009). While the clinician can play an important role in supporting care, 
effective daily management of diabetes relies primarily on the individual’s habits and 
management decisions (Funnell and Anderson, 2004). While monitoring in general, and blood 
glucose monitoring specifically is an essential part of this process, it only of benefit to the extent 
that it informs and brings about better treatment decisions (Klonoff, 2007). Glycemic goals are set 
according to diverse factors such as age, duration of diabetes, life expectancy, hypoglycemia 
awareness, and context. Therefore there are no definite numbers, though common goals might be 
a fasting capillary plasma glucose 80–130 mg/dL (4.4–7.2 mmol/L) and a peak postprandial (after 
eating) capillary plasma glucose  <180 mg/dL (10.0 mmol/L) (American Diabetes Association, 
2018). Another commonly used metric is A1c (or HbA1c), a standardized measurement of 
average blood glucose over the preceding months, with higher A1c associated with higher 
mortality and near normal A1c’s associated with long-term cardiovascular outcomes similar to 
non-diabetic controls (McGill and Ahmann, 2017). However, the diabetes management process 
can be difficult to maintain, and many individuals fail to meet clinical guidelines, such as 
achieving a standard target A1c of  < 7.0% (Miller et al., 2015). It has been estimated that 60% of 
patients with chronic conditions do not strictly follow medical advice, due to multiple 
determinants such as self-efficacy, complexity of treatment, and disruptions to normal schedules 
(Dunbar-Jacob and Mortimer-Stephens, 2001). In practice, achieving diabetes management 
guidelines depends on self-monitoring blood glucose levels and lifestyle factors multiple times 
per day, analyzing this information, and dynamically adjusting numerous factors accordingly 
(Klonoff, 2012). Therefore, as alluded to in the introduction, effective diabetes management is a 
continual and actively engaged process and is not just about following a set of static instructions.  
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2.2.2.1 Framework for patient empowerment 
Given the aforementioned challenges many people with diabetes have in following medical 
recommendations and achieving recommended targets, it is pragmatic to question further why this 
is systematically occurring and how systems can be developed to function better with actual 
patient capabilities. Funnel and Anderson (Funnell and Anderson, 2000) (Funnell and Anderson, 
2004) provide a framework for understanding these conditions and based on this analysis 
advocate for a patient-empowerment perspective. As their work is foundational to this thesis, 
some of their key points will now be reviewed:  
• Much of traditional medical services are focused on acute care, where the medical 
professional bears responsibility for diagnosis, treatment, and outcomes. This approach 
assumes patients should follow medical advice, and therefore emphasizes ‘compliance’ or 
‘adherence’ to a doctor-controlled treatment regime. However, this approach is often 
unrealistic for diabetes, and regularly fails to function within the realities, trade-offs and 
demands of the individual’s life.   
• The vast majority of diabetes care must be conducted by the patient or caregiver, so 
clinician centered approaches are inherently limited. Therefore, while interactions with 
the medical professional are important, it is the choices during daily life which determine 
the long-term outcomes of people with type 1 diabetes.  
• A more patient-centered approach is better met with a more collaborative and 
empowering relationship, that emphasize the role of the professional in assisting the 
patient in making better informed decisions in meeting their own individual goals, with 
the patient taking primary responsibility for daily treatment decisions.   
• While a doctor might be an expert on diabetes care in general, every individual best 
understands the situations of their own life, emphasizing the need for people with diabetes 
to take primary responsibility for their own care and lifestyle choices.   
These points establish the foundation for this thesis’ focus on supporting self-management 
practices. The next section will further discuss various aspects of this process. 
2.2.2.2 AADE7 Guidelines for self-management 
The American Association of Diabetes Educators recommendations or ‘AADE7’ provide an 
evidence-based and widely accepted program for effective self-management of diabetes 
(Educators, 2009). These include: 
• Healthy eating: Appropriate food choices and portions are important for daily care. 
Diabetes management depends on being able to predict the amount of insulin required for 
a given serving, how quickly a given food will cause BG levels to rise, and avoidance or 
moderation of foods that cause glycemic instability. 
• Being active: Regular exercise can improve glycemic control and reduce insulin 
requirements by lowering body mass, reducing stress, and improving insulin absorption. 
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It is also important for reducing the long-term cardiovascular and other risks associated 
with diabetes. 
• Monitoring: Daily measurements of BG levels provide information to help those with 
diabetes assess and adjust treatment. Other self-monitoring, such as blood pressure and 
weight can also be recommended for some individuals.  
• Taking medication: Insulin injections are essential for living with T1 diabetes, which is 
a fatal disease without this treatment. Insulin in the body must be kept in sufficient 
quantities to meet minimum requirements to reduce long-term complications, as well 
maintained within certain thresholds in order to avoid severe short-term complications. 
Effective use of insulin can significantly reduce the long-term risks associated with 
diabetes. Many people with T1D require additional medications to mitigate diabetes 
related complications, or other related conditions. 
• Problem solving: Due to the multitude of factors which can affect BG levels, people with 
type 1 diabetes must quickly make decisions related to medication adjustment, treatment 
for hypoglycemia, dietary choices, exercise and other lifestyle factors that can affect 
management. Even with ‘tight’ management and years of experience there are continual 
challenges in glycemic control. These can be related to changes in health, lifestyle, 
environment, and other hard to control factors. Effective management is therefore 
dependent on continuously finding workable solutions for variable situations. 
• Healthy coping: Psychosocial factors can play important roles in the ability for 
individuals to maintain health and can directly affect the motivation required for daily 
diabetes management. Finding effective ways of managing stress and changing unwanted 
behaviors or habits are important aspects of long-term care. 
• Reducing risks: Lifestyle choices such as excessive alcohol consumption can have 
dramatic short-term effects on BG stability, while long-term behaviors such as cigarette 
smoking can increase the chances of long-term diabetes related complications. In 
addition, regular visits to medical services such as eye and foot exams, can help identify 
signs of degeneration allowing for timely treatment.  
Managing these factors and behaviors can be seen as the cornerstone of diabetes management and 
research, and to the extent that such behaviors are supported, can serve as a useful framework 
with which to judge digital interventions. For example, (Breland et al., 2013) used these 
guidelines to assess diabetes self-management apps, noted that few apps promoted more than two 
of these behaviors, and that none of the apps surveyed could be considered to support all the 
AADE7 recommendations. Similarly  (Eyler, 2013) found that while almost half of the apps 
surveyed supported monitoring (48%), only 5.7% supported healthy coping, although as to 
whether it is necessary for a diabetes apps to support all the AADE7 behaviors in order to be 
effective is an arguable assertion.  
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In order to learn the essential aspects of care, diabetes self-management education is 
recommended upon diagnosis and later as needed (Force, 2006). The AADE7 or other equivalent 
systems can be taught in an educator led weeklong course. Such diabetes self-management 
training and education can lead to improvement in long-term glycemic level (A1c) and improved 
quality of life (Reddy et al., 2016). And such programs might also be effective for reducing long-
term care costs (Educators, 2009). However, while there might be some consensus within the 
medical community as to acceptable long and short-term blood glucose targets, and various 
methods of achieving such control, diabetes management remains challenging for many. A recent 
study (Miller et al., 2015) comprised of people in active diabetes treatment in the U.S. found that 
in the 18-25 year range, recommended diabetes control targets were achieved by only 14% of 
respondents. Furthermore, while glycemic control improved dramatically as participants 
approached 30 years of age, still only 30% of T1D respondents >30 years of age reported meeting 
clinical bio-marker recommendations. Such results argue for the need for additional research, 
especially in regard to sustainable and affordable methods of supporting long-term daily care. 
Among the many challenges for interventions is that practical diabetes management can require 
the individual to adjustment to shifting contexts and varying biological responses due to factors 
such as the effects of exercise, stresses such as illness, and delays in insulin absorption (Peyser et 
al., 2014). In addition, there are different phases of treatment each with its own requirements, 
such as an initial learning phase, stabilization, re-learning, and then eventually transition to long-
term management (Blondon et al., 2013). While early stage diabetes education is essential, the 
primary focus of this thesis is on a later stage, where the individual has already learned the basic 
processes of monitoring and adjusting, and now settles into years or decades of maintenance. 
During this stage, the person with diabetes has considerable knowledge to draw upon but must 
still stay engaged to determine when and how to apply this knowledge according to shifting 
requirements. Therefore, this aspect of the thesis can be seen as an extension of earlier work on 
sensemaking processes (Mamykina et al., 2015), which will be explored in more detail Chapter 6.   
To allow the reader a more intuitive understanding of the blood glucose deviation which might 
occur with T1 diabetes, the following Figure (Figure 2-2) shows a 24-hour span of blood glucose 
values for a person without (top) and with diabetes (bottom). The units on the left show both 
mg/dL and mmol/L which are used interchangeably within this thesis. In addition, common 
factors that can affect glycemic state are pictured at the bottom. While non-ideal, the deviation 
pictured is not extraordinary. 
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FIGURE 2-2 NON-DIABETIC VS. DIABETIC GLYCEMIC VALUES AND CONTRIBUTING FACTORS 
 
2.3 Diabetes Technologies 
While the discovery and production of insulin changed type 1 diabetes from a terminal illness to a 
manageable chronic health condition, regulating dosages is both critical and challenging. Diabetes 
technologies have been essential in improving clinical outcomes and quality of life by assisting in 
this process. The following sections will review established technologies associated with diabetes 
self-management in order to give an overview of primary devices and their role.   
2.3.1 Blood glucose monitoring 
The early days of diabetes self-management relied on urine tests, which were limited in only 
being capable of indicating when blood glucose levels had reached a threshold where glucose was 
excreted through the urine. In addition such tests were unreliable as they were affected by fluid 
intake and being retrospective were incapable of indicating current glycemic state (Clarke and 
Foster, 2012). While blood glucose is a superior indicator, it wasn’t until the early 1980’s that 
glucose meters targeted for personal use became commonly available, and replaced inaccurate 
visually read strips (Clarke and Foster, 2012). Such meters allowed people with diabetes to get an 
unbiased assessment of current glycemic state, facilitating real-time treatment decisions on insulin 
dosages, hypoglycemia treatment, dietary choices, exercise, and other lifestyle factors (Klonoff, 
2012).  Use and frequency of such monitoring has been correlated with decreased A1c, and 
improved clinical outcomes (Klonoff, 2007). These meters have continued to evolve, and are now 
small, low cost, and commonplace. Many of these meters now offer on-board memory for storage 
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of previous readings, data export functions, and basic data analysis, such as mean BG levels.  
However, this technology has significant limitations, as tests rely on finger sticks to obtain blood 
samples and such tests only reveal current value, leaving gaps in time-series data. This can be 
seen in Figure 2-3 where the patient has recorded time, carbohydrates (1 KHE=10 grams 
carbohydrate), insulin, and blood glucose level, and yet there is no knowledge as to values during 
the many hours between measurements. This can be contrasted with retrospective data delivered 
by the device in Figure 2-4. 
 
FIGURE 2-3 DIABETES DIARY 
 
2.3.2 Continuous monitoring of blood glucose 
More recently, the continuous glucose monitor (CGM) has become adopted as a mobile T1D (and 
T2D) technology. It has a small sensor most often inserted into subcutaneous fat in the abdomen 
or upper arm and can be worn for between one and three weeks (see Figure 2-4). As these devices 
measure glucose in interstitial fluid and not directly in the blood stream, this can cause some 
delays in responsiveness to fluctuating BG levels in the 5-10 minute range (Peyser et al., 2014), 
though algorithms have assisted in reducing this discrepancy (Rodbard, 2016).  This newer 
technology offers multiple benefits over early strip-based systems. CGMs offer glanceable 
support for diabetes management decisions by showing trends and rate of change (Pettus and 
Edelman, 2016), allowing a shift from the A1c as a metric of glycemic control to time in range 
(70–180 mg/dL or 4-10 mmol/L) (McGill and Ahmann, 2017), as well as supporting more fluid 
management methods (Katz et al., 2018b). The CGM can also be equipped with a transponder 
which can alert the user when they are exceeding or falling below pre-set threshold levels. Such 
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increased resolution afforded by near continuous and automated recording of data allows for a 
more complete record of glycemic variation, which could be useful for providing greater insights 
on data through analytics and predictive modelling (Donsa et al., 2015). The CGM has been 
shown to be clinically advantageous, with benefits such as reduction in hypoglycemia and A1c  
proportional to frequency of usage (Rodbard, 2016),  Some CGMs, such as the Dexcom G5 offer 
Bluetooth data connectivity with a smartphone app, as well as incorporating cloud services to 
allow for real-time data sharing with other stakeholders, such as family members, friends, or 
medical professionals. A related device is the Flash Glucose Monitor (FGM) (seen in Figure 2-4) 
such as the Abbott Libre, which also has an inserted sensor, though lacking a signal transponder, 
the user must scan the sensor with a meter or NFC enabled smartphone to receive a reading and 
update of recent values. The more recent version of this devices is capable of sending a signal to 
warn of out of range values. Several implantable or patch-based sensors are also in development 
or have recently emerged onto the market, offering more convenient methods of monitoring and 
sharing BG data.   
 
FIGURE 2-4 LIBRE GLUCOSE MONITOR AND SENSOR 
 
The interface of the CGM (or FGM pictured in Fig. 2-4) offers not only the current BG level 
available on single measurement meters, but the continuous measurement and on-board recording 
of data also allow for a retrospective graphing of recent measurement and near term BG level 
prediction. This prediction is expressed as an arrow, showing direction and velocity of glycemic 
change.  Survey research has suggested that the use of the CGM increased frequency and 
percentage of insulin titration and improved glycemic control  (Pettus and Edelman, 2016).   
 27 
Respondents in this study were asked to assess a CGM interface with equivalent BG value, but 
with the arrows indicating a rapid increasing as opposed rapid decrease. With the rapid increase 
indicator (double arrows at 90° upward on a Dexcom CGM), participants suggested an 140% 
increase over their usual correction dosage. The authors note that this shifts the emphasis in 
diabetes management from ‘point-in-time’ to ‘anticipated’ glucose levels. This focus on the use of 
CGM for real-time use as opposed to retrospective analysis, is particularly relevant given the 
challenges in meaningful interpretation of the complex data sets which are relevant to diabetes 
management (Franc et al., 2011), and will be further discussed in Chapter 6. However, despite 
potential benefits CGM use can be impaired by user who are cognitively overloaded by the 
quantity of information, suggesting the need for new interfaces that can decrease data complexity 
(Borges Jr and Kubiak, 2016), which is further addressed in Chapter 7 with the implementation of 
an expanded data gathering infrastructure. 
2.3.3 Insulin pumps, digital pens, and other insulin delivery systems 
Currently there are limited practical alternative to daily injections of insulin for those diagnosed 
with T1 diabetes. While there have been some successes with biological cures, such as implanting 
insulin producing Beta cells (Pellegrini et al., 2016), this technique is not permanent and at this 
time still requires the use of powerful immunosuppressant drugs. Although there is an inhalable 
form of insulin, the high cost restricts widespread use. So, for the time being, injected or infused 
insulin will continue to be the standard treatment. The insulin pen allows for more convenient 
handling and injection of insulin over earlier generation syringes, with a cartridge that is replaced 
every 1-3 weeks. More recently, these pens have become digital, allowing automated recording of 
dosages, and in some cases connectivity through a dedicated smartphone app 
(http://www.biocorpsys.com/connected-injection-devices), although actual usage remains limited. 
Another widely adopted technology is the insulin pump, which better simulates the body’s natural 
production of insulin, through near continuous infusion. This externally worn device weighs 
approx. 100 grams and infuses a fast-acting insulin through a catheter inserted under the skin. The 
user must program dosage rates and notify the system for supplemental dosages (bolus) before 
meals or to correct for hyperglycemia. Though insulin pumps have demonstrated clinical benefits 
such as improved glycemic management and reduction in hypoglycemic events, they require 
motivated individuals who can maintain the device’s operating requirements (Pickup and Keen, 
2002). Insulin pumps and other diabetes devices are also becoming increasingly capable of data 
connectivity, allowing greater opportunities for data sharing and analysis. 
2.3.4 Hybrid closed loop or Artificial Pancreas (AP) 
The “artificial pancreas” or more expectation limiting “hybrid closed-loop system” aims to offer 
more responsive insulin delivery through the linking of a CGM, an algorithm and an insulin 
pump. This approach offers automated insulin dosage correction dependent on current glycemic 
state, thereby freeing the individual with diabetes from the burden of adjusting basal (non-
mealtime) insulin rates.  Early versions of such systems are in usage within patient initiative 
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groups that share source code through GitHub and instructions for setup through non-commercial 
websites (https://openaps.readthedocs.io/en/latest/index.html, n.d.).  There are reportedly >1000 
people using such self-built systems, with self-reported improvements in A1c and time in range 
(Barnard et al., 2018). Commercialized systems are now becoming available, such as the 
Medtronic Minimed 670G which can autonomously adjust insulin rates in response to changes in 
BG levels detected by an interfaced CGM sensor. However, despite the promise of this approach, 
there are factors which suggest that its development should not stop other research approaches, 
including: 
• Challenges in fully automating closed-loop systems due to confounding or hard to 
measure factors such as: exercise, stress, illness, carbohydrates, insulin absorption, and 
technical challenges involved with device integration (Peyser et al., 2014).  
• User dependency on fully automated systems could pose certain risks to user autonomy. 
Freed from the need for conscious reflection, users might not learn effective or accurate 
self-care models independence (Mamykina et al., 2015).  This could be problematic if 
systems were to fail for some reason. 
• The high costs and need for frequent maintenance of such systems as well as various 
psychosocial factors (Barnard et al., 2015) suggest that the closed loop might not be an 
ideal solution for all users. 
• The effect of diverse lifestyle factors on blood glucose levels offers broader implications 
for other conditions or situations where non-professionals must make use complex 
multivariate data to inform critical, frequent, and contextually specific decisions. 
At this time, these systems still require the user to manually enter bolus insulin dosages before 
meals, as the gap between rising BG levels, sensor detection, and insulin absorption can lead to 
consistent out of range values (Peyser et al., 2014), though it is possible that next generation faster 
acting insulins combined with improved algorithms for  automated meal detection  might lead to 
improved autonomous performance for such systems (Turksoy et al., 2016). In summary, while 
the AP is an exciting technology for assisting in daily management and could reduce the need for 
interaction with complex personal data, for the foreseeable future its limitations, and potential 
periods of malfunction or failure, suggest that it remains essential that users be capable of 
understanding and troubleshooting their own diabetes management process. 
2.3.5 Telehealth for diabetes 
The need for informed and multifaceted treatments decisions has led to significant academic and 
industry research focused on top-down tele-health systems. These systems depend on remote 
experts making treatment recommendations, either through accessing the patient’s data remotely, 
or through solely text-based communication. Among potential constellations include transmission 
of data from a health care professional to a specialist for consultation, with re-transmission of 
results, and transmission of data from patients to health care providers (Franc et al., 2011). Franc 
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et al. note that in the case of situated decision support, such a system will have too great a time 
lag, and therefore other support remains necessary. Franc et al. also note that at that time 
telemedicine had failed to show significant improvements in outcomes, and that the future was in 
systems that empowered the patients to take increased role in their diabetes management. One 
recent study claimed small but statistically significant clinical benefits in telehealth coaching 
approaches (Lorig et al., 2016). While an earlier study asserted (Ruston et al., 2012) that the 
clinical benefits of telehealth for T1 diabetes remain controversial, identifying three emergent 
themes related to patients concerns with adoption of these technologies into their management 
routine. These included concerns that involving others in daily management would interfere with 
autonomy, that existing health IT systems (NHS) were inadequate to provide such services, and 
that in-person interactions were necessary for care. Moore (Moore, 2012) suggested a somewhat 
alternative approach, whereby such technologies could be used to provide situated training in the 
model of ‘apprenticeship’. In this proposed model experts train the patient through a series of 
steps leading to independence through empowerment. These included scaffolding where the 
patient learns about their condition and the significance of their personal data, articulation where 
patients learn to discuss their condition, modelling where the coach demonstrates how to make 
decisions, coaching where the advisor focuses on timely nudges, and finally reflection and 
exploration, where the patient combines these lessons to make sense of their own data and 
outcomes. As such this could be seen as an adaption of more traditional self-care training 
program. However, with current infrastructure this approach poses economic and technical 
challenges related to scalability due to the prevalence of chronic diseases. Many health care 
systems are already overstressed and the added responsibility of continuously monitoring all their 
patients’ data could be problematic. While remote observation technologies are valid approaches, 
and might be cost-effective when supported with algorithms, expert advice does not replace the 
need for individuals to practice self-regulation. This is in no way meant to disparage 3rd party 
systems, and it is entirely possible that such systems will outperform purely algorithmic solutions, 
for reasons such as: flexibility of insights, human empathy, contextual awareness, or perhaps 
because human interaction has greater motivational affects. However, scalability and cost-
effectiveness of purely algorithmic systems, as well as the 24/7 nature of disease management 
argue for supporting the individual’s ability to make independent treatment decisions. Therefore, 
even if remote expert assistance systems are proven cost effective and superior to autonomous 
systems, developing technologies to assist in data acquisition as well as methods of supporting 
users in effective independent real-time decision making remains essential. 
2.3.6 Diabetes apps 
The multivariate and data driven aspects of diabetes management, entailing constant analysis, 
calculation, and reaction, make T1 diabetes an excellent candidate for further digital technologies, 
including the development of diabetes apps. This has been taken up not only by numerous 
academic researchers working in the juncture of HCI and medical informatics, but also robustly 
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by industry.  The following section reviews common features of these apps, reviews HCI 
contributions to type 1 diabetes apps, and clinical evidence concerning this approach. 
2.3.6.1 Common features of diabetes self-management apps 
As later chapters present research conducted to assess adoption and utility of popular diabetes app 
approaches, there will now be a brief discussion of these apps in order to establish a foundation 
for discussion. Diabetes apps have commonly included features such as: tracking and visualizing 
health information; integrating sensors to automate tracking; communication with support team; 
remote monitoring; social influence; peer support; accessing information; glanceable displays; 
and entertainment (Klasnja and Pratt, 2012). The ability to store BG data is often a defining 
feature of diabetes apps (Chomutare	et	al.,	2011), and such apps are for the most part based on 
the traditional paper diary paradigm (see Figure 2-3 Diabetes Diary), allowing users to collect, 
review, ponder, and share their personal data. Such systems are increasingly integrating data 
streaming from medical devices such as CGMs and insulin pumps, as well as sensors embedded 
in consumer electronics such as accelerometers and GPSs from exercise trackers, opening up new 
opportunities for further development. The total number of available diabetes apps is challenging 
to quantify due to varied interpretations of what constitutes a diabetes app, multiple platforms, 
and frequent new releases; however, a recent survey cited counts as high as >1000 diabetes apps 
on the Google Play store (Hood et al., 2016). The authors listed journaling/monitoring as the most 
common feature, with apps frequently supporting the recording of glucose level, medication, diet, 
and physical activity. The majority of apps still require manual input of BG levels, and only a 
limited number automate exercise recording. Some apps contain insulin dosage calculators, 
although Hood et al. cautioned that there is a lack of clinical validation for the majority of these 
apps. Data export features are common among apps that allow recording of BG levels. Automated 
adaptive interfaces, and algorithmically supported individualized decision support for T1D 
remains an under explored area, though at the time of the writing of this thesis increased decision 
support is starting to enter the market.  
2.3.6.2 Diabetes apps and HCI 
User-centred methodologies such as participatory design have been used to investigate features to 
integrate into type 1 diabetes self-management apps. Many of these studies have built upon earlier 
work on supporting data reflection practices. Examples include: 
• Mamykina et al. (Mamykina et al., 2008) investigated the use of a browser-based 
interface to assist T2 patients with collecting diverse personal data and disruptive 
experiences to assist with mediated discussion with medical personal. This approach 
resulted from earlier work (Mamykina and Mynatt, 2007) which had found patients often 
unable to make sense of collected data. Both systems made use automated transfer of 
blood glucose tests.   
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• O'Murchu (O’Murchu and Sigfridsson, 2010) and Storni (Storni, 2014) introduced an 
iPhone App TiY (Tag-it-Yourself)  that sought to encourage reflection in diabetes 
management with flexible types of attachments which could support greater contextual 
understanding. This app attempted to empower patients in their relationships and 
discussions with medical support teams, by encouraging the collection of a more holistic 
range of experiences and events related to disease management. Although tags could be 
reused, and such tagging has become common in apps, this method still requires sustained 
effort to collect and interpret collected information.  
• Smith et al. (Smith et al., 2007)  investigated the use of digital photography to aid and 
augment memory, which could facilitate visualization, interpretation and reflection on 
past events. Participants in this study recorded BG levels and meals, which were 
combined into a timeline creating a visual reference as to how a given meal could affect 
glycemic stability.  
• Owen et al. investigated how saved contextual information in the form of tags (Owen, 
2011) and more recently photos (Owen et al., 2015) could support problem solving by 
supporting participants in creating richer diaries for retrospective reflection.  
All of these examples can be seen as extending the paper logbook or diary approach with a shared 
assumption that the addition of new features for recording specific kinds of data will support 
diabetes management. One limitation of such research is that it typically occurs over a fixed 
period of time and therefore is not necessarily insightful into long-term engagement. The 
challenges to long-term adoption demanded by continuous data entry will be discussed further in 
section 2.4, and along with the cognitive and emotional demands placed by these primarily 
reflection-based  approaches, will be a reoccurring theme of inquiry throughout this thesis. 
2.3.6.3 Efficacy of diabetes self-management apps 
Diabetes apps are widely and easily available, on all major platforms (Hood et al., 2016). These 
apps have shown some general positive results in improving daily BG averages. Bonato et al. 
(Bonoto et al., 2017) found significant improvements in A1c in intervention groups using digital 
health approaches, especially in conjunction with access to medical personal. Wu et al. (Wu et al., 
2017) conducted a meta study that concluded that there were statistically significant 
improvements in A1c associated with app use (MD -.44), however such benefits were larger with 
T2 than T1 patients, and this study noted that current apps might not be adequate for meeting the 
complexity of T1D management. One study (Sheehy et al., 2014) looked at mobile apps for 
children and young adults with T1, and found only limited evidence for changes in self-efficacy 
and A1c. This study also noted the great difficulty in maintaining longitudinal use, and that PWD 
tended to stop using diary apps when they felt they had stabilized. In the juncture of medical and 
HCI, the Bant project (Cafazzo et al., 2012) set out to iteratively develop a diabetes smartphone 
app for younger users, which included design features such as wireless data transfer from a BG 
meter, gamification, decision support, and social network integration. This project claimed an 
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average increase of 50% in BG tests per day (from 2.4 to 3.6 per day, P = .006, n = 12) as a 
principal benefit, but detected no change in A1c. A Cochrane Collaboration study on the use of 
computer applications in conjunction with Type 2 diabetes care (Pal et al., 2013) found that 
mobile interventions may be more effective than desktop interventions, and that frequency of use 
was positively significant. This could support Intille’s assertion (Intille, 2004) on the importance 
of the situated delivery of the intervention. Another study surveyed the functionality of existing 
mobile apps (Chomutare	et	al.,	2011) and concluded that many apps at that time suffered from 
poor usability and lack of adherence to evidence based guidelines as expressed in the previously 
mentioned AADE7 behaviors for diabetes self-management. This was echoed in another study 
(Breland et al., 2013), which also noted that it would require additional research to define the 
optimal AADE7 behaviors to include in mobile interventions. And (Hood et al., 2016) recently 
conducted a review of studies on the effectiveness of diabetes apps for mobile health and found 
that much of the published research consisted of small feasibility studies rather than random 
controlled trials, and these studies showed small but statistically insignificant benefits. Of the 
control condition studies located, the authors noted that only one was significant, and suggested 
that more rigorous studies were required to establish clinical benefits, as there is a general lack of 
studies using rigorous medical research techniques.  
Current diabetes apps continue to show areas of limitation not only in demonstrating clinical 
benefits, but also in their ability to integrate into daily management practices. For example, while 
diabetes requires frequent engagement and critical decision making based on complex data 
(Klonoff and Kerr, 2018),  Arsand et al. (Arsand et al., 2007) noted in 2007 that diabetes diaries 
were most likely tools for periodic rather than daily use due to the challenges of maintaining such 
practices, and that self-recorded BG data is often incomplete and bias prone. Blondon et al. 
(Blondon et al., 2013) noted that the process of tracking health information can be burdensome for 
some, while (Mamykina et al., 2015) drew attention to the challenges in interpreting large 
amounts of personal data.  In addition, despite the diabetes paper logbook (see Figure 2-3 
Diabetes Diary) being a common clinical recommendation, it is also challenging to find clinical 
evidence that such continual diary practices improve glycemic control.  There are also notable 
challenges that must be overcome to monitoring in general, with barriers such as that information 
confronts established beliefs, demands undesired actions, reveals unsatisfactory progress, or 
brings about negative emotional effects (Chang et al., 2017).  So, while there has been 
considerable research into designing diabetes apps, the lack of clear benefits and considerable 
challenges argue for continued research, especially for new approaches. Now that we have 
reviewed diabetes, related technologies, and the existing evidence for efficacy, in the next section 
we will return to our review of literature directly relevant to the aims of this thesis. 
2.4 Next Generation Self-Management Approaches  
Despite the widespread embrace of diabetes apps for logging and reflecting on personal data, the 
evidence for the efficacy of this method is equivocal. Chapters 4-6 will present research that 
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suggest that there are inherent flaws with this approach related to cognitive effort and emotional 
impacts that point towards alternate approaches. In this chapter we return to more specifically 
computer science related literature to discuss a model for decision support systems based on a 
simplified feedback loop, and then use this as an organizing structure to discuss components 
which are relevant to the construction of a next generation approach. This will also be needed for 
Chapters 7 and 8, which are premised on the potential of such approaches. 
2.4.1 Foundations for next generation approaches 
In 1950 Norbert Wiener (Wiener, 1988) noted that in referring both to automata and living 
organisms one could define certain common features:  
• Sensory ability of external states, including the capability to detect the effect of one’s own 
actions. 
•  Means of processing this information for the purposes of decision making. Processing 
can either be reflexive as in an embedded system or can change based on learning from 
previous cycles.  
• Means of performing an action 
These components when linked together form a feedback loop, allowing a system to adjust its 
actions as it attempts to reach a goal state. In the following section, this feedback loop model is 
applied to consider potential aspects of diabetes management support systems, which could form 
a next generation approach. 
2.4.1.1 A feedback-loop approach for diabetes self-management 
The Wiener model is appropriate for a closed-loop approach, for example for an artificial 
pancreas where the system is capable of independent action, in this case regulating and 
administering insulin; however, for our purposed this model will be expanded (see Figure 2-5 
Decision Support System Cycle) to reflect an open-loop approach where the human must engage 
in action after considering recommendations or visualizations provided by an interface. Therefore, 
we now restate the previous model with a modification in categorization to better reflect the 
demands of this diabetes self-management use-case.   
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FIGURE 2-5 DECISION SUPPORT SYSTEM CYCLE 
• Data Collection: Blood glucose levels, activity, sleep, location and other contextual 
factors can either be logged by the user, or in the case of a more automated system be 
captured with sensors embedded in wearables, smartphones, or ambient sensors within the 
environment. 
• Analysis: The collected information can be processed by the user, a 3rd party, or through 
some combination of algorithms in order to locate correlations, predictions, or some other 
insights that might be useful in determining an appropriate course of action. 
• Interventions: Information can be delivered to the user through either a human agent, or 
directly from the system for example as text, data visualization, auditory, or haptic output 
through some UI. 
• User Action: The action that the user undertakes based on the intervention, such as a 
lifestyle modification, or alteration in medical treatment.  
The following sections will review for each of these four aspects methods, examples, and 
challenges of implementation. 
2.4.2 Data collection 
As reviewed in 2.3.6.2, user-centered computing research on diabetes management support has 
often focused on the benefits of self-monitoring and collecting personal data to increase 
awareness and engagement with this information leading to increased self-knowledge, such as 
(Storni, 2014) who explored the use of tagging to assist the user’s acquisition of additional 
contextual information, or (Owen et al., 2015) who explored the addition of rich information such 
as photographs for reflection.  Such diary practices can have the benefit of increasing self-
awareness and have been used for diverse conditions such as smoking cessation, weight loss, and 
mental health. Li et al. (Li et al., 2011) in discussing the tracking of personal behaviors, 
highlighted how automation of data acquisition potentially reduces engagement, asserting that 
during discovery phases, when users are actively involved in asking questions and trying to 
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understand correlations, more direct interaction with data can assist in the understanding that can 
be helpful for establishing beneficial behaviors. Automation can therefore inhibit such self-
knowledge.  
2.4.2.1 Barriers to adoption from manual data entry 
However, despite these aforementioned benefits of manual data collection, such practices can 
form a major barrier to long-term use, and that while this engagement can be important when 
people are attempting to understand interactions, during maintenance periods users are better 
served by only being distracted when their attention is required (Li et al., 2011). In addition, diary 
approaches assumes that individuals will be motivated to engage in extensive data collection, 
identification of patterns, and intentional modification of behaviors (Gouveia et al., 2016).  
While journaling approaches that seek to empower the user through engagement with their data 
are appealing, for long-term chronic care such manually recorded diaries are not only challenging 
to maintain, the data quality can also be questionable. Also, the multiplicity of factors, and 
therefore the vast amount of data that would be needed to fully understand cause and effect 
relationships, make this practice especially challenging. Cordeiro et al. (Cordeiro et al., 2015) 
examined food journaling, a small subset of diabetes relevant information, and found many 
barriers to continued and habitual use, such as effort, time, and monotony. The authors noted that 
while digital databases that allow convenient looking up of carbohydrate content and other 
relevant information seem like a valuable tool for assisting in easing this process, there are still 
challenges to adoption. Cordeiro et al. noted that a reference system that doesn’t include all food 
options could be frustrating, and even with those participants who had managed to become 
habitual with their logging, skipping even a few entries could lead to terminating journaling 
practices. Participants also noted social stigma, as logging in front of others could be 
uncomfortable. Arsand et al. (Arsand et al., 2007) used PDA’s and feature phones to explore the 
creation of diabetes diaries. They concluded that such tools would most likely be used 
periodically, and not on a continual basis. Mamykina (Mamykina and Mynatt, 2007) agreed, 
noting that meal diaries, while often recommended, are seldom maintained, and are best used for 
only as a limited intervention. A meta-study (Given	et	al.,	2013) looking at eleven published 
papers that compared diaries with automated BG meter readings, found that manual diaries are 
often unreliable, with many users over-reporting non-existent tests, and under-reporting out of 
range values. This paper concluded that this placed significant doubt as to the use of manually 
recorded daily diaries for treatment decisions. These factors suggest, that even though there are 
some benefits to manual data entry, and that comprehensive journaling might be useful for limited 
periods or to clarify specific events, decision support loops must seek to avoid dependence on 
manual data entry for longer-term diabetes management. 
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2.4.2.2 Automating data collection 
While current diabetes diary apps still rely significantly on manual data entry, a more automated 
approach is commonly advocated in the literature. Arsand et al. (Arsand et al., 2012) listed 
automated data transfer as a primary design consideration for diabetes mobile apps. Another study 
(Maniam and Dhillon, 2015) which looked at barriers to usage of diabetes self-management 
applications, emphasized the need for automating data entry to increase ease of use. While 
established diabetes technologies such as CGMs, connected blood glucose meters, and insulin 
pumps already offer the potential to automatically track glycemic levels and insulin dosages, there 
are many other life-style related sources of data that could also be tracked with existing 
technologies. The ubiquitous smartphone for example, has multiple sensors that could capture 
valuable health-related data. Trends like the Quantified-Self movement, general interest in health 
and wellness, and an epidemic of lifestyle related health conditions have pushed forward personal 
tracking into the mainstream. It is now common for people without clinical health conditions to 
own wearable devices that sense and record movement, sleep, pulse, and other biological markers. 
In addition, it is increasingly common for such devices to communicate data not only to a 
proprietary app, but also to Apple Health or similar aggregators, increasing the potential for more 
general analysis. 
2.4.2.3 Wearables and Sensors 
As it is recognized that the process of data collection can in general be difficult to maintain (Li et 
al., 2011), wearables and sensors offer the possibility to capture less biased data, as well as a 
greater quantity of data, which could be important for automated methods of data analysis. The 
primary attributes that can be measured with sensors include environment, acceleration, location, 
and physiological signals (Lara and Labrador, 2013). Not only can these signals be analyzed to 
perform activity recognition, additional activities can also be identified through their 
combinations. Lara and Labrador note that certain activities are distinctly more difficult to 
identify than others, such as whether the user is ascending or descending stairs, though certain 
complex activities could potentially be identified through combining multiple signals. Therefore, 
through networking multiple sensors, there exists the possibility of making devices more 
contextually aware. Milosevic et al. (Milošević et al., 2011) addressed the capabilities of Body 
Area Networks (BANs) to improve health through intelligent monitoring, and asserted that it was 
feasible to connect diverse health monitoring devices into a personal wearable system connected 
through a smartphone (which forms the basis for the approach taken in chapters 7 and 8). This 
paper also drew attention to the many challenges for context-aware sensing such as the great 
diversity of environments, and the range of physiological conditions that can exist among users, 
noting the range of technical issues such systems must address for effective implementation such 
as: sensor noise; node failure; multi-sensory data integration; battery life; context recognition; and 
filtering for relevance. Paradiso et al. (Paradiso et al., 2005) researched wearable sensors that 
could monitor cardiovascular conditions, using sensors that could be directly incorporated into 
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fabrics with standard processes, so as to minimize cost and invasiveness. While such systems are 
still limited, these technologies might, in the future, increase adoption by limiting social stigma 
and inconvenience, especially if they could harvest energy to reduce the need to charge batteries. 
Another study (Luštrek et al., 2015) looked at how smartphone sensors combined with an ECG 
monitor could detect many separate activities, such as working, sleeping, or being at home; 
however, detecting eating proved to be challenging, especially in the home environment, which 
does place certain limitations on diabetes oriented applications. The authors noted that audio 
could potentially be used, but that such continual monitoring created serious privacy concerns.  
2.4.2.3.1 GPS correlations for T2 diabetes 
Doherty et al. (Doherty et al., 2015) outfitted people with T2 diabetes with a CGM, GPS and an 
accelerometer. A manual journal was also used as a means of data collection for diet and other 
contextual factors not captured by sensors. The authors then attempted to find correlations 
between BG variability and collected location, movement, diet, and exercise data. While the 
authors successfully found correlations between BG and geographic/lifestyle data, these 
correlations were highly personal and could not be generalized between participants. Interestingly, 
diet and medication, often considered essential features for BG prediction, were less significant in 
explaining BG variations than locations and activities. The authors hypothesized that participants 
were capable of calculating medication dosages correctly for carbohydrate intake but were not as 
effective at calculating the effects of other variables. If this were true for T1 diabetes as well, this 
finding could suggest the viability of systems that could function without carbohydrate data, 
thereby opening the possibility of fully automated systems. The authors concluded that ‘time-
series analysis of data could assist in identifying risk factors personalized to the patient.’ While 
there were major limitations, in that study had a small sample size, was only over a 72-hour 
period, and was with T2 diabetes, it offers some support for the multi-device approach researched 
in Chapters 7-8. 
While multi-source tracking systems are not yet implemented for diabetes, the abundance of 
research and available products in this area indicates the technical feasibility of such an approach.  
However, well known issues of abandonment point to the need for qualitative studies to develop 
such systems properly, so that they fit into people’s lives in a non-intrusive and acceptable way, 
which will also be further explored in Chapters 7-8. 
2.4.2.4 Barriers to wearables and automated data collection 
Despite the potential benefits of wearable devices, there are considerable barriers to practical 
implementation both in regard to adoption and to practical limitations for existing technologies. 
For example, it is often observed that the duration of tracking device usage can be brief (Clawson 
et al., 2015). Harrison et al. (Harrison et al., 2015) looked at barriers to long-term use of tracking 
devices in the quantified-self context. The authors noted common barriers included inability to 
accurately track and record physical activities, poor capability for sharing data in a social context 
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across diverse platforms, and insufficient attention to aesthetics and comfort. While there might 
be greater user motivation in the medical context, there are still many considerations which can 
impact adoption. Pantelopoulos and Bourbakis (Pantelopoulos and Bourbakis, 2008) researched 
wearable bio-sensors in the medical context and that different stakeholders had different priorities. 
For example, decision support, comfort, aesthetics, and data security were judged to be higher 
priority for users than for physicians. In this study, many systems scored low on wearability and 
battery life, which could be important features for longitudinal acceptance. It is important to note 
that abandonment does not necessarily indicate that a technology has been unsuccessful. (Clawson 
et al., 2015) notes that abandonment can in some cases be viewed as a success of the technology, 
such as when users chooses to upgrade to devices with greater capabilities, for greater 
compatibility within a social network, or when people’s needs evolve over time. Given that 
people with diabetes can go through cycles where they have different requirements for care 
(Blondon et al., 2013), it is conceivable that a specific sensor equipped device could be applied 
which would then be discontinued once the problem had been identified, or if when a sustainable 
habit had been formed. However, if one accepts that diabetes is a continual process of adjustment 
and re-evaluation, then some degree of monitoring must be continued. Within this context, 
devices can only be effective if used, and therefore establishing methods of long-term engagement 
with monitoring devices is needed. 
2.4.2.5 Limitations of data collection automation for diabetes self-management 
While there are many benefits to automating data capture and recording, there remain substantial 
limitations in capabilities. Manual recording allows tracking of factors such as mood (Hollis et al., 
2015), which might be hard to otherwise capture. And for the diabetes, given that carbohydrate 
intake plays a crucial role in determining insulin dosages, such data is essential for advising on 
bolus injections. While there have been many attempts to mechanize calorie counting, such 
systems are often unwieldy. For example the GoCARB system (Anthimopoulos et al., 2015) was 
able to estimate grams of carbohydrate in meals within 20%. However, this required two 
photographic images from different angles, and a placed reference card. In addition, it would only 
work if foods on a plate were clearly segmented, placing limitations of such systems in real world 
conditions. The CalNag project (Kumar et al., 2016), used a cloud connected scale, database, and 
barcode reader to automate food diaries. While the authors described the system as ‘effortless’, it 
also seems limited in its application in uncontrolled environments. There are also many examples 
of mobile app databases to assist in calorie or carbohydrate counting, such as the Carbs & Cals 
app, however such systems still depend on situated selection of appropriate images. So, at this 
time, the logging of carbohydrates intake is an area that remains impractical to fully automate. 
Given these gaps, fully automated systems will need to find creative solutions to either persuade 
users to manually enter essential data, such as labelling for machine learning algorithms, or 
discover means of working with restricted data sets. 
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2.4.3 Data analysis 
The process of understanding diverse personal data can be challenging and using this data to 
inform better future actions is even more difficult. Automated data processing promises to 
increase the utility of collected data, bridging the gap between these records and high level 
knowledge (Banaee et al., 2013). In an app or support system primarily geared towards reflection, 
the data is often ordered by time to populate a graph or chart or alternately averaged and then 
graphically represented. In contrast, in the case of more active systems of decision support, the 
data could be processed to extract domain and context relevant insights, correlations, or patterns. 
As noted earlier (Klonoff, 2007), acquiring data in itself has no inherent value, it is only to the 
extent that it can inform or motivate better decisions that it is of use. Mamykina and Mynatt 
(Mamykina and Mynatt, 2007) emphasized that many existing health applications make the false 
assumption that individuals will be able to derive correct conclusions from their collected data. 
They also cautioned that users interpreting collected data are susceptible to confirmation bias, and 
therefore this data is often used to support inaccurate beliefs. In addition, many individuals are not 
interested in the data for its own sake, and would rather have access to easy to understand 
knowledge that can be applied (Meyer et al., 2014). In the interaction study discussed in Chapter 
5, I found that people with diabetes were able to understand diabetes related data within apps in a 
literal sense, i.e. they knew how to read through a diary and could explain entries. However, 
drawing actionable information from this data was often challenging, and for some users 
overwhelming, especially given the constraints inherent to current generation mobile devices. 
These arguments argue strongly for new approaches that better support users in obtaining useful 
knowledge from collected data.  
2.4.3.1 Calls within the literature for augmenting data analysis 
Given the rapid growth in new technologies for collecting and analyzing data and the great 
demand for improved and more efficient medical care, there are worldwide efforts to create AI 
systems that assist with diagnosis and treatment for health conditions. Such processing for 
decision support is a common theme within the literature, both for more general health and 
wellness and for diabetes specifically. Lazar et al. (Lazar et al., 2015) in studying abandonment of 
QS devices asserted that offering personalized and tailored advice could help with long-term 
adoption, as users quickly become uninterested in reviewing data.  Supporting T2 diabetes 
learning, Mamykina et al.  (Mamykina and Mynatt, 2007) asserted the potential benefits of 
tailored decision support with connected devices and algorithmic analysis, and more recently 
Mamykina (Mamykina et al., 2015) encouraged the development of tools that not only report but 
also assist in pattern recognition and non-obvious correlation discovery. And Klonoff  (Klonoff, 
2013) proposed that while some patients might have reservations about increasingly digital 
methods of diabetes treatment, such systems could help both patients and clinicians make more 
informed decisions. However, despite such calls, established diabetes apps are for the most part 
only capable of limited automated data analysis. For example, mySugr (mysugr.com) delivers 
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average BG levels, daily deviation, estimated A1c, and other summaries of recorded data. The 
primary tool for reflection is a table of recorded values and a line graph, which plots BG levels 
and insulin dosages over time (see Figure 5-3).  Similarly, OneDrop (Onedrop.today) offers color-
coded circles on a timeline, which scale to reflect entered values.  In both cases, the app offers 
limited support for understanding the implications of collected data. Therefore, there appears to be 
a discrepancy between user need and existing implementation. The following section reviews 
research that could help close this gap. 
2.4.3.2 Examples of automated analysis  
While fully automated mobile diabetes decision support systems for T1 diabetes self-management 
are still at the early stages of development, there is already significant academic research both in 
general health and in diabetes management exploring and supporting the viability of such 
approaches. The following paragraphs discuss a few of the many relevant examples. 
2.4.3.2.1 Lifestreams 
Hsieh et al. (Hsieh et al., 2013) developed the ‘Lifestreams’ software stack which merges diverse 
streamed personal data, assisting in finding correlations between behaviors and markers such as 
stress and diet. This open-source tool using a smartphone app, included modules for feature 
extraction from data, feature selection, pattern identification, and data visualization tools. For 
example, this system identifies the user’s mode of travel by combining GPS, accelerometer data, 
and Wi-Fi points. Other features included identifying important locations and integration of self-
reported data such as mood. Relevant features were then identified through correlation analysis 
and highlighted. Noted examples included the relation between exercise and stress, and behaviors 
that caused consistent changes in glycemic state, such as returning to school. The authors reported 
that the system had successfully identified patterns not otherwise identified by researchers, 
demonstrating the technical feasibility with such approaches.  
2.4.3.2.2 Insulin titration 
There has been some intriguing work with machine learning, to allow the app’s settings to adapt 
to the user’s past history.  A prototype app (Pesl et al., 2016) used machine learning to 
automatically adjust the user’s carbohydrate entries to better predict insulin requirements.  
Therefore, as long as the user was consistent in estimating meals sizes, the system would learn to 
make better predictions from previous results, even if the logged data was inaccurate.  While this 
system still relied on manual data, its ability to personalize algorithms offers an important path 
forward. 
2.4.3.2.3 Predictive analysis 
Continuing with this approach of augmenting glycemic records with data from additional sensors, 
Krintz et al. (Krintz et al., 2015) addressed the use of consumer wearables to predict glycemic 
variability. This study used exercise trackers and diverse mathematical algorithms, in the attempt 
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to correlate exercise with next day glycemic control, in a flexible and individualized manner. 
Even with devices offering only 24-hour summations of exercise, the authors claimed the addition 
of exercise data was helpful in predicting future glycemic variability. The authors concluded with 
a call for the further development of automated systems that dynamically adjust based on 
collected data. User-concerns related to the sorts of devices which might make up such systems 
form the basis of inquiry in Chapters 7-8.  
2.4.3.2.4 Behavior support loop approach 
While not explicitly diabetes related, Pejovic and Musolesi (Pejovic and Musolesi, 2014) 
suggested anticipatory mobile digital behavior change interventions (dBCIs) to make use of 
tracked data to support behaviors.  The authors investigated the use of smartphones to deliver 
timely interventions based on inferred contextual information from onboard sensors. For example, 
they proposed a system capable of predicting onset of depression from activity and interaction 
sensing, which would then suggest a likely positive behavior to offset this potential state, such as 
meeting a peer for social activities. Tool-effect modeling is also discussed, or the mapping of 
interventions to outcomes on an individual basis. They also addressed a potential dilemma with 
exploration vs. exploitation trade-off, or whether to use a proven intervention or experiment with 
a different intervention that might or might not produce better results. The authors caution that 
unknown interventions can have serious consequences, and therefore must be introduced 
carefully. The authors note that this can be addressed, at least partially, by the system first going 
through a period of latent learning, where the system observes behaviors, without offering 
interventions or rewards. This allows the system to learn and map individualized self-motivated 
interventions that have already proven effective in a given situation. This approach might be well 
suited to diabetes, especially in its to adapt interventions to shifting needs and contexts. The 
research conducted in this thesis to understand user concerns for monitoring systems, potentially 
contributes to the future development and deployment of such an approach. 
2.4.3.3 Patient resistance to automated advice 
Beyond the challenges of technical implementation of diabetes decision support systems, there are 
diverse other factors that must be considered. From a medical perspective, Klonoff  (Klonoff, 
2013) cautions that systems that deliver personalized advice, rather than generic knowledge, will 
face greater challenges in demonstrating system safety, and therefore will be more difficult to 
implement. Kanstrup et al. (Kanstrup et al., 2010) created a digital teaching tool to help PWD 
understand how their decisions would affect BG values. Initially the authors envisioned a 
metaphoric GPS model for interaction, which would indicate effective ‘routes’ for BG daily 
management. However, the authors quickly abandoned this approach, as their participants 
indicated they did not want to turn over control of their lives to a computer system. This implies 
that for at least some individuals, such systems must be perceived as complementary or 
cooperative rather than controlling, a finding supported by the user responses in section 8.7. 
Mamykina et al. (Mamykina and Mynatt, 2007) cautioned that ease of use and system trust would 
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be essential in establishing adoption.  And Skrøvseth et al. (Skrøvseth et al., 2015) developed an 
experimental diabetes smartphone app that attempted to deliver data-driven feedback by alerting 
the user to the outcomes of different medication dosages in similar past situations. This app failed 
to achieve clinically significant effects, and therefore was unable to demonstrate whether data-
driven feedback was effective in improving glycemic control.  
Such examples draw attention to the need to carefully research multiple aspects of such systems, 
from the paradigm of interaction, what sorts of insights might be of use, customization, and a 
detailed understanding of user requirements.  
2.4.3.4 Summary of data analysis 
While there are many examples in the literature of computing techniques to assist in data analysis, 
it will take effort to determine the most meaningful and potentially useful correlations to extract. 
Analysis of time series data is a well-explored area; however, finding correlations beneficial for 
lifestyle alteration might pose challenges. Due to the lack of carbohydrate data, this might 
necessitate shifting the system goals away from insulin titration, the primary goal of the artificial 
pancreas. Instead the goal might be to locate tendencies within recorded lifestyle data, which 
could support AADE7 behaviors and decrease glycemic variation, while improving time within 
goal glycemic ranges.  
2.4.4 Interventions: Interfaces and Experience  
Now that we have considered and discussed the use of and viability of automated data processing 
as an approach to reduce the barriers that stem from the reflection process, it is now important to 
consider how such insights are communicated from the system to the user. This next section 
discusses such concerns, in particular interface requirements, and theory that might be relevant to 
creating strategies of interaction.  
2.4.4.1 Intuitive/Actionable 
As discussed earlier, mobile systems offer specific benefits to delivering situated interventions 
when and where they are needed. When designing such mobile systems, one must consider not 
only the limitations on screen size relative to desktop systems, but also that users might have 
interaction expectations related to the device they are using. Harrison et al. (Harrison et al., 
2013a) noted that due to the mobile nature of smartphones leading to varied contexts of  use and 
restricted screen size, cognitive load is an essential factor to be considered in app usability. This is 
especially important as users expect the platform to reduce the stress of effortful thinking. This 
view implies that an app that requires excessive cognitive effort faces a major barrier to adoption. 
This also suggests the need for intuitive interactions, and given the challenges of visualizing 
multivariate data, implying a need to reduce visual complexity. Smartwatches might make such 
needs for simplification even more pronounced. Barr et al. (Barr et al., 2015) also support this 
view that intuitive interaction is an important component of mobile devices, highlighting the ways 
in which smartphones have become an extension of the mind. The authors drew attention to a 
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natural human tendency to seek to reduce cognitive load, and that the success of mobile devices is 
partly in the ability to in a situated manner respond to this need to reduce effortful thinking. This 
concern over cognitive stresses and decision making will be explored and discussed further in the 
research sections of this thesis.   
2.4.4.2 Visual design 
Visual design is important for both engaging the user and communicating content, which is 
reflected in heuristics for assessing mobile apps such as the Mobile App Rating Scale (MARS) 
(Stoyanov et al., 2015), which used aesthetics as a primary criteria, along with engagement, 
functionality, information, and subjective quality. Glanceability, or the ability to quickly inform 
the user of relevant information, could also be an essential feature for diabetes management apps. 
Gouveia et al. (Gouveia et al., 2015) note that as well as data being useful for recognition of 
patterns over time, self-monitoring can be useful for real-time feedback to control behaviors. To 
this end, the authors created an Android mobile app aimed at encouraging physical activity, 
through a tracker, goal setting, and encouragement. This app was placed on the play store for a 
10-month study aimed at better understanding user interaction. The authors found that glances, 
which they define as 5-second interactions for checking status, were the dominant activity, and 
suggested these could be an effective contribution to sustaining engagement.  
They extended this research with a series of prototype watch faces to investigate how to best 
design glanceable feedback, based on the assertion that watch faces are the most effective current 
means of providing frequent interaction. Through an iterative process, the authors designed a 
series of watch faces to explore physical activity tracking and motivation. They suggested that 
glanceable interfaces for behavior change should be:  
• abstract, to allow intuitive perception of data 
• integrate with existing activities, to promote easier and sustainable adoption (integrated 
with time checking by combining faces with temporal functions) 
• support comparisons to targets and norms, to allow immediate status feedback relative to 
goal 
• be actionable, to suggest helpful behaviors 
• have the capacity to lead to checking habits, to sustain continued interest 
• act as a proxy to further engagement, to challenge the user and encourage reflection by 
offering ‘aha’ moments.  
The authors also noted two approaches for building checking habits: 
• Novelty, whereby the interface offers new information to drive engagement 
• Scarcity, whereby information is only available for limited temporal periods 
The authors reported that during the 28-day study period, participants checked their watches an 
average of 107 times per day, with over 80% of interaction involving only a glance with no 
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further interaction. They noted that many participants reporting having checked their watch for 
time and then became motivated by the feedback to be more active. The watch face with an 
integrated social element was motivating when users had activity counts close to others but 
appeared de-motivating if they were too far behind. This finding complements earlier mentioned 
research, and implies that in more critical health interventions, social elements must be carefully 
implemented to avoid the risk of negative effects. The authors suggested one solution might be 
benevolent falsification, altering other participants’ step counts, to maximize positive effects, 
although once again within a more critical health context this might undermine system trust and 
therefore be counterproductive over the longer-term. Another approach to increasing interaction 
was explored with the watch face design ‘Tick Tock’, which explored scarcity by displaying only 
the previous hour’s activity levels. This design was successful in encouraging more frequent 
glancing and frequent bouts of activity, however some participants felt that this lack of cumulative 
credit for activity was de-motivating. This study suggested that watch face paradigms were more 
or less effective depending on specific targeted behavior, for example the hourly update was more 
effective for encouraging more frequent movement, while a daily goal-oriented design was more 
effective for meeting a daily target.  
This research suggesting that it might be beneficial for interfaces to trigger specific behaviors in 
response to different contexts and goals is an intriguing and underexplored area in app design. 
While I did not have time during this thesis to engage in such UI designs, the findings discussed 
in the research chapters offer detailed perspectives on user requirements that might help inform 
such approaches. Given that diabetes care must be addressed even when there are other demands 
on attention, this research on triggering beneficial behaviors with quick interface interactions 
appears especially relevant. Such research could offer guidance to both improving the app and 
user interface deficiencies discussed in Chapters 5 and 6, as well as for further developments of 
the findings of Chapter 6 which draw attention to supporting quick low-cognitive demand 
interactions within specific diabetes management contexts. The importance of context will be a 
reoccurring theme throughout this thesis and will therefore be discussed in greater detail in the 
following section.  
2.4.4.3 Context 
Previous sections have discussed not only the stage of the individual’s relationship with diabetes, 
but also the context of care. An important aspect of context is that individuals are not necessarily 
constant in their needs or desires. Models like the Transtheoretical Model (see section 2.1.2) 
imply that as people move through different stages of personal development their needs and 
capabilities change, and therefore an intervention that is effective at one time might need to be 
different at another (Hekler et al., 2013). With a contextual approach, a system can tailor 
interventions algorithmically, allowing for a more dynamic and targeted approach. There are 
many aspects to be considered in delivering the ‘right’ message to the user. Dey (Dey, 2001) 
noted: “A system is context-aware if it uses context to provide relevant information and/or 
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services to the user, where relevancy depends on the user’s task.” A diabetes or other chronic 
condition support system could potentially integrate location, time, past patterns, medical data, 
and events to predict the current needs of the user, not only in terms of what information is 
displayed, but also in terms of how it is displayed. Sensitive situations where privacy might be a 
concern, such as at work, on public transit, or on a date, could affect how users interact with 
personal data and therefore UI design might intelligently adapt to such situations. For example, at 
home the user might be willing to engage in more cognitively demanding interaction, and the UI 
could adjust with a more reflection-based display. Or the system could record when the user 
typically engages in greater interaction with data and give preference to those times for triggering 
more reflective behaviors. In contrast, in an alternate context such as driving the user has less 
attention to spare and the system might deliver only critical information with highly glanceable 
UI.  
Within the aforementioned research on diabetes apps, one approach has been to build app features 
that support manual contextual data collection. An example might be re-usable tags within a 
mobile apps (Owen, 2011), which once defined allow context to more conveniently recorded. 
However, this approach still requires the breaking of daily routine to record events and assumes 
that the user will know which events will become significant later. While at this time few diabetes 
or health-oriented apps are capable of contextual adaption, researchers are creating the foundation 
through work on situational awareness. For example, Sebillo et al. (Sebillo et al., 2015) built a 
mobile app which incorporated GPS data, thereby alerting the user to correlations between 
locations and glycemic states. The app could also provide helpful information derived from the 
user’s coordinates, such as the location of relevant emergency medical services when traveling in 
unfamiliar areas. Therefore, understanding the contextual needs of users and practical methods of 
designing systems that are sensitive to such needs could be critical for adoption and utility, and 
suggest the need for the domain specific research carried out in the following chapters. 
2.4.4.4 Emotionally sensitivity 
Diabetes management can be emotionally stressful, as interaction with diabetes data can cause 
some to feel burdened by anxiety over long-term physical deterioration, which can lead to 
rejection of supporting technologies (Blondon et al., 2013). And Chang et al. (Chang et al., 2017) 
noted that emotional impacts can cause individuals to avoid interacting with their personal data, as 
unwanted results can cause negative feelings and cause discouragement. This finding places 
specific barriers in diabetes care where unwanted test results can be frequent. Owen et al. (Owen 
et al., 2012) proposed that for those with diabetes,  stored contextual information could help to 
reduce the impact of measurements of unwanted BG measurement, by helping the individual to 
understand why a result had occurred. However, this approach was targeted primarily for 
mediating interactions with clinicians which play only a small part of total diabetes care. As 
discussed earlier, this approach also makes assumptions about user desire to continually record 
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information. This workload for uncertain daily benefits creates a significant barrier to longer-term 
adoption and practicality which will be a continuing theme throughout this thesis.  
As well as emotional challenges related to interactions with data, individuals can also have 
complex relationships with the devices used for disease management. O’Kane et al. (O’Kane et 
al., 2015) investigated how T1D technologies for self-management can create feelings of stigma 
or situational discomfort, influencing how and if they are used in social situations, noting that 
some individuals are reluctant to reveal having a medical condition, and therefore would not use 
diabetes devices in public or in the workplace. However, O’Kane et al. also noted instances where 
people with diabetes intentionally used their devices visibly for specific goals, for example: to 
demonstrate the non-exceptional nature of the diabetes routine; get special considerations; or 
influence a social situation. These concerns over the affective nature of health data draw attention 
to the need to carefully consider such interactions when designing support systems, carefully 
balancing such concerns with the need to communicate essential health information. This theme 
which will also be addressed repeatedly in the research presented in later chapters.  
2.4.4.5 Theory and HCI 
Theoretical considerations have served an important function in the design of health interventions 
(Mamykina et al., 2015) by supporting the transference of acquired knowledge between related 
domains (Hekler et al., 2016). This is reflected in HCI research, where there have been numerous 
studies engaging with or inspired by behavior theory. Examples include Lin et al.  (Lin et al., 
2006) which incorporated multiple elements of behavior theory literature and  the aforementioned 
Ubifit Garden (Consolvo et al., 2009) which investigated goal-setting theory in a persuasive 
technology context. The behavior change wheel (Michie et al., 2011), sought to bring together all 
the potential tools for developing effective behavior change interventions. Despite the attractions 
of such generalizable models, employing such theoretical models into specific designs can be 
challenging (Hekler et al., 2013) as such constructs generally lack clear steps for translation into 
functioning systems. In addition, Hekler et al. notes that as many app-based interventions apply 
only selected aspects of behavioral theories, neglecting specific elements, or combining elements 
from multiple theories, it is difficult to use such projects to validate a specific model. Hekler et al. 
notes that an alternative approach to models are design guidelines, some of which have been 
previously mentioned, and that these are best used as starting points to be tested in an iterative 
manner through user studies. Therefore, while behavioral (Michie et al., 2011) or stage-based 
models (Blondon et al., 2013) might potentially assist in designing interventions for supporting 
diabetes self-management, the vastness of this literature, and that this work does not play a 
prominent role in this thesis precludes a more thorough review. The following section discusses 
select examples, while more in-depth review of cognitive model will follow in Chapter 6 as 
appropriate for discussion. 
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2.4.4.5.1 FBM 
The Fogg Behavior Model (FBM) describes behavior as a result of three primary factors: 
motivation, ability, and triggers (Fogg, 2009). This model also asserts that all three aspects must 
be present for an event to occur, and therefore an intervention must take steps to bolster any 
weakness in any of these aspects to ensure success. These include: 
• Motivators: pleasure/pain, hope/fear, and social acceptance/rejection.  
• Ability: time, money, effort, cognitive load, and routine. 
• Triggers: an initiator, would in this case be primarily associated with some form of 
prompting from a mobile device 
On the last of these, perhaps as suggested by Stawarz et al. (Stawarz et al., 2015) it might be 
possible to link to an already existing behavior as a trigger.  While implementing the negative 
motivators poses ethical and adoption considerations within a health context, discovering means 
of accessing a sense of reward for diabetes management could be compelling, though it could be 
important to attach such rewards to behaviors rather than pre-defined glycemic outcomes (Petry et 
al., 2013). While this thesis does not directly build upon the Fogg model, it does draw attention to 
barriers which could interfere with its success. For example, Chapter 5 provides participant 
responses which suggest that specific UI designs can be demotivating (motivators), be excessively 
cognitively demanding (ability), or lack actionable feedback (trigger). 
2.4.4.5.2 COM-B 
Related to the Fogg model, the COM-B model (Michie et al., 2011) also asserts three factors for 
behavior change to occur:  
• Capability: the knowledge and skills to accomplish an action, both physical and 
psychological 
• Opportunity: the factors that are external to the individual, both physical and social 
• Motivation: the desire both reflective and reflexive to accomplish an action.  
The model then defines nine potential interventions that can be applied to make up for 
deficiencies in those areas: persuasion, incentives, coercion, training, enablement, modeling, 
environmental restructuring, restrictions, and education. This system is used both as a behavior 
model and as a basis for intervention design. One potential criticism of both Fogg and Mitchie’s 
models is that they both define motivation as an essential aspect of a behavior, but do not 
necessarily address how to support positive behavior during periods of especially low motivation 
(Adams et al., 2015).  Adams et al. addressed this concern, promoting the development of 
interventions that focus on the unconscious decision-making process. An analysis that draws on 
the work of Kahneman (Kahneman, 2011), Adams et al. asserted that the great majority of 
published HCI work in behavior modification address system 2 or effortful thinking, and 
proposed ‘mindless computing,’ or technologies that influence behavior without demanding user 
effort.  Among the design considerations promoted were: reflexive rather than reflective thinking; 
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effective use of triggers that incorporate into existing routines; parallel rather than serial, i.e. the 
intervention should be minimally distracting.  However, Mamykina (Mamykina et al., 2015) 
presents a convincing argument that greater self-knowledge will lead to more beneficial habits, 
and that the process of breakdowns in assumptions is vital for the process of learning. In addition, 
persuasive approaches must be carefully considered, as the benefits of positive behavior change 
must be balanced with the risks of reducing conscious decision making, and thereby impairing 
independent action. Persuasive design in general has also been criticized as having an inherently 
coercive aspect (Hekler et al., 2013). The application of persuasive technologies can therefore 
raise ethical and practical concerns, especially with scaled digital interventions where individuals 
are no longer monitored for adverse effects. This is especially true in a health context, where 
delivering damaging advice or disrupting established routines could be detrimental. For example, 
Stawarz et al. (Stawarz et al., 2015) found that systems that rely on automated reminders to trigger 
behaviors can impede self-sustaining habit formation, thereby creating unnecessary dependence 
on technology. The research in this thesis, particularly in Chapter 6 will present an integrated 
model that attempts to balance the need for ease of use with the need to learn effective self-care 
behaviors through active engagement. Considering whether it is either ethical or practical to 
imbed goal behaviors within a personal health system, even general wellness recommendations, 
brings up important issues related to user autonomy, which will be discussed further in the 
following section 2.5 on ethics.  
2.4.4.6 Summary of next generation app approaches 
This section grounded a next generation approach on historic literature suggesting the viability of 
the components to form a feedback-loop where sensors, automated analysis, and interfaces are 
joined together to inform human behaviors. Reviewed literature suggested that while each of these 
components has been researched, there are also substantial challenges to successful 
implementation, such as behaviors that are difficult to capture, user resistance, and lack of proven 
models to design interactions for such systems in a manner that create the right balance between 
user support and autonomy. A significant concern for such systems is the ethical implications of 
introducing such technologies into daily life. The following section will discuss this last theme in 
more detail. 
2.5 Ethical Concerns for Computing Systems 
As discussed in previous sections, the application of ubiquitous computing technologies could 
facilitate a next generation approach for apps, delivering contextually relevant information to 
assist with achieving personalized goals. However, many questions remain in how to design such 
systems without infringing on key ethical concerns such as self-determination or privacy. 
Respecting such needs requires assessment of the user’s preferences as well as due diligence into 
potential impacts of implemented technologies. The following section will briefly review relevant 
ethics, benefits of an ethical approach, and relevance to thesis research on health support systems. 
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2.5.1.1 Ethics general 
Ethics asks questions as to right and wrong and how these beliefs can be categorized and 
implemented in real world situations. Normative and applied ethics are particularly relevant when 
evaluating health technologies. The former attempts to classify what society considers to be 
commonly accepted standards of right and wrong behavior, while the latter is concerned with their 
application to specific, relevant, and often controversial concerns.  For example, the assertion that 
technologist have an ethical obligation to consider the social and personal implications of their 
work is an example of a normative principle (Adamson, 2015).  Applied ethics seeks to address 
controversial topics with a moral component and are often detailed in professional codes of 
conduct, such as the ACM code of ethics and professional conduct  (ACM, 2018).  Applied ethics 
is therefore the area of philosophy that takes theory and applies it to real world moral decisions 
that are directly relevant to professions, specific technologies, and public policy (Beauchamp, 
2007).  
2.5.1.2 Benefits of ethics 
Such codes of conduct can have diverse benefits, such as providing guidance to individual 
members on ethical conduct, and building trust in an organization by convincing the public that 
the members are capable of self-regulation (Anderson et al., 1993). Ethical design reduces legal 
risks, increases brand loyalty, and increase general adoption, as well as to promote the willingness 
to share personal data (Baldini et al., 2016). When implementing such principals, it is worth 
noting that such codes commonly contain both procedural ethics related to the ways that members 
should act as to enable the functioning of their professional organization, and the substantive 
ethics which consider the implications of the accomplished activities (Adamson, 2015). While 
computer ethics such as in the aforementioned professional codes, relates largely to the ethical 
considerations of human actors creating software and devices, machine ethics relates to the 
implications of such devices and their interactions with humans and other machines (Anderson et 
al., 2004). Relevant to health decision support systems, Adamson (Adamson, 2015) asserted that 
in our desire to create autonomous devices we must not only behave in an ethical manner in the 
act of construction, but also assure that these devices make decisions in accordance with the same 
ethical rules governing human actors who they are replacing.  While perhaps challenging to build, 
this also has certain practical advantages, as this allows us to reference diverse established codes 
as a basis for new systems, and thus allowing system designers to focus on integrating accepted 
practices, rather than having to create entirely new ethical standards (Samuel et al., 2010).  
2.5.1.3 Ethics for decision support systems 
As noted earlier in the section on foundational literature, (Meredith and Arnott, 2003) proposed 
that the work of Beauchamp & Childress (Beauchamp and Childress, 2001) on bio-ethical 
principles form a reasonable foundation for decision support systems. Samuel et al. (Samuel et al., 
2010) used these same principles, but in regard to the specific domain of health informatics 
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asserted the utility of adding ethics related to data privacy and security. Wright (Wright, 2011) 
concurred, drawing upon the Beauchamp & Childress principles for the foundation of his 
framework for ethical impact assessment of IT projects, with the addition of specific privacy and 
security concerns. While many of these standards are legally regulated (EU General Data 
Protection Regulation (GDPR)), given the wide range of contexts within which a personal health 
system must function, it is vital that such systems not be considered solely in terms of clinical 
benefits, informed consent, or legal regulation; rather, such systems should also serve the needs of 
the individual within the ethical standards of the culture within which they operate (Gurzawska et 
al., 2017). To this last point, we might add the individualized desires of the user and the contexts 
within which they operate. 
2.5.1.3.1 Learning systems  
Designing and implementing ethical autonomous medical systems that are capable of independent 
learning pose additional challenges, as they are to some degree inherently unpredictable, therefore 
developers cannot be fully responsible for their decision making after training (Thekkilakattil and 
Dodig-Crnkovic, 2015). Therefore, some method of embedded ethics is needed to assure ethical 
behavior, which demands careful research on user requirements in diverse scenarios. This is in 
accordance with Anderson et al. (Anderson et al., 2004) who note that as machines have more 
responsibility, they must have increased accountability. It is important to note that it is not enough 
to just assume that such systems are ethically neutral, as such systems always have inherent 
assumptions and impose structures on the user (Chae et al., 2005). Such considerations are 
especially important with the amplification of effects that comes with widespread adoption of 
algorithms (Brey, 2012). This need for considering the implications of such systems throughout 
the design process is an important consideration which underlies the viewpoint of this thesis. 
2.5.1.3.2 Autonomy and decision support systems 
Given the intention of this thesis to support the development of user-centered systems for self-
management, the ethical principle of autonomy is of particular relevance. Beauchamp & Childress 
(Beauchamp and Childress, 2001) highlighted three important criteria for an act to be considered 
autonomous:  
• The act has to be intentional, a result of an exercise of the will, implying competence on 
the part of the decision maker to make decisions.  
• The act has to be a result of a decision based on informed understanding.  
• The act has to be free of controlling influences.  
Designing computing systems that can lower the cognitive effort required for decision-making, 
while not infringing on these criteria will require systems that are highly responsive to the user. 
For example, many people have priorities in life such as family, career, or lifestyle that can at 
times take precedence over what clinicians might consider “ideal” disease management, such as 
eating on fixed schedules, avoiding alcohol or other intoxicants, or maintaining target A1c 
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through stressful periods. Therefore, systems (or specific aspects or components of these systems) 
that seek to optimize health behaviors could be detrimental or act against the user’s desires, such 
as interfering with social obligations. This theme of understanding user needs within different 
contexts in order to design systems which support user autonomy is integral to this thesis.    
2.6 HCI Methods for Designing and Validating User-Centered Health 
Systems 
The following section will briefly discuss domain relevant work that informs both the user-
centered research methods chosen, and the approaches pursued in later chapters which seek to 
support the design of more effective health management systems. 
2.6.1 Design and the User 
While developing new products for the medical domain poses many regulatory and technical 
challenges, integrating users into the design process can provide valuable design insights. As 
discussed earlier in section 2.4.3.3, Kanstrup et al. (Kanstrup et al., 2010) developed software and 
services for living with diabetes through interviews, workshops, and prototype explorations. 
Interestingly, the resulting prototype, was significantly different from the researcher’s initial 
concept of a ‘GPS’ style guidance systems. This change in approach resulted from participants 
sharing that they did not want a system that would tell them what to do, but rather a way of 
making better informed decisions. The user involvement was therefore beneficial in preventing 
investment in systems users did not actually want as well as emphasizing the balance between 
support and autonomy. The research that will be presented in this thesis suggests that there is user 
interest in additional decision support, but that it must be delivered in a balanced way that allows 
the users to retain control over their lives. Such subtleties argue for extensive user research, and 
methods to allow users to participate throughout the development process. 
2.6.1.1 Participatory design and apps 
Arsand et al. (Arsand et al., 2012) also applied participatory design techniques to develop mobile 
phone apps. While the resulting app was essentially a diary app, the lessons learned included the 
importance of automating data entry, integration with additional sensors, and contextual 
sensitivity, all features which research conducted for this thesis has continued to support. 
McCarthy et al. (McCarthy et al., 2017) used participatory design techniques such as drawings 
and paper prototypes in a workshop with people with T1D, who were teamed with designers to 
explore how blood glucose monitoring devices could be re-designed to address stigma related to 
public use. Strategies such as disguising monitors to look like non-medical items, increasing 
brand identity, and personalization were explored to gain insights into such potential approaches. 
These prototypes helped locate strengths and weakness of such approaches, such as that 
disguising devices might be counterproductive by preventing others from recognizing a medical 
emergency. The authors concluded that this workshop approach was successful in idea exchange 
between users and designers and delivering new concepts. Such studies affirm the importance of 
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including stakeholders in the development process, allowing them not only to comment on 
existing products, but also to determine the direction and approach taken. This aspect of allowing 
the eventual users to play a significant role in product design is also supported by Jones et al. 
(Jones et al., 2017) who drew attention to the need for new technologies to not simply reinforce 
existing hierarchical compliance based relationships in health care, but rather to allow the user to 
adapt technologies to their own needs.  
2.6.1.2 Frameworks for including users into design practices 
In order to integrate users into the design process in a practical manner, Gulliksen et al. (Gulliksen 
et al., 2003) identified principles to assist in user-centered systems design (UCSD), asserting that 
this term was often used too generally. The promoted principles included: User focus should be 
shared by all members of a project, including understanding the detailed requirements of real 
users; Active user involvement through all stages of development; Iterative processes including 
evaluation, documented changes, and redesign in accordance; Understandable design 
representations that are suitable for stakeholders; Prototypes to evaluate ideas with actual 
stakeholders; Evaluation in context; Interface and interaction as dedicated design practice; 
Multidisciplinary approach; Usability expert who should have decision making in regard to 
system usability; Integrated design processes also re-examining and modifying context of use as 
appropriate; Customization for purpose. The authors note that while some have criticized usability 
testing as inefficient in comparison to expert led ‘proper design’, that the users themselves can 
provide needed insights that might otherwise be missed, and therefore it is essential that software 
and system development have usability techniques and user involvement throughout the 
development process. These stated principals are influential throughout this thesis, especially for 
the approach taken in Chapter 8 which suggests a method for lightweight prototyping of multi-
component systems. 
2.6.2 Usability and other methods of assessment 
The user of heuristic analysis will be discussed in more detail in Chapter 8, but the next section 
will discuss important terms which have bearing on this later work. 
2.6.2.1 Usability 
The ease and pleasantness of using an interface can play an important role in the success of an 
application. (Nielsen, 2012) notes that there are five aspects essential for determining these 
qualities for user interfaces, which is frequently referred to as Usability: 
• Learnability: Ease of task accomplishment on first use. 
• Efficiency: Ease of task accomplishment after design has been learned. 
• Memorability: Ease of task accomplishment after pausing use. 
• Errors: Frequency, severity, and recovery from errors. 
• Satisfaction: Pleasure related to use. 
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In addition, Nielsen notes that the degree to which needed features are provided is also critical, 
which is referred to as Utility, which can be seen as fitness for purpose, and therefore is separate 
from usability. This category is also integrated into the criteria suggested in Chapter 8.  
Building on earlier work, Harrison et al. (Harrison et al., 2013b) proposed a usability model 
specifically for mobile applications. This model while building on earlier usability models, such 
as (Nielsen, 2012) or ISO 9241, notes that these commonly used usability models focus on 
features such as effectiveness, efficiency and satisfaction, while cognitive load is often under 
represented. Their usability model PACMAD (People at the Centre of Mobile Application 
Development), fuses multiple existing models in order to create a more complete approach. This 
model draws attention to three aspects which can play a role in mobile usability:  
• User: Abilities and limitations of the user, including level of experience. 
• Task: Objective of use. 
• Context of Use: Environment of use 
This model adds two aspects to the earlier mentioned (Nielsen, 2012) model; Effectiveness, or the 
ability to accomplish a given task in a specific context, and Cognitive Load. This is judged to be 
especially important in a mobile context, as usage can impact both the ability to accomplish other 
concurrent activities such as walking in traffic, while also impacting ability to accomplish the 
application objective. These aspects are of particular interest to mobile systems and play a 
prominent role in understanding user requirements for diabetes management systems and will 
both be reoccurring topics throughout this thesis. 
2.6.2.2 Evaluations frameworks for ethical assessment 
As argued previously, the advent of systems that supplement or replace human decision-making 
necessitate careful consideration of ethical implications. The following sections discuss general 
issues of ethical responsibility for such systems and how assessment and design can be informed 
by such concerns. 
2.6.2.2.1 Ethical design 
An important aspect to consider when designing health management systems is that they can have 
unwanted and potentially hard to predict side-affects such as rewards for step-counting leading to 
a reduction in activities such as swimming that cannot be sensed (Munson, 2017).  Thekkilakattil 
and Dodig-Crnkovic (Thekkilakattil and Dodig-Crnkovic, 2015) suggested that that the relatively 
recent introduction of newer technologies (such as autonomous cyber-physical systems), poses 
special challenges in ethical design due to lack of previous experience to draw upon. The authors 
note that evolving technologies necessitate frequent re-assessment of ethical implications, and 
therefore it is imperative that people developing these technologies engage in independent ethical 
examination of their work, which involves identification of potential moral problems, which can 
be addressed during development processes.  
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2.6.2.2.2 Is legal compliance sufficiently ethical? 
While regulation has an important role to play in protecting consumers, there are diverse reasons 
why it is important to consider implications of new technologies beyond established regulations. 
Examples include the difficulty in codifying the subtlety of complex daily interactions with 
assistive technology, the inherent imperfection of software (Goodman, 2016), the lag between 
innovation and changes in law (European Parliament et al., 2016), and the shifting in 
responsibility from medical personal towards technologists (Adamson, 2015). Therefore, while 
many user concerns such as data usage might be legally mandated, from an ethical perspective 
developers of complex systems should take into account these principals in order to embed 
protections for the user where possible within the systems, as well as take into account how 
developed systems could lead to potential abuses (Luger et al., 2015).  
2.6.2.2.3 Methods of ethical development 
An ethical approach similar to a participatory design methods, suggests integrating stakeholders 
throughout the development process, so that they are encouraged to express concerns and 
influence design (Wright, 2011). This is advantageous not only on moral grounds, but also 
potentially on financial grounds, as poor ethical decisions in design can hurt the success of a 
product or service (Wright, 2011).  There are various methods of incorporating ethical approaches 
into product design. Lahti et al.  (Lahti et al., 2012) advocated for heuristics that could be used 
similarly to the Nielsen Heuristics to support light-weight ethics assessment. These authors 
asserted the value of pre, during and post project analysis, and proposed six heuristics, 
consistency, justice, respect, integrity, autonomy, and awareness, as well as a set of key questions 
meant to assist with evaluation.  
Brey (Brey, 2012) proposed the Anticipatory Technology Ethics (ATE) framework specifically 
for ethical assessment of not yet existing technologies, which therefore cannot be directly tested 
with users. He stressed the importance of early assessment, noting that once a technology has 
become implemented, it is far more difficult to change. Central to this framework is critical 
examination at three separate levels (technology, artefact, application), which are individually 
analyzed to uncover ethical issues. The top level, technology is defined as the general grouping of 
techniques brought together to achieve a common purpose. The artefacts are the devices created 
or derived from the technology, while the application level refers to a specific task or contextual 
use of a device for a particular purpose. The author asserts the importance of examining ethical 
impacts at all levels, from more general to specific, and the importance of ‘forecasting’ (informed 
prediction) for emerging technologies.  Brey suggests two stages of ethical analysis, identification 
and evaluation, with an optional third of recommendation. The author recommends an ethical 
checklist to help identify areas of concerns though noting the need to supplement with domain 
relevant topics that might be missed.  
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2.6.2.3 Summary 
These usability and assessment frameworks helped to inform research approaches taken in later 
chapters. The emphasis on cognitive load appeared especially significant and will be discussed in 
greater detail when exploring user challenges concerning diabetes app interfaces, as will utility 
which is found to undermine otherwise usable systems. Further discussion and examination of 
methods of designing and assessing user-centered systems will occur when appropriate in later 
chapters. 
2.7 Relation of Literature to Thesis 
We have reviewed Type 1 diabetes as a chronic condition and noted the importance of individuals 
engaging in diverse behaviors to maintain health. The review also presented evidence that despite 
many years of research, diabetes management remains challenging for many. We also explored 
some of the reasons such as complexity and emotional stresses that make this care demanding, 
while also demonstrating that many of the required behaviors are generalizable to broader health 
and wellness. We have also noted that smartphone apps with their ability to store, organize, share, 
and communicate diverse data appear well-suited to supporting diabetes self-management 
processes; however, the evidence also suggests that despite considerable efforts, the benefits of 
the current dominant approach remain unclear. Investigation of this discrepancy between an 
accepted system design and user-requirements appears well suited to user-centered research 
techniques. Therefore, in order to improve upon this prior work, we must understand the benefits 
and deficiencies of current approaches, and then look for new approaches that might better fulfill 
user needs. The reviewed literature has also suggested that there exist technologies and methods 
which could help to overcome already known barriers for supporting diabetes care, however these 
approaches entail potential risks and must be carefully consideration before deployment. 
Therefore, we set out to understand discrepancies with current approaches and seek to understand 
concerns and methods which could help foster next generation systems which do not repeat prior 
errors. The following chapter discusses the revised research questions and the methods that have 
been applied to them. 
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Chapter 3: Research Questions and Overview of Methods 
Chosen 
After reviewing the relevant literature and discussing apparent gaps in knowledge and practice, we 
are now in an improved position to clarify the ambitions of this thesis as well as reframe the 
research question in a more comprehensive manner. After this, we will outline the chosen research 
methodologies and identify why they are appropriate for the research question. While this chapter 
will indicate the general methodological orientation of the thesis as a whole, detailed discussion of 
methodologies is reserved till later chapters, as different combinations and refinements of existing 
methodologies were necessary to address the successive stages of the research. Consequently, the 
methodological details are better understood in the context of the challenges uncovered and 
specific research objectives in chapters 4-8. As a general note, while this thesis is concerned with 
technology, the applied research methodologies are not primarily concerned with quantifying the 
performance of specific technical features.  Rather, they are concerned with understanding and 
evaluating the intersection of technology and real-world user needs, as well as more fundamental 
questions about how and why popular designs fail to meet such needs, and what can be learned 
from these failings to improve designs and design methods for next generation products.  
3.1 Expanded Research Questions 
In section 1.2 we introduced the preliminary research question: 
 “How can we improve the practical utility of diabetes apps from a user-centered perspective?”  
As we have seen in the literature review, diabetes management must occur within different contexts 
and people with diabetes are diverse in their needs. T1D does not discriminate, it can occur at any 
age, to anyone, and there is not yet any known means of prevention. Therefore, individuals might 
have different dietary habits, financial resources, access to or preferences for insulin delivery 
methods, lifestyles, responsibilities, cognitive capabilities, and so on. This great diversity of 
requirements for effective management support indicates the need for continued in depth user 
research. So, keeping in mind the wider understanding gained from the literature, we will seek to 
answer the following questions in the subsequent chapters: 
• RQ1: Are diabetes apps actually meeting user needs, and if not why not? (Chapter 4) 
• RQ2: Are the standard user interface designs of diabetes self-management apps sufficient 
for meeting user needs, or are there inherent design flaws? (Chapter 5)  
• RQ3: How could diabetes apps better support user decision-making processes? (Chapter 6)  
• RQ4: What user concerns need to be addressed when developing a next generation app 
approach that relies on multiple networked monitoring devices?  (Chapter 7) 
• RQ5: How can we systemize these concerns to help developers address high-level 
requirements when developing next generation approaches?  (Chapter 8) 
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Within this thesis we will address each of these questions and, given the great diversity of 
individual requirements, seek to offer insights into processes that can assist in determining paths 
forward to design diabetes support systems that better meet user needs. 
3.2 Overview of Methods Chosen  
In order to achieve the practical goal mentioned in Chapter 1 of rethinking existing diabetes apps to 
better help individuals self-manage type 1 diabetes, this thesis seeks to understand the underlying 
requirements of primary users of these apps, the individual with diabetes. Furthermore, this thesis 
seeks to understand ways in which existing products succeed or fail to meet these needs, and 
thereby determine what sorts of questions should be asked when further developing these 
technologies. As such, the primary method relies on in-depth discussions with users, asking them to 
reflect on their experiences and needs, followed by the application of various methods to analyze 
these collected responses.  
3.2.1 Research procedures  
In the following sections, we will briefly review the research methods chosen, and why they were 
selected. As noted previously, there will follow more thorough descriptions of methods within the 
later research chapters. 
3.2.1.1 Chapter 4: Longitudinal user engagement with diabetes smartphone apps 
This pilot study sought to determine if diabetes apps were meeting user needs, and therefore 
engaged people with diabetes who had previous real-world experience and insights with these 
products. This study used a combination of a questionnaire which collected demographic 
information and a short semi-structured interview about participants’ experiences and reflections 
on the prior usage of diabetes smartphone apps. Notes were taken during the interviews for 
qualitative data collection. All collected data were anonymized and input into a spreadsheet for 
further thematic analysis and summing of responses. 
3.2.1.2 Chapter 5: Diabetes app user-interaction study 
Drawing on the insights from the initial pilot study, this next study sought to determine if the user 
interfaces of popular diabetes apps were sufficient for helping users to make sense of diabetes 
relevant information. To this end diabetes data were pre-entered into representative diabetes 
smartphone apps so that each user could view the same data within different interfaces. Participants 
were then asked questions related to functional and affective aspects of apps with respect to this 
data and asked to “think aloud” as they used the apps. These smartphone screens and participant’s 
hands were recorded with a webcam which captured these interactions along with an audio 
recording. Videos were transcribed, and then coded in NVivo according to the following 
categories: app, interface type, emotional response (positive, mixed, negative, neutral), and 
expressed usefulness (helpful, mixed, not helpful).  
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3.2.1.3 Chapter 6: User interaction analysis and a Questionnaire for investigating 
cognitive processes of T1 diabetes self-management  
This study drew upon the same interviews in the previous study based on apparent discrepancies 
between user responses and the cognitive models discussed in 2.1. This pre-preliminary analysis 
was then used to propose an expanded diabetes self-management model.  Then to test this theory 
with a larger sample size, this study made use of an online questionnaire to collect quantitative and 
qualitative data related to diabetes self-management thought processes and methods. All responses 
were input into an excel spreadsheet for quantitative and qualitative analysis, and results were 
analyzed for statistical significance with Jupyter Notebooks using Python 3. 
3.2.1.4 Chapter 7: User Concerns for multi-device monitoring  
The conclusions derived from previous chapters suggested that eco-systems of devices could 
provide a path forward for diabetes apps, however as discussed in 2.5 such systems could raise 
increased user concerns. Technology probes are used to assist in the co-design of new technologies, 
and draw upon an interdisciplinary approach to investigate the use of technologies in real world 
situations, technical feasibility, and to inspire further design (Hutchinson et al., 2003). The use of 
technology probes has previously been used in diabetes focused HCI research, with Mamykina et 
al. (Mamykina et al., 2008) employing the MAHI mobile application which automated blood 
glucose recording into augmented logs for assisting with the development of reflective thinking 
skills among newly diagnosed type 2 people with diabetes. Mamykina et al. noted that the 
disruption the probe causes while integrated into daily activities can provide valuable insights into 
new technologies. This study drew upon this methodology to investigate user concerns related to a 
next generation approach for automated diabetes decision support systems using multiple 
connected tracking device. This chapter reviews semi-structured interview with participants at the 
beginning and end of the 4-week study, in order to determine emerging concerns, reflections on 
specific devices, and to suggest technologies needed to meet these concerns. These quotes were 
then organized thematically to suggest emergent questions to be considered by developers of next 
generation diabetes decision support systems.  
3.2.1.5 Chapter 8: DUETS  
Attempting to meet the challenges of applying diverse qualitative findings to actual product 
development cycles, this chapter reviews the development and deployment of a tool for stakeholder 
reflection on multi-component health support systems. The iterative design process for the method 
is reviewed, and then the tool is assessed through a series of mediated focus groups examining a 
proposed diabetes decision support system. In order to establish value of this approach, it is 
compared to an existing heuristic-based system. The first session engaged a Berlin-based diabetes 
analytics startup and lead them through a series of questions and use of the card-based system to 
reflect on their proposed product. This was followed by a second study with people with T1 
diabetes who engaged in a similar process. In the 3rd session, cumulative responses were brought 
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back to the startup, who engaged in a mediated discussion of product concerns.  The responses for 
each session were then combined to identify which techniques were helpful in locating new 
concerns, allowing comparison of DUETS with the heuristic approach and the value of the 
different DUETS components. 
3.2.2 Ethical considerations   
In accordance with The Open University’s ethics for research with human subjects, all studies were 
submitted to, undergone review, and granted favorable opinion (see Appendix A) by the Human 
Research Ethics Committee. This process involved the submission of a Proforma which included a 
description and rational for the project, project personal, research protocol, key ethics 
considerations, and general project management. While all research was considered low risk, in 
accordance with these standards all measures have been taken to guarantee the full anonymity of all 
participants in the studies which have been completed as part of this thesis.  This concludes the 
background perspective, foundational knowledge, and outline of procedures which have guided the 
research direction of this thesis. The next chapter will begin the review of the research undertaken 
to investigate the research objectives.    
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Chapter 4: Adoption of Diabetes Apps Pilot Study  
This pilot study was motivated by informal anecdotes suggesting that, despite the great number of 
available diabetes apps and the daily challenges of diabetes care, many people with T1 diabetes 
who had tried such apps were not integrating them into their daily self-management practices. I 
was, at the time of this pilot study, unable to find published longitudinal studies describing how 
commercially available diabetes mHealth apps were being used in the wild. It was hoped that by 
interviewing individuals who had sought out and used these products under natural conditions, 
more organic patterns could be revealed. Using a questionnaire with demographic and open-ended 
questions, this pilot study looked at the real-world behavior of people who had already used a 
diabetes smartphone app, in order to learn more about the impact of these products in their lives 
and to thereby seek answers to the following question: 
• RQ1: Are diabetes apps actually meeting user needs, and if not why not? 
In the process of answering this primary question, the additional sub-questions will be considered 
as well: 
• RQ1.2: What are real world patterns of use?  
• RQ1.3: Which reasons cause people to stop using available apps? 
• RQ1.4: How effective are these current app approaches for meeting user needs? 
4.1 Introduction 
There has been a great deal of persuasive computing research on encouraging healthful behavior 
through the use of ubiquitous computing devices, but relatively little on their long-term use for 
supporting chronic health conditions in non-observational settings. As previously discussed in the 
review section, diabetes management depends on careful and ongoing attention to and active 
engagement with diverse data in order to inform management decisions. There was also a 
discussion of inconclusive evidence related to mobile phone-based apps as an effective intervention 
for diabetes management. This study was motivated by informal anecdotes suggesting that, despite 
many hundreds of available diabetes apps (Breland et al., 2013), most people with diabetes who 
tried them were not embracing these products. This pilot-study asked people with T1 diabetes who 
had used a diabetes smartphone app to reflect on their previous experiences, to try and learn to 
what extent these products were supporting and being integrated into self-management routines. 
This chapter reports on their reported experiences, preferences, and habits, and patterns of use with 
diabetes apps.  
4.2 Methods 
A survey composed of demographic, app experience, and other non-demographic semi-structured 
questions was undertaken for data collection and thematic analysis (see Appendix B: Chapter 4: 
Adoption Diabetes Smartphone Apps). Participants were recruited through diabetes related social 
media, diabetes related events, a diabetes related Meetups, snowball sampling, and at a diabetes 
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conference held in Leipzig, Germany. Participants resided in either EU countries or North America.  
Inclusion criteria included: adults owning a smartphone and previous or current experience with an 
app used in conjunction with T1 diabetes management. In order to investigate natural patterns of 
use, participants were not requested to download or sample additional products. A total of 26 T1 
diabetics, or parents in the case of diabetic minors (the parent was involved with diabetes 
management) were interviewed. Age range: 11-61 years, mean age was 31.9 years (SD 11.6). Time 
since diagnosis: range 1-54 years, mean of 15.8 years (SD 12.5). Gender: 38% female, 62% male. 
All respondents were guaranteed confidentiality. Ethics approval was granted by The Open 
University Human Research Ethics Committee. There were no financial incentives offered. The 
questionnaire (see Appendix B: Chapter 4) began with questions on user characteristics, product 
choices, reason for these choices, previous and current patterns of diabetes and non-diabetes app 
usage, and opinions on diabetes apps used. This was followed by a short discussion with 
participants that focused on their feelings, observations and experiences with diabetes and non-
diabetes related smartphone apps. While these initial questioning had focused mainly on usage 
patterns, such as reasons for continuing or ceasing use, the emotional dimensions quickly came to 
the forefront. Given the exploratory nature of this research, questions were then added to probe this 
issue in greater depth. The new questions included “Please describe the feelings you get before, 
during and after using a diabetes (and non-diabetes) app” and “What is your opinion of the 
diabetes (and non-diabetes) apps you have used?” Notes were taken by hand during interviews and 
then transcribed into an Excel worksheet for analysis and tallies. Given the exploratory nature of 
the analysis, an emergent coding or open coding approach was chosen (Lazar et al., 2017) in which 
I looked for common themes among responses. This involved repeated reading of the source 
material and discussions with my thesis advisors. After the two primary themes of app 
functionality/utility and affective impacts were agreed upon, examples were color coded within the 
spreadsheet. These themes as well as the more specific responses will be reviewed in the following 
sections. 
4.3 Results 
The following paragraphs discuss the results from this pilot study. First answers to the questions 
will be reviewed, which will be followed by a more in-depth discussion of users reported grounds 
for abandoning smartphone apps. (To view the collected responses, see: Appendix C: Results and 
other Outputs, Results from Chapter 4 diabetes app adoption) 
Question: Previous experience with logging data in a paper log book? 
All participant (26/26) reported having previous experience logging diabetes data, with all but one 
having used paper diaries and one participant reporting having only used an excel spreadsheet. This 
is unsurprising as daily logging is commonly recommended self-management practice. 
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Question: Which diabetes apps have you tried? (See Figure 4-1) 
 
FIGURE 4-1 APPS TRIED 
Participants cumulatively recalled trying 19 different apps. MySugr was the most popular with 10 
participants reporting that they had tried it, followed by SiDiary with 4. There was no other app 
that was noted by more than 2 participants. This list is likely to be incomplete as at least 7 
participants reported having tried at least 5 diabetes apps yet no participant listed by name more 
than 2 different apps.  
Question: Do you use smartphone apps every day, if so which? (See Figure 4-2) 
 
FIGURE 4-2 DAILY USE OF SMARTPHONE APPS 
While not surprising given that a owning a smartphone was a study inclusion requirement, 24/26 
participants reported using smartphone apps daily, with 1/26 reporting no app usage, and 1/26 
reporting only using email. Of these daily app users, all reported using social media such as 
Facebook and/or Twitter every day, with many reporting usage multiple times per day. P4 noted 
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that Facebook gave “...distractions, funny videos, entertainment, friend”, and “...helped stay 
connected, take part in other’s life” and that “Entertainment is the main thing.” P14 reported 
using Pinterest and WhatsApp 5-6x per day, “Pinterest is inspiring and relaxing. WhatsApp is for 
social contact.” And P21 said that she looks at Facebook when she doesn’t have anything else to 
do, reported being happy when using, and that it is out of mind when she closes it. The high 
adoption rates and positive responses to social networking apps indicate that these users were ready 
daily adopters of smartphone apps. 
Question: How helpful did you find diabetes apps? (See Figure 4-3) 
 
FIGURE 4-3 HELPFULNESS OF DIABETES APPS 
The majority of participants (20/26) reported that they had found diabetes apps “somewhat” or 
“very useful”, with only 4 reporting that they were “not helpful” or “not needed”.   
Question: In which ways were diabetes apps helpful? (See Figure 4-4) 
 
FIGURE 4-4 REPORTED BENEFITS OF DIABETES APPS 
In this question participants were asked to identify from a check list all ways that they had found 
diabetes apps to be of benefit, or to write in additional answers if needed. As many individuals 
noted more than one benefit the total number is more than the number of participants. 20/26 
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participants found some benefit. Motivation (7), logs for doctors (8), and data visualization (11) 
were the most commonly cited and the only benefits noted multiple times.  
Question: Are you currently using a diabetes app? (See Figure 4-5) 
 
FIGURE 4-5 CURRENT DIABETES APP USAGE 
Despite the positive responses and benefits noted in the previous questions, this did not translate to 
high levels of daily adoption, with 18/26 reporting they were no longer using diabetes related apps, 
and only 2/26 reporting current daily usage. 3/26 reported using the app solely for periodic storage 
of BG meter data, with no additional data input. The remaining 3 participants reported using apps 
intermittently, varying from several times a week, before medical visits, or to troubleshoot specific 
problems.  
Question: How long did you use diabetes apps before abandoning them? (See Figure 4-6) 
 
FIGURE 4-6 DIABETES APP ABANDONMENT 
Of the 18 people who had completely abandoned diabetes smartphone apps, 10 reported 
abandonment within 1 week, and an additional 5 before reaching 1 month. Only 3/26 reported 
having used apps for over 3 months and then abandoning use, suggesting that perhaps some form 
of habitual usage is formed sometime after 1 month.  
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Question: Why did you stop using diabetes apps? (See Figure 4-7) 
 
FIGURE 4-7 REASON FOR DIABETES APP ABANDONMENT 
Of the people who ceased diabetes app usage, 13/18 reported either the closely related “too much 
work” or poor “cost/benefit ratio” as a major contributing factor to ending use. Other reasons 
included: no benefit (2/18), use of continuous glucose monitor (CGM)/Pump based record keeping 
(2/18) and lack of app flexibility (1/18). Of the non-adopters, 9/18 listed manual data entry as a 
major barrier. Some participants noted that returning to paper-based logging was quicker and more 
flexible, or that they had moved to using PC based software, which was compatible with their BG 
meter. For those using a pump or CGM, the inability to exchange data between devices was a 
reported barrier.   
4.3.1 Participant reasons for diabetes app abandonment 
The following discusses in more detail participant responses related to why they had stopped using 
diabetes apps.   
4.3.1.1.1 Functionality/Utility 
Many participants reported that these apps did not provide sufficient benefits to management. P4 
noted that, “All Apps offer the same functionality, maybe some nice graphs, but I can’t see the 
benefit.” P26 “If I am spending time on it, it needs to give something in return. Decision support.” 
P19 noted that she “...liked idea that she could use phone, because she always has it with her and 
doesn't need a pen. Was hopeful but found it annoying that she always had to record data.”.  And 
P6 noted that “...time is better spent on other issues than data entry.” P25 found diabetes apps 
“...too complicated to use, faster to use paper.” Lack of integration with other devices was also 
noted, such as P17 who found the App good, but noted that the info is in meter/pump combo 
device.  P7 noted that it was too much work to enter in app as well. There were also difficulties 
with medical team acceptance with 4 participants reported that their medical team was resistant to 
the viewing of digital data. P21 stated, “My doctor doesn’t understand digital.” As P21 was 
expected to bring paper logs, he switched back to paper logging. P4 reported his doctor wanted a 
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very specific data structure, and P4 was unable to find an app that would deliver the to the doctor’s 
specifications.  
4.3.1.1.2 Negative emotional impact 
In addition to these technical barriers there were also apparent emotional challenges to longer-term 
adoption as well. Upon further probing as to “feelings” imparted from app use, 12/26 of 
participants also expressed that the use of apps had negative emotional side effects, which could 
have reduced their desire to use these products. Some respondents felt that using a diabetes app 
made them feel more excluded or vulnerable. P3 said that the diabetes app “reminds me of my 
weakness.” P11 stated that diabetes Apps make him feel like an “outsider” as opposed to Facebook 
which makes him feel like “...one of the crowd...” And P16 noted that “A diabetes app is a constant 
reminder that you have a life-threatening chronic condition.” P13 felt her emotions tied to entering 
BG values and felt bad when entering perceived “bad” values. P14 reported having stopped using a 
diabetes app because she didn’t like entering out of range values and felt she wasn’t improving. 
And P20 felt having to enter out of optimal range values negatively influenced feelings. For some 
participants, feedback from an app can also feel judgmental. P5 reported that negative feedback 
from app made her feel bad. P25 didn’t want to be judged on numbers, arguing the app doesn’t 
understand context and doesn’t want to be told she is “50% out of range”. P25 explained that she 
might sometimes run her blood glucose levels out of ideal range for a reason, for example if she is 
going on long run or to a party where she is going to drink, she might choose to allow her BG value 
to go high and doesn't want to be judged on that. And for some daily app usage caused a constant 
long-term negative association, as noted by P16: “I see my diabetes as my credit rating, I don’t 
want to be reminded of it every day – only when there’s something I need to be aware of...”  
4.4 Discussion 
The following section discusses the finding of this pilot-study in light of the initial research 
questions. 
4.4.1 RQ1: Are current diabetes apps effective in meeting user needs? 
While 20/26 participants reported that there were benefits to diabetes apps, 18/26 had stopped 
using diabetes apps, and only a small number were using them as routine management tools. The 
most frequently noted benefits were for motivation, logging data for doctor’s visits, and for 
visualizing data. Although given the discrepancy between benefits and adoption, these did not seem 
to sufficient to overcome usage barriers. As such, though for some users they do demonstrate 
benefits, this study suggests that these apps are not sufficiently effective in meeting user needs for 
daily management. 
4.4.2 RQ1.2: What are real world patterns of use?  
While the results of this pilot study would suggest diabetes app abandonment is common, these 
apps were successful in meeting specific needs for some users. 2/26 were using them as daily diary 
tools, 1/26 participants reported consistent use of an app to collect data before a doctor’s 
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appointments, and 2/26 reporting using them routinely though not daily. There were also an 
additional 3/26 who continued to use apps for downloading and visualizing collected data from 
their blood glucose meter. These results demonstrate areas which deliver value to at least some 
users, and therefore might be further developed in future apps. 
4.4.3 RQ1.3: Which reasons cause people to stop using available apps? 
The most frequently cited ground for ceasing app use (8/26) was related to workload, with and 
additional 5/26 noting the closely related “benefits to workload” ratio.  It is apparent that users 
wish for additional automation of data entry, but as to whether this would lead to long-term daily 
use is not clear from this data, without addressing other user concerns related to benefits. Wireless 
transfer of blood glucose data is already available in a few devices, but it is not clear that this in 
itself will lead to long-term adoption without these apps offering additional benefits. Apps with 
automated data input through hardware connection were used by two of the longer time users but 
lead only to periodic downloading to facilitate data export and for app-based data visualization. For 
example, P4 sought out the iBGStar meter which offers hardware integration with the iPhone, “I 
thought it would help, (but) assembling all the data didn’t help, still needed to interpret.  Didn’t 
offer anything more.”  
4.4.4 RQ1.4: How effective are these current app approaches for meeting user 
needs? 
We found that the mentioned apps contained many of the elements which form the basis of 
persuasive computing techniques. For example: Bant integrated with twitter for social sharing; 
mySugr offered gamification through challenges and virtual rewards; the majority offered the 
ability to track personal data and offered visual interpretations of collected data. Glucose Buddy 
and others offered programmable reminders. mySugr, the most often mentioned by our 
participants, features a cartoon figure, reminiscent of a Tamagotchi pet, which could be “tamed” by 
entering in sufficient data daily and responded to BG data. Despite mySugr’s use of multiple 
persuasive strategies, at the time of survey it had only become adopted daily by 1/26 users and this 
single habitual user reported a strong personal connection with the company, including being a 
beta-tester.  
As many respondents reported spending considerable daily time on social media, it is questionable 
whether engaging with a smartphone app is in itself the primary barrier. Rather, this study 
suggested that these apps failed to deliver sufficient rewards to justify the efforts of use, while in at 
least some cases causing negative emotional impacts. It was also unclear from this study to what 
extent users were able to make use of collected data, as presenting users with the ability to view 
collected data does not automatically translate to increased comprehension of the meaning of this 
data, and many lack the ability to translate numbers into better decision making (Mamykina et al., 
2008). Some participants expressed interest in app-based decision support (5/26) for insulin 
dosages or diet, which deserves further research. As discussed in the literature review, diabetes 
management is a constant tradeoff between freedom and risk-avoidance, and even highly motivated 
 68 
individuals will frequently have frustrating periods. This suggests the need for continued 
investigation into how data can be presented to optimally assist informed decisions without 
demotivating the user, and how to tailor strategies to the individual preferences of the user which 
form the basis of inquiry for later chapters. 
4.5 Conclusions 
The adoption of the smartphone throughout the world, combined with the economic scalability of 
apps has provoked much interest in the use of this technology for supporting health care. However, 
this pilot study suggested that commonly available diabetes apps were either infrequently 
integrated into daily diabetes care or, for a majority of users, completely abandoned. Participants 
drew attention to numerous technical hurdles to overcome, such as better integration with health 
care providers, and workload associated with data entry. However, it was not clear from this pilot-
study or the available literature whether overcoming these barriers would be sufficient to meet user 
needs. This pilot-study also suggested that there might be essential flaws in the app interaction or 
interface design, such as negative emotional impacts associated with diabetes app usage or lack of 
sufficient cognitive support for understanding data.  
The following study sought to further explore these questions through more in-depth examination 
of these apps. Of particular interest was trying to determine if, given a future where all data entry 
could be automated, current app design approaches would be adequate for supporting positive and 
productive interactions, whereby users could derive meaningful insights from collected data. If this 
were the case, then the argument could be made that the basic design of these logging apps was 
correct and the research emphasis should be placed on automated data collection and integration. 
However, if users reported unpleasant interactions, or excessive cognitive stress this might suggest 
that the basic design assumptions of these apps might be flawed and in need of further 
development. The following chapter will discuss the study undertaken to provide insights into these 
topics. 
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Chapter 5: Data, Data Everywhere, and Still Too Hard to Link 
The pilot study in the last chapter found that many participants reported favorably on aspects of 
diabetes apps, noting benefits of data visualizations and advantages for motivation. However, for 
the most part these apps were rarely integrated into daily usage, and often completely abandoned. 
This next study set out to investigate in greater detail the benefits and deficiencies of specific 
diabetes app interfaces in order to better understand more specifically why these interfaces were 
failing to meet user needs. Therefore, this chapters asks the following question: 
Are the standard user interface designs of diabetes self-management apps sufficient for 
meeting user needs, or are there inherent design flaws?  
This section presents a user-interaction study using pre-entered diabetes relevant data within 6 
different commercial diabetes diary apps. From analysis of these sessions with eight user interface 
designs, user requirements, interface benefits, limitations, and implications are considered, 
revealing that while certain benefits are provided, these interfaces often fail to explicitly address 
the cognitive and emotional requirements of users. Resulting from thematic analysis of these 
interactions, and with the goal of improving these apps three challenges are posed for developers of 
diabetes systems: reducing cognitive demands for usage, increasing emotional sensitivity; and 
methods of activating the user’s already acquired knowledge. 
5.1 Introduction 
As reviewed earlier, successful type 1 diabetes (T1D) management typically requires careful and 
deliberate balancing of multiple medication and lifestyle factors, which must be assisted by 
frequent interaction with diverse data to inform these decisions. The interfaces of mobile health 
apps aim to support this process by assisting in the discovery of relevant trends and patterns in 
collected data. However, relatively little is known about how well existing interfaces support 
specific T1D user requirements such as frequent decision making, extraction of relevant insights 
from complex data, and emotional coping. In order to investigate these issues, this chapter 
describes 16 mediated sessions in which people with diabetes explored relevant data using typical 
diabetes smartphone apps. This research focused on the logging or diary paradigm, which has 
become a de facto mainstay of daily diabetes management smartphone apps, a carry-over from the 
paper-based record book. Such apps currently have two primary mechanisms for assisting in daily 
self-management: the first in the increased engagement with data caused by the act of logging, and 
the second in the ability to reflect on and learn from this collected data in order to inform future 
decisions. Automated data entry is becoming increasingly viable, at least for blood glucose records, 
to a certain extent for exercise, and insulin dosages. And while many participants in the pilot study 
expressed a desire for such automation, such functionality is not yet commonly available. Given 
this lack of working commercial offerings and the challenges both technical and ethical in building 
fully functional prototypes, it is not known whether such automation alone would manage to 
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improve these apps to the point where they would meet user needs for diabetes decision support. 
These apps typically offer multiple methods of visualizing the same collected data, as well as other 
functionality such as data sharing, or customizable notifications. These many features can prevent 
studies focused on general benefits from providing useable evidence as to the effectiveness of 
individual components (Klasnja et al., 2017). Therefore, systematic and reproducible methods are 
needed to understand how specific features of differing approaches are respectively succeeding and 
failing to meet user needs. To investigate how specific data visualization techniques can assist 
users with obtaining value from collected data, I populated 8 existing commercial diabetes apps, 
with a single standardized data set. This enabled systematic within- and across-subject comparisons 
of interface designs, while at the same time mitigating confounding variables which could have 
resulted from using personal data. For these reasons while using personal data would be valuable 
for other purposes, it would have not been optimal for this study. While this research was type 1 
diabetes specific, given the ubiquity of such methods of data presentation it is possible that the 
issues investigated here have wider implications for mobile health apps, for other chronic 
conditions, and potentially for health, wellness, and data driven lifestyles more generally. 
5.1.1 Visualization of personal data and design issues 
While there has already been a review of data visualization, there now follows a brief review of 
concerns especially relevant to this chapter. As noted earlier, understanding complex personal data 
can be challenging (Mamykina and Mynatt, 2007), and an important aspect of these apps is to help 
the user in this process. To this end, many of these apps make use of standard graphic 
visualizations such as plots, graphs, tables, and charts, which are considered to be effective 
methods for seeing tendencies and discovering correlations (Bollier and Firestone, 2010). However, 
there is a lack of specific research on the effectiveness of such techniques for assisting the lay-user 
in understanding complex multivariate data. Within this medical context, this interaction must be 
carefully designed, as presentations of data can reinforce biases rather than lead to actual insights 
(Mamykina and Mynatt, 2007). It is also not clear that current products are adequate for meeting 
user needs, as most available diabetes oriented products are primarily for the collection and 
visualization of data, and are often difficult for users to employ (Doryab et al., 2015). And while 
there are many papers that have assessed the effectiveness of an app (Gouveia et al., 2016), 
usability and the limitations of  screen dimensions (Lapin, 2014), or describe a participatory design 
process (Arsand et al., 2007), there is still little available research specifically addressing how 
mobile UIs support self-management processes through assisting actual users in extracting 
actionable insights from collected diabetes relevant data.  
5.1.2 Efficacy and known barriers to adoption  
As discussed earlier, despite considerable effort in assisting diabetes management with mobile 
digital informatics tools, and some positive results (Wu et al., 2017), the last chapter discussed 
some of the  considerable barriers to long-term adoption, while actual efficacy of apps remains 
controversial. In addition, the affective nature of interventions must be carefully considered, with 
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(Blondon et al., 2013) noting how tracking could increase feelings of disease burden while 
(Breland et al., 2013) questioned the clinical validity of many of these apps. Such inconclusive 
results suggest the need for further research to better understand the individual components that 
make up these apps, and how to improve them as tools for supporting better self-management 
practices. 
5.2 Methods for the Study 
In order to compare the utility of different data visualization paradigms, we initiated and analyzed 
mediated sessions in which people with diabetes explored pre-collected diabetes data (see “data 
preparation” section below), These sessions employed 8 representative methods of visualizing data 
taken from 6 free iOS apps. The visualizations examined were: daily logbook, scatter plot, 
connected scatter plot, daily logbook w/ graph, pop-up cards, statistics, data table, and pie chart 
(see Figures 5-(1-8)). 
5.2.1 Apps included in the study 
The app selection criteria were designed to address three considerations. Firstly, we prioritized 
coverage of what our cohort actually uses, by selecting the 3 apps most commonly mentioned in 
the pilot survey reviewed in Chapter 4 (mySugr, SiDiary, and iBGStar). Following that, apps were 
selected from the app store to ensure representation of principal UI techniques of data visualization. 
Finally, we made selections from within these categories, prioritizing free apps of particular 
research or industry interest: e.g. Bant was developed by a medical center through a participatory 
design process, with several academic studies on its use; Accu-chek was the centerpiece of a 
commercial diabetes product eco-system; Diabetik was a patient initiative, crowd funded project. 
While there are newer UI’s, these methods of data visualization are standard and widespread. 
5.2.2 Assumptions guiding study design 
This study did not test usability in regards to entering data, which is a known barrier to adoption 
(Katz et al., 2015), as the primary focus of this study was the ability of interaction designs to 
support retrospective analysis of collected data. Pre-entered diabetes data was used within the 
chosen apps so that all users would be viewing identical information. While this methodology has 
the limitation that the data has not come from the individual participant, and therefore lacks 
personal contextual cues, it also offers the following advantages for our specific study goals which 
could have been inhibited by the use of actual personal data.  
• This study sought to gain knowledge as to a specific UI’s ability to communicate 
information, as opposed to helping people remember events, which would be a valuable 
(but different) study question.  
• A standardized data set also limited confounding variables; for example, if one participant 
had easier to locate patterns or more ‘ideal’ measurements, this could have complicated 
comparison between subjects.  
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• A common data set also allows a uniform and testable within subject experience across 
multiple apps, interface elements, and users.  
• Finally, reproducibility is also a benefit of such an approach, as well as providing a 
convenient method of comparing new UIs against older interfaces.  
If users could readily extract significant value from such data, and reported favorably on such 
interactions, this would suggest that they could do at least as well cognitively with their own data. 
By contrast, if users struggled to understand or interact with data, or expressed clear concerns for 
cognitive, affective, or other reasons apart from conventional usability issues, then this might 
indicate the need to address the underlying interaction paradigms themselves. In addition, such 
empirical qualitative research can help to form an evidence-based foundation for future design 
(Hekler et al., 2013). While in early planning stages we considered using printouts, ultimately it 
seemed important to use an actual device to test interactions. I mounted iPhone 5s running iOS 9 
mounted into a custom-built lightweight rig that allowed a fixed webcam to record audio and visual 
interactions. The participant held the phone in one hand naturally, while manipulating the 
interfaces with the other (see Figure 5-1). 
 
FIGURE 5-1 RIG FOR DOCUMENTING APP INTERACTIONS 
5.2.3 Data preparation and procedure 
It was originally hypothesized that we could measure the success of an interface, according to time 
and effort required to locate specific pre-determined insights. To this end, I fabricated 1 month of 
diabetes data in consultation with a diabetes care professional. However, it became apparent that 
such an approach was overly artificial as several participants (P1-P4) noted that the recorded values 
didn’t look authentic, and the act of probing for clearly defined solutions seemed too removed from 
natural interactions. To correct for these discrepancies, I recorded 14 days of my actual diabetes 
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data comprised of blood glucose levels, carbohydrate intake, exercise, and insulin dosages (Katz 
and Price, 2018). There were 173 resulting entries recorded into each of the 6 selected apps. This 
new set was then used from the 5th participant onward. However, as these pilot observations on UIs 
were generally consistent with later results, relevant participant observation have been included. 
Participants were not notified as to origin of data, as to not bias responses. The sessions began with 
a briefing and a consent form. This was followed by a short profile questionnaire on personal 
characteristics, product choices, and patterns of diabetes app usage (see Appendix B: Chapter 5 
User-Interaction study forms). Participants were then read the interaction procedure and instructed 
to ‘think aloud’ as they used the apps. To increase engagement, it was suggested that participants 
might role-play that they were advising a newly diagnosed person with diabetes who was showing 
them personal data or alternately to imagine that the data was their own. A variable length semi-
structured user interaction session lasting between 20-65 min. was then conducted. Participants 
were asked questions which were informed by the pilot study presented in the previous chapter, 
particularly utility of the interface and affective nature of the interactions:  
• What do you see about the BG control in this period? 
• Would this system help you make better decisions about your diabetes management? 
• How do you feel about this interface? 
• How does this interface make you feel about being diabetic?  
The order of the apps presented was random, though due to time limitations and some UIs more 
quickly reaching saturation of opinion, the focus remained on interfaces which were receiving 
richer or more varied responses. This led to not all interfaces being viewed by all participants, and 
therefore not all denominators are equivalent. Videos were transcribed, and then coded in NVivo, 
according to app, interface type, and the two themes which emerged from the pilot study, emotional 
impacts and app utility. The use of NVivo allowed for the videos and texts to be viewed 
synchronously, thereby supporting easier classification of the responses to the relevant interface. 
Responses coded as describing an emotional response were then further classified within the 
ordinal sub-categories: positive, neutral, negative. Responses coded as referring to the utility of the 
app were classified into the ordinal categories: helpful, mixed, not helpful.  I had originally hoped 
that this approach might produce opportunities for statistical analysis of different design 
approaches. However, the relatively small sample size caused by the challenges in participant 
recruitment and large amount of time required for data processing curtailed the validity of this 
approach. Therefore, an alternate approach was selected that sought to present the diversity of 
participant responses. After the participant responses had been classified, they were then filtered 
according to app interface and ordinal classification, in order to select representative quotes. 
Preference was given to what I judged to be particularly emphatic or descriptive responses. The 
quotes classified as affirmative (helpful, positive) will be presented within the text under the 
heading Benefits, while negative responses are presented under Limitations.  
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The Open University Human Research Ethics Committee granted approval (see Appendix 1: 
Chapter 5), and there were no financial incentives offered.  
5.2.4 Participants 
I recruited 16 type 1 diabetic adults through a Berlin based diabetes and technology Meetup, 
convenience sampling, and a 1-day Berlin-based type 1 diabetes event. The inclusion criteria 
included being type 1 diabetic, over age 18, and speaking conversational English. Age range was 
from 25-49 years with a mean age of 33.7 years (SD 7.5). Time since diagnosis ranged from 2-31 
years, with a mean of 13.5 (9.1). Gender was 5 females and 11 males. Overall, 13/16 participants 
worked or studied in a diabetes related field, information technology, graphic design or software 
design, and 9/16 reported post-graduate education, thereby this group was potentially biased 
towards diabetes knowledgeable and engagement. All participants reported they were comfortable 
with smartphones and 13/16 had previous experience with diabetes diary apps. At the time of the 
study only 1/16 of the participants was a current daily user of diabetes logging apps, and three 
participants stated that they still used diabetes apps on occasion. This rate of diabetes app adoption 
was in accordance with the pilot research discussed in the previous chapter. 
5.3 Findings (Organized by 8 Visual paradigms) 
The following sections report on observations in regard to participants’ interactions with the 
selected interfaces. Reporting on known and easily fixable usability shortcomings such as slow 
scrolling or insufficient font size, are excluded. In some instances, more than one example of an 
interface paradigm was tested, and their results have been combined, though due to space 
limitations, only one interface of each type is pictured. The analyzed benefits and limitations for 
the selected apps are grouped by the 8 identified interface paradigm as follows:   
• Daily Journal 
• Daily Logbook with Connected Plot 
• Non-Connected Scatter Plot 
• Pop-up cards; Statistics 
• Data table 
• Pie chart.  
5.3.1 Daily Journal Interface  
(see Figure 5-2 Diabetes Journal/logbook) 
While the daily journal is considered a principal component of diabetes self-management apps, 
users had mixed response as to the utility of this approach for reflecting on collected data. 
Participants were, for the most part, capable of retrieving stored data from these interfaces and 
understanding significance, but many found locating correlations across multiple days or finding 
deeper insights challenging. As the smartphone-based log allows the collection of extensive data, it 
could be useful for distinct goals, such as recording data before a medial appointment, but appears 
limited as a daily management tool by itself. 
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5.3.1.1 UI Benefits 
P7 found the Accu-chek logbook serviceable, stating “it’s very easy to scroll through it forward 
and see.” P7 was also able to assess a day in a meaningful way, “…if I had 16.0 one of my tests…I 
need to take immediate action to bring it down, even 14.0…so having 3.0 is the same, you would 
have some sugar to bring it back up…” P7 also emphasized the common theme that such records 
would be useful for interacting with clinicians, “very good records of everything …I’ve got good 
amount of information to hand off to my doctor” P9 explained that such apps support recall of 
specific diabetes relevant data, “…well I understand what it’s saying…on an individual point by 
point basis …I can understand each one, like time, action, and then amount”  
5.3.1.2 UI Limitations 
Despite benefits for browsing data, it was not clear how useful this function is for situated self-
management. P7 when asked if this interface would help with daily diabetes management, stated “it 
gives you a lot of information, so it has the potential to (help) but the likelihood is, if I put up this 
data, I wouldn’t bother to look…so it probably wouldn’t help…. I’m a little bit overwhelmed with 
information.” P12 felt a disconnect from such interfaces, “it’s just about numbers…” P15 brought 
up the negative emotional aspects of tracking diabetes, “…I have a feeling that I have to record 
everything, so I have actually to track my life every year every hour almost… it’s not a good feeling 
at all…I’m not feeling free…if I track what I’m doing all the time.” And P9 firmly rejected the 
paradigm, “I probably wouldn’t use something like this, I would just find it frustrating and time 
consuming and not …providing me what I would want…  
 
    FIGURE 5-2 DIABETES 
JOURNAL/LOGBOOK 
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PLOT 
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5.3.2 Daily Logbook with Connected Plot  
(see Figure 5-3 MySugr Logbook/ Connected Plot) 
This interface combines a daily diary and a graph, which scroll together in unison. This appears to 
add value, and responses tended to be improved over the logbook alone. Still, underlying patterns 
across multiple days remained difficult to locate. This interface could be helpful for attaining a 
daily overview.  
5.3.2.1 UI Benefits 
Pairing the logbook with a graph enhanced the ability to understand the flow of data and was in 
general better received than the diary alone. For example, P6 stated “…this here is actually quite 
nice because you can see the graph…if you have the diabetes diary you don’t have the distance 
between the points…just from time to time when you test …so that’s actually better.”  Such an 
overview could be useful for assessing a day, for example P5 reflected, “If this was my day… I 
(would) immediately … see why this was a bad day…I didn’t do proper therapy.”  
5.3.2.2 UI Limitations 
However, 8/12 participants who interacted with this interface noted that the benefits of this system 
were still limited by lack of support for understanding underlying patterns. P16 questioned the 
value for data analysis, “…I like the option to kind of wander through your glucose levels and so 
you can easily see if it (there) were rough times or everything went well, but…(to) get a deeper 
understanding, I don’t think it’s really helpful for me.” And P11 expressed visual overload, “it’s 
just too much going on, there’s no focus.” P3 drew attention to the limits of this interface for 
understanding connections across multiple days, “it’s not easy to compare two days, you have to 
always scroll up and down.” P3 also noted an inherent challenge in this paradigm, that the lack of 
screen space necessitates putting more contextual information in a submenu or slider, “(it’s) really 
annoying that you can only see more information if you click on it…so for analyzing, it’s really 
difficult to see what’s going on in your day.”  
FIGURE 5-6 ACCU-CHEK 
CONNECTED PLOT 
FIGURE 5-7 DIABETIK 
STATISTICS 
FIGURE 5-8 IBGSTAR 
DATA TABLE 
FIGURE 5-9 SIDIARY 
PIE CHART 
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5.3.3 Non-Connected Scatter Plot (Fig. 5.4) 
(see Figure 5-4  iBGStar Scatter Plot) 
Scatter plots are a common means of displaying time series data, however some participants found 
this UI overwhelming. This UI can give a general overview of control, but, recognizing patterns, 
time of day, or translating this overview into actionable information can be challenging.  
5.3.3.1 UI Benefits 
The primary use of this interface appears to be general retrospective assessment of frequency of 
in/out of range values and overview of deviation. When asked to reflect on the data, P11 observed, 
“so again most of them were alright… but a lot of them were too high and some of them were too… 
low.” Some participants noted that this could help motivate their diabetes management, for 
example when asked what they would think if this was their graph, P6 said “seeing this many high 
blood sugars, I’m thinking oh man you should do something, you have to change something.” 
5.3.3.2 UI Limitations 
Despite some benefits, 10/13 participants who interacted with this interface expressed reservations.  
P9 noted that the lack of connecting lines between dots made it difficult to understand the time 
series relation between data points, “the data … difficult to put it together…without the lines, 
there’s so many points of data. It’s hard to distinguish the trends…” And P4 noted, “no, these dots 
don’t tell me anything because they don’t have a relation to the other dots.” P7 noted the lack of 
greater insights, “to find out what to do, I would probably have to look at each individual data 
point and kind of aggregate the knowledge.” And P16 stated, “(it’s) not easy to extract what I think 
needs to be extracted...” And understanding daily patterns was not well supported as P6 noted, 
“…this system lacks the ability to easily view time of day.”  In general, the lack of context seems to 
restrict the value for translating this collected data into actionable information. As stated by P8, 
“there`s no context provided to explain why the value is that high, so I can`t draw any conclusions 
from it.” And P12 noted the negative affective impacts from viewing red dots indicating out of 
range values, observing that the viewed values would be “...demotivating, because maybe I tried to 
do my best to have more green dots… I failed.”  
5.3.4 Pop Up Cards  
(see Figure 5-5 iBGSTAR Pop-Up Cards) 
Pop-up cards received positive feedback for allowing primary interfaces to remain uncluttered 
while allowing on-demand access to additional contextual information. While accessing such 
additional data is needed to understand the cause and effect relationships that affect BG levels, 
placing such information into sub-systems appeared to create excessive cognitive load.  
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5.3.4.1 UI Benefits 
Providing additional contextual information allows for in depth information, such as insulin 
dosages and exercise, without cluttering up the primary interface. P16 noted, “actually I like that… 
because it looks …clean and if you want more data you can get it.” 
5.3.4.2 UI Limitations 
In terms of understanding individual entries, this system appeared serviceable. However, in the 
larger context of understanding the implications of data, the sub-system creates cognitive 
challenges. P8 noted, “the entries are easy to understand… it`s pretty accessible, but the analysis 
isn’t.” This is especially problematic in pattern recognition across multiple days, an essential 
aspect of self-management. P3 observed, “…there’s too much information. Too many 
numbers…and (to)… compare the number here above …I’ll have to switch through...to 
compare…two dates.” And P9 observed, “…it just makes it a lot more time-consuming. It’s harder 
to process the data because…to …get the information for everything that I need, (I have to) to go 
through each point individually…” And P9 continued, “…I feel…a little bit frustrated trying to 
figure out what I needed to do. Using this it seems like it would be a lot of work to get the 
information that I would want out of it.” 
5.3.5 Connected Scatter Plot  
(see Figure 5-6 Accu-Chek Connected Plot) 
Connecting data points on a graph appeared to increase readability by better conveying the 
sequential nature of events and conveyed a general assessment of BG control. However, gaining 
more in-depth insights remained challenging, especially on a mobile device. While there are some 
benefits, this still appears to be a tool for general assessment rather than specific event decision 
support.  
5.3.5.1 UI Benefits 
Like the scatter plot, this visualization also gives a broad overview of glycemic stability. However 
relative to the non-connected plot, connecting the data points increases the ability to perceive the 
relationship between measurements. P8 observed, “...because the dots are connected…it (is) 
possible to see some kind of trend.” While such an overview could also suggest potential treatment 
improvements, as noted by P4 who suggested that this deviation could indicate the need to adjust 
insulin therapy, “… this going up, going down, going up… cycle.  I would say the (basal) insulin is 
not working well.” P9 also felt that while viewing such information could be stressful, it could also 
be beneficial, “… it would be frustrating to see, but also a little bit empowering knowing that I 
could see what I needed to do to make it better.” 
5.3.5.2 UI Limitations 
The small screen on the iPhone 5s appeared to limit the value of this graph, especially in terms of 
labeling, determining time of day, and correlations. P16 noted, “…we are always looking for 
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parallels between times and values or accidents and value, it’s really hard to tell because the 
screen is so small…” P9 agreed, stating “it’s hard to tell where the times are, because this just 
listed on it on a … daily basis but I think that’s probably just an issue it’s dealing with it on such a 
small screen.” P9 concluded, “I think it would be more useful on a computer than on the 
smartphone.” And P7 reported mixed impressions, stating “this is cool stuff…you’d want to look at 
(it), but not on a daily basis, it would be kind of like if you want to reflect on the last week or the 
last month …” P7 on observing the out of range values observed, “I would feel pretty negative 
about fact that I had gone high and it probably a little bit confused about how to improve 
it…there’s not really any indication about what to do to improve the situation I’ve definitely can 
see that it’s bad but…” and P5 similarly found the tool to have limited value, saying “…just the 
graph doesn’t really help…you just see the value. It’s useless. (It) gives you that good day or a bad 
day feeling but…” And P15 had a similar response, “the only conclusion I can make is that I was 
six times too low and many times too high, but I don’t even see the day here…(it’s) complicated.”  
5.3.6 Statistics  
(see Figure 5-7 Diabetik Statistics) 
Statistics allow a glanceable summary of time series data. Some participants noted this to be 
motivating through drawing attention to the need for greater attention to care. However, such 
numbers can be difficult to understand, or can hide important details.  
5.3.6.1 UI Benefits 
Statistics, especially when presented without visual clutter, can help alert users to important general 
tendencies.  P11 commented on the Diabetik interface, “…simple clean overview of your highs and 
lows…this gives you a first indication of if you have a problem.”  P11 reflected on this interface, 
“…the average seems to be a bit little bit too high and …21 times too high blood sugar. I would 
…look a little closer about the high blood sugar.” Having the time period clearly labelled, seems to 
be important for some users. P7 was positive about this feature noting, “I like how it was broken up 
into month summaries…” And P15 noted that cumulative data could help with general goals for 
diabetes management, “I will try to reduce …how many times for example I’m too low.” And P9 
felt that seeing personal data as numbers instead of viewing the high points on a graph was less 
stressful, “…sometimes …when I look at big, overarching trends they can be discouraging. But 
sometimes it also gives it makes me feel more empowered to change things…the fact that it has 
numbers, and the way that it has it laid out, instead of it being like ups and downs, and seeing all 
the things from the graph, it …doesn’t make me feel as bad about it.” 
5.3.6.2 UI Limitations 
Yet for other participants, information presented this way were perceived as limited in utility. P15 
suggested it would not provide sufficient actionable data to guide action, “I mean somehow it’s not 
enough...I want to see the reason…for example I need to see whether it was in the night, and if it 
was in the night…was it too low…or too high...” P15, who holds a PhD in mathematics, also 
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observed that average can be a misleading statistic,“…so I definitely see how many times it was too 
high, (and) how many times it was too low and this is actually interesting information for me and of 
course the average blood sugar. But average is a complicated number. So, I don’t know …how to 
interpret this average.” P16 also brought attention to the potential misleading nature of averages 
based on small numbers of data points, “…it’s not the average, but just the average based on those 
three four five tests I had that day, and that is actually wrong information.” For some users, 
statistics are challenging to apply, as P6 stated, “…my goal range, my average, ok so I can see the 
average of my blood sugar at breakfast lunch dinner at bed time …it’s too confusing for me.” The 
inclusion of standard deviation brought mixed responses. P5 was positive, “I think that standard 
deviation is much more important than Hb1c (a cumulative 3-month average of BG levels) or 
overall … hypers (hyperglycemia) or hypos (hypoglycemia).” However, for others these features 
offer limited real-world value. P1 stated, “I don’t think these are super helpful because they just 
aggregate a lot, and I don’t know enough about statistics, and I don’t know what do with that…I 
know what deviation is, but I have no idea how to relate it to the number of tests.”  
5.3.7 Data Table  
(see Figure 5-8 iBGStar Data Table) 
Data tables are an established form of interaction with diabetes information, a method of 
organizing data extended from the hand-written diary. Therefore, this form has the advantage of 
familiarity, and also provides the ability to view many days simultaneously. While some users were 
positive about this UI supporting quick overviews, others were either confused, or felt that such 
structures were not useful. 
5.3.7.1 UI Benefits 
Having many days of BG values in simultaneous view, especially when color-coded, allows for 
easy recognition of out of range values. P16 found this useful, noting “for me it is much more 
structured, …I get first attracted to compare all the post breakfast entries, and at the first glance I 
see that they are too high, but I actually see the low ones, 50’s and 60’s they were out of my sight 
somehow.” Noticing such details could be important for adjusting insulin dosages, as the low BG 
values could argue against a general increase in morning insulin. In contrast, averages could hide 
such insights. P9 also expressed that such formats were useful, “…It seems like to me you can get a 
holistic view of each day, seeing what your blood sugars were.” P16 noted that such data 
structuring was “helpful and easier to understand right away…I can just compare the entries for a 
given time zone like what we have post-breakfast. I can easily compare (that) they are all too high 
for example…(to) change the dose or the meal.”  
5.3.7.2 UI Limitations 
Despite some benefits for trend discovery, the volume of data was cognitively challenging for 
some. P3 observed, “I’m overwhelmed with numbers…if you look at (it) as a normal user and the 
first time you are confused and overwhelmed by information.” And P11 also found the format not 
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especially helpful “…it’s (like) getting through (spread) sheets…it feels technical, you don’t get an 
overview.” And P16 was critical that the format was poorly suited to her needs, “what I don’t like 
is what I always hate about log books. It’s this breakfast, lunch, dinner, night thing, because my 
day is just not structured like this. I feel like I am supposed to have that given structure and I just 
feel I don’t want to.” P15 found this paradigm although familiar, was not delivering needed added 
value, explaining “…for me that is just a piece of paper…That is what my doctor wanted… he gave 
me a piece of paper with such a table and said okay now you can write it down…it is not useful at 
all.” 
5.3.8 Pie Chart  
(see Figure 5-9 SIDIARY Pie Chart) 
The Pie Chart gives a quick sense of values in set ranges and appeared to successfully impart a 
general assessment of distribution. However, it seems limited in its ability to support decisions. It 
might be a tool best reserved for occasional demonstration of a particular insight or observation. 
5.3.8.1 UI Benefits 
This interface was effective in communicating a general overview of how often the data was within 
certain glycemic ranges.  P15 noted, “ok, I definitely see what is the percentage of my desired 
range, where I want to be, and (how often I was) too low, and where I (was) too high or really too 
high…I see that only 37 percent is in my desired range, and I definitely sees that I’m too low too 
often.” And P6 could interpret this chart to suggest the need for modification in management, 
“okay so … it tells me I have to improve something if every third test is high, really high blood 
sugar I have to do something. 20% is nearly ok, only 37% is okay, and I think it should be much 
more. So, I have to work to get my average value down.” 
5.3.8.2 UI Limitations 
Despite certain benefits, this chart lacks support for interpretation. P9 explained, “the pie chart 
probably wouldn’t help me make decisions, but it would probably help me just to understand how 
I’m doing in a general way.” And while P9 rated this interface as “easy” to understand, also stated 
that the “utility of it is limited.” And P11, a professional designer had a strong negative response to 
pie charts in general, “…I hate to look at pie charts, it makes me vomit. I really, really, hate it. So, I 
wouldn’t open the app and look at it. I think it’s too ugly.” 
5.4 Discussion 
Throughout analysis of participant responses, it appeared that these interfaces were for the most 
part capable of helping people reference data. Furthermore, participants were well aware of the 
meaning of these data points. In this sense, the usability of these UIs is reasonably successful. 
These UIs are also well suited to giving broad overviews which can be helpful for assessing 
performance and for some users can be motivating. However, the communication in regard to self-
management is largely implicit, depending on the user to interpret data. Explicit and specific 
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actionable information is generally limited. Given the frequent demands of diabetes management, 
this study indicates the need for more actionable interfaces, that offer a cognitive load sweet point 
where useful knowledge is easier to acquire, while still keeping users mentally engaged with their 
data. One path forward might be for these apps to offer better filters to help users sift through data 
or specific contextual clues which could indicate where to focus attention. In addition, there are 
indications that excessive focus on past data is not well suited to user’s actual needs for situated 
decision making and can place emotional strain in some circumstances. 
5.5 Three Questions for Designers of Mobile Health Apps  
In the previous sections, selected quotes drew attention to benefits and shortcomings of specific UI 
paradigms in relation to user interaction with a sample diabetes relevant data set, drawing attention 
specifically to two areas, cognitive and affective challenges. The following three sections identify 
unresolved design issues for designers of diabetes self-management apps. The first two sections 
relating to the cognitive and affective challenges, and a third more general question related to 
accessing the extensive self-care knowledge shown by our participants. For each section there is:  
• An open question raised by the study 
• Current approaches 
• Problems or shortcomings 
• Challenges 
• Possible directions in which answers might lie.  
By evidencing each of these areas of concern and by identifying those that seem to have most 
impact on users of health apps for diabetes, attention is drawn to the potential for improvement of 
well-accepted UI paradigms in this area, and to emphasize the importance of finding new 
approaches for health app interaction design.  
5.5.1 Improving interaction with data  
How can we design engaging UIs that lower the cognitive demand associated with interacting and 
deriving value from complex data? 
5.5.1.1 Shortcomings 
There was a relatively low adoption of these technologies among our participants, despite a 
majority of individuals reporting technological skills and interest in diabetes products. It did not 
appear that the positive aspects of the interfaces created sufficient enthusiasm to encourage active 
and frequent engagement. As P11 said, such interfaces are like “filling out an Excel spread sheet 
for the rest of my life.” While it might be thought that increasing automation of data collection 
could help overcome this problem, the study suggested that these standard data visualizations can 
create confusion and cognitive overload for even educated, and technology adept users. For 
example, information presented on multiple screens or hidden on sliders, created excess cognitive 
load. P3 noted how difficult it was to compare information across multiple days if it was not 
simultaneously visible. Such limitations suggest that increased automation will not cause these 
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apps to provide adequate support for utilizing collected data, without rethinking the general 
assumptions of these methods for visually presenting data. 
5.5.1.2 Current approaches 
The apps in the study used widely accepted methods for visualizing data. In many cases, 
participants felt that the described interfaces could assist in gaining overviews and informing 
management decisions. The plotted graphs, especially with connected dots, were successful in 
communicating frequency of test within certain ranges and gave an overview of variation. For 
example, P4 noted how such extreme variation could be indicative of the long-acting insulin 
needing adjustment to smooth deviation. Statistics, and pie charts were appreciated for giving 
benchmarks for performance, with P11 noting how such overviews could give a clear indication of 
problems that needed to be addressed. Data tables, especially when color-coded, allowed quick 
overview of multiple days, and could help to detect obvious patterns, such as sequential elevated 
morning glucose levels. P9 noted that such structures helped with getting a quick overview of a 
day.  
5.5.1.3 Challenges 
Parts of this first design challenge is neither new nor original, but, given continued acceptance and 
application of these visual techniques and the evidence presented, it is critical that new methods be 
explored, especially in regard to multivariate data. As noted previously (Mamykina and Mynatt, 
2007), care must be taken in development to assure that such interfaces challenge rather than 
confirm biases. In the case of health apps in general, and diabetes apps in particular, designers need 
to consider the challenge of reducing the cognitive demands of interacting with complex data in the 
context of usage requirements, such as: high frequency; short time periods; varied contexts of use; 
emotional sensitivity (see next section), and lack of situated professional assistance.  
5.5.1.4 Potential paths forward 
One simple but often overlooked and underexplored visualization technique is to offer a tilted 
arrow showing trends (first derivative) over appropriate time scales. This approach fits well with 
regular automated data collection. For example, the home UI on the Abbott Libre supplements 
standard display elements such as current BG level, and graph of BG over time, with a vector 
arrow showing current rate and direction of BG change (see Fig. 5-10). This interface element is 
compelling, allowing for practical and glanceable situated advice. The user feedback in this chapter 
appears to suggest further exploration in departing from conventional graphs and charts as standard 
daily management tools, in favor of simpler and more intuitive approaches.  
5.5.2 Emotional sensitivity 
How can we design emotionally sensitive interfaces that draw attention to important but 
unwelcome information while continuing to engage the user? 
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5.5.2.1 Shortcomings 
Collected health data can have an affective aspect that must be carefully considered when 
designing UIs. Alerting the user to urgent information, such as a dangerously out of range BG 
values, must be balanced with maintaining long-term engagement and not causing undue stress. As 
P16 recalls about their experience using a diabetes app “it’s nice when your blood glucose levels 
are under control, but once it’s not… the app doesn’t help you, and…I (got) more frustrated by the 
messages and the designs…” When people with diabetes are having a difficult time controlling 
blood glucose levels, they can feel vulnerable, and being confronted with this perceived failure can 
be counterproductive.  
5.5.2.2 Current approaches 
One approach in diabetes apps is gamification, for example the use of an animated ‘monster’ in the 
popular app mySugr. However, such approaches can be self-defeating. For example, P16 felt the 
monster trivialized disease management, stating, “I’m an adult, and I feel treated like a child.” Or 
P11 who commented on the same app’s sound effects, “I really hate the sound… it’s just too 
playful for me.” The Akku-Chek app, chose to use blue for elevated BG levels, rather than the 
more conventional red, which was perceived positively by P12 who remarked that they liked 
having this color scheme as it reduced stress.  
5.5.2.3 Design challenges 
Due to variations in personality, it is not clear that there are universal solutions when it comes to 
affective requirements. For example, while P9 noted how seeing numbers instead of out of range 
points reduced stress, P15 drew attention to how having their life reduced to a continuous set of 
numbers created a sense of burden. Similarly, while P12 noted how viewing red dots could have a 
demotivating effect on diabetes management, P7 observed, “I don’t really know why the high 
numbers are blue because… blue seems like a good thing to me.” As out of range BG values not 
only demand immediate attention but are also a constant reminder of long-term risks and failure to 
maintain adequate control, there are diverse factors to be balanced. Examples include variation in 
personalities, contexts, and, levels of urgency. 
5.5.2.4 Potential paths forward 
It is vital that user tests be carried out not only with ‘good’ data, but also with ‘bad’ data, which is 
to say data that reflects undesired states. However, different users have different goal ranges, which 
can vary according to context. For example, P4 noted “I need to put my blood sugar at 250 (mg/dL) 
when I’m working because I don’t want to (have) low sugar on machines.” This highlights the 
importance of clarity about care targets for different individuals in different contexts, not just in 
interaction design but also when personalizing data for testing purposes.  The importance of 
variation in individual preferences might suggest the need for adaptive interfaces or better options 
of customization. While this is a perennial topic of research (Bailoni et al., 2016), it is largely 
unexplored in the present context. 
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5.5.3 Triggering acquired knowledge 
How do we design UIs that trigger the user’s acquired knowledge at the appropriate time? 
5.5.3.1 Shortcomings 
Throughout the study, participants drew upon their already acquired and often extensive knowledge 
as they sought to make sense of the data. For example, P1 noted that a low BG was probably 
caused by exercise, before looking for confirmation. Similarly, P4 suggested that a high BG level 
could have been caused by an insulin dose that was supposed to last 24 hours, but, in her 
experience, due to shorter actual action, is best administered in split dosages so as to not leave gaps 
in coverage. Such examples lend support to the previously discussed Mamykina et al.’s 
sensemaking theory (see section 2.1.7) which asserts the importance of learning and then accessing 
a catalog of mental models that allow for practical and sustainable management. However, the 
findings suggest that it is far from easy to recognize which relevant knowledge could be applied to 
a data pattern, and this could be even more difficult when users are under common pressures such 
as cognitive, affective, attention, or time. The key shortcoming here is simply that none of the 
representative health apps appears to directly address this problem. 
5.5.3.2 Current approaches 
Some apps, such as mySugr, include contextual tags paired with icons for common factors that can 
affect BG levels, such as manual work, sickness, or travelling. However, these are entirely 
dependent on the user’s motivation to participate in extensive logging and effortful reflection.  
5.5.3.3 Design challenge 
In a slight modification of Intille (Intille, 2004), we need to find ways to help trigger the right 
model, at the right time, in the right way. Due to the off-putting drudgery (for many) of maintaining 
continual diaries, acquisition and delivery of such information needs to occur without continual 
manual data input from the user.  
5.5.3.4 Potential paths forward 
It appears that systems able to meet such challenges will need to learn about the individual user, 
and what specific knowledge they must access in a given context. One possible starting point is the 
work of (Pejovic and Musolesi, 2014) on ‘tool-effect-modeling’, which proposes a system that 
correlates sensed behaviors with desired outcomes. Once these connections have been established, 
they can then be used to create an anticipatory positive feedback loop. Thereby encouraging the 
personal and specific behaviors that have been previously beneficial. While this appears a 
compelling approach, care must be taken to not trigger incorrect models, which could bring about 
harmful actions. Also careful attention must be taken as to the nature of this human machine 
relationship: (Ohlin and Olsson, 2015) is an insightful paper on this subject. Other relevant work 
includes (Doryab et al., 2015) on ranking behavior impact factors, and (Gouveia et al., 2016) for 
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work on glanceable displays that provoke the user to ask meaningful questions rather relying on a 
system supplying explicit answers.  
5.6 Limitations  
As noted previously, participants did not reflect on their own personal data, which through greater 
familiarity and attached memories could have increased insight extraction. The approach to 
recruitment may have led to a non-representative overly technically literate and early-adopter 
group. This may have biased findings towards the success of the technology; however, the many 
challenges encountered by this group might suggest even more problems with less technologically 
literate users. Many apps tested (5/6) used mmol/L as units for stored BG values, while some users 
were only familiar with mg/dl. While they were instructed as to the conversion factor and provided 
with a conversion sheet, this might have decreased performance (see Figure 2-2 Non-Diabetic vs. 
Diabetic glycemic values and Contributing factors).  
5.7 Conclusions 
Sessions with 16 users interacting with representative UI designs for diabetes self-help apps have 
been analyzed to see how well they meet users’ needs. This study draws attention to two principal 
areas of failure: excessive cognitive demands on users to extract value; and the need for emotional 
sensitivity given the affective potential of these interactions. Cognitively, these apps require too 
much effort to make sense of data and locate meaningful insights, exposing users to visual 
confusion and cognitive overload. Emotionally, the complex relationship users have with their data 
appears inadequately considered. This section also proposed 3 questions for designers to advance 
these tools so that they can serve a more meaningful role in people’s lives.  
If the purpose of such apps is variously: to provide a digital tool for periodic troubleshooting of 
specific problems; recording diverse data for interaction with a health care provider; and to give the 
patient broad overviews of collected data; then one may consider these apps tolerably successful. 
These participants were generally comfortable browsing through and understanding the 
significance of individual data entries, and in most instances, given a little time for close 
examination, could understand data within graphs and charts. Yet, as this study has illustrated, 
users’ day-to-day needs appear somewhat different, with many participants noting the challenges in 
understanding their personal data and maintaining active engagement with the diabetes care 
process. As discussed earlier in the literature section, the majority of diabetes care is self-care, and 
patients should be enabled to independently make frequent well-informed care decisions. Based on 
these premises, the current study gives evidence that these current diabetes apps are inadequate for 
such goals. Given the number of apps based on a narrow range of interaction and similar UI 
designs, one must ask why so many app developers continue to deliver apps that fail to adequately 
address users’ problems, require significant daily effort to assemble representative data, show 
debatable improvements in outcomes, and have low adoption rates. 
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While the desire to avoid medical regulation is a factor, perhaps it is also because they adhere to an 
approach that is too closely tied to clinical requirements and conventions that focus on a mediated 
session with a clinician, and thereby are ill suited to actual user requirements and expectations 
which are primarily oriented towards self-management. It is worth considering that this might not 
just be a matter of adding new ways for patients to record more data, automation of data entry 
alone, more attractive color schemes, or even more visually appealing designs and interactions. 
Rather there is a need to re-consider how to help users draw value from real and often noisy 
diabetes data. Furthermore, there must be realistic assessment of available cognitive expenditure 
and emotional resilience given the contexts and frequency of usage. In summary, despite some 
tangible benefits from these UIs, we appear to have a widespread and repeated failure to understand 
user requirements combined with a lack of willingness to challenge established conventions.  
The primary objective of this chapter was to provide empirical evidence for the benefits and 
limitations of specific methods of representing diabetes data. However, these talk-aloud sessions 
also produced rich data on how people with diabetes describe their sensemaking process, as well as 
in-depth stories of past experiences with diabetes care. As I sought methods of analysis, I turned to 
the Mamykina et al. (Mamykina et al., 2015) Sensemaking framework as a structure to categorize 
these statements. Through this process, I found that while many participant statements aligned well 
within this framework, there were other statements that were ambiguous, appearing to fall 
somewhere in between the reflexive responses of system 1 thinking and the effortful problem-
solving which defines system 2 thinking (Kahneman, 2011). Participants often appeared to display 
a stream of conscious weighing of multiple factors which appeared to simultaneously share aspects 
of each. This discrepancy between the collected data and the Sensemaking framework suggested 
the need for further analysis. The following chapter will discuss this process and the following 
research that suggests possible approaches to design diabetes decision support that are more 
compatible with lived cognitive practices.  
 
   88 
 
 
Chapter 6: Fluid Contextual Reasoning  
While mobile technologies, such as blood glucose meters, have long been an essential part of the 
diabetes management process, the previous chapter provided evidence from talk-aloud interaction 
sessions suggesting that designing interfaces that adequately support reflection and decision-
making on multivariate diabetes data remains challenging. Dual-process models (Kahneman, 2011) 
are a widely accepted approach to understanding such cognitive tasks. However, evidence from the 
user-interaction study discussed in the last section suggested that in demanding and complex 
situations, some individuals approached disease management in distinctive ways that do not seem 
to fit well within existing models. On the basis of the resulting analysis, this section posits Fluid 
Contextual Reasoning to explain how some people with diabetes respond to particular situations 
and discuss how an extended framework might help inform the design of user interfaces which 
better reflect how participants appear to interact with diabetes data. This finding motivated, and 
helped frame a second study, a survey (n=192) to investigate these behaviors in more detail, which 
will be discussed in the second part of this chapter.  
6.1 Proposing Fluid Contextual Reasoning 
As discussed earlier, smart devices could potentially become an automated ‘doctor in the pocket’ 
health system, intervening, guiding, and altering lifestyle and medical choices. However, designing 
and implementing effective behavior change interventions remain challenging (Hekler et al., 2013), 
while creating and promoting Decision Support Systems (DSS) raises critical ethical questions. 
Meredith and Arnott (Meredith and Arnott, 2003) outlined key concerns: who bears responsibility 
for recommendations; potential impact on the user’s cognitive structures; and dangers to autonomy 
such as interfering with the user’s right to make final choices. Stawarz et al. (Stawarz et al., 2015) 
concured, noting how automated reminder systems can inhibit independent habit formation, 
thereby causing vital behaviors such as medication adherence to become technology dependent. 
One potential approach to alleviate such concerns could be to support rather than replace existing 
self-care models and behaviors (Pejovic and Musolesi, 2014). For this and other reasons, it is 
essential for designers to understand the existing practices and mental processes of those who live 
with these chronic conditions.  
6.1.1 HCI and Cognitive models  
While there was earlier discussion of theory within the literature review chapter, in order to draw 
attention to the line of reasoning that led to the conclusion of this chapter, the following paragraphs 
will briefly review relevant cognitive theory. 
6.1.1.1 Dual-process cognitive theories 
Dual-process cognitive theories are a leading conceptual approach to understanding the reasoning 
process (Mamykina et al., 2015). Such cognitive theories exist in numerous permutations, with 
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diverse empirical and theoretical backing (Evans and Stanovich, 2013). Evans and Stanovich 
(Evans and Stanovich, 2013) define a generalized version of dual-process theory as: 
 “…one in which rapid autonomous processes (Type 1) are assumed to yield 
default responses unless intervened on by distinctive higher order reasoning 
processes (Type 2). What defines the difference is that Type 2 processing 
supports hypothetical thinking and loads heavily on working memory.”  
Such dual-process approaches have been influential in HCI. Li et al. (Li et al., 2011) discussed in 
section 2.1.7, researched reflection on personal data to increase self-knowledge, observing two 
primary phases of interaction: maintenance and discovery. In the former, participants were 
primarily trying to sustain the behaviors or steps needed to achieve established goals. This phase, 
with its low cognitive demands is analogous to Type 1. In the latter phase, people were asking 
questions, trying to establish cause-and-effect relationships and goals, analogous to Type 2. 
Mamykina et al. (Mamykina et al., 2008) researched how specifically supporting reflective 
processes can lead to realization of cause and effect relationships, thereby enabling diabetes self-
management behaviors. This research led to the Sensemaking theoretical framework which was 
discussed in the foundational studies section (Mamykina et al., 2015), identified the cognitive 
processes used in self-management behaviors, also essentially a dual-process theory. To review, 
this variant, especially relevant to this paper, proposes a dynamic interaction between two modes of 
daily management, habitual and sensemaking. Further, it presents three key stages of decision-
making that occur in both modes: perceiving new information related to condition, understanding 
this information, and action based upon this information. Sense-making behaviors are typically 
triggered when the individual notes a ‘gap’, such as an unexplained out of range BG level. In such 
instances the new information does not fit into an established self-care heuristic, and the individual 
must experiment with new behaviors (sensemaking). Such hypothesis testing leads to the formation 
of new mental models which eventually can be used in an effortless and largely unconscious 
manner. This theory emphasizes that the ability to operate predominantly in the habitual mode is 
important for sustainable self-care, as sensemaking is cognitively demanding. 
6.1.1.2 Tri-process theories 
While there are many examples of dual-process theories in the literature (Evans and Stanovich, 
2013), there are far fewer tri-process theories. Stanovich (Stanovich, 2009) suggested that it might 
be useful to distinguish between two aspects of Type 2 thinking: reflective and algorithmic 
thinking. Alternatively, Varga and Hamburger (Varga and Hamburger, 2014) proposed a tri-axial 
continuous model of control, effort, and speed, asserting that this model allows for better 
classification of real world behaviors: the skilled automobile driver on an unfamiliar road offers a 
clear example. Such a driver has an acquired set of driving skills, which allow for fluid control over 
the vehicle in most circumstances. But, in a context of unfamiliar roadways, she must remain 
attentive and actively engaged. The same basic skills are still applied, but the driver cannot 
function in the largely reflexive mode used on the habitual daily commute. This example offers 
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intriguing parallels to the person with type 1 diabetes who applies a set of acquired self-
management techniques and mental models to navigate the shifting contexts of daily life.  
This chapter investigates how people with type 1 diabetes make decisions for disease self-
management both in routine and abnormal circumstances. This research reviewed suggests a 
cognitive process, under-explored in the literature, that allows people with diabetes to engage in 
rapid stream-of-consciousness navigation of complex situations. We present evidence for this 
process, which we refer to as Fluid Contextual Reasoning (FCR) and suggest that it can serve a 
practical function by allowing a workaround for the respective limitations of more typical ‘fast’ and 
‘slow’ thinking. The second part of this chapter concludes by showing how aspects of FCR are 
already being supported by more recent technologies, and suggest ways in which, based on this 
expanded model, user interfaces for diabetes management could more closely address users’ 
cognitive requirements within specific contexts. This research may have implications for scalable 
health interventions more generally and may help embody an ethical path forward for supporting 
rather than supplanting functional self-care knowledge and models. Even more generally, this 
work, though domain specific, could have relevance to other domains that require informed but 
non-expert users to interact frequently with vital complex data. In order to further our 
understanding of these lived practices of decision-making, we conducted the following studies.  
6.1.2 Methods 
This section used the collected responses from the same sessions which formed the basis of the last 
chapter, in which 16 PwT1D talked aloud as they reflected on 14 days of pre-collected diabetes 
relevant data (BG, carbohydrates, exercise, insulin dosages). As an exploratory technique, I divided 
participant responses into short statements. I then attempted to categorize them line by line. 
Initially by System 1 and 2 (Kahneman, 2011), and then by the Mamykina et al. framework (see 
Figure 6-2).   
Participant observation Sys. Mamykina 
Classification 
FCR Classification 
I wasn't measuring that much 1 Perception gap: BG data_retrieval: BG 
so why it wasn't measuring 2 perception_gap: Time data_retrieval: Time 
yes, so ok this was a night 2 perception_gap: Time data_retrieval: Time 
yes so this day wasn't that good so I see 2 perception_gap:Data FCR:UI 
that I woke up 2 perception_gap:Data FCR:UI 
and it was too high  2 inference_construction: 
Data 
framework_access: UI 
and try to reduce it 2 inference_construction: 
Data 
data_retrieval: Time 
but it didn't work 2 inference_construction: 
Data 
FCR:UI 
and tried it harder 2 inference_construction: 
Data 
data_retrieval: BG 
and then I was too low 2 perception_flow: BG framework_access: Self-
Management it's tells me that I was trying too hard to 
reduce it 
2 perception_gap: Dosage data_retrieval: Time 
so probably next time should shouldn't be 
that strict 
2 perception_flow: BG data_retrieval: Time 
TABLE 6 -1 INVESTIGATORY CLASSIFICATION OF EACH PARTICIPANT STATEMENT 
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While many statements fit well into these frameworks, some statements were challenging to 
classify. In these statements the participant appeared to be quickly weighing multiple factors to 
make judgements (see Table 6 -1).  Table 6-1 was preliminary and is only provided to illustrate this 
initial exploratory process, therefore its sub-categories were discarded and will not be further 
discussed. 
6.1.3 Findings 
The following section reports on participants’ responses during the user-interaction sessions. The 
Mamykina et al. (Mamykina et al., 2015) sensemaking framework is applied as a filter through 
which to analyze these selected excerpts.  
6.1.3.1 Support for a dual-process sensemaking perspective 
During the user-interaction sessions, many participants provided detailed descriptions of the steps 
they undertook to successfully cope with diabetes. P11 for example said: “I think decision-making 
(on) diabetes…it has a lot of steps.  The first step is just recognizing you have a problem … like I 
have a lot of highs. The second step would be…when do I have a lot of highs? What did I do? Did I 
do certain things and then had a lot of highs? What…could the problem be? And then take action 
and then play around a little bit… but carefully.” In this quote we see evidence of the multiple 
stages described in (Mamykina et al., 2015), the first being the perception of a gap, (“you have a 
problem”). P11 then describes the inference stage of considering the circumstances, leading to the 
construction of a hypothesis, which is then followed by experimentation. P11 continues, “And then 
in the last step would be …when I recognize that I had this problem in the morning, first I was 
trying a little bit with the basal dosage and then it helped a little bit and then I thought okay now I 
can play a little more extreme. So, I changed my basal dosage from 12 to 19. OK that’s kind of 
extreme but it worked out fine. My blood sugar is good again.” P11 has detailed the hypothesis 
testing, leading to the discarding of the old model (I need x units of slow acting insulin at night) to 
be replaced by the new model. Now that this new model for insulin dosages has been validated, 
P11 can return to the habitual behavior of a set nightly insulin dosage. To review, in the preceding 
example we can see the full cycle of the described framework. The ‘gap’ is the recognition that 
there are too many elevated BG levels, which initiates a series of inferences, which lead to 
experimentations, and finally the restoration of a habitual behavior. As long as BG values are 
judged to be satisfactory, a standardized treatment has been decided upon, no longer requiring 
cognitive effort. 
A more routine use of sensemaking can be seen in P7 looking through several days data in a digital 
logbook: “… they’ve taken the same amount of insulin with way less carbs in the morning and they 
still had problems keeping the blood sugar down. So… they need to … in the morning… increase 
the amount of insulin that it normally takes for a meal.” In this case the gap is once again elevated 
morning BG, the hypothesis is insufficient morning insulin, a second case is observed in the 
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logbook with less carbohydrate intake, which further supports this hypothesis. Presumably this 
would then be tested to see if it improves after breakfast BG levels, without undue hypoglycemia. 
However, we also found examples that did not fit as easily in the described schema. P4 describes a 
process of managing diabetes during a Saturday night of partying. P4 upon reflecting on recorded 
data showing non-stable BG values on a Saturday night relates, “... at night to have a blood sugar 
like this is always difficult because when you … drink then you have a problem to get out of there 
[unwanted BG level] depending on how much alcohol your body is having. … the most dangerous 
thing is drinking sweet stuff … also I know that and at 3:00 in the night 55 [mg/dL = 
hypoglycemia] so I mean when you drink no sweet stuff then you’d just like Schnapps [an 
unsweetened concentrated alcohol]… then it’s not a big issue when the only issue is that getting in 
a low sugar because then your body can’t take sugar again and it’s busy with alcohol when you 
drink sweet stuff and beer and this stuff then you need almost to inject [insulin] because your blood 
Sugar’s going up but this is not allowed at all to inject for alcohol so I think it’s really good to 
drink schnapps and dance … and drink cola because the way how to you can resolve the night 
because you can control your blood sugar with dancing, smoking weed, and pushing it up with 
Coca-Cola again” In this quote we see P4 balancing multiple factors that can have an 
unpredictable effect on BG levels, using multiple mechanisms to cope with potentially risky 
behaviors. We see habitual fixed models, such as to not inject insulin while drinking alcohol so as 
avoid the risk of severe hypoglycemia, and to not drink sweetened alcohol, as that will overly raise 
BG levels. However, there are also context dependent models, such as using dancing to lower BG 
levels while drinking (how much? How vigorous?), or to use Coca-Cola to raise BG levels. It is not 
clear from the quote which effect marijuana has on BG levels, but either for medical utility or 
quality of life, it has been incorporated into P4’s dynamic equation. With so many unpredictable 
factors on BG levels, as well as potential risks, it would be difficult to classify this process entirely 
as an ‘effortless’ habitual mode, but with all the cognitive impairment, distractions, and frequent in 
the moment adjustments, enacting such a process of diabetes management would be difficult to 
classify this in a strict sensemaking mode. This appears to have some similarities to the 
aforementioned expert driver, who can draw upon multiple skills in a fluid manner, adapting them 
to shifting contexts. 
6.1.4 Discussion 
As well as supporting the Mamykina et. al Sensemaking framework, this chapter also describes a 
mode of operation that appears to allow those with sufficient accumulation of self-management 
models, to assess and act upon complex context-dependent multivariate data. Further, they can do 
this in a flowing and relatively low-cognitive manner that allows them to process information that 
is too complex and has too many variables and unknowns to be literally ‘solved’. This appears to 
be achieved through linking and adjusting multiple co-existing models. Further differentiating this 
mode from sensemaking, we do not see the recognition of a clearly defined ‘gap’, effortful 
thinking, nor necessarily a process of learning leading to the creation of new models nor discarding 
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of old ones. We have labeled this mode of thinking fluid contextual reasoning (FCR). FCR draws 
on behaviors at the intersection of the dual-processes (Figure 6-1); however, it combines them in 
new and distinctive ways – as discussed below. Table 6-2 provides a table (non-exhaustive) that 
suggests potential categorization.  
 
 
 
 
   
            
 
 
 
 
Habitual 
(Type 1) 
FCR 
Sensemaking 
(Type 2) 
Implicit,  
Effortless 
Low-demand Active   
Engagement 
Explicit, 
Effortful 
Applying existing static, 
rule-based models 
Adapting/combining 
multiple existing models 
Hypothesis testing/ 
Creating new models 
Algorithms: 
Practiced / discrete 
Algorithms:      
approximate 
Algorithms: 
demanding or novel  
3 * 3 = 9 
3.1* 2.9 ≈  
3 * 3 = 9 
3.1 * 2.9 = 8.99 
Reflexive/ 
Reacting 
Improvisation/ 
Navigating 
Reflection/  
Solving 
Chunked memory Connecting Chunked memory 
Loading working 
memory 
“If this, then that” “Some combination of this and that” 
“Could this cause 
that?” 
TABLE 6-2 CHARACTERISTICS OF SELF-MANAGEMENT MODES 
6.1.4.1 Habitual 
This mode is defined by reflexive responses, habitual behaviors, or scripts activated in specific 
situations. Accessing such models allows for the low cognitive demands needed for rapid 
responses. These can be either a single action or a sequence of previously learned steps, models, or 
formulas. A multi-part habitual model might be: for elevated BG take a correction shot of 1unit 
insulin per 50 mg/dl, drink water, test again in 1 hour. As this response is already learned and 
tested, there is no need to contextually re-adjust.  
FCR 
Sense 
making 
Habitual 
FIGURE 6-1 SELF-MANAGEMENT MODES 
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6.1.4.2 Fluid Contextual Reasoning 
FCR is proposed as a combination of mental models being adjusted and applied to a specific 
context with increased awareness of how factors relate to past, present, and future to allow 
‘navigation’ through a time continuum. An example might be rather than just counting 
carbohydrate content of a meal to calculate insulin dosages, considering other factors such as 
exercise that might occur hours later, recent trends in insulin sensitivity, and amount of fat in meal. 
Indicative of this state is stream of conscious layering and combining of models, with little demand 
on working memory, and little concern for establishing new self-care models.  
6.1.4.3 Sensemaking 
A recognition of an unexplained event (gap) leading to: discovery of a new pattern; cause and 
effect analysis; explanation of what caused an event to occur; or a learning process, with conscious 
creation or revision of specific model(s). An example might be: Through experience one realizes 
that eating pizza typically causes hypoglycemia, followed by hyperglycemia. One hypothesizes this 
could be due to combination of considerable carbohydrate and fat which delays digestion. 
Therefore, it makes sense to try splitting insulin bolus dosages next time to see if that helps. If this 
is confirmed, this can transition to a habitual mode. The initial figures show a visualization of the 
Mamykina et al. self-management model (Fig. 6.2), while the second shows a revised model with 
the addition of FCR, which sits between the other modes (Fig. 6.3). The next section will 
investigate this proposed mode. 
 
 
FIGURE 6-2 MAMYKINA ET AL. (MAMYKINA ET AL., 2015) SELF-MANAGEMENT SENSEMAKING FRAMEWORK 
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FIGURE 6-3 SELF-MANAGEMENT WITH FCR  
6.2 Fluid Contextual Reasoning: An Investigatory Survey  
This second section further investigated the FCR hybrid-mode hypothesis through a survey 
inquiring about the decision-making processes of PwT1D in relation to diabetes self-management 
in specific circumstances, thereby answering the question: 
• RQ3: How could apps better support user decision-making processes? 
The survey provided evidence for widespread use of FCR as defined in the previous section, across 
all demographics, particularly in association with of CGM adoption and increased number of 
insulin boluses. In the following sections we will review the methods, procedure, and findings for a 
follow-on study, then conclude by showing how aspects of FCR are already being supported by 
more recent technologies, and suggest ways in which, based on this expanded model, user 
interfaces for diabetes management could more closely address users’ cognitive requirements 
within specific contexts.  
6.2.1 Methods 
During earlier research, as participant recruitment was often challenging, we decided to use an 
online survey to increase sample size. I developed an online survey through an iterative process 
with at least 5 people with T1 diabetes providing feedback, with the questions being discussed and 
repeatedly revised. This was followed by the resulting survey being taken by three pilot 
participants online, with further revisions based on answers and feedback after each session. The 
survey was then finalized and submitted for ethics approval. Inclusion criteria were diagnosis with 
T1 diabetes, in medical treatment, and a minimum of 18 years of age.  The survey was distributed 
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online through social media including multiple T1 diabetes Facebook groups, Twitter, and, after 
undergoing an approval process, the online portals for the Diabetes UK and US based TU Diabetes 
online community. There were no incentives offered other than the appeal to help with diabetes 
research and the option to receive outcomes, which was done via email after the results were 
published (Katz et al., 2018b). 
6.2.2 Survey contents 
The first part of the survey was demographic in nature, establishing age, gender, duration of illness, 
diabetes devices used, and frequency of BG testing and insulin injection. This was then followed 
by a series of open-ended questions, allowing for gathering more in-depth information. Questions 
8-10 were two-part, with the first part defining a scenario and requesting analysis procedure, and 
the second part asking for a description of how the situation was managed. These questions were 
split, as in our initial user testing, this two-part format appeared to generate more thorough 
responses. Questions Q7-14 were each designed to initiate different aspects of the proposed 
expanded FCR model. For example, question Q7 which asked participants to discuss a routine 
situation was predicted to bring about a habitual response, while Q8 in asking participants to recall 
a surprising situation, would be expected to provoke a gap situation that should initiate 
sensemaking. These questions are presented in condensed form below, with expected outcome 
tendencies. (See Appendix B, Chapter 6: FCR Survey forms for full list of questions.)  
Q: Scenario Action Expected outcome 
#7 Normal BG Insulin dosage 
calculation 
Habitual mode 
#8 Recall surprising out of range 
BG event 
Description, analysis, 
treatment procedure 
Gap situation, sensemaking 
#9 Recall out of range event 
with obvious cause 
Description, analysis, 
treatment procedure 
Habitual mode treatment 
#10 Recall out of range event 
caused by novel situation 
Description, analysis, 
treatment procedure 
Gap situation, sensemaking 
#11 Change in diabetes 
management since diagnosis 
Description Tendency towards FCR management 
#12 If CGM user, effect on 
management  
Description Tendency towards FCR management 
#13 Measure current BG, report 
factors 
Description, analysis Dependent on prior answers 
#14 Management process for 
meal with current BG 
analysis, treatment 
procedure 
Dependent on prior answers 
TABLE 6-3 SELF-MANAGEMENT SURVEY AND PREDICTED RESPONSES 
 
6.2.3 Procedure 
Data were exported from the Google form used for collection, imported into an Excel spreadsheet, 
and then anonymized. Of the n=206 initially collected surveys, 14 were eliminated (3 completed 
under observation during the development process, 4 duplicates, 1 that was underage, and 6 that 
were judged too incomplete to provide meaningful data), for a total of n=192 responses. The 
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extended framework (see Appendix C: Results from Chapter 6 FCR) was used as a schema, which 
was expanded by domain specific self-care models extracted from the collected responses. Such 
categories included: insulin, exercise, diet, blood glucose, testing, context, devices, time, place, 
health cycles, interfaces, etc. After I composed the initial coding schema, it was applied to the 20 
responses. A secondary coder then reviewed the responses, and the coding schema was discussed 
and refined. For example, the habitual mode category for insulin use included: fixed insulin/carb 
ratios, fixed BG correction factors, and fixed insulin doses. The FCR category for insulin use 
included: considering factors such as insulin on board (when not monitored by device), insulin 
sensitivity in relation to a specific context, intentionally waiting variable times between bolus and 
meal, micro-dosing insulin based on context, adjusting dosages according to trends. Sensemaking 
activities including: learning self-management models, researching how context changes insulin 
sensitivity, retrospective analysis of insulin effect, calculating new insulin/carb factors, and 
experiments to determine new fixed dosages. After frequent discussions, co-coding, and 
comparisons with a second and third coder, I coded the remaining data. Intercoder reliability was 
checked with a sample of 20 responses with a resulting Cohens Kappa = 0.698. After all responses 
had been classified as habitual, FCR, sensemaking, or non-classifiable, counts were summed, and 
analyzed.  
6.2.4 Findings 
The following sections review the frequency of answers classified as either habitual, FCR, or 
sensemaking from the survey. Table 6.4 reviews this information sorted by demographic, while 
Table 6.5 reviews the responses to the open-ended questions.  The “n” in the table refers to total 
number of classified respondents within a specific demographic; this number can be lower than 
total participants due to answers that were missing, vague, or non-relevant. Totals show the count 
of participants who have been classified as exhibiting at least one instance of the three behaviors, 
emphasizing individual capability for exhibiting a mode of decision-making. For example, if P015 
were to be classified with 5 instances of Habitual, 0 instances of FCR, and 6 instances of 
Sensemaking, this would be indicated as (1,0,1).  
6.2.4.1 Cognitive mode in relation to demographics 
In this section, we review the three modes in relation to demographic information. The tally of 
results indicate that while habitual and sensemaking were most frequent, all three states were 
prevalent across all demographics. FCR appeared to be significantly associated with CGM usage, 
might have a slight increase with the first 10 years since diagnosis, and a small but significant 
correlation with bolus and testing frequencies. 
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Number of participants who have exhibited a given behavior    
Habitual FCR Sensemaking  
n= n>0 %>0 n>0 %>0 n>0 %>0 
Age in years 
18-24  25 23 92 19 76 25 100 
25-34  51 50 98 38 75 50 98 
35-44 42 39 93 27 64 40 95 
45-54 30 27 90 18 60 28 93 
55-64  30 25 83 26 87 29 97 
65+ 13 12 92 10 77 13 100 
n.a. 1 1 100 1 100 1 100 
Gender 
female 146 135 92 105 72 143 98 
male 43 39 91 31 72 40 93 
other 3 3 100 3 100 3 100 
Time since diagnosis in years 
< 1 7 6 86 4 57 7 100 
1-2 14 14 100 9 64 13 93 
3-5  15 12 80 11 73 15 100 
6-10  14 14 100 11 79 14 100 
11-20  43 41 95 33 77 42 98 
21-30  45 42 93 32 71 42 93 
31-40  30 27 90 19 63 30 100 
41-50  13 10 77 11 85 13 100 
50+ 10 10 100 8 80 9 90 
n.a. 1 1 100 1 100 1 100 
CGM/FGM use 
yes 117 104 89 96 82 112 96 
no 75 73 97 43 57 74 99 
Insulin pump user 
yes 121 110 91 89 74 117 97 
no 71 67 94 50 70 69 97 
Daily BG testing frequency 
1-2 7 7 100 3 43 7 100 
3-4 25 24 96 13 52 25 100 
5-7 50 49 98 33 66 50 100 
8-12 48 46 96 38 79 45 94 
13-17 15 11 73 13 87 15 100 
18+ 46 39 85 38 83 43 93 
n.a. 1 1 100 1 100 1 100 
Boluses/shots per day 
1-3 14 14 100 6 43 14 100 
4-5 99 94 95 68 69 97 98 
6-8 53 45 85 45 85 51 96 
9-11 21 19 90 16 76 19 90 
12 + 2 2 100 2 100 2 100 
n.a. 3 3 100 2 67 3 100         
TABLE 6-4 FREQUENCY OF SPECIFIC BEHAVIORS 
6.2.4.2 Age in years 
There were consistent and prevalent habitual and sensemaking behaviors across all age groups, 
with no indicators that any of the three categories are related to participant age.  
6.2.4.3 Gender 
No apparent significant correlations related to gender. 
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6.2.4.4 Time since diagnosis in years 
No statistical significance in correlation, although there might be a slight upward trend in FCR 
within the first 10 years after diagnosis. 
6.2.4.5 CGM/FGM use 
Non-users of CGM/FGM might have a small tendency towards more habitual responses as opposed 
to users. CGM users appear to have an increase in FCR classification as opposed to non-users (82% 
vs. 57%), a Fisher Exact Test showed a p< 0.01, demonstrating significance in this category.  
6.2.4.6 Insulin pump use 
No apparent evidence for correlation between method of insulin delivery and reasoning modes. 
6.2.4.7 Daily BG testing frequency 
Frequency of daily testing appears to be associated with an increased tendency towards FCR 
categorization, as shown by bar graph progression in Fig. 6.5 Sensemaking appears consistent 
among all groups. Habitual thinking might decrease slightly with increased testing frequency, 
though this might be due to the small sample in the ’13-17’ (n=15) group. Means were determined 
for each demographic, which were then used to perform a Kendall’s Tau test, performed with the 
SciPy Stats package in Jupyter Notebook. The increase in FCR behavior was found to have a small 
but significant correlation with daily testing frequency (Tau 0.20, p < 0.001). 
 
FIGURE 6-4 DAILY TESTING FREQ. VS. % W/ COGNITIVE MODE 
6.2.4.8 Boluses/shots per day 
While Sensemaking and Habitual modes appear unrelated to number of shots per day (Fig. 6.6), 
there appears to be a small correlative relationship between increased frequency of insulin injection 
and FCR mode. The same procedure was followed as in the previous paragraph, with indications of 
a small but significant correlation between injections per day and FCR classification (Tau 0.19, p < 
0.001).  
 100 
 
FIGURE 6-5 BOLUS/DAY AND.  COGNITIVE MODE 
 
  
Habitual FCR Sensemaking  
n=       n= %     n= %    n= % 
Q07. Normal BG/ response  
189 73 39 116 61 0 00 
Q08. Recall surprising BG event  
166 23 14 6 04 137 83 
Q08b.Treatment procedure  
167 86 51 22 13 59 35 
Q09. Out of range w. obvious cause  
178 17 10 12 07 149 84 
Q09b. Treatment procedure  
177 132 75 21 12 24 14 
Q10. Recall out of range event w/ novel situation  
143 2 01 3 02 138 97 
Q10b. Treatment procedure  
129 67 52 24 19 38 29 
Q11. Change in diabetes management since diagnosis 
  28 11 39 7 25 10 36 
Q12. If CGM user, effect on management 
  39 1 03 29 74 9 23 
Q13.  Current BG, report factors  
142 28 20 46 32 68 48 
Q14. Management process for meal w/ current BG  
164 85 52 79 48 0 0 
 
TABLE 6-5 COUNTS OF RESPONSES TO OPEN ENDED SURVEY QUESTIONS 
6.2.4.9 Q07. Factors for insulin dosage under normal BG conditions 
Q07: Imagine that it is time for you to take an insulin dosage for a meal. You check your blood 
glucose level, and as you expect it is in a normal range (70-140 mg/dl or 3.9-7.8 mmol/L).  Please 
describe the factors you might take into consideration to determine how much insulin to take for 
this meal. 
These responses appear to lend support to the (Mamykina et al., 2015) model, as without a ‘gap’ to 
initiate effortful thinking, we do not see the effortful sensemaking process. This question on routine 
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management practices produced only habitual (39%) and FCR (61%) responses. Common 
examples of habitual responses were simple algorithms, such as fixed insulin to carb ratios. In 
contrast FCR was evidenced by answers by hard to quantify contextual situations such as P141 
“Carbs, exercise, stress, illness.” Also common were references to hypothetical events such as 
future exercise. 
6.2.4.10 Q08. Describe situation w. serious and surprising blood glucose value  
Q08: Please try and remember a situation where you had a serious and surprising high or low 
blood glucose value (e.g. despite being careful, you had an unexpected dangerously low blood 
sugar on an airplane).  Please describe that specific situation, and your thought process about it. 
Please be as detailed as possible. 8b. In the last example please describe how you managed the 
situation. 
 
In contrast to the Q07, this question was formulated to elicit a ‘gap’ situation response, which was 
reflected in 83% of responses being classified as sensemaking. P030 recounts, “I learned the hard 
way as a teenager the effects alcohol can have on your blood sugar. I took my normal bolus the 
next morning with breakfast and went back to sleep. Next thing I remember is waking up very 
confused, with a very painful mouth and body.” In this example, we see the learning process and 
formation of models related to alcohol consumption. Or P060 who stated, “I guessed wrong about 
carbs in a meal and over-bolused.” Thereby showing awareness of a specific cause and effect 
relation. However, the second part of this question on treatment procedure resulted in substantial 
habitual responses (51%). For example, P141 recounted treating unexpected hypoglycemia with 
“15g fast carbs then slow carbs like biscuits or bread.” Thereby demonstrating the initiation of a 
script of behaviors. Sensemaking was also common in Q08b (35%), typically the establishment of a 
new habitual model, for example P154 noted, “It made me consider potential options for keeping 
items by my bed to test or treat lows instead and keeping my phone close too in case I needed to 
call for help.” 
6.2.4.11 Q09.  Describe out of range event w. obvious cause 
Q09: Please try and remember a time that you had done something that had caused your BG level 
to be out of ideal range, but you immediately understood why (e.g. eating too much cake at a 
birthday party). Please describe that specific situation, and your thought process about it. Please 
be as detailed as possible. 9b. In the last example please describe how you managed the situation. 
 
I hypothesized that indication of an obvious cause would reduce sensemaking, in comparison to the 
‘surprising event’ of Q08, however this was not reflected in the totals, which produced almost 
identical proportions to Q08. However, this discrepancy was reconciled in the second part of the 
question on treatment procedure, where we see substantially more habitual (75%) responses, and a 
resultant drop in sensemaking behaviors, such as new model formation.  
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6.2.4.12 Q10. Recall out of range event w/ novel situation 
Q10: Please try and remember a situation when you were in a novel or unusual situation that 
dramatically affected your blood glucose level (e.g. arriving in a different time zone, becoming 
distracted by unusual circumstances after taking a shot, miscalculating an insulin dosage, an 
unusual food, etc.) Please describe this specific situation, and your thought process about it. Please 
be as detailed as possible. In the last example please describe how you managed the situation. 
This question was designed to evoke a specific ‘gap’ situation, an unwanted BG value in a novel 
situation. This led to 97% of participants responding with a sensemaking response. The second part 
of the question had similar response patterns as Q08b, with a majority (52%) of habitual responses.  
6.2.4.13 Q11. Change in diabetes management since diagnosis 
Due to the small number of categorizable responses, this question will not be further discussed. 
6.2.4.14 Q12. If CGM user, effect on management 
If you use a CGM or Freestyle Libre, in which ways has it changed your diabetes management 
process as opposed to using strips? Please be as specific as possible. 
While Q12 also had only a small number of responses that could be categorized, 74% of responses 
were categorized as FCR, further supporting the link between CGM use and FCR in diabetes 
management.  
6.2.4.15 Q13.  Current BG, report factors 
Please check your blood glucose and record the value in the space below. Describe everything that 
comes to your mind and what factors might have contributed to this reading. 
Asking participants to analyze their current BG produced 48% in the sensemaking mode, followed 
by 32% in the FCR mode. Habitual responses lagged at 20%. 
6.2.4.16 Q14. Management process for meal w/ current BG 
Imagine that you are going to take insulin now for a meal.  Given your current BG value, please 
describe what factors you would take into consideration, and the process you would use to decide 
on an appropriate insulin dosage. 
This question prompted relatively even habitual and FCR responses (52% vs. 48%). Habitual 
responses often related the use of simple procedures. For example, P205 answers, “I would only 
dose for the carbs I was about to eat.  1 unit for every 15 carbs.” While FCR responses often show 
fluid balancing of multiple models and emotional factors, such as P199 noting “I would eat low 
carb if I have a high reading but as I’m at work I only have soup for lunch which is 18g of carb so 
have to eat that, I know as I’m high it’s not good as I would prefer to be in range before eating, but 
as I am hungry I need to eat, this is where I really get frustrated with T1, I would therefore take an 
extra 20% dose on insulin to bring me down, as when running above 12 I also become more insulin 
resistant.” 
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6.2.5 Discussion 
In the following sections, we will first consider the general findings regarding the proposed 
expanded cognitive framework for diabetes self-management: habitual, FCR, and sensemaking 
modes. Then, we will apply these three modes to discuss existing diabetes related UI’s. And 
finally, we will discuss how the theoretical and practical outcomes of these study results could be 
applied to the design of diabetes related UI’s. 
6.2.5.1 Habitual 
Habitual modes are a means of low-cognitive demand reaction, particularly important for treating 
out of range situations with obvious causes.  These treatment algorithms can be relatively complex, 
such as multi-factor calculation of insulin dosages, given that this remains context independent. As 
P136 notes about calculating insulin dosages, “I did in my head for year, so the formula is burned 
into my brain.” This mode is crucial for quick responses, especially as out of range conditions were 
frequently cited as causing cognitive impairment. Such as P064 describing a particularly bad 
hypoglycemic episode, “I was disoriented, sweaty, dizzy, couldn’t see straight. I was able to test 
my blood sugar and it was 17 [mg/dL = severe hypoglycemic). At that point, my only thought that I 
could muster was to eat whatever I could find to try to keep conscious.” References to this mode 
decreased substantially in Q08b and Q10b, where the novelty of the situation doubled the incidence 
of sensemaking behaviors. We concur with (Mamykina et al., 2015) that this mode is largely 
dependent on ready access to models incorporated through the sensemaking process, and that the 
low cognitive demands appear consistent with Type 1 thinking. 
6.2.5.2 Sensemaking 
In instances (Q08, Q09, Q10) where participants were asked to recall surprising out of normal 
range situations, sensemaking was a dominant mode. In support of the (Mamykina et al., 2015) 
model sensemaking appears an essential activity for building models, with extensive examples 
where participants recalled a specific situation that led to new habit formation or critical lesson. For 
example, P049 who described having a hypoglycemic episode on a plane, and not getting up to get 
glucose from the overhead bin because of an activated fasten seat belt sign. “I played by the normal 
rules, though I shouldn’t have. I should have gotten up at the moment I realized I was getting into 
trouble.” The evidence appears to support that sensemaking can be seen as the foundation for both 
habitual and FCR modes. In its effortful ability to overcome assumptions, biases, or habitual 
behaviors, it is consistent with Type 2 thinking. 
6.2.5.3 FCR 
While FCR thinking is less prevalent than habitual and sensemaking modes, it appears common 
throughout all demographics, independent of gender or age. It appears associated with CGM use, 
frequent BG measurements, and frequent bolus injections, and possibly a slight increase within the 
first years after T1 diabetes diagnosis. These correlations are at least partially, by definition, due to 
characteristics such as ‘frequent course correction’ and ‘watching of trends’ being strongly enabled 
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by CGM technologies and increased insulin application. It also possible that the building of the 
flexible models used in FCR are enabled by the frequent checking and increased interactions 
supported by CGM and potentially other technologies which enable convenient data access. FCR 
appears most commonly in response to ‘normal situations’ (Q07 61%), relating the factors of 
‘current BG’ (Q13, 32%), and for ‘projected management process for a hypothetical meal (Q14, 
48%). It is neither a retrospective tool, (Q08, 4%, Q09, 7%, Q10, 2%), nor a prevalent treatment 
mode for surprising (Q08b, 13%) nor for out of range events (Q09b, 12%, Q10b, 19%). FCR does 
not appear to be a replacement for the habitual and sensemaking modes, nor the correct method for 
all situations, especially such as treatment for excessive hyperglycemia, where the automatic 
response of habitual mode might be preferable. FCR might also not be ideal for unexplained 
circumstances, where the desire to avoid such situations in the future point towards sensemaking 
and formation of new preventive models. As FCR appears to share some traits of each of the two 
other principal modes, it might be viewed as existing somewhere in a spectrum between the two 
other modes. At the same time, leaving aside any claims about dual or tri-process cognitive models, 
FCR appears at the least to characterize distinctive user behaviors with apparent implications for UI 
design, as discussed below.  
6.2.6 Current UI’s 
In the following section, we will consider two commonly used UI’s and consider how their 
elements might relate to the discussed theories.  
6.2.6.1 Diabetes Logging App Statistics UI’s 
 
FIGURE 6-6 STATISTICS UI 
The diabetes diary app, as previously discussed in the introduction/supporting technologies section, 
is a common approach for situated diabetes self-management. Figure 6-6 Statistics UI shows an 
example of such an app with the statistics tab displayed. This UI displays statistics that could help 
guide management through trend discovery. Using the previously noted coding scheme, I would 
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classify this UI as requiring ‘effort’ to apply to management decisions, and that its utility would be 
for ‘Reflective or Hypothetical thinking’. Therefore, this UI could be classified primarily as a 
sensemaking tool and be used primarily for ‘gap’ discovery. Such gaps could be useful for drawing 
attention to the need to question existing habitual behaviors or undergo hypothesis testing to form 
new models. Such an interface would have limited benefits for supporting habitual modes, or FCR 
modes, and given the lack of sensemaking in evidence from Q14 (management process for current 
meal), would not typically be of use for individual treatment decisions. As such, it could be seen 
primarily as a tool for intermittent use, which is in agreement with research discussed in previous 
chapters. 
6.2.6.2 CGM/FGM UI 
 
FIGURE 6-7 ABBOTT FGM/CGM UI 
 
Figure 6-7 Abbott FGM/CGM UI shows the UI for the Abbott Libre Flash Glucose Meter. There 
are four primary design elements: current time, current BG, arrow showing direction and rate of 
change, and a graph showing the previous 8 hours of measurements with goal range in blue and an 
apple marking a meal. The time function could be a component of all three reasoning modes, 
dependent on context. For example, time checking can be habitual behavior. It can be useful for 
helping to establish context for FCR, or can be used as a sensemaking tool, for specific and 
determined problem solving. The BG value is largely a habitual tool, with reflexive interpretation 
of ‘too high’, ‘too low’ or ‘about right’, although it is also critical in FCR navigation and course 
correction and could be interpreted according to the requirements of a given context. It could also 
trigger sensemaking mode, when departing significantly from expectations. We classify the arrow 
as largely an FCR tool, as its implications are dependent on multiple contextual factors such as 
insulin on board, time of day, food already eaten, desired state, and relation to recent state. The 
graph as well could be used in all modes, dependent on context. Its use could be habitual, for 
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example to assure the user that they are generally in range over a given period; it could be used as 
an FCR tool for assisting in navigation through time, by helping to show general tendencies. It 
could also be an ‘effortful’ sensemaking tool, especially in conjunction with additional recorded 
data, to help understand specific cause and effect relationships. In summary, according to our 
coding scheme, this UI incorporates aspects of all three modes, and can be flexibly applied 
according to situated user requirements.  
6.2.7 Implications for future adaptive UI design 
The following sections discuss potential practical applications of this research for future UI 
development as related to the three modes. The research discussed in this chapter suggests that a 
binary model of cognition could be insufficient as a diabetes UI design framework, offering 
inadequate support for dynamic management techniques. An interface that is specifically geared 
towards habitual (Type 1) thinking is quick to use but might not engage the user’s cognitive 
abilities to challenge their biases. Conversely a sensemaking (Type 2) interface, such as a robust 
diabetes diary app, offers a means of overcoming such biases through effortful analysis of collected 
data; however, the high cognitive costs associated with insight extraction could be a barrier to 
frequent interaction. So, the designer of a diabetes support systems using only a two-aspect model 
faces a challenging question: how can UI’s support interactions with complex data in a manner that 
is of low enough cognitive demand to allow for frequent usage while still encouraging non-
reflexive mindful engagement? The following section attempts to address this concern, the 
implications of an expanded model, and its application to design. 
6.2.7.1 Habitual: design implications  
The habitual mode appears most relevant for addressing out of range events with understandable 
causes. As these situations can be cognitively and affectively stressful, interfaces should support 
and trigger familiar and easy to understand treatment steps. Wherever possible, such interfaces 
should attempt to help the user to integrate and link such behaviors into already existing behaviors, 
and thereby establish actions that become independent of interface interactions (Stawarz et al., 
2015). 
6.2.7.2 FCR: design implications 
As FCR relies on the flexible use of multiple models, a supporting interface should help to trigger 
appropriate models at contextually relevant times and suggest other factors that might be relevant 
to support active engagement with diabetes management. As FCR is a largely an in-the-moment 
technique, graphs, charts and other cognitively demanding and primarily retrospective interface 
elements should be de-emphasized in favor of easy to understand elements such as short text, and 
icons where appropriate. Short animations might also be relevant. Ways to determine the 
appropriate personally relevant model triggers must be further researched, as well as means of 
determining personally relevant context for activation.  
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6.2.7.3 Sensemaking: design implications 
Our study suggests that sensemaking is a dominant behavior when encountering out-of-range or 
novel situations. Traditional UI elements such as graphs and charts might be appropriate in such 
contexts to help users find specific correlations, or to help illustrate relevant insights. The emphasis 
should be on helping users to hypothesis test and construct new models, which can subsequently be 
used for less cognitively demanding habitual and FCR modes. As sensemaking is effortful, it is not 
for continual application; therefore, context awareness or some means of cognitive load sensing 
(Rafiqi et al., 2015) might be used to determine when the user is amenable to such in depth 
engagement. 
6.2.8 Ethical considerations 
As interfaces for supporting medical practices seek to impact behaviors, their implementation has 
bio-ethical implications to principles such as beneficence, non-maleficence, justice, and autonomy 
(Beauchamp and Childress, 2001). Here we consider ethical concerns for each of the 3 cognitive 
models. 
6.2.8.1 Habitual 
As habitual behaviors can be critical for rapid responses, it is important that interfaces neither 
inhibit these reactions, nor interfere with successful strategies. This could argue against sustained 
UI engagement as a successful metric in such circumstances and point towards the importance of 
helping to support independent and intrinsically motivated behaviors. For example, if a user 
becomes dependent on their smartwatch to remind them to bring glucose when exercising, they 
might forget to take insulin when their watch battery is empty. Such concerns could argue that 
ideally such critical behaviors should be technology independent when possible. As these behaviors 
are largely reflexive, respecting autonomy requires that persuasive and habit-forming systems are 
respectful of the personal preferences of the user and have some means of assuring that the 
individual has made an informed decision.  
6.2.8.2 FCR 
As FCR depends on the access and adjustment of multiple self-care models, it is important that 
beneficial models are accessed, and adjusted in an appropriate manner. Ethical UI’s might help this 
process by helping users to record personally relevant and desired self-care models, and then 
triggering these models in a contextually appropriate manner. Care must be taken that the user 
maintains the ability to choose what are appropriate suggestions without inappropriately forcing 
users into sensemaking mode, as this could inhibit frequent engagement. 
6.2.8.3 Sensemaking 
As sensemaking is essential for forming self-care models, UI’s should assist with informed 
investigation of beneficial models, while offering some means of warning about the formation of 
harmful models. Given that rapid access of such models is essential for the other modes, UIs should 
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help to support integration of such models into practice. Care should be taken that users are 
educated into being able to engage in such practices independent of technology. 
6.2.9 Limitations 
This interaction research was conducted with a technology capable group and non-personal data 
which could have effects on results. The use of online recruitment could prejudice towards an 
engaged and knowledgeable sub-group, and therefore may not be broadly representative. 
Qualitative coding is always open to interpretation, especially regarding intent. As such this study 
is primarily exploratory, and not necessarily indicative of broader occurrences of these behaviors, 
nor how they may occur in ‘in-the-wild’ settings. 
6.2.10 Conclusions 
This chapter presented evidence that many people with diabetes can make decisions with their 
complex data in a manner that does not easily conform with established cognitive models 
associated with habitual (Type 1 analogous), or sensemaking (Type 2 analogous) thinking. The 
former is largely reflexive, and therefore limited in its ability to exhibit variously: contextual 
consideration of complex multivariate data; hypothetical thinking as to potential events or 
outcomes; and awareness of highly variable situations. By contrast, the latter requires substantial 
cognitive effort, hence is ill suited to continual repeated application. While FCR is not necessarily a 
challenge to the fundamentals of two minds thinking, the behavior that we have evidenced does not 
readily match either. It appears conscious and engaged with complex scenarios, but there is not 
necessarily identification of a ‘gap’ situation, nor is there inherent discarding or formation of new 
models. UI designs based solely on a two minds theory have to choose between two extremes, 
thereby offering no clear guidelines for frequent engagement that retains critical and hypothetical 
thinking. The inclusion of FCR could allow for such a state. While earlier work (Varga and 
Hamburger, 2014) appears relevant, we are not aware of deliberate integration into current diabetes 
UI design. Such an extension could help to provide a useful framework to analyze increasingly 
adopted tools such as CGM’s and help suggest new designs. FCR does not invalidate the other 
modes, and we observed no cases where participants displayed FCR without displaying the other 
modes as well. FCR could be viewed as a workaround, to conserve cognitive resources, using 
models built up through sensemaking and experience. FCR, while not as prevalent as habitual and 
sensemaking, was found to be common among all demographics within our survey population. 
These conclusions suggest that all three modes are important tools for diabetes self-management, 
and greater care should be taken that UIs for supporting self-management support these different 
modes within appropriate contexts.  
As there is a significant body of research supporting dual-process theories, it would be premature to 
challenge the perceived wisdom. However, there are more modest ways of viewing FCR mode as a 
useful cognitive workaround or adaption that allows individuals to accomplish domain specific 
requirements within the limitations of dual-process thinking. This chapter has presented evidence 
that users appear to have found a way to integrate essential aspect of two recognized cognitive 
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modes in order to interact with complex and hard to calculate data streams. This appears to allow 
them to weigh and make predictions on likely outcomes, and use those insights to make vital 
decisions, all in a fluid and frequent manner. This suggests that support of such mental processes 
through medical UIs merits further exploration. 
Continuing with this consideration on the practical application of this expanded framework, it is 
worth re-emphasizing that the FCR mode appears to be associated with the use of an already 
existing ubiquitous computing technology, the continual glucose monitor. As discussed in section 
6.2.7, the user interface of the continual glucose monitor offers an intuitive and easy to apply 
feature, an arrow representing direction and rate of change of blood glucose. One can imagine that 
it might be useful for an interface to remind the user of previous exercise, relevant sleep patterns, 
the impact of specific locations. However, just as the data collected by the CGM extended the 
capability of the more traditional blood glucose monitor, likewise these other context aware 
functionalities are likely to also largely rely on the sort of consistent and accurate data best 
delivered by automation (Donsa et al., 2015). However, such an approach would be dependent on 
the user’s willingness to adopt and maintain required sensors and devices. At the time of this thesis, 
such diabetes decision-support systems are not yet available. Therefore, we lack knowledge on 
both the viability of this approach as well as how to design such systems in a user-respecting 
manner. Therefore, to help lay a user-centered foundation for the development of such systems, the 
following chapter probes user concerns on monitoring and data aggregation by outfitting people 
with diabetes with a simulated diabetes lifestyle monitoring system.  
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Chapter 7: User Concerns for Multi-Device Diabetes 
Monitoring  
While previous chapters have considered the design deficiencies of existing diabetes logging apps, 
this chapter seeks to contribute to a user-centered approach for a next generation diabetes 
management system that continually tracks and aggregates sensor data to offer personalized 
support. This chapter discusses the results of a 4-week technology probe in which participants were 
outfitted with multiple networked devices in order to learn more about user perceptions of such 
monitoring, and thereby glean insights into user-centered requirements of this approach. Through 
detailed analysis of interview responses both before and after the study period, this chapter reports 
on user concerns related to sharing of different kinds of personal medical and behavioral data with 
different stakeholders, potential software solutions that might help to better support these 
preferences, and finally emergent questions for designers of such next generation systems.   
7.1 Introduction 
The previous chapters have reviewed common limitations of diabetes smartphone apps and 
suggested that increased use of sensor technologies could reduce barriers to adoption and improve 
the quality of acquired data, which could open new opportunities for diabetes support such as 
improved glucose prediction (Donsa et al., 2015), classification of the impact of specific behaviors 
on health (Doryab et al., 2015), or association of GPS location with glycemic variability (Doherty 
et al., 2015). As discussed earlier in section 2.3.2, the continual glucose monitor (CGM) already 
offers an existing example of such a next generation device, replacing the workload and discomfort 
of finger stick blood glucose tests with a periodically inserted sensor that not only delivers at a 
glance past and current glycemic state, but also uses the collected data to offer an arrow to inform 
the user on direction and rate of glycemic change. However, current generation CGM’s are 
primarily devices for just one aspect of diabetes management, blood glucose levels. While they do 
allow additional lifestyle and other data to be manually recorded, they are currently limited in their 
ability to integrate and correlate other relevant automated data streams such as behavioral 
indicators (Rodbard, 2016).   
While there is substantial interest in implementing more complex sensor-based decision support 
systems, there are substantial barriers to implementation not only in complexity of diabetes 
treatment, meeting regulatory standards, and sensor accuracy, but also with user engagement 
(Doryab et al., 2015). Even though such sensors reduce the burden of manual data collection, the 
need to continuously wear or maintain these consumer devices could be perceived as burdensome 
(Harrison et al., 2015) or could pose risks to user privacy (Pejovic and Musolesi, 2014). Such 
psycho-social impacts could potentially discomfort the user or potentially lead to device rejection 
which would limit data quality and thereby impair system efficacy. While potential workarounds 
using personalized advice from a professional or aggregated data from other users might assist with 
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onboarding users (Pejovic and Musolesi, 2014), such systems might need a substantial training 
period before acquiring enough data to become capable of delivering perceived value to the user. 
Therefore, a willingness to maintain use of such devices for a period of time with only limited 
benefits could be essential for the success of such systems. 
Despite public acceptance of wearables and wide-spread adoption of sensor-laden smartphones, 
due to the lack of actual implementations there remain gaps in knowledge about user concerns with 
such diverse monitoring within the chronic disease management context. There is also a pressing 
need to develop practical, ethical, and low-cost ways to test systems, as well as further knowledge 
needed in improving adoption of wearables in general (Clawson et al., 2015) and increasing user 
motivation (Lazar et al., 2015). Therefore, further research is required to determine not only how to 
technically develop such systems, but also the qualitative and psycho-social implications of 
implementation. This study sets out to meet such needs through a user-centered, low-risk, and 
economical approach that probe user concerns, experiences, and thoughts for future support 
systems.  
7.2 Methods 
This chapter describes the results of technology probe approach (Hutchinson et al., 2003) applied to 
learn more about user requirements in real-world settings. Among the primary questions addressed 
were: 
• What are user concerns with sharing of different sorts of personal data of multiple device 
monitoring systems, and how large is the impact of who it is being shared with?  
• How might these concerns alter after awareness of being externally monitored and exposure to 
relevant devices?  
• What are potential solutions to addressing emergent user concerns? 
• What are key questions for designers of such systems to address?  
To answer these questions, this study first asked participants about their opinions on different sorts 
of data sharing, then equipped them with multiple tracking devices which allowed constant external 
monitoring. At the end of the 30 day study period they were asked again about their opinions about 
data sharing and their experiences with the devices, to see how such opinions change with exposure 
and knowledge of external monitoring, which could be relevant for an actual system’s onboarding 
process (the study form and full list of questions are available in Appendix B: Chapter 7 Wearables 
Study Form). The Open University’s internet-based data aggregator (Packrat) used manufacturer 
provided APIs to collect personal user data from a commercial smartphone tracking app, step 
counter, and in-bed sleep monitors (see Figure 7-1 Probe Architecture).  As real-time CGM data 
was not available for the majority of devices used by participants, this data was gathered 
retrospectively. This system thereby prototyped the data gathering architecture of a diabetes 
decision support system, engaging participants with multiple devices and awareness of external 
monitoring. The study details were as follows: 
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• Pre-study questions sought to establish participant sentiment, attitudes, and experiences 
with diabetes management, tracking devices, and data sharing in a variety of contexts and 
with different stakeholders.  
• Post-study questions repeated the pre-study questions to investigate changes in attitude, as 
well as questions related to study experiences and perceptions on included devices. 
Data Processing: All participant interviews were fully transcribed and aggregated in an Excel 
spreadsheet. In addition, all responses were imported into Nvivo and then classified by device, 
stakeholder, data type, and sentiment (positive or open, neutral or mixed, negative or closed) to aid 
with integrating results and to support thematic analysis.  The qualitative time-series visualizations 
were created in a desktop publishing program (Adobe InDesign) to aid with understanding trends. 
Due to the small sample size, statistical significance of responses is limited. The emphasis is 
therefore placed on conveying a spectrum of user concerns in order to establish a foundation for 
consideration and discussion when developing future systems. These procedures will be discussed 
in more detail in the following sections. 
7.2.1 Devices and Architecture 
Devices were chosen for their ability to automate the collection of potentially relevant data, ease of 
use, off the shelf availability, and existing public API. Table 7-1 Study Devices 
 outlines the study devices chosen and their attributes, which is followed by Figure 7-1 Probe 
ArchitectureError! Reference source not found. which illustrates the system architecture. 
Device Sensor Placement Benefits Drawbacks API Output 
Jawbone UP  Accelerometer -Wrist 
-Waist 
-Low cost 
-Battery life 
-Appearance 
-Limited data output 
-Daily step 
count 
Beddit in-bed 
sleep monitor 
Pressure -In bed -Detailed data 
-Plugs in/no 
batteries 
-Invasive of private 
space/habits 
-Recording must be initiated 
and terminated each session 
-Hours slept 
-Respiration 
-Pulse 
-Time awake 
Moves App In-phone 
sensors 
-Smartphone -Behavior Tracking 
-Phone already 
adopted 
-On private phone 
-Battery drain 
-Invasive 
-Location 
-Activity  
Abbot Libre 
(Flash Glucose 
Monitor) 
Blood 
Glucose 
Back of Arm  -Convenient 
tracking of BG 
-no calibration 
needed 
-Sometimes inaccurate 
-No calibration possible 
 
 
-Data 
downloaded 
from device 
Dexcom 
Medtronic 
(Continual 
Glucose Monitor) 
Blood 
Glucose 
Abdomen -Accuracy -Frequent calibration required 
-Sometimes inaccurate 
-Data 
downloaded 
from device 
TABLE 7-1 STUDY DEVICES 
 113 
 
FIGURE 7-1 PROBE ARCHITECTURE 
7.2.2 Pre-study procedure         
The study was limited to adults currently undergoing treatment for T1 diabetes, residing in Berlin, 
and current users of continual glucose monitoring. Potential participants were sent an information 
sheet via email with an overview of the study and consent form. If participants were willing to take 
part in the study, an appointment was then made for the researcher to meet the participant in the 
location of their choosing. It was suggested by the researcher that this visit be in-home in order to 
set up the sleep monitor, but participants could choose any other location if they so desired. Only 
one participant preferred to have the appointment at their place of work, the remaining chose a 
home visit.  All participants were familiar to the researcher, having previously taken part in studies 
or diabetes related co-design workshops, which led to an engaged and technically adept group. No 
compensation was offered, other than the option to keep the fitness tracker and access to any 
insights discovered in the study. Study approval was granted by The Open University Human 
Research Ethics Committee.  
7.2.3 Study protocol 
At the initial meeting, participants were asked to complete a consent form at which time they were 
assigned a participant ID number. This was then followed by a brief survey on basic demographics 
and previous use of technology. The researcher then read out loud an introduction statement to 
clarify the terms of the study and emphasizing that the study would offer no advice or suggestions 
about diabetes management, and that all participants should consult with their physician before 
making alterations in therapy. It was also emphasized that participation was entirely voluntary, and 
they were at liberty to stop using any device or app for any reason at any time. Following this 
 114 
introduction, there was a semi-structured interview on the participant’s opinions regarding 
monitoring and sharing of various kinds of personal data with different stakeholders. After the 
intake interview was completed, the Beddit app, Jawbone UP app, and Moves app were 
downloaded from the Apple App store or Google Play store, installed on the participant’s 
smartphone and then registered using an anonymized Gmail account. The apps were then paired 
with the Open University Packrat data aggregator, participants were issued the requisite devices, 
and finally the participant’s CGM was checked to make sure that the date and time were correct. 
This onboarding process took approximately 1 hour per participant, including interview, app 
installation, and registering devices with the Packrat data aggregator, this workflow can be seen in 
Figure 7-2 Study Protocol. 
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Recruitment through social media, 
snowball, and previous research contacts.  
Potential participants are provided with 
study information by email. 
After at least 48 Hours potential 
participants are contacted again and 
asked about desire to participate. 
Patient given paper copy of information sheet, completes Consent form, and assigned participant ID, and 
completes intake survey. Researcher reads out introduction form, which if followed by the semi-structured 
intake interview. Beddit, Jawbone UP move, Moves app are then installed on participant’s phone, and 
registered anonymously. Users are then signed up on Packrat and devices then registered on Packrat. Finally, 
the user’s CGM is checked for accurate time and date. 
 
4 weeks of activity data collected  
Researcher interacts with 
participant if technical issues arise 
during period 
Patient returns the Beddit, exports CGM data for study period, and completes 
the recorded exit interview. At this time if desired Apps can be de-installed 
from smartphone, and data sharing with Packrat will be disabled.  
FIGURE 7-2 STUDY PROTOCOL 
   116 
 
 
7.2.4 Study participants 
Participant gender was 4 Female and 4 Male. Mean age was 35.6 (SD 9.4) years, with a mean time 
since diagnosis of 16.75 (SD 14.2) years. The following table shows demographic information for 
the participants:  
P 
# 
Gen. YOB Diag. Occupation Insulin  BG  A1C  Past Tracking Knowledge/Experience 
1 F 1980_ 2007 Graphic Designer MDI Libre 7.7 Google Fit Diabetes App Design  
2 F 1991 2009 Fundraiser/Marketer Pump Libre 6.8 Runtastic Diabetes Startup 
3 M 1987 2006 Engineer/Founder MDI Libre 7.2 Google Fit 
Mi fitness band 
Diabetes Device Startup 
4 M 1985 2014 Software Engineer MDI Libre 6.8 Runtastic Software Engineer 
5 F 1988 2002 Marketing Analyst Pump Medtronic 6.6 - Pregnancy 
6 F 1965 1968 Educator Loop Libre 7.2 Step Counter DIY Closed loop 
7 M 1972 1995 Medical Sales Pump Dexcom 4 5.9 Gamin system Ultra-Athlete/Diabetes 
device sales 
8 M 1991 2008 Designer Pump Libre 7.0 Apple Watch 
Echo watch 
Mi Band 
Diabetes Device Startup  
MDI = multiple dose injection, Pump = insulin pump, Loop = Hybrid closed loop, A1c below 7.0% is recommended goal 
TABLE 7-2 STUDY PARTICIPANTS 
 
During the study period, 5 participants were using insulin pumps, 3 used insulin pens, all 
participants were adopters of continual blood glucose monitoring, with 6 participants using the 
Abbot Libre, 1 using Dexcom G5, and 1 using the Medtronic sensor. The group as a whole were in 
good control of their diabetes with a self-reported mean A1c of 6.9 (SD=.5) with all participants 
near or below the recommend A1c of 7.0% (see 2.2). The majority (7/8) had previous experience 
with some sort of exercise tracking, using consumer apps and products such as Runtastic, step 
monitors, or apple fit. All participants were diabetes technology literate and had been recruited 
through their active participation in the diabetes activist community. The majority of participants 
(5/8) had previous experience in diabetes related work such as consulting for pharma or were 
actively involved in diabetes related startups. Of the remaining participants, one had recently built a 
DIY closed loop system, another was highly engaged in her first pregnancy, while the last was a 
PhD mathematician and full-time software engineer. As such this group could be considered an 
early adopter community and thus not broadly representative. 
7.2.5 Data visualization 
Interpreting the resulting qualitative data placed certain challenges, especially regarding the time 
series aspect of change in attitude over time (before and after study). The small sample size 
restricted the use of statistical methods. An initial attempt to color code this qualitative data with a 
numeric (-2 to 2) or color spectrum (green to red indicating openness to sharing data) failed to 
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communicate sufficient group detail or trends. Such translation also lost the subtleties of user 
reasoning and lost the many dimension captured by qualitative data. After much experimentation, I 
chose the following method, which resulted, with further modification, from an after-dinner 
conversation with research clinicians and computer scientists. While I am not aware of previous 
use of exactly this method, it is entirely possible that it exists within the HCI or other literatures. As 
such I can make no claims of novelty, only that it appears effective within the requirements of this 
use case. The process was as follows: 
• Interviews were transcribed and entered into an excel spreadsheet, organized with 1 row 
per participants and each question in a separate column. 
• Each participant response was categorized according to general sentiment. The quote was 
reduced to a short representative excerpt, which was done to allow placing within the graph 
while maintaining readability. While with a larger format the full text could have been 
included, this reduction has the benefit of being easier to read. As this process is 
interpretive and reduces information, ideally this would be repeated by additional 
researchers for comparison. The following two examples demonstrate my reasoning 
process for reducing quotes, with the bold type showing the excerpt included in the graph:   
P2 on willingness to share GPS data with doctor stated: “I would be all right with that if I 
knew what they were using if for. For example, in a quarterly session when we look at it 
together and analyze together, I’d be fine with it. If the doctor is really just analyzing it 
with my diabetes.” While the first sentence could have been selected, I chose the second 
sentence as it gave a specific example of an acceptable use. The third sentence was not 
selected, as it primarily clarifies the previous sentence. I classified this quote as between 
“neutral” and “open” as P2 was willing to share but wished to maintain control over how 
and when such sharing occurred. The sentiment is consistent throughout the quote, so 
while a different excerpt could have been chosen, all would have been presented on a 
similar place on the graph. 
P5 on willingness to share GPS data with insurer stated: “I think I wouldn’t like them to have 
access to my location and to my exercise pattern again. This feels again a bit too personal for me 
and doesn’t make sense. Where I am, exercise, what I do and CGM, how am I doing at the moment 
is really a lot of information about me. All in all, it feels like somebody’s got full control.” In this 
case I chose the excerpt where the participant notes how the data feels too personal, as this both 
clarifies the sentiment of the first sentence while still expressing unwillingness to share. While the 
following sentence adds more detail, it is longer so is ill-suited to the space limitations. The final 
sentence on loss of control is an important detail, though I chose not to select it as it could be 
harder to understand on its own. Once again as the sentiment is similar throughout, alternate 
selections would not have altered the graph.  I classified the sentiment as private, though less so 
than those who flatly rejected any sharing with this their insurer, such as P2 who stated “No way at 
all.” 
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• A graph is constructed with the time series aspect along the x-axis. As there are were only 
two time points within this data, there are only two segments, ‘before study’ and ‘after 
study’. This system could therefore be used to visualize qualitative data over a more 
extended study period by adding more segments. 
• The y-axis of the graph is labelled with an ordinal scale representing participant sentiment. 
For example, from ‘Highly private’ to ‘Highly open’. 
• Each participant quote is placed into a text box, and the text box is situated on the 
appropriate position on the axes. Participant number remains paired with the quote, and 
each participant has consistent color-coding to assist with interpretation. 
• Each participant’s text boxes along the x-axis are linked.  
• As the excerpting loses much of the context and richness of the participant responses, after 
each graph there is a discussion of the responses that uses the full quotes. 
At the end of this section after the analysis of the qualitative data, there will follow a reflection on 
the benefits of this method of data presentation. 
7.3 Results 
The following sections will be structured as follows: 
Section Sub-sections 
User Concerns 
 
• Views on diabetes management 
• CGM data and device 
• Exercise data and device 
• Sleep data and monitoring device 
• Summary of findings by stakeholder 
 
Technologies for Unmet 
User Needs 
 
• Real-time data flow controller 
• Real-time data purpose visualizer 
• Data blurring 
• Tailored reports 
Questions for 
Developers of Future 
Systems 
• Added workload and adoption 
• Emotional impacts monitoring 
• Unwanted or distressing information 
• Stigma 
• Differing relationships of trust with stakeholders 
• Trust 
• Personal preferences 
• Transparency 
• Privacy 
• Economic Security/Vulnerability 
 
TABLE 7-3 STRUCTURE OF THE RESULTS 
7.3.1 Interviews: User concerns 
This section presents and then discusses the interview sessions. The included figures show the 
range and attitude of responses, both before and after the 4 week study period. Participants were 
asked questions both before and after the study period as to: 
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• Current satisfaction and challenges with diabetes management. 
• Self-observed changes during study. 
• Their attitudes towards sharing various personal data: in a general sense, with doctors, with 
insurers. 
• Experiences with each of the devices. 
Each of these topics will be discussed in turn, first with the question asked, then with a discussion 
of changes in attitude resulting from the study. 
7.3.2 Views on diabetes management 
This first set interview questions related to current satisfaction with diabetes management and 
existing challenges. These questions were asked to establish whether participants had unmet needs, 
to what extent the potential capabilities of an automated diabetes decision support system might be 
of use, and how the study might have influenced these attitudes. 
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7.3.2.1 Q: How satisfied are you with your diabetes management? 
As this question sought to gain insights into general satisfaction, this graph represents these 
responses with increased satisfaction represented by elevation along the y-axis. 
 
FIGURE 7-3 SATISFACTION WITH DIABETES MANAGEMENT 
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While the majority of participants reported blood glucose levels either below or near goal standards 
(see Figure 7-3 Satisfaction with Diabetes Management), all stated that they had some aspect of 
their diabetes management they would like to improve. The figure shows two primary groupings. 
The more contented group expressed being satisfied, though all conditioned this response with the 
desire for further improvement. P2 for example hoped that improved access to technology would 
increase her control, “...I'm looking to get the full CGM covered and then I can really make use of 
all the features of my pump. Apart from that I am quite happy. I’ve got a good team and good 
motivation...” P7 who reported the best A1c (5.9) of the group was somewhat dissatisfied, noting, 
“The A1c is quite good but...I have to invest too much time and effort to reach that goal. I wish 
more automation.” The second ‘somewhat unsatisfied’ grouping all expressed specific challenges 
in their daily management. P8 said “I’m a little bit unhappy because I have an issue at night, that I 
don’t really...know what’s going on there...sometimes I’m super stable at night, sometimes, I have a 
peak, so the sugar goes to 300, and I have no idea what this caused. Yes, and work, it’s changing 
every day. So, new things appear, and new things happen.” And P3 “...some days it just does what 
it wants to do that doesn't matter how much I try to get it under control...But some days it's just out 
of control.” Post-study, while four participant’s (P:1,2,5,6) responses were consistent with the first 
interview, there were some changes.  Figure 7-3 suggests the general distribution remains similar, 
with P4 a minor outlier. Of those experiencing the greatest change in a positive direction, P3 noted 
having changed to a different insulin, and modified his diet, noting “the last two weeks I am 
extremely satisfied with my diabetes management.” P8 reported solving night time problems 
through the use of new technology, noting he “...converted the Libre into a CGM to have the data 
on my wrist. It's...annoying to keep the battery life on and to charge the watch...but by this I 
automatically deal more with my disease and that helps...I'm not wearing the watch every day...I'm 
trying to calm down a little bit regarding this real-time data thing.” P7 reported the greatest 
negative trend in attitude, becoming overburdened as “...it takes too much time and too much 
energy to handle it carefully enough...” Taken as a group, the distribution remains similar though 
there appears to be some variation over time as participants either solved or became overwhelmed 
by existing challenges. Given the small sample size, it is difficult to determine an obvious trend. 
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7.3.2.2 Q: What are your greatest challenges in diabetes management? 
P Challenge (Pre-Study)  Category Challenge (Post-Study)  Category 
P1 Calculating what I'm eating...  Cognitive ... what I eat because I'm constantly eating and sometimes I 
don't have the patience to wait...until my insulin reacts 
Behavioral 
P2 Keeping up my 
motivation...and...using the 
data that I gather 
automatically. 
Affective 
Cognitive 
Keeping up my motivation...even if you do the same thing 
every day exactly it doesn't mean that you get the same 
results... 
Affective 
Cognitive 
P3 sometimes things don't make 
sense... 
Cognitive The unexplained stuff... Cognitive 
P4 ...low sugar in the 
night...headaches the next 
day... 
Cognitive ...keep(ing) a steady profile. Not to have too many jumps up 
or jumps down...especially...in the night. 
Cognitive 
P5 I think the greatest challenge 
is...psychological.  
Affective It’s managing constant changes in my insulin doses...during 
pregnancy.  
Cognitive 
P6 ...I just want to get it a little 
bit better, to go from 7.2 to 
maybe 6 HbA1c.  
Cognitive ...getting my values and analyzing them in the right way.  Technical 
Cognitive 
P7 (after a marathon)...staying 
in a good range is not that 
easy....  
Behavioral 
Cognitive 
Always keeping in mind the most important facts as activity, 
insulin, carbohydrates and the factor x, which is the unknown 
thing.  
Cognitive 
P8 At the moment, it’s keeping 
enough insulin in the fridge... 
Behavioral ...the motivation. Like in times where you have personal 
issues or in your career or, yes, with your family then this is 
on top.  
Motivation 
TABLE 7-4 CHALLENGES IN DIABETES MANAGEMENT 
This question set out to gather information into each participant’s challenges in diabetes 
management, responses are listed in Table 7-4 Challenges in Diabetes Management. These have 
been classified according to attitude (Krönung and Eckhardt, 2011), with the addition of a category 
for technical functionality (this classification structure will be discussed further in the following 
chapter). Cognitive challenges appear most common, with 12/16 responses noting difficulties in 
interpreting data in order to optimize treatment, though often in these cases this leads to other 
challenges. P1 notes primarily a cognitive challenge in “Calculating what I'm eating especially 
because I think I'm eating all the time even though I'm not.” P5 described initial emotional 
challenges of management and how this impacts behaviors, “...diabetes...  a lot of stress and fear 
that I won’t manage to do something, which might stop me from actually doing something...”  And 
P3 notes the difficulties in understanding relationships between factors and how this impacts 
physical and emotional state, “sometimes things don't make sense...it just skyrockets and then you 
try to correct and then it doesn't work, and you have to inject loads of insulin to get it down again 
and then it starts kind of a roller coaster...it's really it's really exhausting.” And P2 also referenced 
all three categories, “Keeping up my motivation...using the data that I gather 
automatically...gathering more data because I'm really, really bad at logging stuff.”  These factors 
continued to be related by participants after the study. P5 who was pregnant, noted that “It’s 
managing constant changes in my insulin doses...I will be starting the third trimester soon, and I 
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really need much more insulin than I did before being pregnant.” P7 drew attention to the general 
cognitive challenge of diabetes “Always keeping in mind the most important facts as activity, 
insulin, carbohydrates and the factor x, which is the unknown thing. Because...it's changing every 
day.” P8 noted “...motivation. Like in times where you have personal issues or in your career or, 
yes, with your family ...” Overall, these quotes suggest that participant’s challenges in diabetes 
management are ongoing, not easily solved, and often combine multiple inter-related challenges, 
such that a failure in glycemic control can impact the other factors. These statements emphasize the 
continuing cognitive, emotional, and behavioral challenges of T1 diabetes management even for 
those with access to available technologies, and that many seek further assistance.  Many of these 
statements suggest that systems capable of alleviating cognitive workload are desired, though care 
must be taken that they do not in other ways increase burdens nor add to emotional stresses. This 
emphasizes the importance of understanding user concerns and preferences, so that such systems 
will integrate into daily life. In all these cases, understanding and making decisions informed by 
personal data plays an essential part of the management process.  
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7.3.3 CGM data and device 
The following sections review participants’ responses to question related to sharing of their CGM 
data: in a general sense, with their doctor, and then with their insurance provider. This is followed 
by a discussion of user’s reflections on the use the continual glucose monitors during the study 
period.  
7.3.3.1 Q: How do you feel about sharing your CGM/blood glucose data generally? 
 
FIGURE 7-4 SHARING CGM DATA: GENERAL 
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This question (see Figure 7-4 Sharing CGM Data: General) probing attitude towards non-specific 
sharing of BG data brought a spectrum of initial responses, ranging from open to very private.  P3 
for example stated, “I don’t mind”, and P2 was willing to share such data as “...I want to help 
science improve life with this condition, so I immediately see the benefits.” Others were less willing 
to share data such as P6 who said that while willing to share with her doctor and friends, and 
accepted non-secure apps, she “...would prefer to keep them really private...I am my data. If you 
see my data, you know exactly how I was, what I did, if I felt well or bad. It's a very private thing. It 
tells a lot about me and my lifestyle and how my day was. For a diabetic, they live through their 
data...” And P4 felt a need to keep such data secure, “Definitely not, also not with my friends...I 
think it’s something very private.” While 5/8 participant’s responses remained consistent before 
and after the study, there could be a slight trend towards more neutral responses for those who had 
originally given more extreme answers (P3, P4, P7), while those who stayed consistent might have 
become slightly more open to sharing this data.  P4 demonstrated the largest change in attitude, no 
longer considering this data to no longer be completely private noting,” ...I would say one to one is 
fine if I know the person, but I wouldn’t share it just with anyone...” In contrast P3 went from being 
unconcerned with this data, to now stated, “Only with my medical team.”  
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7.3.3.2 Q: How do you feel about sharing your CGM/blood glucose data with your 
doctor? 
The next questions asked participants about their willingness to share data with their physician to 
explore how the confidentiality offered by the physician/patient relationship affected their sense of 
privacy and vulnerability. 
 
FIGURE 7-5 SHARING CGM DATA: WITH DOCTOR 
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In contrast to the previous graph, in Figure 7-5 Sharing CGM Data: With Doctor there appears to 
be a consistent clustering of responses indicating a high willingness to share and trust clinicians. 
All participants reported that they were comfortable with their doctor having access to their CGM 
data. P5 was representative stating, “I think he has to have as much access as possible.” Or P8 who 
explained, “...the doctor can help me better understand what I’m doing, because so many things 
belong to the disease.” However, P2 elaborated that desire to engage in such sharing was 
contingent on personal trust and relationships, “Since I have a very good doctor, a very good team 
I would feel ok with that. I would see the benefits. I'm already in touch with my diabetes nurse 
through WhatsApp. So sometimes I snap a photo off of my graph to tell her how things 
are...although I've also seen doctors with whom I would not feel comfortable sharing all this data... 
I didn't feel that they had my best interests in mind.” And P4 noted that the confidentiality of this 
data was legally protected, and hence posed no risk to privacy. While there was some varying of 
placement of responses, this could be due to brevity or ambiguousness of answers. 
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7.3.3.3 Q: How do you feel about sharing your CGM/blood glucose data with your 
insurance provider? 
 
FIGURE 7-6 SHARING CGM DATA: WITH INSURER 
Initial responses (see Figure 7-6 Sharing CGM DATA: With Insurer) were similar to the general 
sharing question, though distinctly less positive in comparison to sharing CGM data with 
clinicians.  There was a cluster of 3 participants who reported being unconcerned about such 
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sharing at the initial session. P3 for example noted that “This is not a problem.”, and P8 noted 
having to send the data for coverage. P7 was reserved, but expressed willingness with adequate 
transparency, “If someone would explain and I would understand, I would think about it. But first, I 
would say no.” However, others such as P2 were hesitant, explaining “...in contrast to my doctors, 
I am pretty sure that they don't have my best interests in mind...I think they're looking to just 
maximize their profits and they could use my data accordingly and they could punish me for 
unhealthy behavior or whatever they deem unhealthy.” And P6 feared the economic pressure 
stemming from health data, “I would not like it because I don't trust them for the future... I think 
data will be capitalized in some way or another...” The graph (Figure 7-6) suggests a trend towards 
considering CGM data more private, with those who had been more open re-considering, and those 
who were already hesitant becoming resolute. P1 for example became more cautious, shifting from 
being unconcerned to noting “Depending on how it's going to effect the coverage.” And P5 became 
more suspicious, moving from “I wouldn’t mind.” to a more cautious “...maybe they would try to 
sell me something and take advantage of the information that they get...Maybe they would 
somehow also be judgmental and limit my rights when I do something wrong...I don’t trust them. I 
would have to understand why they can access it.” At the later stage, all but P3 express some level 
of hesitancy or discomfort with sharing this data with insurance providers. This would seem to 
suggest that increased awareness of external monitoring has increased a sense of potential 
vulnerability from CGM data concerning this stakeholder. 
7.3.3.4 General participant reflections on CGM usage 
All participants were already habitual users of CGM technologies, and as most reported no change 
in their relationship to this device. As P7 explained, “... (I have) had the CGM since 2011, so this is 
always the same.” And P3 shared his habituation as “...Not only do I love (Libre), I can't be 
without it...if a sensor fails or if I'm between sensors, that's a major source of stress.” Only P1 
noted that being part of the study changed her perception of CGM use, “...sometimes, when I did 
really bad...oh they are going to see it... I felt...more conscious of it...” Though P1 did not see this 
necessarily as negative, noting “I think it is a motivation for me, because I think I need to do a bit 
better because some people are going to see it.” However, P1questioned whether this would be 
beneficial over the long term, “...at the same time I don’t know if that should be the motivation. It 
should come from myself... you can try to please people, but for how long can you please people.”  
More generally, data collection and observation connected with the study did not appear to change 
participant’s relationship with their CGM usage, although external tracking of CGM data might 
increase stress among some users.  
7.3.4 Exercise data and monitoring device 
The following sections review participants’ responses to question related to sharing of their 
exercise data: in a general sense, with their doctor, and then with their insurance provider. This is 
followed by a discussion of user’s reflections on the use the exercise tracker during the study 
period.  
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7.3.4.1 Q: How do you feel about sharing your exercise data generally? 
 
FIGURE 7-7 SHARING EXERCISE DATA: GENERAL 
 
In Figure 7-7 Sharing Exercise data: General at the beginning of the study participants were either 
open to sharing this data, or at least open with certain limitations on sharing. P1 said, “I don't have 
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a problem sharing.” P4 had a similar response, “It’s also not a problem. I even share it over 
Runtastic with my friends.”  P7 was open to sharing, but wanted to retain specific controls, “If I 
were to have a coach, I would share the data, or I would share the data with friends, just to 
challenge each other, but I wouldn’t like my insurance to know about my data.” P2 noted 
additional concerns as such data could contain “...patterns that show opportunities to manipulate 
you as a consumer. Although I do see the opportunities for medical research.” P5 who noted being 
against social media in general, “It depends on the purpose...but not social media.” Most 
participants had consistent post study opinions on openly sharing exercise, with slight movement 
towards this data being considered more private for P2, P5, and P6, who all expressed increased 
conditions for willingness to share data. P6 explained, “...I just don’t like sharing it at all with 
some unknown...Like the internet. For me, it’s good to know if I exercise or not. I like it for my own 
purposes and maybe for my best friends... “Ah, she’s doing yoga, maybe I can join her.” That’s a 
nice thing to do and to know, but not on a bigger level.”   
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7.3.4.2 Q: How do you feel about sharing your exercise data with your doctor? 
 
FIGURE 7-8 SHARING EXERCISE DATA: WITH DOCTOR 
In the left side of Figure 7-8, 7/8 participants reported being open to their doctors viewing their 
exercise data. Most expressed no concern, as P6 explained “Yes, it's okay because she sees the 
consequences on my glucose and (A1c), so it's good if she knows.” Only P7 was expressed 
reservation “I wouldn’t mind let(ting) him know how active I am, but I wouldn’t like to let him 
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know where and when I am active... I would like to share data with my friends or family, but not 
with others outside that circle...my doctor is interested in how I handle or manage my diabetes, 
connected with sports, to find out things or mistakes, I would share that data for that reason.” 
After the study two participants reported substantial changes in attitude. P6 became more 
concerned with uncontrolled sharing, altering from “it's good if she knows” to “No, that’s private 
too. My doctor should have access to my CGM data because, that’s what she’s there for. But 
everything else should be my decision to share it or not share it.”  P7 changed in the opposite 
direction, now seeing direct value in such sharing, “I think he needs to have that access... otherwise 
he cannot understand the whole diabetes thing.” P2 underwent a less dramatic shift narrowing 
access from, “I would be fine with that.” to “I wouldn’t like it in real time, but they could have 
regular updates on a monthly basis or something like that.”  
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7.3.4.3 Q: How do you feel about sharing your exercise data with your insurer? 
 
FIGURE 7-9 SHARING EXERCISE DATA: INSURER 
As can be seen in Figure 7-9, initially 6/8 participants expressed resistance to sharing exercise data 
with their health insurer. While P1 and P3 were open, considering such sharing to be “No 
problem.”, other participants were far less trusting. P7 was more open given the right incentives, 
“Only if they...pay me something...I’m very active, so they can see I do something to improve my 
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health.” And P8 added similarly “I think if they asked for it to cover things, I’m more willing. If 
they just generally collect all that data, I wouldn’t. So, I always need to know why they want to see 
it.” However, others were dismissive of such sharing: P1 “Also not.”; P2 “It's none of their 
business.”; P4 “I would say no data at all.”; and P6 “No. That's private because the only reason 
for them to know it is to have information which to make money.” At the end of the study responses 
were generally consistent, though P6 noted some additional potential willingness to share data if 
given the right incentives. 
7.3.4.4 General participant reflections on using the Jawbone up for exercise 
tracking(steps) 
This device itself received mixed responses. While some found it non-obtrusive, other participants 
found fault with its aesthetics, comfort, and issues related to wearability. P1 noted, “...I sometimes 
forgot that I was even wearing it. And it was interesting because some people asked me about it. 
Like some kind of new interaction...” Others found it irritating as a wristband but adapted. P4 
reported, “I was wearing it next to my watch and it was a little bit disturbing. Then I started to put 
it into my pocket. It was fine actually.” P5 had a similar concern, with a similar resolution, “When I 
wear it on my belt and not as a watch, then completely fine.” However, for P5 this was not related 
to physical comfort, but rather that it was “...about aesthetics. I like my watch and it doesn’t look 
good when I have two.” For P2 the device brought unwanted attention, “...it’s a bit annoying 
because my watch is here, and the band is there, and it just kind of got a little bit annoying that 
people asked me about it all the time. I'm very used to it, especially in the summer with any 
diabetes devices, but it's more natural for me to explain those are just part of me and the tracking, 
maybe I don’t identify with it enough.” And while P3 didn’t find the device intrusive, he was also 
disturbed that the tracker didn’t give credit for certain exercise, “It didn't bother me at all. (though) 
I felt that the fitness tracker was not accurate because it didn't recognize [exercise] I did in the 
fitness studio to do even though it was very intensive exercise.” And some, such as P7 rejected the 
tracker, as he experienced skin irritation from the band and found it redundant, “No, I just stopped, 
I quit...I already have my own fitness wearing device, so I don't need two of them.”  These 
responses suggest that future multi-device systems should allow users options as to which devices 
they use and where they are worn to meet personal preferences.  Ideally the user could incorporate 
existing devices when possible. Systems that restrict such choices might create significant barriers 
to use, especially when devices replicate functionalities of already adopted and preferred devices. 
This points towards the importance of industry standards and open API’s to allow maximum 
configurations or potentially minimizing number of worn required devices. 
7.3.5 GPS data and device (smartphone) 
The following sections review participants’ responses to question related to sharing of the GPS data 
which was collected from the Moves App on their personal smartphone. In turn will be discussed: 
in a general sense, with their doctor, and then with their insurance provider. This is followed by a 
discussion of user’s reflections on GPS monitoring during the study period.  
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7.3.5.1 Q: How do you feel about sharing your GPS/location data generally? 
 
FIGURE 7-10 SHARING GPS DATA: GENERAL 
Participants were then asked about their general willingness to share GPS location data. Figure 
7-10 suggests that participants perceived this data as slightly more sensitive than the CGM data, 
with all participants expressing a desire to maintain some level of control, though the sample size 
limits significance.  P7 was the most open, reported sharing such data for specific purposes, such as 
“...On a bicycle trip if you don’t want to stay as a group, close together... you can see on your 
screen where other sports friends are riding... I don’t mind sharing data as long as I know that it’s 
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kept safe.” While P8 similarly noted also using location services, but only for short times, “I share 
it for half an hour or an hour for co-ordination to find people, but, except that, I wouldn’t share 
it...I feel uncomfortable if someone would know where I am.” P3 noted feeling “Not comfortable. It 
says publicly where I am and where I've been so that's quite spooky.” And P2 had specific 
concerns, feeling “A bit uneasy…. I know how helpful it can be for scientists...but I think it can also 
be used in a way to manipulate me as a consumer.” And P6 stated “Well, for the study it's okay... 
(but I wouldn’t) make it public...the notion that everybody who wants to can locate me (can)...It 
doesn't feel good.” The after-study distributions were generally consistent. P5 might have been 
slightly more open, with a stated willingness to share with “people I trust”, while others such as P6 
who had previously stated some reservations about public sharing confirmed these feeling, “I don’t 
like it. Because, I don’t want someone I don’t know knowing about my whereabouts. It’s just a 
sensation of privacy...for a study, it’s okay, it’s not a problem at all, but I won’t do it any longer.” 
The interviews suggested that the majority of participants felt GPS data to be at least somewhat 
sensitive, and though there were some variations, this appeared constant at both interview sessions. 
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7.3.5.2 Q: How do you feel about sharing your GPS/location data with your 
doctor? 
 
FIGURE 7-11 SHARING GPS DATA: WITH DOCTOR 
As can be seen in Figure 7-11, initially participants appeared concerned about sharing GPS data 
with their doctor, with only P4 and P1 being open to such sharing. Some such as P2 indicated a 
willingness to share if access remained controlled “...I wouldn't be comfortable with live data, but 
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after the fact I could be OK with it because I see the medical benefit...if I just give my data away 
freely then who knows.” Others such as P5 were reflexively negative but might be open to sharing 
if they understood distinct value to their health “I think if location could help...maybe in steering 
diabetes, then I wouldn’t have a problem with this, but I think I just don’t see the point. It makes me 
feel a bit scared that one certain person whom I know might have such a lot of information about 
me.”  After the study the general distribution of responses is similar, though 5/8 participants appear 
to have changed their general perception of such sharing. P4 had increased concerns with location 
data, changing from “It’s fine”, to “Not really. I don’t think doctors should know it. I don’t see how 
it would help actually.” As did P6, who shifted from ‘I don’t have an opinion” to “That’s private.” 
For P8 in contrast this data became less sensitive, who shifted from being comfortable with in 
office retrospective analysis, to “If he's not sharing that data with someone else, then I think it's 
also okay.” The responses suggest the importance of transparency of such sharing, especially 
concerning justifying potential benefits, and for patients to be able to retain control over access. At 
the end of the study 4/8 participants appear open to sharing, suggesting that increased use and 
consideration of the technology increased willingness to share for at least some participants. 
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7.3.5.3 Q: How do you feel about sharing your GPS/location data with your 
insurer? 
 
FIGURE 7-12 SHARING GPS DATA: INSURER 
As evident in Figure 7-11 sharing location data with insurers was with the exception of P1, viewed 
negatively. Many such as P3 struggled to understand how this would provide benefit, “Oh that's 
like too invasive. I don't see how that would bring any value.” P5 noted similarly, “This feels again 
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a bit too personal for me and doesn’t make sense.” And P6 explained “It's private. It's my life. I 
don't want to tell everyone where I am going, or what I'm doing.” As did P8, “I think this is 
something that shouldn’t interest them...it’s private.” At the end of the study 7/8 continued to not 
want to share this information with P1 remaining unconcerned about this data. P7 remained 
skeptical, though on further questioning suggested being open given sufficient grounds “I don't 
know why they should have. (If they could tell you a good reason?) I'm very curious about that 
reason. If they have one, then I could accept, I would agree, but I cannot imagine such a reason.” 
Except for P1 participants showed consistent distrust of insures having access to their GPS data, 
and appear to require strong justification for altering such opinions.  
7.3.5.4 Moves App on Smartphone 
Many users expressed concerns about their locations being tracked, with some expressing that 
while it was acceptable within a research context, they were often uncomfortable with such 
tracking. Some participants reported dissatisfaction with this app on both practical and emotional 
grounds. P1 noted she stopped using the app because the constant GPS caused excessive battery 
depletion, “...my phone was dying.” P2 also expressed concerns with such monitoring, “It was 
OK...for science...I'm not sure I would be comfortable with it all the time. Because I just don’t want 
to share that data with anyone right now.” P3 stated, “GPS location is tricky. I don't want to share 
it.” When P3 was asked about the apparent discrepancy between this opinion and current use of 
Google products, P3 explained that it was a matter of context and related to this data being 
associated with medical data, “It's different...if it's a medical device...I know the dynamics of 
carrying the phone, and who has access to it, and what are the possible implications...That brings 
me value...recommendations around me for example, and I (get) paid back a lot of free services 
with this data. So, it's kind of fun. I gave my consent for this. And the in the case of a medical 
device and who am I sharing this with, is it my insurers, is it my care team…Maybe it's irrational 
but I still don't feel comfortable doing it.” However, P3 later reflected on sharing such data, “...if 
someone can convince me that sharing my location...brings value to me directly or to the group or 
to society. I guess I would reconsider that.” And while P6 didn’t find the app itself invasive, P6 
also observed “… I didn’t notice it at all, but if it was without the study I would have put it off...I 
don’t like to get tracked, that’s not a nice sensation...I don’t trust the big systems, it’s just a, kind 
of, little bit of data paranoia.” Given the current acceptance of such tracking in connection with 
free services such as Google Maps and Facebook, this discrepancy should be further investigated 
for further implications. P3 noted that this discomfort was directly related to the medical context 
and association with medical data. Medical systems that incorporate such data might need to 
educate the user as to specific benefits and consider trust building as an essential aspect of design.  
7.3.6 Sleep data and monitoring device 
The following section reviews participants’ responses to question related to sharing of their sleep 
data. This is followed by a discussion of user’s reflections on the use the sleep tracking device 
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during the study period. Due to an error in the questionnaire, participants were only asked as to 
general sharing and not with doctors and insurance as with the previous devices. 
7.3.6.1 Q: How do you feel about sharing your sleep data generally? 
 
FIGURE 7-13 SHARING SLEEP DATA: GENERAL 
As viewed in Figure 7-13, this question regarding sleep data also showed a range of responses with 
a slight bias towards more private. P4 who was open to sharing this data said, “I feel I can share 
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this...it’s less private somehow.” Others such as P8 needed to understand direct benefits before 
consenting to such sharing, “I wouldn’t (to) because I don’t know why. If it’s for my health and my 
doctor wants to see that, I probably would...” However, some participants felt such data to be 
sensitive.  P2 for example noted “Well that would be super scary. It depends on who I'm sharing 
this with. But if it would be out in the open, I wouldn't feel comfortable doing that in the long run.” 
While the distribution is similar in the closing interview, there was some individual change in 
sentiment with P7 and P8 reporting less concern with sharing this data, while in contrast P4 and P1 
considered this data more sensitive after the study period. P1 expressed increased concern about 
sharing sleep data, “I felt like I was sleeping too long after many days of work...and then I am 
going to be judged about it...” And where P4 had previously been unconcerned with sharing sleep 
data, it was now considered more sensitive or private “My doctor or a person who wants to analyze 
the data and I know this person most likely it’s fine, but if it’s just some company or just sharing it 
on a website with someone, I wouldn’t do it because I think it’s too private.” In contrast some 
participants considered this data less important. P7 and P8 went from stating a need for justification 
for sharing to no longer caring, with P7 saying “No, I don't mind, it doesn't matter.” And P8 “I 
think that's not a big issue.”  
7.3.6.2 Beddit sleep monitor 
While some participants reported interest in the data delivered, there were noted barriers to 
sustained use.  P4 noted the sleep data offered meaningful insights, “... how long I sleep... was 
super interesting...I sleep only seven hours or less. I always thought I’m sleeping eight or more. I 
also have seen that sometimes I was super tired the next day. Then I just checked out the profile 
and have seen that I was basically not sleeping very deep. I think if it basically makes sense and it’s 
not too invasive into lives, then it’s fine.” However, while such data can be informative, some 
questioned its actual benefit, P6 observed “Sleep tracking was fun to have, but since it’s told me 
every time that I snore...I didn’t like it so much, because I don’t want to know about it.” And P6 
noted that such information was on its own of limited utility, “... it tells me if I slept well, but I 
notice myself if I have slept alright. I prefer my own sentiments about my sleeping habits.” P8 
noticed a similar negative impact, “you think you feel well, but then you see that you haven't slept 
well, because your device tells you. You automatically feel bad afterwards.” For some such as P3, 
transporting the physical device was problematic. “The sleep tracker is really interesting...the 
insights and data... I don't sleep that often in my bed and sometimes I sleep in the office, or pass out 
on the sofa, or I forget to turn it on, but every time I used it I was very impressed with the data I got 
from it.” For those participants who were able to use the automatic function, non-sleeping time in 
bed complicated usage. P2 reflected, “...on the weekends I spend a lot of time in bed, so that's when 
I have to switch off the automatic function. So that also meant that when I got to bed in the night, I 
had to turn it on and I kept forgetting and then sometimes the power was off, so it felt like kind of a 
hassle to me...” And P1 noted “...the first thing that I turned off (after the study) was the sleeping 
tracker, because I had to press a button and say I am going to sleep now and when I wake up I 
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have to stop it again. One day I forgot it, and I was like I forgot it, I am going to ruin all the values 
and so finally when the time was over, I was like I don’t have to do this anymore. anything that 
adds a task, in the long term isn’t going to work out.” For others, having in-bed habits monitored 
seemed invasive. P2 noted, “Although the information is very interesting to me and obviously to 
any researcher, I don't think that I’d feel very comfortable with this in the long run...” And P7 who 
folds up his futon each day, found having to set the monitor each day overly burdensome, 
especially when his girlfriend was spending the night. He explained, “I used it a few days, but 
whenever my girlfriend was visiting me, or I was out staying at her house, I didn't bring it with me. 
Because I didn't want to explain what it is and what I do and so on. I had to think about it, how to 
use it, to place it when preparing for the night and so on.” And P8 reported that turning on the 
device and the gamification aspect was disruptive to sleep routine, “...every night I touched this 
button to track my sleep and somehow, I was focusing on sleeping and that made sleeping harder. 
Because I always said, "Okay, I have to sleep because I want to have a high score, and, while 
thinking about sleeping, I wasn't able to sleep.” While participants expressed interest in their sleep 
pattern data, the device displayed barriers which might limit its suitability for daily data collection. 
These included: the need to activate and de-activate device every sleep session; transport and 
installation of device for alternate sleep locations; perceived invasiveness of in-bed monitoring; 
negative emotional effects from negative reports; and potential feelings of stigma from partners. 
These factors might suggest that rewards of use might have to be substantial to encourage long-
term and sustained use. Further research with such devices with actual benefits beyond delivering 
sleep data would need to be tested to resolve such questions.  
7.3.7 Summary of findings by stakeholder 
The following sections discusses key emergent themes from the previous interviews organized by 
stakeholder. 
7.3.7.1 General attitudes toward data sharing  
• Participants showed awareness about the risks of sharing their data, with a tendency 
towards caution, with many concerned about commercial exploitation.  
• Many participants were already sharing their blood glucose data with non-medical 
stakeholders for emotional or logistical support, though in a controlled way, such as pre-
selecting data to share or with trusted stakeholders.  
• While some participants were willing to use GPS services for specific purposes, many were 
wary as the perceived such data could lead to safety, financial, or non-specific emotional 
risks. 
• While participants were willing to share data for research purposes, many perceived their 
blood glucose data as containing sensitive insights into their lives. 
• Sleep data could be perceived as sensitive, requiring permission and purpose for sharing, 
and some were clear that they didn’t want such data in the public sphere. 
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• Exercise data appeared less sensitive than other types, though there were some concerns 
stated around commercial vulnerabilities. 
7.3.7.2 Doctor summary 
• Participants wanted to share their blood glucose data with their doctors, though some noted 
this was dependent on having a good personal relationship. 
• Exercise data was often perceived as directly relevant to diabetes management, and 
participants were unconcerned about sharing such data with their doctor. 
• GPS data was perceived as being sensitive or potentially out of the scope of the 
patient/doctor relationship, with some participants expressing the need to understand 
benefits to willingly share such data. 
• Though some participants had complete trust in their doctors, many wanted to maintain 
control over which data they would share and when. 
While participants were often open to sharing with their medical professional, many expressed a 
desire to understand the purpose and benefits of sharing data. This could suggest that systems that 
collect data for use by medical staff should offer user education as to potential benefits, or 
alternately avoid real-time sharing and instead focus on tools for delivering retrospective insights at 
time of appointments, rather than linking of complete sensor data to patient records. While reported 
concerns were not dramatically changed, it is possible that the period of increased awareness of 
tracking caused some participants to become more cautious about sharing data, especially real-time 
with their clinician. This could imply the need for longer-term systems to integrate easy to use 
ways to share specific data with clinicians during appointments. 
7.3.7.3 Data sharing: Insurers 
Participants were often more distrustful of insurance company’s motives for collecting their data 
than their clinicians, and many of those who were willing to share wanted a clear understanding of 
the specific purpose for which it was being collected and/or substantial personal benefits.  
• Sharing CGM data with insurers drew mixed responses. Some participants were concerned 
that insurers would use such data to penalize individuals for their behaviors. 
• GPS data appeared to be viewed as personally sensitive, invasive, and not relevant to the 
needs of the insurance industry. 
• Exercise data was also often reported as private in this context. 
Many participants expressed distrust of the motivations of their insurance company and were 
resistant to granting insurers access to their personal data, especially without transparency of 
purpose. If insurance companies want to promote the use of personal tracking technologies, they 
might need to find ways to establish better personal relationships with customers through a greater 
sense of shared purpose or find ways to assure users that their data is protected from insurer access.  
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7.4 Reflecting on the Visualization Method 
After the discussion and analysis of the collected participant responses, this section will reflect on 
the potential benefits and limitations of the visual representation method: 
• Text: Richness of responses remains available in comparison to dots. 
• Transparency of coding: The placement of participant response is transparent, and open to 
re-interpretation. One criticism could be that the use of excerpts rather than the full quote 
could introduce coding biases. I justify this approach given the physical limitations of the 
A4 print format and the need for legible text, and that fuller responses were included in the 
following text. However, the use of digital media such as pdf would allow for additional 
text. An alternate approach might be to use excerpts, but to display the full text with when 
the box is selected. 
• Ordinal: Allows for visualization of the ordinal aspect of responses, which would be lost in 
a more tabular presentation. 
• Change over time: Easy interpretation of change, method could be used for any number of 
data points if there were additional interviews at later times. Change over time is easily 
viewable by angle of linking arrows, as are changes from positive to negative attitudes. 
This could be important for understanding product adoption or understanding how changes 
in a product or service influences user sentiment. 
• Bias of response: Groupings or trends in sentiment are easily accessed. 
• Comparison between graphs: Multiple graphs can be easily compared, for example to see if 
a particular participant was consistent in their attitudes across different types of data. 
• Easy to access spread sheet for deeper inspection: As the question and participant remain 
linked, source materials can be easily accessed for further inspection of outliers. 
As the following sections do not concern the above points, they will not make use of this method 
7.5 Technologies for Unmet User Needs  
The previous sections have discussed user concerns related to sharing data and the use of specific 
common monitoring devices within a connected health context. Many participants have noted that 
using such devices could not only decrease privacy, but also increase feelings of economic or 
medical vulnerability. Such feeling could potentially jeopardize acceptance of multiple-device 
monitoring systems.  As one of the goals of this technology probe is to suggest new technologies to 
meet user needs, the following section proposes software-based solutions to alleviate concerns 
relating to contextual data sharing, transparency of data processing, anonymization, and sharing of 
selected information.  
7.5.1 Real-time data flow controller 
Many participants expressed the desire to retain control over the distribution of their data, and in 
some cases expressed reluctance to adopt medical systems that didn’t support such control. For 
example, when asked about what sorts of assurances would support daily adoption of a medical 
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tracking system, P4 said “That I definitely know what kind of data is shared and that I can always 
remove it. Basically, I have access to it and can remove it or I can export it. For example, I have 
disabled all the Google services on my phone. I am enabling them only when I really use them.” P4 
noted concern over losing control of data once it is released, “... it’s just like a black hole. Imagine I 
trust someone and share the data but then I realize that somehow the people or the company are 
not really...responsible with my data.” This desire for control over personal data was further 
detailed by P7, “I always want to know who gets which data from me concerning everything: my 
behavior, situation, blood glucose level, or whatever. It is my data and I would like to know who 
knows it.” Similarly, P2 states “...I very much want to be in touch with who receives my data when 
and why.” This sense of agency appears critical, as P3 explains about sharing personal data, “...I 
would happily consent to sharing it, but not if I am forced to share it.” And we can also see that 
this control must be easy to change or grant only specific access, as P3 notes, “I'd like to share 
what's necessary with my doctor not just to make an input dump.” These quotes suggest that users 
desire a tool that assists with convenient permissions for personal data. However, as P6 explains 
“...you always just agree to those… 50 pages long... Agreements. That means that I give it off my 
hand... I would like to be in control. Even if practically I’m not doing it, because I get bored and 
never read them to the finish and just want to go on with my app.” While new GDPR standards 
specify reduced text, based on these statements more visual means of both granting, editing, and 
suspending permissions for each aspect of personal data would better respect user preferences, 
allowing convenient control over when, where, and with whom they choose to share their personal 
data.  
7.5.2 Real-time data purpose visualizer 
A user-centered system for data control, could also integrate a means of helping users to in real-
time see how their data is being or will be used. While such transparency of purpose is expressed in 
the General Data Protection Regulations, this could pose challenges for explaining complex 
algorithms, evolving systems, and for researchers who might not yet know exactly how they might 
use collected data. In the interviews, participants were unsure how correlations in personal data 
might hold insight for diabetes management, such as P3 who said “...I really don't see the value in 
sharing more than...glucose, exercise, (and) diet...with my doctor.” And P3 noted that knowing 
purpose of data processing is important for consent, “Ok so I share it and then it's anonymized but 
with whom, does it bring anything? Would it help find a cure for diabetes, then sure...if it 
is...crunched in a big machine that takes a lot of anonymized (data)  that comes out with 
breakthroughs...but if it's sharing for the sake of sharing, then no” Similarly P6 noted both the 
potential vulnerability of personal data, and the desire for understanding what is being done with 
the data, “You see a lot of your personality in your data, and that is very private, I think, and I 
would like to choose to whom I give it. The more the person can read out of it, the more I want to 
know him, know what he’s doing with it.” And P8, “I don't understand why they need that, and if I 
don't understand, then the transparency is missing in that. If it's a black box and I give data 
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somewhere and don’t get feedback on that, I don't know why I should share that.” These quotes 
suggest software that could allow real-time feedback on how data is being used would better 
respect user autonomy. Likewise, such systems could request access to use data for research 
purposes, which the user could grant for specific times or for specific data. As P1 notes, “I think 
(with) my medical data (it) is important to me to know who's going to have access to it...I generally 
don't have a problem giving access to my information if I know it's for a study...”  
7.5.3 Data blurring 
People can engage in actions which they might want to remain private. GPS and other data pose 
risks to their ability to maintain such anonymity. Preventative medical services are often offered 
non-judgmentally, for example anonymous distribution of clean needles or bleach kits for HIV-
AIDS prevention. In order to protect autonomy, health guidance systems should consider how to 
offer analytics services while preserving anonymity. For example, if an individual had a record of 
an emergency room visit associated with visiting a certain location, their insurer might be tempted 
to leverage that insight financially, or even normal behaviors like eating at certain restaurants could 
be considered risky for a person with poorly controlled diabetes. P1 noted such vulnerability when 
asked about how she felt having her GPS position monitored during the study, “At some points I 
felt uncomfortable... I don't have anything to hide. But I thought maybe this is what people will 
want to hide the most. For example, ...maybe if you're going to a bar and you have to work the next 
day...or I'm going to an ice cream place...” And P2 said, “I have nothing to hide. But should I ever 
want to rob a bank or have an affair. I think I would think about these things and try to hide my 
data...that's something I wouldn't want to share or want to have out there for whoever to gain 
access to...if I have a tracking device I would leave it at home...”And P3 similarly noted, “Well I 
know that people have a sensitive reflex to sharing...some of this stuff with either employer or the 
authorities because not everyone does things that are perfectly legal all the time. So. Let's say 
hypothetically, theoretically, speaking if I was about to do something and that is not necessarily 
legal or in a grey zone...I would not want to share that stuff.” Participants frequently expressed a 
willingness to share their data for science that they might not otherwise share but needed to feel 
safe in doing so.  P4 noted, “If I knew that the data was anonymized, and it’s hard to track, to 
conclude that I was doing it, then it would be fine. I could share it, most likely, with anyone if there 
is some benefit from using the data.” In addition, if crowd sourcing such data could provide 
valuable insights to others, it is crucial that users be assured that the data will be fully anonymized. 
P8 noted, “Restaurants or activities, yes, I’m more likely to share if it’s anonymous.” Allowing 
users to disable tracking systems at specific times is not a complete solution, as missing data could 
reduce health benefits, or create suspicious missing data. Therefore, some means should be 
incorporated into such systems that supports anonymizing location and other identifying data while 
still allowing robust pattern recognition, machine learning algorithms, and other means of distilling 
value from collected data.   
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7.5.4 Tailored reports  
Users with chronic health conditions must coordinate care with diverse stakeholders such as 
partners, family members, school or workplace, medical personal, payers and others. Patients might 
want the ability to share only specific aspects of their information dependent on these relationships. 
For example, P2 explained “I wouldn’t like (data sharing) in real time but(rather)...regular, 
updates on a monthly basis or something like that...I also don’t like the idea of them accessing the 
CGM values in a live stream so that they could check up on me... It might be for the right reasons 
but it also unnecessary because I am capable of taking care of myself.” And P3 said, “Well I'd like 
to share what's necessary with my doctor not just to make an input dump...the doctors have super 
little time to look at things anyways....maybe if there will be some kind of 
automated...software...that has more abilities than humans to crunch this stuff and come out with 
things that traditional health care professional or a team couldn't come up with.” And P6 notes of 
sharing CGM data her doctor, “Yes, she needs to do it. She never reads them. I always give them to 
her, but they never talk about it.” Doctors might not have time to make sense of large amounts of 
sensor data, though this data might contain information that is important for their understanding of 
patient needs. This would suggest the value of a tool to assist with pre-processing and then sharing 
contextually relevant information. Such tool could have other templates or guides with varying 
levels of specificity for other stakeholders and their requirements, and if trusted could help to limit 
many of the stated concerns. 
7.5.5 Summary 
The following capabilities could be important components of designing more user-centered health 
management systems 
• Assist users in conveniently controlling and altering 3rd party access to specific data. 
• Allow users to view how and for what purposes their data is being used. 
• Blurring functionalities to properly anonymize shared data according to user security 
preferences. 
• Tailored reports to export insights without exporting data. 
7.6 Questions for Developers of Future Systems 
Now that we have discussed concerns related to data sharing and devices, and implication for new 
technologies, the following section examines representative quotes from the interviews and uses 
them to pose questions for designers and developers of future system. These questions could be 
used both in a heuristic sense for stimulating critical examination of a product, or to initiated dialog 
between stakeholders. 
7.6.1 Added workload and adoption 
Not only does data entry poses known challenges to daily adoption, any added workload creates 
challenges to continual use. As P1 describes it “...so finally when the time was over, I was like I 
don’t have to do this anymore. Anything that adds a task, in the long term isn’t going to work out” 
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And P2 noted “I had some issues with the sleep tracking device sometimes it didn't work or I forgot 
to turn it on because on the weekends I spend a lot of time in bed so that's when I have to switch off 
the automatic function so that also meant that when I got to bed in the night I had to turn it on and 
I kept forgetting and then sometimes the power was off...it felt like kind of a hassle to me”.  And P3 
notes the challenges placed by requiring work, though notes that this is manageable with sufficient 
rewards, “... manual entry is a no go... the...Beddit…because of the fact that you need to pair it and 
connect and so on that's why I didn't do it. The freestyle Libre...there is a no problem scanning the 
sensor because that's something I want to know straight away.” These responses indicate that 
while users might be willing to engage in repetitive tasks, such workload must deliver consistent 
perceived value. 
Q: Does your product in any way add to daily workload? If so, what rewards does the user receive 
to justify this time and effort? 
7.6.2 Emotional Impacts of monitoring 
Participants often discussed how their awareness of being externally monitored could increase 
stress, fearing that they were being judged externally for their ability to control their diabetes 
values. P1 was concerned about such monitoring, “I think if (my BG values are) OK I have nothing 
to worry about, but if (my BG) is doing really bad…then everyone is going to see it and think (I) 
don’t care about it...” P2 added that having continuous data streaming to a doctor could be 
counterproductive as it might lead to conscious and laborious effort to alter data, “I don't even want 
to have to think about whether or not I have anything to hide...if I manipulate the data I'm 
automatically gathering then that would make things way more complicated and also (a) more 
negative experience…”  P8 explained that such external observation could lack situational context, 
leading not only to external judgement, but also internalized pressure, “...if you don’t know what 
the person did, the high value, you think, “Oh my god, he didn’t manage his disease." But maybe it 
was something really stressful or it was an accident or whatever...there's only that number and if I 
don’t have the chance to explain myself, why this number was there, I feel guilty...” These 
responses suggest that not only must monitoring systems be trustworthy in their data handling and 
representation to other stakeholders so as to protect users from counterproductive stress, but also 
that such trust might be essential to prevent system rejection. 
Q: Is the information collected by your system accessible to any stakeholder other than the primary 
user? If so, what is your strategy for: 
-mitigating feelings of surveillance? 
-assisting the user in taking breaks from monitoring if they desire? 
-allowing them to control how data is presented? 
7.6.3 Unwanted or distressing information 
Personal data can be interpreted by the individual as judgmental or indicative of performance, 
which can increase stress in counterproductive ways. P8 noted how such monitoring and scoring 
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could make it more difficult to sleep, "Okay, I have to sleep because I want to have a high score, 
and, while thinking about sleeping, I wasn't able to sleep.”   Also noting that receiving such 
information could negatively impact mood, “...you think you feel well, but then you see that you 
haven't slept well, because your device tells you. You automatically feel bad afterwards.” Such 
presentation of scores or other ways of interpreting data must be considered carefully to avoid such 
effects. 
Q: Have you researched how the information or feedback you provide impacts your users 
emotionally? What strategies do you have in place for delivering data in a way that minimizes 
undue stress? 
7.6.4 Stigma 
The use of even non-medical devices can create feelings of stigma or discomfort in specific 
situation. As P7 explained about not wanting to set up the Beddit device in front of his girlfriend or 
being questioned about a wristband. Interestingly no participants noted their blood glucose sensor 
as being stigmatizing, though this might be a function of time of use or perceived value.  
Q: How might your product or service create stigma in specific contexts? How might this stress be 
lessened? Is it possible to build for breaks in usage? 
7.6.5 Differing relationships of trust with doctors and other stakeholders 
User willingness to share their data with others can be dependent on personal relationships, and it 
should not be assumed that users will have full trust in their medical team. P2 for example was 
comfortable sharing personal data with their doctor but noted “...I've also seen doctors with whom I 
would not feel comfortable sharing all this data.” And users might want to edit or only share 
certain data, such as P6 who noted “My doctor should have access to my CGM...but everything else 
should be my decision to share it or not share it.” Or P7 who felt that sharing GPS was provisional 
on understanding why it would be beneficial, “I need to understand why he needs to have the 
access to my location.” These quotes emphasize the variability between users and their 
relationships with others, and that systems should be flexible enough to allow for appropriate 
customization. 
Q: Does your product provide personal data to medical personal or other 3rd parties? If so: 
-what controls does the user have to manage when and which data is visible? 
-could such controls be modified quickly during an appointment to allow discussion of a specific 
topic? 
7.6.6 Trust 
Participants often noted concerns about the use of their personal data, such as P1who noted, “...I 
think if I really don't know what's going happen with my information... maybe it's going to be sold 
to third parties, and I don’t have any knowledge...” P2 was concerned that data might be used “...to 
manipulate me as a consumer...” or that insurance companies might “...punish me for unhealthy 
behavior or whatever they deem unhealthy.” And others noted that there was a difference between 
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normal tracking, such as P3 who said, “...It's different. Because it's a medical device.” Systems that 
depend on open sharing of data should must take deliberate steps to build trust for users such as P8, 
“if I don't understand, then the transparency is missing...If it's a black box and I give data 
somewhere and don’t get feedback... I don't know why I should share that.”  Given the need for 
such systems to be continually gathering data in order to offer value, and the increased privacy 
concerns in a post Cambridge Analytica world, systems should carefully examine how to 
encourage and guarantee user trust in their products. 
Q: Why should the user trust your product? What assurances can you promise, and how can you 
guarantee they will be followed? 
7.6.7 Personal preferences 
While some participants were comfortable with the devices in the study, others were not. P5 for 
example fount that the step-counter was acceptable “When I wear it on my belt and not as a 
watch...” Whereas P7 found the tracker unwelcome “... I just stopped, I quit. Because it was, I felt 
uncomfortable with that because I already have my own fitness wearing device, so I don't need two 
of them.” This implies the need for systems to be adjustable to the device preferences of the user, 
rather than attempting to dictate specific devices. Ideally users will have multiple options both in 
terms of devices and where they are worn of installed. 
Q: Does your device or systems allow the user to adjust or alter components to meet their needs or 
preferences? If not, how is this justified? 
7.6.8 Transparency 
The desire to retain control and consent of personal data usage was often expressed as a concern. 
P3 explained, that such control could be essential to sharing, “I like to be in a position to give my 
consent and not be coerced into giving away my data...if I have the assurance that it is protected 
and it would be used in the proper way and not abused, (and) that it (is) secured...I would happily 
consent to sharing it, but not if I am forced to share it.”  There were differing factors which 
appeared to impact willingness to give consent. For example, some participants noted the 
difference between ongoing real-time sharing and retrospective analysis for a specific purpose. P2 
clarified, “I wouldn't be comfortable with live data, but after the fact I could be OK with it (if) I see 
the medical benefit... If...that could improve the analysis of the data that I've gathered.” For P2 this 
appeared to be a precautionary step, “...if I just give my data away freely then who knows.”  P3 
noted an increased willingness to share depending on purposed, “Would it help find a cure for 
diabetes? Then sure...but if it's sharing for the sake of sharing, then no.”  And P6 noted, “The 
more the person can read out of it, the more I want to know him, know what he’s doing with it.” An 
ethical and user-centered approach should consider how to embed transparency by design, rather 
than just meet minimal legal requirements. 
Q: Is your product transparent to how the data is being used? How do you keep the user informed 
and updated? 
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7.6.9 Privacy 
Comprehensive tracking can be invasive. As P6 explained, “I am my data. If you see my data, you 
know exactly how I was, what I did, if I felt well or bad. It's a very private thing. It tells a lot about 
me and my lifestyle and how my day was. For a diabetic, they live through their data, so I think it's 
private.” Location was considered especially sensitive, as P8 noted, “With location, it’s difficult 
because if you’re going home every day, you know where this person lives. So, with GPS, I 
wouldn’t (share) because it’s hard to anonymize...” Or P1 who noted, “... if you're going to a bar 
and you have to work the next day... (or) an ice cream place...” And others were particularly 
concerned about being monitored during specific situation, such as P5 who shared “...I might have 
a problem in intimate situations, like having sex. I think I wouldn’t like to wear a tracking system.” 
These quotes emphasize the role that trust plays in collecting personal data, and the need to design 
systems that assure user privacy.  
Q: Is the information collected by your system visible to any stakeholder other than the primary 
user? If so, how do you: 
-Plan for monitoring pauses in sensitive contexts? 
-Plan for reengagement after pauses in usage? 
-Allow user to control how and which data is shared?  
 
Q: Does your product or service make use of GPS data? 
-In which ways do you protect the user from vulnerability, such as being identified, or having that 
data associated with their medical data? 
 
Q: Does the proposed system have a system of consent which helps the user to easily control who, 
when, and for what purpose each of their different data types will be used? 
- If not, how do you justify this? 
-How could you implement such measures? 
7.6.10 Economic Security/Vulnerability 
Another common concern related to health data was that it could lead to financial risks for patients, 
either in the form of penalties for unhealthy behaviors or through targeted marketing. There were 
differences in opinion regarding incentive-based systems for behaviors. P8 reflected, “You hear 
about insurances who are thinking about rewarding or punishing people for certain behavior … 
and as long as that takes place within a certain legal and reasonable framework...if people who 
behave unhealthily and behave recklessly, e.g. if someone is smoking a lot even though they know it 
is unhealthy, and they become very sick, the community has to bear those costs…There should be a 
differentiation or compensation... If people get into trouble though without their fault, they should 
not be asked to pay.” P4 was concerned that the sharing of exercise data with insurers could have 
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similar risks, “Health insurance has interests in your health or how healthy you are. They could 
monetize it in a specific way, so I don’t think it would be a good thing.” And P2 when asked how 
she felt about sharing CGM data with insurers said, “Not good at all because in contrast to my 
doctors, I am pretty sure that they don't have my best interests in mind. So, I think they're looking 
to just maximize their profits and they could use my data accordingly and they could punish me for 
unhealthy behavior or whatever they deem unhealthy.” And for some it was not their current state, 
but potential future risks to themselves or others, such as P8 who noted that such judgement could 
potentially prevent data monitoring and sharing, “At the moment, I can share because my glucose 
values are very good, but I guess when something happens, and my glucose values are out of 
control and I don't know how to change that, I feel lost, and if they charge me on top, that could 
change the way I use the data and share the data.” And P8 noted, “I need to be sure that no big 
company is exploiting the data for their own advantages and benefits.” These concerns suggest that 
data monitoring systems face suspicion over how data could be used against patients’ financial 
interests. Given that non-ideal behaviors might contain especially useful data for determining 
health insights, means or policies should be found to protect patients from being penalized for 
monitoring.  
Q: Does your business model involve using individual’s personal data for targeted marketing or 
use by 3rd parties?  If so, how do you protect the user from any harms that may result? 
These questions can be located as a list in Appendix C: Results from Chapter 7. 
7.7 Study Limitations 
The implemented tracking system was not capable of delivering actual real-time insights to 
participants, and such benefits might have changed user concerns. Recruited study participants also 
were previously known to the researcher and had participated in earlier studies and workshops 
which might have impacted trust and feeling related to privacy. 
7.8 Future Work 
It is not yet established if the data collected within this study contains insights which might help to 
form a behavior change feedback loop. Future work will include analysis of this data, as well as 
assessment of engagement with each of the devices. 
7.9 Conclusions 
While this study has limitations that could restrict the generalizability of findings, it contributes 
insights into user needs and preferences in an area with few actual real-world products to draw 
upon. While economic forces are driving the innovation needed for new approaches to reduce the 
costs of chronic health conditions, it is critically important both ethically and practically, that these 
systems are designed with the needs of the user placed at the forefront. Given how little is known 
about the issues investigated, and difficulties in exploring any social/technical situation that does 
not currently exist, this chapter contributes insights into user needs from the sorts of technologies 
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that are likely to make up such systems. Through the use of technology probe implemented with 
potential early adopters of next generation diabetes monitoring systems, this chapter has: 
• Identified user concerns related to privacy and potential vulnerability from having 
behaviors and medical data tracked and attitudes towards specific devices. 
• Defined and explored a method of representing ordinal time series qualitative data to 
support identification of distribution, trends, and changes. 
• Explored how exposure to such systems can cause changes in perception. 
• Suggested software solutions to meet allow users to maintain control over important 
aspects of their personal data. 
• Derived important questions for developers of future health related systems. 
While user concerns and requirements for diabetes decision support systems have been a major 
focus of the preceding chapters, they have been identified for the greater goal of contributing to the 
improvement of actual systems that are responsive to user needs. However, there is a potential gap 
between academic knowledge and translation to product design. Therefore,  the next chapter will be 
concerned with designing and testing a methods of implementing such qualitative requirements into 
product design processes. 
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Chapter 8: DUETS: A Card-Based Tool for Stakeholder 
Reflection  
8.1 Introduction 
The preceding chapters have presented empirical evidence suggesting that the dominant approach 
for diabetes smartphone apps, the daily diary or logging app, can fail to adequately address user 
needs. This thesis has also suggested that a promising approach to overcoming these deficiencies is 
through networking sensors and processing the collected data to deliver targeted interventions. 
However, despite the potential benefits, such continuous monitoring with multiple devices could 
also be more invasive than existing solutions. Given that such next generation diabetes decision 
support systems are not yet available for user experience research, I deployed a technology probe 
with a simulated diabetes monitoring systems to learn more about user perceptions. The previous 
chapter discussed these results, bringing attention to diverse and potentially complex user concerns 
related to privacy, trust, and potential vulnerabilities brought about by continuous and diverse data 
monitoring and sharing. As T1 diabetes management depends primarily on self-care (Funnell and 
Anderson, 2004), it is crucial that such systems be designed in a manner agreeable to users so as to 
support engagement and adoption. However, designing systems based on rapidly evolving 
technologies challenges traditional health industry practices that have relied on slow and risk-
adverse development cycles. With the move towards more active automated interventions, it is vital 
that such systems respect the complex eco-systems of user’s lives, supporting the user’s goals, 
emotional needs, and behaviours, while still respecting individual privacy and autonomy.  Though 
rapid iterative design has proven itself in many industries, it remains challenging within the heavily 
regulated and ethically sensitive field of medicine. Consequently, there is a need for effective 
criteria and methods able to support design processes for health systems in ways that are safe yet 
can support rapid iterative design practices. Accomplishing this will require careful consideration 
of questions such as:   
• What are potential criteria for evaluation? 
• What are appropriate formats for assessing new systems? 
• How can these methods be implemented to support system designers? 
• What sorts of outcomes would such methods produce? 
• How can such methods be evaluated for effectiveness? 
This chapter engages with such questions through an iterative design process, which integrates the 
collected research conducted during this thesis to propose a card-based system called DUETS, to 
facilitate stakeholder reflection and critical discussion. The tool and method resulting from this 
procedure were then implemented and evaluated through structured sessions with stakeholder focus 
groups. While the proposed tool has been tailored to the requirements for diabetes decision support 
systems, the basic methodology and modular approach could with appropriate modification and 
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supplementation be adapted for a wider range of products and services that depend on complex 
eco-systems of devices and user interactions. The basic structure of this chapter is as follows: 
• 8.2: Reviews specific concerns for diabetes decision support systems and 
suggest five categorical criteria for system assessment. 
• 8.3:  Review of relevant literature and discussion of implications for design 
of DUETS  
• 8.4:  The components and iterative process for designing the DUETS 
system 
• 8.5:  Review and discussion of the procedure and results of three 
stakeholder focus groups sessions using the DUETS system. 
• 8.6:  Discussion of the DUETS approach. 
8.2 Suggesting Criteria for Assessing Health Self-Management 
Systems 
Previous chapters have used empirical research techniques to explore barriers to adoption of 
diabetes apps, user interaction with these apps, the ways in which people with diabetes think about 
and make decisions based on their medical data, and user concerns associated with the use of 
monitoring systems. The findings of the previous chapters have been combined into five categories 
of user requirements for self-management technologies:  
• Adoption & Utility (System Functionalities): Previous chapters in this thesis have drawn 
attention to the diversity of user requirements needed from diabetes decision support 
systems, and how deficiencies in functionalities can be associated with abandonment. 
Systems features should be designed to support and empower the user in achieving 
personally relevant goals in a way that is compatible with their lifestyle. This calls for 
systems and their interfaces to reflect actual user needs, while being sufficiently flexible 
and customizable to meet individual preferences. Ideally, self-management systems should 
allow the user to determine which devices and functionalities they wish to engage with and 
adapt to contextual needs.  
• Emotional Impacts: Chapters 4, 5, and 7 have all discussed ways in which personal health 
data can bring about feelings of stigma or vulnerability in specific situations and drawn 
attention to the way in which specific UI design elements can reinforce counterproductive 
emotions, thereby reducing engagement, or causing system rejection. Therefore, it is 
critical that designers are diligent in minimizing negative impacts, especially given the 
potential for user sensitivity to undesired diabetes related data.  
• Behaviors & Actions: Preceding chapters have drawn attention to the importance of the 
individual with diabetes engaging in behaviors to support both their general health as well 
those specific to diabetes such as treating severe hypoglycemia. Systems should therefore 
ideally both support and encourage a wide range of beneficial behaviors while taking steps 
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to minimize overreliance on technology that might create unnecessary vulnerabilities if the 
technology were to fail. 
• Cognitive demands: Chapter 5 and 6 discussed the frequent awareness and decision-
making required by diabetes care and emphasized the importance of considering the 
cognitive demands placed on the user. System designers should work with users to assure 
that interfaces support convenient task completion without overloading, confusing, or 
misrepresenting information, while still helping users to learn from their data to build self-
care models. 
• Consent & Control (Privacy & Security): The technology probe in the previous chapter 
highlighted perceived privacy risks and other user concerns that can emerge from multi-
device monitoring. Participants expressed the desire for control over how their data was 
being used, accessed, and presented.  Systems should be designed to be responsive to user 
desires for transparency and control over their personal data. 
Taken together these criteria form a preliminary framework for identifying key user concerns for 
systems designed to support the self-management of chronic health conditions. These categories 
and their criteria are expanded upon to form the basis for the Concerns cards described in section 
8.4.2, and for purposes of convenience will be referred to as User-centered Self-management 
Criteria (USC). 
8.3 Practical Application of User-Centered Self-Management Criteria 
Now that initial criteria for evaluation have been defined, the next step is to determine appropriate 
processes for application. In order to do this, we must first extend the literature review to consider 
emergent topics related to the following topic: 
• What is the role of the user in the design process? 
• What are appropriate formats of system assessment (the use of questions and heuristics)? 
• What are practical methods of applying USC (the card system)? 
8.3.1 The role of the user in the design process 
This section reviews and discusses literature concerning design practices that asserts that 
integrating end-users and other key stakeholders is an important component of designing more 
useful products. User-centered design for example endeavors to meet the needs of the user, 
emphasizing simplicity, ease of use, transparency of state, and clarity of purpose (Norman, 2016). 
Integrating the users of a technology into the development process can help assure that products 
will more accurately respond to their needs, overcoming deficiencies of domain knowledge and 
misconceptions that might be held by system developers (Gulliksen et al., 2003). Furthermore, as 
new technologies can impact essential rights such as privacy and autonomy (Wright, 2011), it is 
critical that such issues be addressed during the development process to avoid not only harm to the 
user, but also risks in trust and reputation to the developer (Wright and Friedewald, 2013). 
Participatory design directly involves and integrates workers and other users fully into the 
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development process, not just for their observations, but also as contributors of design ideas and 
solutions (Gulliksen et al., 2003). By asking questions as to how technology can be developed to 
retain and support humanistic values, participatory design methods can also support humanistic 
beliefs such as democracy and quality of life (Muller and Kuhn, 1993). This literature affirms the 
importance of including stakeholders in the development process, allowing them not only to 
comment on existing products, but also to determine the direction and approach taken. Integrating 
the eventual users so as to play a significant role in product design is supported by Jones et al. 
(Jones et al., 2017) who drew attention to the need for new technologies to not simply reinforce 
existing hierarchical compliance based relationships in health care, but rather to allow the user to 
adapt technologies to their own needs 
8.3.2 Questions as a tool for assessing health self-management systems 
This following section considers appropriate methods of assessing interfaces and digital systems. 
Nielsen et al. asserted that there are essentially four ways to assess an  interface, formal analysis 
techniques, automated procedures, empirical user experiments, and heuristics judgements (Nielsen 
and Molich, 1990). Nielsen et al. noted the practical limitations of the first two, and that empirical 
evaluations are time, labor, and expertise intensive, and are therefore often neglected. Therefore, 
Nielsen et al. advocated for heuristics. Relevant to the objectives of this thesis, Kientz et al. (Kientz 
et al., 2010) observed that persuasive health technologies pose significant challenges for 
assessment, as they can require working prototypes to assess reactions. Kientz et al. also noted that 
extended deployment can also be needed for assessment as long-term adoption can be a critical 
factor of effectiveness. Despite this last complication, heuristic evaluation offers many practical 
benefits, though it often relies on the knowledge or intuition of the user and can therefore lack 
standardization (Nielsen and Molich, 1990).   
8.3.2.1 Heuristics as a means of system assessment 
To assist with standardization Nielsen notably developed a list of ten heuristics including: visibility 
of system status; match between system and the real world; user control and freedom; consistency 
and standards; error prevention; recognition rather than recall; flexibility and efficiency of use; 
aesthetic and minimalist design; help users recognize, diagnose, and recover from errors; help and 
documentation (Nielsen, 2003).  Nielsen and Molich (Nielsen and Molich, 1990) found that people 
were generally willing to accept that there was a usability concern once identified, and that the 
aggregated results of 3-5 independent evaluators were capable of discovering a substantial 
percentage of key errors at relatively low cost and effort. However, heuristics have their practical 
limitations, they are primarily for identifying problems and can be limited in their effectiveness for 
providing solutions to identified problems, and therefore limited for assisting in pointing towards 
paths of further innovation (Nielsen and Molich, 1990). Drawing upon Nielsen’s methods of 
heuristic evaluation, Kientz et al.  (Kientz et al., 2010) developed a modified set of heuristics aimed 
specifically at persuasive health technologies, observing that Nielsen’s usability heuristics were 
limited in their specificity in certain critical aspects, such as predicting effectiveness in bringing 
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about behavior change and long-term adoption. Kientz et al. therefore created a tailored set of 
heuristics that included: Appropriate Functionality; Not Irritating or Embarrassing; Protect Users’ 
Privacy; Use of Positive Motivation Strategies; Usable and Aesthetically Appealing Design; 
Accuracy of Information; Appropriate Time and Place; Visibility of User’s Status; Customizability; 
Educate Users. Validating this approach of heuristic domain customization, Kientz et al. found 
their system was more successful in locating more severe concerns and problems more relevant to 
persuasive health technologies (Kientz et al., 2010). Especially given the cost, time, and effort of 
developing fully functional medical prototypes, not to mention the economic and ethical challenges 
of testing medical products, some form of heuristic analysis appears a promising approach for 
assisting developers with early identification of relevant concerns.  
Questions as an alternative to heuristic statements 
However, despite the popularity of a heuristic approach, there are some features of multi-
component health systems that suggest alternative approaches might offer specific advantages.  
First, heuristics have typically been designed for use by expert evaluators, which contrast with our 
needs for methods that can be used by diverse stakeholders who might not have prior familiarity 
with usability concepts. Also, the multiple contexts of use and specific demands of diabetes 
management might not be adequately addressed with such guidelines. Wright et al. (Wright, 2011)  
asserted that when context is critical, questions can yield more flexible and context-sensitive 
assessment than heuristics, especially to investigate the embedded privacy and ethical values which 
are essential when designing and developing new technologies. Drawing on this literature, I chose 
to investigate this more open question-based approach given our objective to provoke discussion 
and reflection. 
8.3.2.1.1 Wright’s framework 
Wright proposed a general framework for ethical impact assessment, applicable for diverse 
information technology systems. This system uses a set of questions within a multi-part 
methodology and combines with privacy and data concerns with the bio-ethics principles advocated 
by Beauchamp and Childress (Autonomy: respecting right of the individual to make independent 
decisions regarding their own welfare; Non-maleficence: avoiding within one’s capabilities causing 
harm to others; Beneficence: maximizing benefits to others while balancing costs and risks; Justice: 
equitable distribution of costs, risks, and benefits) (Beauchamp and Childress, 2001). While this 
paper makes a convincing case for the use of tailored questions, the objectives of this approach are 
to define a formal assessment process for major IT infrastructure projects, and such a 
comprehensive and intensive approach might create too large of a barrier to function within more 
agile and iterative development practices. Therefore, while embracing the open question format as 
suggested by Wright, the needs of the use-case point towards an approach that can support 
designers/developers and other stakeholders in a lightweight and time efficient manner to critically 
examine and discuss systems.  
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8.3.2.1.2 Data privacy and control as an important aspect of assessment 
Wright and Friedewald (Wright and Friedewald, 2013) asserted that privacy and ethics should be 
considered interrelated and could be assessed in an integrated process. The authors drew attention 
to the need for science and technology to support essential and fundamental human rights, and that 
privacy is an important aspect of such rights. Wright and Friedewald also drew attention to the 
shifting and hard to define nature of what an individual considers to be private, and the need to 
consider such issues within the context and effect of a given technological implementation, and that 
as privacy is an integral part of social interaction it should be considered when designing and 
developing new technologies. Wright and Friedewald also noted that greater potential risks demand 
more in-depth stakeholder involvement, and that such feedback is essential to help locate or 
identify concerns that have escaped earlier assessment. The authors also drew attention to 
information flows as a critical part of assessing such risks. It follows then that methods of helping 
stakeholders to understand these flows could be an important aspect of the development process. 
This places certain procedural challenges, given the diversity of user data which can be captured by 
commonplace sensor equipped devices, the hard to predict insights that might be extracted from 
such data, and the possibilities of this data being shared or sold to external 3rd parties. In addition, 
as systems and the way data are processed can evolve through the development and implementation 
process, there is a need for practical methods of iterative reassessment by relevant stakeholders.  
8.3.2.2 Summary of key points for assessing health self-management systems 
This section has drawn attention to a number of key points which can be integrated with the 
criteria from the previous section to help suggest a design process: 
• Integrating users throughout the design process is beneficial in helping to assure that 
products meet user needs as well as helping to protect the developer ethically and 
reputationally.  
• Use of questions to guide heuristic analysis and identification of key concerns to support 
lightweight testing procedures, especially before operational prototypes can be used for 
empirical testing. 
• Embracing methods that can help guide iterative and incremental process. 
• Multiple stakeholders to gather diverse viewpoints. 
• Tailoring questions to the use-case as needed to reflect specific domain requirements. 
• Embracing an ethical perspective that respects privacy and autonomy placing priority on 
patient needs. 
• Integrating information flows and helping users understand system function as an essential 
aspect of the discussion process 
Combined with the framework for User-centered Self-management Criteria the above approach 
forms a basis for system evaluation. The next section discusses methods of applying these 
questions to generate concerns. 
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8.3.3 Practical methods of application: Support for card-based approaches 
The preceding sections discussed emergent user requirements for diabetes decision support systems 
and methods from the human-centered computing literature for assessing and developing user-
centered systems. Given these requirements we now examine relevant literature to suggest 
appropriate methods of application. While Nielsen and Kientz et al. employed lists, researchers 
have also used other methods which might better support more creative interaction. For example, 
Halskov and Dalsgard (Halskov and Dalsgard, 2006) developed a card based system to inspire 
collaborative design.  Knowledge relevant to specific projects was translated into Domain Cards, 
while specific devices or applications of technologies were recorded onto Technology Cards.  The 
authors asserted that tangible objects such as cards can assist design processes through focusing 
and supporting constructive interactions, as well as supporting new idea synthesis. Luger et al. 
(Luger et al., 2015) also promoted the use of cards as a design instrument to help students and 
designers understand often inaccessible legal regulations in regard to data protection and privacy.  
Through consultation with domain experts, they produced a series of cards which addressed issues 
such as data breach notifications, informed consent, and privacy by design. Their study highlighted 
the need for data privacy concerns to be integrated throughout the design process. Lucero et al. 
(Lucero and Arrasvuori, 2010) developed playful experiences cards to facilitate brainstorming and 
scenario building. Thingclash (http://thingclash.com) also used cards to engage stakeholders in 
critical conversations about unforeseen uses, outcomes, risks, and conflicts resulting from 
implementation of connected technologies, within a broader goal of emphasizing the need for such 
devices to serve and respect the needs of users rather than primarily those who stand to profit 
financially from their implementation.  The cards consisted of personas, places, and things, which 
were used to create situations, which were then analyzed for potential conflicts, risks, and other 
concerns. And Mora et al. (Mora et al., 2017) noted that while IoT technologies allow for 
augmenting or improving existing objects, there existed few tools for supporting the creation of 
new ideas. The authors noted that while a human-centered perspective on user experience and 
usability have long been integrated into software development, involvement with IoT is still 
relatively unexplored. The authors suggested that card-based tools are useful in aiding factors such 
as: engagement, communication, inspiration, collaboration, diversity of opinion, and 
externalization of thoughts.  
While lists might be sufficient, the examples above suggest that card-based systems have proven 
effective for supporting collaboration, ideation, and integration. Therefore, while making no claims 
as to the primacy of this approach, I selected cards as an appropriate avenue of exploration and 
potential method of assisting developers with designing more user-centered health systems. 
8.4 DUETS: Design Process and Components 
Given the requirements for supporting diabetes self-management described in the initial section and 
influenced by the collaborative design and system assessment techniques reviewed in the second 
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section, this section proposes DUETS as a method for Designing User-centered, Emotionally 
sensitive, and Transparent Systems. This section will discuss: 
• Iterative design process which has resulted in the current version of DUETS. 
• Review of the current DUETS components. 
8.4.1 Design process 
This section discusses and reviews the stages of the iterative process that took place in designing 
the DUETS cards. While the reviewed literature guided the elements and format, multiple versions 
were tested and improved before a version was found adequate for study purposes.   
Version 1: Taking a ‘minimal viable product’ approach, the first prototypes (Figure 8-1) featured 
hand written architecture cards. First trials session resulted in feedback that system structure was 
too hard to understand, and that all cards appeared too visually similar.  
 
FIGURE 8-1 DUETS V.1 
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Version 2: The second version used hexagons to represent devices and stakeholders (Figure 8-2). 
These nodes were then connected with arrows to show information flows and other dependencies. 
 
FIGURE 8-2 DUETS V.2 
Version 3: In order to visually differentiate between nodes, color coding was added for three 
categories: people, companies, and devices (Figure 8-3). Hexagonal nodes were replaced with 
octagons to allow for more connections and the building of more visually appealing structures. 
People and companies were separated on the assumption that the commercial nature of companies 
could create different goals and ethical responsibilities. Arrow cards to show direction of 
information flows were added, with blank spaces to write in details. Nodes cards made use of 
tokens to prompt consideration of details that might be relevant to each node, and an open space in 
the middle for the placement of relevant Concerns cards. 
 
FIGURE 8-3 DUETS V.3 
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Version 4: The token system was adopted for the connectors as well in order to prompt reflection 
on what sorts of information might be flowing between nodes (Figure 8-4). This prototype was 
made use of a scenario for a hypothetical diabetes startup which offered insights derived from 
wearable devices, offering incentives and purchasing opportunities. This scenario was constructed 
to generate consideration of issues which might emerge from app-based commercialization of 
health care, incentive systems, and conflicting interests. The scenario and cards were then trialed 
with a small group of board game designers, who constructed the system from the description and 
then used the concern cards to analyze the system components. Users suggested moving away from 
octagonal nodes to circles in order to allow more flexibility when constructing system architecture. 
The test group also found the use of colored backgrounds on tokens problematic for readability.  
 
FIGURE 8-4 DUETS V.4 
 
Version 5: In response to user feedback, this version moved to a circular design for nodes, and all 
white background on tokens to provide maximum contrast with black font (Figure 8-5). Colored 
outlines were then used on tokens, to indicate category. This version was trialed with the lead 
developer from a diabetes startup. This test indicated the current sizing of the nodes and connectors 
was too large for system construction on a standard sized table. The circular tokens were also 
problematic in two respects: they were slow to cut out, which might inhibit people from making 
their own sets and decreased the usable area for labelling.  
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FIGURE 8-5 DUETS V.5 
Version 6: Circles and tokens 
In response to the last session, the physical size of the nodes and connector cards were reduced to 
decrease required table space (Figure 8-6). The colors of the nodes were re-designed, and the cards 
representing people were altered with a more inclusive gradient to better reflect skin-tone diversity. 
Tokens became squares to maximize font size to space ratio, as well as to decrease trimming time. 
This system was then tested with a lead designer from a Berlin-based startup. He suggested that the 
lack of pictures for devices and stakeholder was too visually confusing and that the basic 
architecture was inappropriate, noting “It looks like a molecule.” In addition, this participant 
became disengaged during the time required to locate and place pre-printed attribute tokens.  
 
FIGURE 8-6 DUETS V.6 
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Version 7: Smaller Rectangular cards 
In response to the criticisms in the previous session, a desire for greater usability, and on review of 
the literature, the next iteration was influenced by the Tiles approach (Mora et al., 2017). 
Therefore, icons were added to reduce cognitive demands, and tokens were discarded for checklists 
with tick boxes on each side of the list to indicate direction of information or influence flows 
(Figure 8-7). This version was then used for the studies and will be discussed in more detail in the 
following section.  
 
FIGURE 8-7 DUETS V.7 
8.4.2 Components of DUETS cards 
The following section describes the categories and content of the current state of the DUETS cards: 
Concerns Cards which raise domain-specific questions for reflection and discussion; Architecture 
Cards (also called nodes) used to describe the high-level structure of multi-component systems; 
and Attributes Cards, which list information that might impact stakeholder concerns or impact their 
relationships. This system is designed to be an easily expandable modular approach which can be 
adapted to different domains, and supplemented as needed to reflect alternate hardware, 
stakeholders, or services (see Figure 8-8). The full cards set can be viewed in Appendix C: Results 
from Chapter 8 Duets: Duets Cards. 
8.4.2.1 Concerns Cards 
These cards are grounded on earlier research (Nielsen and Molich, 1990) that asserts that the 
identification of user concerns can be an important aspect of developing user-centered systems,  
and that further tailoring for a specific application can assist with identifying pressing and relevant 
areas in need of improvement (Kientz et al., 2010). The Concerns cards are organized by the 
earlier proposed criteria for system assessment. Each card addresses one concern, though 
sometimes additional short questions are added to prompt further reflection. Questions are left 
open, and do not suggest specific solutions.  
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They are also numbered to assist with record keeping. These questions on these cards are based on 
the research conducted during this thesis and discussed within preceding chapters and were 
designed to provoke reflection and discussions leading to the identification of domain relevant 
concerns on the following topics: 
• Adoption & Utility (19 cards): The ratio between perceived benefits and demands, and how 
this can inhibit system adoption has been a frequent topic of discussion in previous 
chapters. These cards ask questions to help assess how different product features could 
impact value and workload for the user and their willingness to integrate products into 
daily self-management practices. 
• Emotional Impacts (5 cards): As disease management and interaction with personal health 
data can be stressful, it is important that interventions are carefully considered in terms of 
their affective implications for the user. These questions seek to provoke consideration of 
how a system or UI might produce stigma, discouragement, other counter-productive 
emotions, or be insensitive within specific contexts. 
• Behaviors & Actions (4 cards): User behaviors are vital for maintaining health and 
managing crisis situations. These cards contain question which help examine and 
determine how systems can best support self-care behaviors throughout a range of daily 
activities. 
• Cognitive demands (17 cards): As discussed in earlier chapters, users make use of different 
cognitive processes within different contexts. These questions are designed to help 
designers reflect on manner in which systems are placing appropriate cognitive demands.  
• Consent & Control (11 cards): Personal data can be sensitive, especially in a medical 
context where patients are concerned that aggregated forms could cause them to be 
financially or in some other form targeted. These cards ask questions as to how data is 
used, the transparency of the process, and the capability of users to maintain control over 
their information. 
8.4.2.2 Architecture Cards 
The Architecture cards support visualizing multi-component systems, helping users to consider 
which devices, services, stakeholders, and companies make up a proposed system and the 
relationships between them. Movable cards can also enable convenient modifications and provoke 
suggestions for alternative configurations. All cards contain space for note taking or the marking 
down of relevant attributes. The four categories are as follows.  
• Devices: These cards picture hardware which make up systems including consumer 
products such as smartphones and smartwatches, medical devices, and data storage.  
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• Services: These cards help users to consider the relationships between needs and potential 
supporting services such as health coaching, clinical care, education, analytics, and 
monitoring. 
• Stakeholders: Individuals who might be exchanging information or services within a 
described system. This includes patients, family, peers, co-workers and anyone to whom 
the patient may have a personal relationship. 
• Companies: Care providers, corporations, startups, and others are indicated with these 
cards. These have been segmented apart from the Stakeholder due to the differences in 
personal and legal obligations.  
8.4.2.3 Attributes Cards 
The Attribute cards list specific relevant details which might help participants to understand or 
consider the relationships between nodes in the architecture, as well as arrows to assist in 
considering direction of information flows, asymmetric relationships, or implied dependencies. The 
cards include checkboxes to prompt consideration and notation of relevant details. The six 
categories are as follows.  
• Data: Collected information that is moved during transactions.  
• Goals: Motives or hoped for outcomes of different stakeholders. 
• Actions: Activities that are occurring as part of normal system function. 
• Traits: Health conditions or other qualities which might need special considerations. 
• Emotions: Feelings that could occur with or during system use. 
• Responsibilities: Duties or demands placed on stakeholders.  
 
     
Concerns Device Services Stakeholders Attributes 
FIGURE 8-8 DUETS CARDS 
8.4.3 Summary 
The preceding section has discussed the iterative development of a card-based system to support 
stakeholder reflection and concern identification on multi-component health self-management 
systems. The following sections set out to assess utility of these cards.  
 170 
8.5 Assessing the DUETS system through Three Stakeholder Focus 
Groups 
This section discusses methods and procedures used to assess the utility of the DUETS system, and 
how it might in practice assist with critical reflection on and support iterative design of health 
management systems. As I had already engaged in several rounds of feedback and iteration, at this 
stage I wanted to have more thorough feedback on several aspects of the design in order to 
determine the following: 
Q1. Is the DUETS approach useful for assessing and generating new ideas for early-stage next 
generation apps both with developers and potential users?  
Q2. Would DUETS add value over the Kientz et al. heuristics? If so, in which ways? 
Q3. Would visualizing a system (Architecture and Attributes Cards used with Concerns Cards) add 
value over using the Concerns Cards alone? 
Q4: In which ways could DUETS be improved to increase utility? 
In order to address these questions efficiently, I used the following procedure initially in a session 
with product developers, then with potential end users. Note that the procedure was designed 
primarily to assess the DUETS approach, rather than the product under development. First, I asked 
participants to note their prior concerns. Second they applied the Kientz et al. heuristics as per 
(Kientz et al., 2010) to note any emerging concerns. This was followed with same procedure using 
the Concerns cards. Finally, the app system was constructed and assessed with the full DUETS 
deck. The final session returned to the same developer team to review the process and assess the 
results from the first two sessions. The structuring of the session in this way was designed to 
address Q’s 1-4 above. 
The Startup 
At the time of the study, the startup had already invested over two years in data analytics research 
seeking to process smartphone and wearable sensor data to detect correlations and patterns, and 
thereby offer personally relevant insights. While their initial emphasis had been on providing 
analytics services to device manufactures, they had more recently decided to develop a patient 
focused app to showcase their technology. To this end they produced a presentation which included 
a brief description and three screen shots of a mocked-up smartphone app with each screen offering 
a combination of an informational alert, a data visualization, and short text explanation. These 
concept screens offered the following benefits: 
• Alert the user to events or patterns detected in data, such as hypoglycemic events, and offer 
them the opportunity to tag such data.  
• Alert the user to unusual detected behaviors such as physical activity, sleep patterns, or 
location, and offer suggestions as to how this might impact glucose level.  
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• Predict future behaviors such as physical activity or sleep from retrospective data, and offer 
suggestion based on these predictions.  
For the purposes of convenience, the description and screen shots (see Figs. 8-9, 8-10, 8-11) will in 
this chapter be referred to as the ‘app concept’. 
8.5.1 Procedures & methods 
At the beginning of the first two focus groups, each participant received an information and consent 
form, as well as a multi-page form with a series of questions relating to concerns and suggestions to 
improve the system. Each page was explained and then filled out before participants moved on to 
the next page. The procedure was as follows:  
1. Prior concerns: after a briefing, participants note any concerns they have with the app 
concept based on their prior knowledge. 
2. Reflection with heuristics: Participants independently read through the Kientz et al. 
heuristics and note any emergent concerns related to the app concept. 
3. Reflection with Concerns cards: Participants use the DUETS Concerns cards consider any 
additional emergent issues with the product. 
4. Visualizing system with DUETS Architecture cards: The components of the product are 
visualized using the Architecture and Attributes cards, and participants then sort again 
through the Concerns cards, placing them at the relevant point on the architecture and 
noting any emergent concerns.  
5. Feedback: Participants reflect on the process and give feedback. 
This multi-step procedure was designed to assess the added value of each stage, which could be 
assessed by new concerns generated. The Kientz et al. (Kientz et al., 2010)  heuristics were chosen 
as a control as they were developed for assessing persuasive health technologies, and claimed 
greater domain relevance than the standard Nielsen Heuristics. As per the stated protocol of Kientz 
et al. each participant was given the heuristics printed on a single sheet and wrote down emergent 
concerns. At each stage throughout the workshop participants were asked to write down new 
observations, the heuristic or concern card that had initiated this observation, and rank what they 
felt to be the 3 top concerns, and then note any ideas or product suggestions. After the sessions had 
been completed the forms and any recorded discussions were transcribed and organized within the 
self-management criteria framework as discussed earlier. As per Nielsen protocol, participant 
responses were combined, and duplicates removed, as well as responses that had already been 
recorded unless there was new insights or details. For the developer sessions there were no 
incentives offered other than study results, while the user group was offered a 30 Euro Amazon gift 
card. The study was considered low-risk, and ethics approval was granted by the university ethics 
committee. The following sections details participants, and other specifics of the three focus 
sessions. 
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8.5.1.1 Details of first focus group with developer team 
The first session took approximately 2 hours to complete. Participants were all members of the 
product development team: P1 a 29-year-old software engineer, P2 a 35-year-old backend engineer, 
and P3 a 41-year-old upper level manager with a computer science background. All were male. The 
follow up review session took approximately 1 hour. 
8.5.1.2 Details of second focus group with people with diabetes 
The second session took approx. 2 hours to complete with a 10-minute break after 1 hour. 
Participants all were people with T1 diabetes (n=6), 5 female, 1 male, Mean 32.8 years old (SD 
14.1).  Participants were recruited through previous studies and the Berlin Diabetes and 
Technology Meetup. All were familiar with diabetes self-management technology, and all had 
previous experience using continual glucose monitors and/or pumps. In addition, two were 
currently using self-built hybrid closed loop systems, and another was highly engaged with diabetes 
technology development.  
8.5.1.3 Details of third focus group with developer team 
The final session contained the same participants as the initial session. In this session, there was a 
modified procedure, whereby the developer team reviewed their initial sheets from the first session 
and were then asked to list their insights from the initial session such as features to be added or 
excluded, concerns, or new insights. These sheets were then discussed in a group discussion. They 
were then asked to read over data from the user session and mark any aspects that seemed 
noteworthy. This was then discussed as a group as well.  
8.6 First focus group: Development Team Assesses the App Concept 
The following section reviews and discusses participant responses from each stage of the 
assessment process. The mockups below were supplied by the developer team as potential 
functionalities of their proposed app. 
 
FIGURE 8-9 UI ADVERSE EVENTS 
 
FIGURE 8-10 UI: IRREGULAR 
ACTIVITY 
 
FIGURE 8-11 UI: HABIT PREDICTION 
 
8.6.1 Prior concerns 
This section reviews the observations of the developer team as they were asked to reflect upon and 
note any concerns related to their app concept.  
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Adoption & Utility: P1 noted “Information must be relevant”, “Real-time information must most 
likely need to be processed on the devices”, and “Medical recommendations are dangerous”.  P2 
noted that since current continuous glucose monitor manufacturers do not offer a real-time API, “... 
We can’t be as real time as we would like”, that there is a “lack of insulin data”, it being hard to 
“identify relevant pieces of information for different users”, and that “some cards display 
interesting information that might be not relevant”. P3 noted that “Information we can provide 
right now to app user is not relevant enough and does not solve a pain point”, and that due to the 
lack of real-time BG and insulin data “...a lot of the more interesting scenarios/notifications cannot 
be implemented right now” There were also concerns as to optimizing as “different diabetics may 
have wildly different needs and we might be optimizing for one single group” And that “Users do 
not want yet another app and (to) use multiple apps in parallel.” Emotional Impacts: The 
developer group noted some general concerns with the affective aspects of their app, with P1 
noting that “Information might be annoying”, and that “Historical data seems overwhelming.” 
And P2 observed that “The apps can be annoying if it notifies too much.” Behaviors & Actions: 
There were limited concerns at this stage with P1 noting “Information must be actionable.” 
Consent & Control: P1 wrote that “Users have privacy concerns.” 
Summary: In this first stage the developer team noted 12 concerns, demonstrating that they were 
aware of challenges to the viability of their concept app. They were especially concerned with the 
limitation placed by currently available technologies, and whether they would be able to deliver 
useful information, especially given diverse needs of different users. However, at this stage these 
concerns were often non-specific, and lacked clear paths forward for improvement. 
8.6.2 Reflection with heuristics 
In the second stage of this session the developer team were given a single page printout of the 
Kientz et al. heuristics and asked to read it over and write down any additional concerns.  
Adoption & Utility: As with the first stage, the majority of noted concerns were specifically about 
the features offered by the app. P1 observed that “... we have only briefly considered positive 
feedback/gamification.” P2 noted “Currently our solution is totally automatic, so no user input is 
allowed”, and that therefore “Not using the phone would mean we don’t have any data.” P2 also 
became more aware of certain general missing functionalities, such as “User status not provided” 
and “No customizability.” There was also increased awareness of the company’s current 
limitations, as “Our knowledge about user interaction design is limited”, and “Our interface 
design capabilities are limited.” And the observation that “The technology is hard to validate.” P3 
was concerned that “Our activity recognition is not 100% accurate, so it may provide wrong 
notification/information”, and that “There may be delays due to technology limitations and we will 
not provide the information at the right time + place.” Emotional impacts:  P3 noted that “The 
user may not want to be bothered about their condition at all.” Cognition: P1 wrote “Parts of our 
technology might be hard to explain”, P2 was concerned about a lack of “...user education”, and 
P3 wrote “We stay on surface with information that truly promote learning and thereby does not 
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engage the user.” Consent & Control: P2 expressed concerns that users might have unjustified 
concerns which could create resistance to adoption, “even though our App is completely 
anonymous, it can be perceived as a threat to privacy since it detects and logs all user actions and 
identifies patterns based on them.” 
Summary: The heuristics helped identify 14 new concerns, drawing attention to some specific 
missing features such as “rewards”, “status” and “customizability”, and some aspects additional 
limitations of the notifications which could need further refinement. Also, while many of the initial 
concerns were domain specific, the heuristics added more general health technology concerns, 
especially identifying gaps in the team’s skillset. User education was noted as an area needing 
additional work, and threats to privacy were noted, though not considered an actual risk. 
8.6.3 Reflection with Concerns cards  
In this stage the development team was given the DUETS Concerns cards and asked to note any 
additional emerging concerns that had not previously been noted. 
Adoption & Utility: P1 observed that the app as designed had limited ability to incorporate user 
feedback to train the algorithm and questioned “How do we incorporate manual feedback for 
automatically recognized activities/habits?”, and questioned, “How bad is manual entry really?” 
P1 also noted that the “The product is entirely based on user data, it has a very cold start.” P2 
added, “Product is meant to be used on a daily basis. Benefits can surpass required effort, but 
currently there’s no way of making the user aware of benefits.” And P2 wrote “Ideally it would be 
accepted by doctors. We are interviewing several diabeticians to check what can be relevant to 
them, but we need to put more effort on this matter.” And while the lack of customization had been 
noted in earlier stages, P2 noted “There is no user customization, and no justification.” P3 also 
more closely considered the lack of user customization, “We may need extensive customization 
options.” Emotional impacts: The Concerns cards helped the developers become more aware of 
the affective aspects of their product, and the need for better product research with users. P2 wrote, 
“Some cards could be stressing since they are warning about likely future adverse events.” P3 also 
became more aware of the limitations of their development process, as “We have not done any user 
testing yet how users react to notifications/information in real-life. We only interview people.” 
Behaviors & Actions: P1 observed “With great notifications come great responsibility (people 
might rely on us).” and that “Education might be undervalued by us” Cognition: P1 reflected 
“What are real problems for diabetics?” P3 added, “We provide little guidance on the effect of 
possible user actions after getting information from our system.” And that “The product will not 
work on its own, i.e. the user still needs another app see his/her historical data.” Consent & 
Control: P1 noted “Improvements to the medical outcome/diabetes management are even harder to 
validate.” And that “The technology only works if people actually use phone/watch.” And that “We 
should focus more on the patients.” And P3 wrote, “People may feel uncomfortable seeing tracked 
and a third-party app having all their behavior and medical data.”  
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Summary: The use of the Concerns cards helps identify potential product flaws across all 
categories, with 20 new concerns identified. While many aspects of these concerns had been 
previously noted, the concern cards appeared to produce more detailed observations and deeper 
consideration of how their product might impact the user. The need for greater emphasis on user 
research and involvement was also noted. In terms of features, the developers noted several 
detailed interaction challenges, such integrating manual feedback, and improving the onboarding 
process until the algorithms became trained. In terms of emotional impact, the developers noted the 
need for greater user-testing, especially on interface color choices, and stress related to predictions. 
Concerns directly related to user behavior were also added, noting the importance of user-
education, and potential adverse effects of system use. The impact of the technology on user 
autonomy was also noted, which is a crucial ethical concern.  In terms of user data, whereas the 
developers had only previously noted that users might have privacy concerns, there was more 
specific reflection on how such user discomfort might prevent the app from functioning.  While 
many of these issues such as privacy of data were integrated into the Kientz et al. heuristics, the 
cards appeared to add more detail and broader consideration of how these concerns might interact 
with the user. 
8.6.4 Visualizing system with DUETS Architecture cards  
In this stage the researcher assisted the developer team in visualizing their proposed system with 
the Architecture cards (see Fig. 8). The Concern cards were then divided among the team, and they 
were then instructed to sort through the cards, placing them onto places on the architecture that 
seemed most relevant to specific concerns. Adoption & Utility: While there were 6 cards placed at 
various locations on the architecture, all these concerns had been addressed in previous stages and 
are therefore not discussed further. Emotional Impacts: The developer team noted 2 new concerns, 
placing the card related to stigma and user interfaces on the smartwatch card. While the team had 
previously noted the potential negative emotional effects of undesired predictions, at this stage they 
added to the patient card the concern card related to the negative effects of undesired actual 
information. While a subtle difference, this card has additional design implications:  one relates to 
predictions alone, as opposed to encompassing the user’s own retrospective data. Cognition: The 
developers placed the card related to triggering the user’s existing knowledge on the smartphone 
and noted the importance of their service delivering visualizations that would minimize 
misinterpretation of collected data. Consent and Control: While in stage 1 and 2 the developers 
noted privacy concerns, the more specific Concern cards were placed on various components of 
the architecture. These included the card related to the use of personal data by 3rd parties; trust; and 
transparency related to stakeholders within the network. P1 reflected that “Privacy might be a 
bigger concern than I usually think.”  
Summary: There were 10 new concerns noted and the use of the visualization appeared to help 
developers consider the ways in which users might have legitimate concerns about 3rd party data 
use. This drew attention to the need for increased transparency to promote user trust. 
 176 
8.6.5 Developer Team Feedback: 
The development team wrote the following feedback for the DUETS system. P2 stated, “I think 
this has been a really useful process in order to identify the system’s concerns. Having to think 
about the problems and let me find my actual concerns and put into perspective the ones I was 
focused on.” There was also critical feedback, P1 noted “Marking which data exactly flows from A 
to B seems useless for our case.” P3 suggested that noting which data was aggregated and/or 
anonymized should be better indicated. There was also the suggestion that participants be 
encouraged to create Concerns cards during the reflection process, and that the process should 
include more time for group discussion. 
 
 
TABLE 8-1 CONCERNS LOCATED DURING FOCUS GROUPS 
 
8.6.6 Summary of developer session 
Given these examples of the developer’s reflections, it is useful to now reflect on this process. Each 
stage of the session produced additional concerns (Table 8-1), with the observations becoming 
more detailed and specific to the use-case. The Kientz et al. heuristics were successful in drawing 
attention to many concerns, especially in Adoption & Utility category. The Concerns cards 
delivered more detailed user-centered concerns, such as the need to engage stakeholders more 
directly in the development process, as opposed to the heuristics which tended to be interpreted by 
the developers as pointing towards the need for more staff. While the Architecture cards did assist 
with the identification of some concerns, the process was somewhat unengaging, and benefits were 
not clear cut, though this might have been due to the cumulative fatigue from the multi-stage study 
design which would be avoided in a non-research study context. Though there were important 
concerns identified with the visualized system, especially with privacy vulnerabilities, these 
 Adoption 
& Utility 
Emotional 
Impacts 
Behaviors 
& Actions 
Cognition Consent & 
Control 
Totals 
Developer focus group n=3, novel concerns located 
Prior  7 3 1 0 1 12 
Heuristics 9 1 0 2 2 14 
Concerns cards only 6 3 2 3 4 18 
 DUETS (all cards) 1 2 0 2 3 8 
totals 23 9 3 7 10 52 
Users focus group n=6, novel concerns located 
Prior  13 5 0 2 1 21 
Heuristics 5 4 0 1 2 12 
Concerns cards only 16 7 1 6 4 34 
 DUETS (all cards) 17 6 2 4 4 33 
Totals 51 22 3 13 11 100 
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sessions suggested that the DUETS system is still in need of further improvement to increase 
usability. Now that we have reviewed the observations of the development team, the next section 
will review a follow-on session with a focus group of patients. 
8.7 Second focus group: People with Diabetes Evaluate App Concept 
This second session was with people with T1 diabetes, the general target group of the app. This 
session was carried out to allow a between group comparison of the methods and identified 
concerns. The basic protocol was similar to the initial sessions, with some minor variations which 
have been previously discussed in the methods and procedures section. 
8.7.1 Prior concerns 
This section reviews the concerns recorded by the session participants after receiving the briefing 
provided by the AI startup. Each category will be discussed in turn as before, with repetitive in-
group observations removed.  At this stage, the PWD user group identified 21 concerns. Of these, 
14 had been identified by the developers in the prior-knowledge stage; 3 in the heuristics’ session, 
and 1 using the Concerns cards.  Thus, this preliminary session chiefly duplicated concerns 
identified by the developer group, though at times in richer detail. 
Adoption & Utility: P5 was concerned that the app would provide “Too many notifications from 
the system,”, too much “non-relevant information”, and “No turn off mode for meetings or when I 
just want to get nothing.” P7 cautioned, “Another additional system? Should be really good and 
give info that is not available otherwise.” And that it would be “...great only if it really can predict 
problems.” P8 expressed concerns that the system omitted usual diabetes parameters such as 
“Insulin dosage, nutritional, intake, stress”, and that as configured, “Parameters seem secondary 
to what we know/seem to know.” Which echoed developer concerns about the need to explain the 
reasoning of the system. There were also comments related to system transparency or a desire to 
better understand functionality. P6 wanted to know “Is the system able to detect or learn new 
behaviors?” And P9 had a series of such questions which might provide a useful starting point for 
the startups marketing department, asking “How does it do all these things? What data is it based 
on? How reliable is the data? How does the algorithm behind it work? Is it certified, FDA 
approved, etc.? Are the actual suggestions for my therapy really based on algorithms or does a 
medical professional check them? Will the system be integrated with other medical devices?” 
Emotional impacts: Participants expressed a number of concerns about the emotional impact of 
such systems, from general pre-existing system fatigue such as P6, “User is already tired of apps 
and devices.” Annoyance with suggestion was another concern, with P9 questioning “Will it be 
annoying?”, and “Will I grow tired of it?” P5 was concerned that she would “... just click on the 
‘ok’ button, because I’m already annoyed.” While P6 was concerned that about having “No trust 
in the suggestions’ safety”. Cognition: P5 was concerned that there would be “Too much text to 
read”, and that if one didn’t understand why suggestion were being given, this could cause 
unwelcome cognitive stress “Why is it asking me that right now for god’s sake?” Consent & 
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Control: P6 expressed the sole concern related to data privacy, noting a “General lack of trust in 
the data’s safety.” 
Summary: The user group identified 21 concerns, with 14 of them having been identified by the 
developers in their prior-knowledge, 3 being identified in heuristics session, and 1 using the 
Concerns cards. There were 2 concerns not explicitly mentioned by the developers in any of their 
sessions. While the developers had expressed concerns about delivering value, the users noted that 
some added value shouldn’t cause too much added effort. There was also 1 feature suggestion for a 
quiet mode. In summary this session was quite similar to concerns expressed by the developer 
group, though at times offering more details. 
8.7.2 Reflection with heuristics 
Following the protocol of the first session, participants were provided with the Kientz et al. 
heuristics and asked to note any additional concerns. As the principal outcome was the location of 
new or richer concerns, duplicates have been removed. 12 new concerns were located, though once 
again all but 2 had been identified by the developers at some stage. Of these, the developers 
identified 6 with the use of the heuristics, and 2 with the use of the full DUETS system. The users 
found 2 new concerns: 3rd parties becoming annoyed by increased interaction; and risks of 
accidental sharing of data on social media - which was not an offered feature. User identified 
concerns continued to be more detailed and descriptive than developer concerns. 
Adoption & Utility: P9 was concerned about “Functionality, so that I will actually use the system”, 
“Design”, and “Visibility of progress.”  P8 noted “How will the system know that I have been 
sleeping? Phone could have been forgotten or left somewhere for charging, while PwD was 
active”, adding “Night time isn’t always sleep time (parties or night shifts).” And P7 wrote 
“design should be simple and not decorative, with additional info available only as an option.” 
Emotional impacts: P5 expressed concern that over-engagement with such systems could be 
socially stigmatizing, “Too many people around me are getting interested what I’m doing all the 
time with my phone-questions about my diabetes + judging.” Adding, “People (could get) annoyed 
because they think I’m playing with my mobile phone the whole time.” And noted the importance of 
“positive communication and (to be) motivating.” Cognition: P5 was concerned that the “UI has 
too many information graphics, animations, text, overwhelming not on the point.” Consent & 
Control: There were some details added to user concerns about privacy. P9 wondered, “is my data 
safe? Can I trust the company with it? What is it used for?” And P5 had concerns about 
“Accidently sharing my diabetes data on twitter or Facebook, with the family WhatsApp group.” 
Summary: The reflection with heuristics helped locate 12 new concerns, though once again all but 
2 had been identified by the developers as well. Of these, 6 had also been identified with the use of 
the heuristics, and 2 with the use of the full DUETS system. There were 2 new concerns: 3rd parties 
becoming annoyed by increased interaction, and risks of accidental sharing of data on social media, 
which was not an offered feature. User concerns continued to be more detailed and descriptive than 
developer concerns. 
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8.7.3 Reflection with Concerns cards  
With the same protocol as the first developer session, the Concerns cards were distributed to 
participants who were asked to independently write down any concerns with the described system 
they had not previously noted. The comments have been classified according to the card that was 
noted as having generated the concern, even though in some cases their content may have been 
relevant to another criteria category. At this stage, the users identified 36 new concerns, although 
19 had been previously identified as concerns by the developer group. Many of the novel concerns 
were in the form of suggestions for new features, such as integration with clinical software. There 
were some newly stated concerns around the need to minimize workload for the user - which the 
developers might have missed, given the manual data entry already eliminated by the app. There 
were also concerns expressed about business models and developer motives, and the ability to 
operate system remotely without sharing data.   
Adoption & Utility: P6 noted the need for customization as “If alteration would be limited, number 
of possible users is lowered”, adding that user should be able to “Choose or opt the kind of 
assistance”, “If a certain kind of field of support is not wanted, inhibit the display of all related 
inputs” and that  “All info/alerts provide by the system can be deactivated.” There was also a 
request for a feature that would “Show the remaining time/actions until the system is able to work 
properly/ best if there is investment needed. Tell why and for how long.”  P6 also was concerned 
about correctability or some means of the system detecting and omitting faulty data such as, 
“...wrong sensor readings, data that derives from that should not be interpreted.” And that existing 
interface designs appeared to have “No way to retrospectively collect or delete sensor data on a 
pre-existing CGM.” P6, also suggested that “The product could be used solely by the PwD, but it 
could be greatly beneficial if it could be implemented into a software that the diabetes team uses to 
interpret patient data.” P8 questioned “Are the rewards actual glycemic control improvements or 
...abstract? this is unclear.” P7 drew attention to the need for alarms to not be disruptive, 
“(Noise/alarms) important point (had an alarm going off in a theater).”  P5 noted that the apps 
messaging was not explicit enough, “You seem more active than usual doesn’t help me... what does 
this mean? Positive? Negative? Missing the main point, not relevant info visible for me in that 
moment”, and also observed that on the screen that displays, “Are you cycling to work today?” 
where is the ‘yes’ ‘no’ button? Just want to answer fast and put the mobile phone back in my 
pocket.” P5 suggested this app could be counter-productive for users who want a decrease in 
diabetes workload, “More thinking and working on diabetes because I’m getting lot of 
notifications”, and “Users need immediate benefits gift for what they’re doing-like information, 
positive feedback...their therapy has to get better and less thinking... otherwise they won’t see the 
reason to use it.” And P5 warned system developers of the need to offer transparency of function, 
predicting “Users won’t trust product because they don’t understand how it’s working.” 
Emotional impacts: While the emotional impacts of UIs had been previously noted in earlier 
stages, P9 added some details that might be of use to developers, noting “Design choices should be 
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positive & non-judgmental...You might want to (re) think using the color red esp. for high blood 
glucose.” And also suggested that to alleviate stigma, “Privacy option like on the Apple watch 
could be an option. Like the choice between showing the content of a notification right away and 
just showing you have a notification by (startup)” P5 was critical of the mockup UI design, as it 
“Looks clinical, old graphic design, it’s not motivating me to use it, old and new UI design 
elements are mixing.” Cognition: Participants reflected on how the product fit in with their 
decision-making thought processes. For example, P5 asked “What is the goal of the product? To 
think less about diabetes or to teach people?” and noted that assessment “Depends on the main 
goal. The examples are asking but aren’t supporting in that moment.”  P5 also noted a desire for 
“Retrospection just later, I’m not interested in that in all moments” and added, “I want to use the 
product as little as possible.” This comment draws attention to how successful health app 
engagement might differ from other products such as social media.  P9 wondered “How does it 
help me to improve my daily therapy decisions? Will it keep me focused on what actually counts or 
will it confuse me, cause too much work, distract me in specific situations in the long run (focus 
energy wisely + effectively).” P9 also suggested that the system could help with the sensemaking 
process if the algorithms could help “Consider adverse events like clogged infusion sets.” And P6 
hoped that the system could detect outliers and problematic data to assist with better quality data 
set collection, “Show which input / data lead to the confusion-possibility to reset parts of the 
collected data.” Consent & Control: Some participants raised more detailed questions related to 
the use and transparency of collected data. P9 wanted to be better informed as to question such as, 
“Who is behind this product? Why should I trust them? Is the patient the primary stakeholder? 
How is money being earned from this? Is my data being used for anything other than my own 
therapy improvement? How will I be able to access the product? How much will it cost?”  And P8 
noted that how much information is being collected from user “should be made very clear since its 
all individual data, you probably don’t need a bigger group for functioning = no need to give data 
away.” 
Summary: The user group identified 36 new concerns, although 19 had been identified as concerns 
by the developer group. The majority of novel information was either in the form of suggestion for 
new features, such as integration with clinical software. There were some newly stated concerns 
around the need to minimize workload for the user, which might have been missed by the 
developers as they might have assumed the lack of manual data might cause little added workload. 
There were also newly stated concerns, not just around transparency of how system function, but 
also around business models and developer motives, as well as the ability to operated system 
remotely without sharing data.  
8.7.4 Visualizing system with DUETS Architecture cards 
In this last stage, in a departure from the originally planned protocol, the participants engaged in a 
45-minute free flowing conversation prompted by questions read out loud by the moderator from 
the Concerns cards. The discussion was recorded with permission and transcribed. The comments 
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have been sorted according to the category of the card which provoked the discussion, and where 
the conversation has evolved further according to the category judged most appropriate. This user 
discussion session produced 35 new concerns, with 23 of them not having been mentioned by the 
developer group. Of these, 11 were suggestions for new features. This session appeared especially 
useful for eliciting detailed observations and thoughts about new functionalities or interaction 
approaches. 
Adoption & Utility: Participants discussed in detail their needs from diabetes product.  While P7 
had previously noted that she was already using many products, and a new product be in 
competition with existing apps and responsibilities, she added “I’m really full, with the system I’m 
using now. It consumes a lot of my time. And for anything to be getting extra time, which is not my 
dog, my kids or Netflix, it has to be really good.” Participants also suggested that such a system 
would have constrained time to prove itself. P9 would give it “Less than a month”, P5 “A few 
weeks”, P7 “A few days maybe, usually they are very quick” P8 added, “I would prefer right away 
if it’s going to access my retrospective data. If not, then a few days.” After this discussion, P9 
reassessed to, “Not more than a week....and that’s only passive. If I actually have to do 
something…” Such comments could indicate that the proposed system must find ways of 
delivering perceived values quickly in order to retain users. Participants also desired a high degree 
of customization, emphasizing impact on adoption, “Everything should be opt-in....notifications 
that you don’t want...will kill any app and you will stop using it.”  P6 agreed noting “Yes, this 
should be an opt-in option...you have to say, ‘I want to have them’ not that you get them always.” 
Participants also desired that such a system be highly flexible in terms of which devices it allowed 
as well as which devices are required to deliver insights.  P9 explained, “...if I only want to use my 
CGM and my smartphone, let’s say, but I don’t want to use the fitness tracker, then it should still 
be able to work. And if I disable the GPS function it should still be able to work. I might be aware 
that it won’t have all the functions. It won’t be as useful as it potentially could be...It has to 
accommodate my personal preferences.”  P8 suggested that being able to customize the format of 
notifications might be important, “...if it’s going to show them the insight right away, they would be 
more likely to use...if it’s just a secret notification and you would have to interact with it, to 
see...the message.” P8 thought the development team “...should rather focus on designing watch 
interfaces...” as this might be more practical as “you cannot go and check every phone notification 
all the time.” Though P5 cautioned, “...not everybody wants to wear a watch, so I think 
it’s...interesting how they are creating the notifications on the lock screen...” P8 suggested using 
questions to assist with the customization process, “If you do in a quiz in the beginning where you 
ask the person, ‘Do you prefer this or that?’ If it’s just five questions and it will show you an 
example where you get a question and like a phrase, like a recommendation, not a question, then 
you would just pick whatever you like.” Noting this approach would be “...easier for the end user 
than to have a million of options that you can toggle on and toggle off.” P8 also noted the 
importance of having diabetes related adjustable settings such as “threshold values, where a low 
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begins and a high...It’s completely different to a toddler or ...to a pregnant woman. So, if you 
would have hard coded when it’s a low or a high, that’s just not going to work.” Participants also 
suggested new features that could improve the final product.  P7 suggested “You could (integrate) 
weather...so you see you’re going to your workplace and you’re using a bicycle, but the wind is 
very strong today, so probably your blood sugar will go down...That would be...information I did 
not have before.” P9 also found this connecting of data to be a compelling feature, especially if it 
helped to connect “...objective information with my subjective analysis...that could be really 
helpful.” P9 added another example, “I have a lot of days where I just sit in the office and I don’t 
move a lot. And, for me, it would be helpful...to get the information ...on Mondays you’re super 
busy and that just wreaks havoc on your blood sugars.” P9 also thought some sort of intelligent 
reminder might be a compelling feature, “...it could be really helpful when it learns that I go to this 
place (yoga class) every Tuesday. I’m active and I always go low. It could be really helpful to have 
this reminder a few hours earlier to actually make the decisions more seamless...” P9 also 
suggested that the app could ask questions when detecting outliers, which could help form a 
valuable record for retrospective analysis, “... the typical endo appointment (they look at your 
graph and ask) “Okay, on Tuesday 22 March, what happened there? You went low.” That makes 
absolutely no sense, but the app can do that in a really seamless way, if I feel like answering that 
question, “Hey S., you went low, half an hour, glad you’re feeling better now, but what was that 
about?” P9 continued, “And then I can say, “This was my own fault.” Like I mis-calculated or I 
worked out and I didn’t realize that I had to eat something or maybe it was the weather. And, then, 
based on that, if I actually feel like it’s worth giving the data, putting in all that extra effort, then 
maybe I can in the end, enjoy the benefits of this additional knowledge...if we, actually, gather data 
in a useful way, this could be something I would use in the long run.” P8 noted that while live-
streaming to the clinician is “...useless, but if ...you have the appointment, those insights are really 
gold...” Towards the end of the session after considerable discussion on customization P9 
suggested that the product might need to clearly define a subset of the population, “...it’s worth 
deciding on a target group and making harsh decisions and accepting that either this won’t be used 
by me, because it’s too simple and it doesn’t give enough information, or it won’t be used by them, 
because it’s too complicated.” Emotional impacts: Participants discussed the ways in which apps 
could be annoying or stressful. P9 noted “even if I find one tool within this really useful, if the 
others annoy me... I will never use it again.” And was concerned that having so many devices 
could lead to such problems, “...if I go low...I already have my CGM giving me an alarm. If there 
are like five apps at the same time telling me to do something and then if I don’t react quickly 
enough it will give an even worse alarm and call my boyfriend...it won’t be useful.” And P4 was 
also concerned about too many messages and the importance of careful selection criteria, “I think it 
will be important to highlight some messages... I would be really annoyed if I got like 10 messages 
every few hours and I think I would delete it, because I hate apps that do that.” Participants also 
stressed how the wording of such messages could create unwanted affective interactions, and how 
sensitive they can be to such interaction. P9 noted “I think language is really important...if it’s 
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worded in a negative way that puts blame on me in any way, I would immediately stop using it. I 
would not like to use it if it calls me a diabetic, for example, instead of person with diabetes.” And, 
“I would not like...anything that sounds like I don’t have a choice, like, ‘Do this, do that.’ I think 
the actual structure and the wording of the suggestions is really important, because if I feel like I’m 
being governed by this app and it tells me to do this immediately, that’s the kind of language that 
would need to be reserved for very specific situations...” But P9 also felt that such interactions 
“should give me an option but shouldn’t be any kind of authority.” P6 suggested that to avoid such 
tones “Maybe it could ask questions, if this would be better than to say, “Do this, do that.” 
Although P9 was resistant to the approach, sharing “That’s also a really, really individual thing, 
like I hate that kind of thing, if it’s a chat-bot, I know that so many people really like it, they feel 
that it’s more personal and more attainable. I hate it. If the machine acts like a person…” 
Participants had some concerns about use of color. P8 felt that Red should be used sparingly as 
“...it’s like you did something wrong, error. It’s an emergency color.” P9 suggested that red should 
be reserved for “when I’m below 60.” And that perhaps shouldn’t be used at all “...for high blood 
sugars. Like, I know I’m high, I know that pizza is still somewhere there and I’m dealing with it. 
And the color red should only be used as an exception really.” Besides general concerns with data 
privacy, there were also concerns on trusting medical products. P9 said, “...I’m not sure if it needs 
FDA approval...but some kind of certification, because that was my first question or my first idea. 
Like, how does it actually analyze these things? Like, what’s the algorithm? Who designed it? 
Why? With what goal in mind? And how can I be sure that it’s, actually, scientifically sound? So, 
why should I trust, not only the company with my data, but why should I trust the information that 
it’s giving me.” Behaviors & Actions: Elaborating on the developers’ initial concerns about 
actionability, P9 suggested “...instead of lunchbreak in the kitchen, which involves 20 steps maybe, 
go for a walk and get lunch outside, something like that...take it a step further and analyze and 
come up with a specific action that could help me.” Cognition: Simplicity and ease of use was 
desired. P7 said “If I have to sit there and read everything and give numbers and push, ‘Okay’ etc., 
if it gets too complicated, I won’t use it.” P7 likewise noted, “It consumes less time if I see 
everything with one look and I don’t have to scroll over to the other things.” P8 stressed the 
importance of making interfaces usable by lower education users, “...not everybody is able to read 
graphs. So, I guess, the majority of us who are designing these products have a high school 
education, but the users most likely don’t...So, is there a way to visualize it in a way that they would 
still understand?” And P8 was especially interested in system that helped the individual learn more 
about what factors affects diabetes management, “So, I think there’s a big potential in finding out 
what, actually, has an impact on you as a person. And, again, this is different for everybody.” 
Consent & Control: Participants had mixed opinions on the use of GPS tracking. P7 stated, “I 
don’t want people I don’t know knowing my whereabouts.” But in contrast P9 felt it to be a 
question of benefits “...If it’s...used in a way that’s beneficial for my diabetes therapy, I ...would, 
potentially... go for that trade-off...”  P8 was also unconcerned about GPS tracking “...because a 
number of my apps do that already.” However, P8 elaborated “... I would be concerned about the 
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way (GPS) is used... it suggested (to) me to go to a mozzarella place. So, this is not really diabetes 
related. So, I feel like the suggestions the system would give you based on your location and your 
CGM, should not be something that pushes you to spend money.” And P8 continued, “...it feels like 
advertising and I don’t want to be used for that, just because I have diabetes.” In terms of data 
sharing, P8 suggested that “It should be modular, just like everything in the system. Like, for 
example, if I would like to let my doctor have access to my CGM readings and the insights, but not 
let them see my GPS all the time. Also, for partners or parents, it should be completely optional 
when you would like to track which.” Noting “...I like my partner having the option to live track my 
glucose levels, but not my doctor. I don’t want my doctor calling me because I’m low or I’m high.” 
8.7.5 Summary of user session 
 In general, the users appeared able to draw upon their experiences to give more detailed examples 
than the developers. For instance, while the developers questioned “How do we incorporate 
manual feedback for automatically recognized activities/ habits ...?”, a user suggests “Are you 
cycling to work today” where is the ‘yes’ ‘no’ button. Just want to answer fast and put the mobile 
phone back in my pocket.” Or while a developer noted “The user may not want to be bothered 
about their condition at”, a user explained “...therapy has to get better and less thinking... 
otherwise (we) won’t see the reason to use it.” Or while a developer might be concerned that 
“Parts of our technology might be hard to explain”, a user provided insights towards desired 
answers “...how does it actually analyze these things? Like, what’s the algorithm? Who designed 
it? Why? With what goal in mind?”  
8.8 Third focus group: Developers Review and Discuss Previous 
Sessions 
In the final session the developer team reviewed their original responses as well as the results of the 
PWD user session. Upon the start of the session, the developer team stated that in the intervening 7 
weeks since the initial session, their company had undergone a large pivot. P2 noted, “We changed 
the concept to focus on diabetes Type 2 and focus on habit formation. This happened as we felt the 
previous concept was not compelling enough and did not address a true need.” And P1 added 
“...Type 1 diabetes ...we don’t know enough about it.” P3 listed that they had concerns that 
“Availability of data was not very good, Unclear what problems we were solving, T1 people have 
very heterogenous needs.” P3 noted that their first session “... helped catalyze our decision to shift 
our product concept.”  Upon reading over the user responses, P3 observed that their initial session 
had successfully identified the majority of high-level issues, while the user session had offered 
deeper insights into features. P3 added, “I think getting this kind of user feedback can be very 
beneficial, but our old concept was in a very early stage. Maybe too early stage for this kind of 
feedback. I don’t think it was really clear what we wanted to achieve with our concept.” One of the 
developers noted that they thought the DUETS process would offer more benefits with frequent 
brief sessions. 
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Summary: The developer group was positive about the first session for helping them to realize the 
flaws and shortcoming of their app concept. They concluded that due to technical limitations 
beyond their control, the abundance of T1 requirements, and their insufficient domain knowledge, 
they should undergo a significant product pivot.  
 
8.9 Discussion Duets Tool and Process 
This chapter has proposed a method for organizing insights gathered through diverse research 
methods into Concerns cards, which are then used with other cards that assist with creating a light-
weight visual prototype of complex health system architectures. The aim of this approach is to 
engage diverse stakeholders with focused critical reflection and ideation on complex health eco-
systems. The following sections is structured through discussion of this section’s research 
questions.  
Q1. Is the DUETS approach useful for assessing and generating new ideas for early-stage next 
generation apps both with developers and potential users?  
The initial session helped the developers to understand design challenges inherent in diabetes 
decision support systems and they credited the process with helping them to confront critical gaps 
between their concept and a desirable product. DUETS components drew attention to the need for 
increased understanding of their user, as well as serious product design flaws. These issues were 
clarified to such an extent that it became apparent to the developer team that they had neither the 
knowledge nor technical capacity to meet actual needs effectively. Such critical product assessment 
could benefit developers, since the competition posed by the great number of diabetes apps already 
on the market heightens the value of ‘failing fast’ before significant investment. The patient 
sessions appeared useful for  in-depth analysis of concerns and generating ideas for new features. 
Within the limitations of this preliminary evaluation (noted in Limitations), the DUETS system 
appears to provide a usable framework for assessing the featured prototype.  
As the developer focus group identified the majority of higher-level patient user group concerns, it 
appeared useful for helping to anticipate more general user concerns. It might be suitable for initial 
assessment, which could be followed by user focus groups after initial concerns have been located 
and solved in house, and when developers are looking for more in-depth insights, or are searching 
for new features. It is worth emphasizing the continuing challenge with health product development 
in the distance between system designers and users. The intention is that DUETS can provide a 
suitable tool for bridging this gap, and therefore it is critical that additional testing is done with 
additional stakeholder groups to assure communication between the full spectrum of system 
participants.  
Q2. Did DUETS add value over the Kientz et al. heuristics? If so, in what ways? 
DUETS appeared beneficial for suggesting concerns not previously known nor located by the 
Kientz et al. heuristics, with both the developers and patient group discovering many additional 
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concerns. In addition, it helped the developers to confront that products of this kind might be 
greeted with suspicion by users, and the consequent need to actively build trust with users, and the 
need for clear statements of purpose.  
Another issue that needs further research relates to why the Kientz et al. heuristics did not 
necessarily lead to concern identification even when referenced. For example, the concern related 
to “incorporating manual feedback” might be seen as implicit in Kientz et al. Heuristic 6, that 
states that the technology should allow manual editing or updating of data. And concerns that the 
app could interfere with autonomy might be inferred from Heuristic 10, which refers to the need to 
educate users. Explanations for missing these concerns at the heuristic analysis stage might be that 
these heuristics were developed for expert evaluators, and the developers and patients lacked the 
knowledge to fully exploit the heuristics, or alternately that the density of the heuristics inhibited 
their effective use. If the latter were true, breaking the heuristics down into shorter sentences on 
cards might help to alleviate this problem. This suggests that further research is needed to clarify 
the extent to which the Kientz et al. heuristics are well-suited to a non-UX professional 
stakeholders, especially if they are adapted into the DUETS cards. 
Q3. Would visualizing a system (Architecture and Attributes Cards used with Concerns Cards) add 
value over using the Concerns Cards alone? 
Despite apparent benefits, specifically for helping to draw attention to data privacy and 
transparency concerns, there was some uncertainty on the effectiveness of the Architecture cards, 
which should be addressed by further studies. This could be done with a between-group study, with 
one group only using Concerns cards compared to the other using Concerns cards and Architecture 
cards. The patient session with the Architecture cards did produce many concerns, though this 
could have been due to the engaged conversational nature of this session. Further research is 
needed, especially as to process optimization. 
Q4: In which ways could DUETS be improved to increase utility? 
As DUETS is intended as an expandable modular approach, the work presented in this paper 
should be seen as a starting point requiring further development, especially in regard to other use-
cases. In addition, care must be taken that it doesn’t frame discussion so as to restrict outcomes. 
Therefore, these cards should not be seen as comprehensive nor a substitute for all other research 
methods, but rather as a way of operationalizing acquired knowledge on user requirements. For 
example, the Concerns cards might need additional cards when used with other health conditions to 
better reflect domain specific needs. This could be accomplished through adding concerns 
identified through other research methods, as well as concerns that emerge through DUETS 
sessions. It is therefore important to not restrict exploration to the current Concern cards. The 
Architecture cards might also require supplementing, to reflect additional devices or services. 
Likewise, the process for integrating DUETS into actual product development workflows requires 
further development. A worksheet or set of instructions might be added to increase utility. It is also 
important to draw attention to what DUETS is and what it is not. For example, there are user 
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requirements that might emerge only with actual long-term product use which emphasizes the 
importance of investigating contexts of use or appropriation within real life. Perhaps the current 
system might integrate a more open or less literal architecture to allow for better addressing such 
issues or suggesting supplementary research methods. 
 
8.10 Future Work 
DUETS is an expandable modular system. The use of cards could be customized, for example by 
the inclusion of additional cards to reflect identified needs. Concerns identified by developers could 
be added to the Concerns deck either for in-house discussion after iteration, or to elicit feedback 
from other stakeholders. Likewise, Architecture cards could be easily added to, reflecting new 
devices or services. While DUETS supported concerns identification, further development is 
needed. The Kientz et al. heuristics elicited many concerns, especially with the developer team, and 
could be directly incorporated into the Concerns cards. The Behaviors & Actions category elicited 
the fewest Concerns and might benefit from additional cards or clarification. Despite apparent 
benefits, specifically for helping to draw attention to data privacy and transparency concerns, there 
was some inconclusiveness on the effectiveness of the Architecture cards, which might be 
addressed by further studies. This could be done with a between-group study, with one group only 
using Concerns cards compared to the other using Concerns cards and Architecture cards. Given 
the bio-ethical implications of decision support systems (Meredith and Arnott, 2003), the 
framework  proposed by Beauchamp & Childress (Beauchamp and Childress, 2001) might be an 
alternative to the current criteria, with augmentation for privacy and security (Wright, 2011) and 
technical features. System usability might be improved by reducing the number of Concerns cards.   
8.11 Limitations  
This study is an exploratory case study. No claim is made regarding a rigorous comparison between 
methods. The small sample size limits the generalizability of conclusions. The sessions did not 
randomize procedure order, which could influence the quality, quantity and ratios of identified 
concerns. The user group was an engaged and technology aware group, and their insights might not 
be broadly representative. The researcher brought prior knowledge which could have influenced 
outcomes; the utility and usability of the DUETS system without such support might be different. 
DUETS was developed for a diabetes use-case and therefore might require additional or different 
cards for other health conditions. Some apparent benefits of DUETS might be due simply to use of 
a question-based rather than a statement-based format. The added benefits of the Architecture cards 
as opposed to using the Concerns cards alone requires further investigation given the small sample 
size and variables.  The proper assessment of the value of the DUETS system for helping to support 
more user-centered, emotionally sensitive, and transparent systems requires further development 
both for the cards and their method of integration into design processes. In general, the system 
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needs further refinement to lower cognitive effort. Further testing and iteration are called for 
throughout. 
8.12 Conclusions 
Through three sessions, the first and third with the developer team of a funded startup, and the 
second with a motivated user group, the DUETS tool was assessed for its ability to assist in the 
location of concerns which could impact the effectiveness of multi-component user-centered health 
systems. In the initial developer session, DUETS contributed to the team identifying, in under 2 
hours, critical failings in their app concept, technical limitations, and domain knowledge which, by 
their own account, led to the decision to make a substantial pivot. Supporting such early strategic 
decision-making can be valuable, given the high costs associated with developing functional 
medical systems. The session with potential users validated the developer’s concerns, added in-
depth experiences that supported the reasoning behind these concerns, and identified many 
suggestions for potential features. Within the limitations previously outlined, these sessions 
evidence how the DUETS tool can be used as a method both for developers to critically examine 
their assumptions and concerns for early stage products, and for potential users to offer critical and 
constructive critiques.  
DUETS appeared successful in drawing attention to the high-level concerns related to 
functionalities, emotional impacts, and cognitive demands, as well as drawing attention to user 
privacy and security concerns, in particular emphasizing the need for product transparency. The 
DUETS process drew attention to aspects of requirements for user-centered design, such as greater 
integration with stakeholders and their needs, and clear identification of true user problems. Given 
that the DUETS tool helped the developers to locate many of the high-level concerns held by the 
user group, it may have a useful role in helping developers to locate user concerns during early 
stage development. Following subsequent prototype iteration, DUETS may provide utility in the 
design process to elicit and marshal in-depth critical stakeholder feedback.  
In summary, DUETS offers a modular card-based method, readily expandable and tailorable, that 
can be used to visualize and assess multi-component health systems that involve a complex ecology 
of devices, services, and stakeholders. By facilitating an overview of the information flows 
between components, stakeholders, and services, as well as considering resultant implications, this 
approach could support developers and other stakeholders in assessing relationships, identifying 
concerns, and suggesting new features for next generation health support systems. 
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Chapter 9: Conclusions 
Chronic health conditions are burdensome both to those afflicted as well as stressing health systems 
worldwide. Ubiquitous computing technologies offer diverse opportunities to improve treatments 
for chronic health conditions. This thesis has focused on improving the process whereby these 
technologies are used to gather and process data to supply targeted information to inform better 
decisions. Type 1 diabetes is a compelling use case to apply such capabilities due to both its 
severity and need for each individual to make frequent self-care decisions informed by complex 
data. Yet, the dominant app-based approaches based on effortful reflection on collected data have 
shown poor adoption (Chapter 4), lack needed cognitive and emotional support (Chapter 5) and are 
not well tailored to users’ actual diabetes decision making processes (Chapter 6). A next generation 
approach that leverages wearable sensors and automated data processing could offer more explicit 
support for daily care; however, these more comprehensive systems bring with them a range of user 
concerns such as privacy, emotional impacts, trust, autonomy, security and others, which could 
inhibit adoption (Chapter 7). Therefore, the development of next generation systems requires 
practical methods to make sure that such concerns are properly addressed. Such methods could 
potentially support developers in anticipating user needs, while helping diverse and  potentially 
non-technically knowledgeable stakeholders to understand complex technologies so they can 
participate throughout the design process (Chapter 8).  
To summarize: this thesis began with anecdotal observations that existing T1 diabetes smartphone 
apps were not meeting user needs. Through a series of user studies, diverse reasons behind this 
shortcoming were uncovered. Finally, these findings were integrated through an iterative design 
process, suggesting a method for alleviating or avoiding these pitfalls in next generation systems. 
In this concluding chapter we discuss:  
• Answers to each of the research sub-questions (Chapter 3.1) and review the principal 
findings and outputs of Chapters 4-8 
• Primary contributions of this thesis to diabetes care as well as wider implications 
• Overall research limitations 
• Future work 
• Concluding remarks 
9.1 Research Questions: 
The beginning of this thesis asked the research question: 
“How can we improve the practical utility of diabetes apps from a user-centered perspective?” 
This question was then explored and addressed through the following five sub-questions which will 
be attended to in turn: 
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9.1.1 RQ1: Are diabetes apps actually meeting user needs, and if not why not? 
(Chapter 4) 
This question was addressed through a questionnaire, with demographic questions to establish user 
characteristics, and open-ended questions that asked participants to reflect on their previous 
experience with diabetes apps. While most participants reported that there were benefits to diabetes 
apps, the majority had stopped using them. And of those who continued with use, only a small 
number were using them as part of daily management routines. Despite this, these apps were 
successful in meeting specific needs for some users, such as tools for recording data before 
meetings with clinicians or visualizing collected blood glucose measurement data to provide 
overviews. This suggested workable areas of utility which might be built upon in future apps. 
Workload in using the apps, especially in relation to benefits, was the most reported area in need of 
addressing, with many users expressing the desire for additional automation. However, in the case 
of apps which already delivered such functionality, automation of blood glucose value input alone 
did not appear to be sufficient to promote frequent use. While not expressed as the primary reason 
for abandonment, and without having been prompted, 50% of users reported negative emotional 
impacts of using these apps. Given the evidence resulting from this study, despite some positive 
user assessment, this generation of diabetes apps appears insufficient for supporting user needs, 
especially as tools for daily care. This prompted the subsequent study to gather more in-depth 
knowledge as to how users interacted with these products. 
Principal findings and outcomes of RQ1 
The principal findings and outcomes which resulted from addressing this question included:  
• Knowledge of specific barriers to the adoption of diabetes apps.  
• An n=26 data set of people with T1 diabetes user characteristics; and their experiences with 
a specific generation of diabetes-specific and other apps. 
• Insights into areas in need of further investigation and improvement for diabetes self-
management apps. 
 
9.1.2 RQ2: Are the standard user interface designs of diabetes self-management 
apps sufficient for decision support or are there inherent design flaws ? (Chapter 
5) 
The previous chapter suggested that there were specific flaws with the approach of diabetes logging 
apps. However, there were unanswered questions as to whether the primary flaw was in the 
workload associated with data entry which could be solved through automation of data entry. 
Therefore, I used a talk-aloud study to investigate the capabilities of diabetes logging app UIs to 
support user interactions with already entered diabetes relevant data to isolate the sensemaking 
process. This approach led to a detailed characterization of the benefits and limitations of diverse 
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UI elements in this context, as well as identifying specific areas in need of further consideration for 
next generation systems.  
This study revealed, through analysis of participant responses, several positives in current app 
interface designs. Namely, these interfaces were capable of helping people to reference data, to 
attach high-level meaning to specific data points, and were in most cases usable. They were also 
found well suited to giving broad overviews of condition management. However, despite these 
benefits, the examined logging app interfaces appeared to have two principal areas of failure. 
Firstly, these apps require too much cognitive effort to make sense of data and to locate meaningful 
insights applicable to treatment decisions. This exposes users to visual confusion and cognitive 
overload. Secondly, the complex emotional relationship users have with their data appears to have 
been inadequately considered by designers. Neglect of this aspect of app design can lead to 
demotivation and interaction avoidance. Analysis of these interactions suggests three principal 
design challenges for next generation apps: more active support for users to gain utility from their 
data, methods of building and triggering the user’s self-care models, and increased emotional 
sensitivity related to interaction with undesired data.   
Principal findings and outcomes of RQ2 
The principal findings and outcomes which resulted from addressing this question included:  
• Empirical evidence for the benefits and limitations of specific and frequently used data 
visualization UI designs. 
• Specific design challenges for next generation health management apps. 
 
9.1.3 RQ3: How could apps better support user decision-making processes? 
(Chapter 6) 
Evidence collected from the user-interaction study discussed in Chapter 6 led to positing a refined 
version of the Mamykina et al. (2.1.7) model for diabetes self-management to better account for 
observed practices. After this refined model was characterized based on available evidence, an 
online survey of demographic and open-ended questions on diabetes management practices in 
varying contexts was conducted to further investigate its validity. The expanded model defines 
three cognitive states: the previously accepted habitual and sensemaking modes, augmented by the 
newly proposed mode ‘Fluid Contextual Reasoning’ (FCR) which describes a process of balancing 
multiple contextual factors using previously learned knowledge, thus allowing for dynamic course 
correction when navigating complex situations. This expanded cognitive model provides both an 
answer to the question posed for this chapter, as well as a UI design framework for next generation 
diabetes management systems that will offer more active decision support.  
Principal findings and outcomes of RQ3 
The principal findings and outcomes which resulted from addressing this question included:  
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• An expanded self-management model that builds upon previous academic work to define 
an under-represented cognitive process.  
• A proposed framework to apply this model to assess existing self-management UI’s as well 
as to support the design of next-generation diabetes self-management UI’s.  
• An n=192 rich qualitative data set of patient responses detailing methods and practices of 
diabetes self-management. This data set could be further mined to provide guidance to apps 
that seek to support self-care learning and activation of appropriate behaviors. 
 
9.1.4 RQ4: What user concerns need to be addressed when developing a next 
generation app approach that relies on multiple networked monitoring devices? 
(Chapter 7)  
Previous chapters suggested the need to minimize workload while still delivering information that 
could support complex decision making in an emotionally sensitive manner. Multiple networked 
sensors appear a likely component of an approach for meeting these needs. However, the lack of 
currently functional systems of this kind restricts current empirical knowledge of user concerns 
resulting from such comprehensive health and behavior monitoring. In order to help fill this gap, a 
4-week technology probe in which participants were outfitted with multiple networked devices 
with external data aggregation established a setting and altered context to user routine. This 
enabled investigation of user perceptions of such monitoring, and thereby insights into user-
centered requirements for development of this intensively networked approach.  
The results of the probe showed that study participants showed awareness of the risks of sharing 
their data, with many concerned about commercial exploitation. While some participants were 
willing to use GPS services for specific purposes, many were wary as they perceived emotional, 
safety, or financial risks. Many participants perceived their blood glucose data as containing 
sensitive insights into their lives. Sleep data could be perceived as sensitive, requiring permission 
and purpose for sharing. Exercise data appeared less sensitive than other types, though there were 
some concerns mentioned around commercial vulnerabilities. 
While participants were generally open to sharing much of their data with medical professionals, 
many expressed a desire to understand the purpose and benefits of specific cases of sharing data 
while expressing that personal relationships were an important aspect of this sharing. This could 
suggest that systems that collect data for use by medical staff should offer user education and 
transparency as to potential benefits, or alternately avoid real-time sharing and instead focus on 
tools for delivering aggregated retrospective insights at the time of appointments. Many 
participants expressed distrust of the motivations of their insurance company and were resistant to 
granting insurers access to their personal data, especially without transparency of purpose. If 
insurance companies want to promote the use of personal tracking technologies, they might need to 
find ways to establish better personal relationships with customers through a greater sense of 
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shared purpose, or to find ways to assure users that their data is protected from access for insurance 
evaluation.  Analysis of the study responses drew attention to specific concerns related to the 
following: added workload and adoption, emotional impacts of monitoring, unwanted or distressing 
information, stigma, differing relationships of trust with doctors and other stakeholders, trust, 
personal preferences, transparency, privacy, and economic security/vulnerability. This study 
suggested that users have considerable concerns about such comprehensive monitoring, and while 
they might accept certain risks to gain benefits, failure to address these concerns properly could 
create additional psycho-social stresses upon users or lead to devices abandonment. The diversity 
of user needs and complexity of such systems suggested the need for tools to help support the 
design process. 
Principal findings and outcomes of RQ4 
The principal findings and outcomes which resulted from addressing this question included:  
• Evidenced information about attitudes towards sharing specific kinds of personal data with 
different stakeholders. 
• Evidenced information about user attitudes toward the use of specific kinds of monitoring 
devices. 
• Evidence of how participant attitudes towards sharing of personal data are influenced by 
external monitoring. 
• A list of user concerns that could be applied to heuristic analysis of next-generation health 
monitoring systems.  
• Four suggested software solutions to help mitigate user concerns related to the use of 
health monitoring systems. 
• A potentially novel method for visual analysis of change in individual and group attitudes 
over time. This method is readily applicable to other qualitative research containing 
participant attitudes and could be used for ordinal data. 
 
9.1.5 RQ5: How can we systemize these concerns to help developers address 
high-level requirements to avoid the production of non-user-centered apps? 
(Chapter 8)   
The previous chapters explored diverse user concerns and requirements for diabetes support 
systems and drew attention to specific ways in which current diabetes app approaches have not 
properly reflected these needs.  The preceding chapters also asserted that a likely path forward 
depends on systems capable of delivering more active decision support in a manner which 
compliments user’s existing cognitive processes. Given the complexity and diverse potential 
negative consequences of such an approach, this chapter sought to develop a practical method to 
apply the findings of this thesis to the design of such future systems. This resulted in DUETS, a 
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card-based system to facilitate stakeholder reflection and critical discussion on complex diabetes 
management systems. The following paragraphs briefly review the components and design process.  
• The findings of the thesis were organized into five categories of user requirements for self-
management technologies: Adoption & Utility, Emotional Impacts, Behaviors & Actions, 
Cognitive demands, and Consent & Control.  
• These concerns were then implemented through an iterative design process to develop a 
card-based system to visualize, assess, and modify multi-component health systems.  
• This system was then applied to two focus groups, the first with a team of developers and 
the second with a group of people with T1 diabetes. These sessions evidenced the 
suitability of the DUETS tool for two different but related purposes: firstly, as a method for 
developers to critically examine their assumptions and concerns for early stage products, 
and secondly for potential users to offer critical and constructive feedback on multi-
component systems.  
• DUETS showed evidence of drawing attention to at least two kinds of relevant concerns: 
firstly, high-level concerns related to functionalities, emotional impacts, and cognitive 
demands, and secondly user privacy and security concerns.  In particular, DUETS 
highlighted to designers the need for product transparency. More generally, the DUETS 
process drew attention to diverse results of the research conducted for this thesis, in this 
way supporting the developers in understanding the importance of integration with 
stakeholders and their needs and helping the developers to identify user concerns.  
In the first focus group session, the DUETS tool helped the developers to locate a majority of the 
high-level concerns held by the user group, thereby demonstrating that it could be effective in 
helping developers to locate user concerns quickly during early stage development. This second 
session demonstrated that DUETS provided a tool and method for explaining complex systems to 
patient stakeholder groups and assisting in structured constructive discussion. In these various 
respects, the DUETS method contributes to an answer to the research question. 
Principal findings and outcomes of RQ5 
The principal findings and outcomes which resulted from addressing this question included:  
• Five categorical criteria for assessment of user-centered health systems.  
• A set of questions which have been applied both as developer heuristics and to focus 
stakeholder discussion.  
• A flexible and extendable card-based system for visualizing, assessing, and modifying 
multi-component IoT systems, usable both by system designers and other stakeholders.  
• A tested process for applying the DUETS system to help locate user-centered concerns. 
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9.2 Primary contributions of this thesis 
While the previous section summarized the findings and outputs of this thesis, this section will 
summarize the principal contributions of the thesis. These are organized first by contributions 
specific to diabetes in relation to human-centered computing literature, followed by contributions 
with broader implications. 
9.2.1 Contributions specific to diabetes  
The thesis provides the following primary contributions to knowledge to support the further 
development of apps and other tools for decision support for diabetes self-management. 
• This thesis provides the first systematic empirical evidence that apps that rely exclusively 
on tools for collecting and reflecting on personal data fail to adequately support the 
diabetes self-management decision making process, and the first thoroughly evidenced 
characterization of the principal reasons for that failure. Stemming from this contribution 
to knowledge, the thesis also provides a practical contribution to improving future apps by 
drawing attention to the faulty but widespread design assumption that users primarily 
desire new tools to record and view additional data. Indeed, the predominant approach in 
the existing literature to improving such apps focuses almost exclusively on new tools for 
supporting the sensemaking process (Smith et al., 2007), (Owen, 2011), (Storni, 2014), 
(Owen et al., 2015) but crucially does not into account that people with diabetes are 
already overburdened by their data.  
• A systematic account of the specific benefits and limitations of widely used methods of 
visualizing diabetes data. This contribution to knowledge also serves as a contribution to 
practice by providing reference for designers for appropriate use in designing decision 
support tools for diabetes self-management and was previously absent from the literature. 
• An expansion of Mamykina et al.’s Sensemaking framework to better represent 
participant’s apparent cognitive processes. The expanded framework suggests a means of 
interpreting existing products and explaining specific ways in which they fail to support 
reasoning processes. The framework also acts as a tool for designers to extend current 
products to better support user needs. 
9.2.2 Contributions with implications beyond diabetes  
Beyond diabetes, this thesis has contributed a conceptual framework for the design of decision 
support systems applicable to a wide range of domains where individuals must make real-time 
decisions informed by complex data in a manner that augments rather than replaces user reasoning. 
In contrast with previous work based on a dual process cognitive approach for supporting cognitive 
processes, this thesis characterizes a previously little explored third option. Technology designs 
based on the dual process model limit themselves to targeting either conscious and effortful 
learning or triggering unconscious and reflexive action. By contrast, this thesis has identified 
recurring user behaviors not well characterized by the dual model, that balance and combine 
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elements of both poles. The thesis has explored ways in which designers might support such user 
behaviors, thus providing new benefits while reducing cognitive costs, thereby supporting 
continued tool use.  The new approach does not seek to replace previous approaches, but rather to 
complement and expand the options for designers and users.  This approach has relevance to the 
self-care of demanding chronic conditions generally, as well as to other situations involving the 
need for rapid real-time decisions informed by complex data. 
It is instructive to consider this wider contribution in the context of the wider literature. In the 
foundational period of ubiquitous computing Weiser (Weiser, 1991) advocated for “calm 
computing” where small computers embedded throughout the environment could anticipate and 
satisfy user needs. Rogers (Rogers, 2006) questioned this approach advocating instead for the 
importance of engaging and empowering users. Both Li (Li et al., 2011) and Mamykina et al. 
(Mamykina et al., 2015) integrated aspects of both these approaches, noting the benefits of 
reflexive action for maintaining routine and in-depth reflection to support learning. This thesis 
recognizes both of these aspects as important but advocates an extended and more balanced 
approach by the inclusion of tools that support a middle ground. This involves working with the 
user to lower the effort required to determine responses to complex situations while retaining active 
engagement.  
9.2.3 Key questions for diabetes app designers 
This section lists key questions for diabetes apps and decision support systems derived from the 
research conducted for this thesis.  
Functionality 
• Have you considered the full range of stakeholders who will in some manner interact with 
this product? How can all their needs be balanced while still addressing the needs of the 
primary user? 
• Does the product in any way add to user daily workload? If so, how can you assure that the 
benefits exceed time invested, especially in the early stages of use?  
• If this product is intended for situated decision making, could the user be better served by 
more pre-processed data or more glanceable information? 
Emotional Impacts 
• How can we design emotionally sensitive interfaces that draw attention to important but 
unwelcome information while continuing to engage the user? 
• Are the design choices such as color, sounds, and interface elements motivating or 
demotivating? Are they sensitive to the feelings of the user within different contexts such as 
date, job interview, public space, etc.? How has this been tested in a way appropriate to 
intended usage? 
Cognition 
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• How do we design UI’s and interactions that can help users learn and retain a personal 
library of beneficial behaviors for managing specific situations? 
• How do we design UIs that trigger the user’s acquired knowledge at the appropriate time? 
• How can we make it cognitively easier for users to consider their context when making 
decisions? 
Privacy and Security 
• Does your business model involve using individual’s personal data for targeted marketing or use by 
3rd parties?  If so, is it possible for you to consider an alternate business model? 
• Do you consider the patient the primary stakeholder?  If not, how is this justified and is the reasoning 
fully transparent to the user? 
• Is the information collected by your system visible to or accessible by any stakeholder other than the 
primary user? If so, how do you:  
-Enable user to pause monitoring in sensitive contexts?  
-Allow user to control which and how data is shared? 
Behaviors & Action 
• How could your system support the user’s self-care actions becoming more independent from the 
system over time? 
• How can a system help to reinforce already existing positive behaviors? 
• Could this product interfere with the user engaging in necessary actions? If so, how can this be 
minimized? 
 
9.3 Research Limitations 
Due to the diversity of research carried out in this thesis, research limitations have appeared at the 
end of each of the research chapters. While to repeat the full list of these limitations would be 
impractical, there are some limitations which have acted as reoccurring themes throughout this 
thesis and are therefore worthy of reiteration.  
While diabetes rates might soon be approaching nine percent of world population, people with 
Type 1 diabetes are estimated to constitute only five to ten percent of this group; therefore, since 
they constitute less than one percent of the general population, finding people with T1 diabetes 
willing to participate in technology-oriented user studies poses recruitment challenges. The 
recruitment methods often drew on those already active with, or interested in, diabetes 
technologies. This may have caused biases which restrict broader application. In addition, these 
recruitment challenges led to some participants appearing in more than one study, which may have 
also introduced biases related to familiarity with the subject matter. Thematic sorting and selection 
of interview quotes to discuss may have introduced confirmation or selection biases, however as 
these quotes have primarily been used to draw attention to the existence of user concerns, the 
primary limitation would be in omission rather than commission – by contrast, in the chapter 6 
FCR study, where statistical claims were asserted, a second coder was used to validate the coding 
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methodology and establish inter-coder reliability. While this provides a level of validation, the FCR 
model has not been validated as a cognitive model by measuring cognitive load, for example by 
measuring pupillary response (Iqbal et al., 2004). Finally, since all research was conducted 
exclusively with people with Type 1 diabetes, generalizability of findings to those with T2 or other 
forms of diabetes, as well as to more general health and wellness requires further investigation. 
9.4 Future Work 
This thesis stemmed from an observation about the non-adoption of a class of apps.  It addressed 
many questions as to why this was occurring and considered how future systems might be better 
designed. Many questions remain. The following section discusses future work arising from the 
research.   
9.4.1 Empirical validation of the FCR model to move towards a theory 
This thesis has hypothesized that FCR exists somewhere between habitual and sensemaking in 
terms of cognitive load.  A natural next step would be to further investigate FCR as a cognitive 
model, and further develop a design framework that could be applied to develop new UI’s based on 
this work. Such UI’s might have adaptive elements which support each of the three modes in turn, 
dependent on contextual requirements. Potential research questions might include: 
• Is there a measurable and reproducible spectrum of cognitive load demand related to 
interacting with specific smartphone interfaces and paradigms? 
• What are effective techniques of measuring such cognitive load within situated contexts? 
• Is ideal cognitive demand context dependent, and if so, how can this be determined and 
applied in a practical way? 
• Given sufficient delivered value, would optimizing cognitive load demands to context 
increase adoption?  
• Is it possible to design UIs for the different cognitive demands suggested by the FCR 
model? 
• Might Shannon’s information theory have a role to play in optimizing such interactions? 
 
9.4.2 Refining the DUETS system 
The DUETS cards introduced in Chapter 8 would benefit from further development.  New specialty 
Concerns cards might be added, such to draw attention to specific domains such as ethics. The 
work of Wright et al. (Wright, 2011) could provide a useful framework. Another approach might be 
to move from a paper-based system to software, which could enable additional functionalities, such 
as: 
• Tool box of objects: DUETS could offer a large selection of sensors, devices, and services 
which could use a drag and drop method to visually build systems. 
• Data streams: The above components could have their potential data streams already built-
in, thereby prompting options to assist system visualization. 
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• Intelligent concerns: Visualized systems could suggest concerns for stakeholders to reflect 
upon, for example warning about potential risks to privacy or security from specific 
sensors being connected to specific stakeholders. 
• Implementation of services: The user services suggested in Chapter 7 (Real time Data 
Flows, Data purpose resolver, Data Blurring, Tailored reports) could all be integrated into 
the DUETS systems, either for purposes of discussion, or eventually as a tool kit to help 
users visually control and construct their personal health network. Potentially this could 
move DUETS from a research tool into personal software. Great care would have to be 
taken to allow this system to offer the usability required for non-expert configuration and 
use. 
Research questions include: 
• Might some form of gamification make the system more enjoyable to use? 
• How could the card system be improved to make it easier to use? 
• Could the concerns question set be expanded and categorized so that a given system 
configuration would suggest certain specific questions? 
• How could DUETS be expanded to analyze feedback loops? 
9.4.3 Ethical assessment of diabetes systems 
As discussed earlier, the DUETS system was originally conceived to assist with ethical assessment 
of diabetes management systems. There are diverse questions that emerge with active algorithmic 
decision support in a health care context. Some examples might include: 
• Is it ethical for a company to only allow their service to be accessed if the user gives 
consent to have their data collected? This could be considered extortive in certain medical 
situations and therefore non-ethical. 
• In the case of personal health systems that monitor and aggregate personal data, is 
adherence to the EU General Data Protection Regulation (GDPR) sufficient for protecting 
the user? 
• Are financial penalties for risky behaviors, such as visiting a high-risk location, ethical? Is 
it permissible for health systems to restrict certain user behaviors in exchange for 
coverage? 
• What is the balance between encouraging healthier behaviors and infringing on autonomy? 
Does the use of interventions in cognitive biases constitute unethical manipulation? How 
can such system reflect user preferences, given that many users might not understand or 
have little desire to engage in complex system configurations?  
  
9.4.4 User-centered AI 
The next-generation approach suggested in this thesis will require AI algorithms that can process 
collected data and offer personally relevant suggestion. Despite the promise of automating human 
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cognitive processes, there are significant barriers to successful implementation — and the potential 
for adverse effects on users and society. Challenges for designers include insufficient or inaccurate 
data for training or analysis, problems in identifying and communicating contextually relevant and 
personalized usable insights, developing interpretable ML algorithms, and avoiding algorithms that 
can spread destructive biases. Overcoming these limitations will require careful understanding and 
integration of diverse processes behind interactions with human users, so that systems can 
appropriately support human cognitive processes, psycho-social requirements, and complement the 
needs and goals of individual users. Relevant research questions might include: 
• Which ML techniques will produce the best results for extracting meaningful and 
actionable insights from personal data to support a given chronic health condition or 
optimize a desired beneficial behavior? 
• How is the relationship between the system and the user designed to optimize transitions 
between system automation and required user intervention? 
• How can systems prompt users for needed training data in a manageable and sustainable 
manner? 
• What assurances are required for the user to trust the system? 
• How can systems be developed to support and augment cognitive processes while 
developing user autonomy? 
• What are the requirements for the user-centered design of AI-augmented networked 
pervasive health systems? 
• What are effective methods of evaluating AI-augmented networked pervasive health 
systems? 
 
The above issues illustrate the need to develop comprehensive user-centered approaches for the 
integration of AI methods into pervasive digital health systems, considering the multiple 
sensitivities of human users, diverse stakeholders, and wider society.  
9.5 Concluding Remarks  
Throughout this thesis I have had the opportunity to participate in forums, workshops, interviews, 
and conversation in four different countries (Germany, US, UK, France), seven different cities 
(Berlin, London, Paris, San Francisco, Oakland, Mannheim/Heidelberg, Leipzig), and with many 
hundreds of people with T1 diabetes who come from and live all over the world. This thesis is 
foremost about those who depend on diabetes technologies every day, their needs within the 
complex and diverse ecosystems that form their daily lives, and finally how we can design systems 
to help support them. It is critical to realize that while clinical metrics are important, life quality is 
the central goal, not an afterthought.  
One of challenges in researching and designing effective diabetes interventions is the need to 
balance that which can be measured and that which can only be felt. On the one hand, there is 
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strong evidence that maintaining in range glycemic values reduces medical complication. On the 
other hand, the individual’s perceptions and feelings about their care and their life play vital roles 
in determining ability to maintain motivation and self-care practices. Furthermore, both aspects are 
intertwined: stress makes diabetes clinically harder to manage, and presentation of undesired health 
data values can increase stress and frustration. Each individual must find a personal balance 
between risk avoidance and their life as they choose to (or must) live it. Therefore, practical 
interventions must find ways to integrate both objective and subjective aspects of the diabetes 
experience. Another aspect of diabetes to consider is that the human body is a noisy system. 
Diabetes is seldom completely mastered. There will always be some measurements that are higher 
and others that are lower. Approaches that seek to reward results therefore risk frustrating the 
individual who does everything right and yet has an unpredictable outcome. Diabetes management 
is about each individual finding a balance that works for them within their life and re-balancing this 
approach as context changes. The approaches and findings in this thesis such as FCR embrace this 
dynamic approach, and a principal conclusion of this thesis is that an intervention must be 
developed that takes into account complex ecologies of care and the uncertainty which they imply.  
On a final and personal note, it is my hope that the insights gained from the challenges I have faced 
living many years with diabetes have in some way benefited this research, offering a perspective 
both as an academic and as a user. I would like to encourage those who have a condition or 
viewpoint that places them at certain disadvantages to see this also as a strength for the experiences 
so gained.   
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10.2.1 Chapter 4: Adoption Diabetes Smartphone Apps  
 
 
Never  
1-5 days per month  
6-15 days per month 
16-27 days per month  
everyday
0  
1-2  
2-4 
4-6  
more than 6
Continual Glucose Monitor (CGM)
yes
no
proceed to section 2
proceed to section 3
1
Diabetes smartphone Apps questionnaire
This questionnaire and semi-structured interview is being conducted by Dmitri Katz (+49(0)177 494 4496, 
dmitri.katz@my.open.ac.uk), a PhD student at The Open University, UK. Dmitri is interested in improving 
diabetes care by investigating how mobile apps on smart phones can be designed to improve the lives of 
people with diabetes. We will be asking about your previous or current use of apps and do not advocate the 
use or non-use of any app, and will not give any advice on diabetes treatment. The questionnaire should 
take about 5 minutes to complete. The semi-structured interview should also take about 5 minutes but may 
take longer depending on your answers. There are no known risks to taking part in this research. You do 
not need to identify yourself, but if you choose to provide any personally identifying information it will be 
stored separately from your answers and identified only by a code number. If you do choose to provide 
contact details or personally identifying information it will be stored securely in accordance with the UK Data 
Protection Act 1988 and relevant European Data Protection legislation. If you have any questions about 
this research, please contact Dmitri directly. If you have any concerns about the research you can contact 
Dmitri’s supervisor, Dr Dalton (+44 (0)7908 64 9005, sheep.dalton @ open.ac.uk).  Thank you for your time.
Q1.1 How often do you keep a paper diabetes diary or log of information such as medication           
dosages, blood sugars, diet, etc:  
Q1.2 Have you ever used a diabetes smart phone App: Yes             No 
General questions:
Q1.3 If  Yes, which App(s) and on which device(s)?
Q1.4 Approximately how many diabetes apps have you tried in total?  _______
App name Device/OS
Q 1.5 How many times per day do you measure your blood sugar?
Q 1.6 Are you currently using a diabetes smartphone App? 
This interview took ______ minutes
Participant No. Date:           /           / 
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Section 2
If you are currently and regularly using a diabetes App:
Q2.1 What is name of the main App you are currently using? __________________
Q2.2 Why did  you start using the App? Please select all that Apply
doctor’s/primary caregiver’s recommendation  
pharmacist’s recommendation    
friend’s recommendation     
internet/blog recommendation    
health insurance suggestion  
clinical/academic evidence    
unplanned (e.g App Store)    
something else?__________________ 
Q2.3 How many days do use this diabetes App in an average week? (choose one)
one day    
2 to 5 days   
everyday    
more than once per day
other_______________________
 
Q2.4 How long have you been using this App? (choose one)
1 day  
2 days -1 week   
1 week -1 month  
1 month- 3 months  
3 months- 6 months  
longer than 6 months  
Q2.5 In which ways has this App helped you? (Please check all that Apply)
logs/records for caregiver(e.g. doctor)  
motivation     
diet/recipe support    
reminders/alarms    
medical advice/education   
data visualization/insight   
doesn’t help     
other_______________________
Q2.6 Do you find this App helpful? (choose one)  
Very helpful   
somewhat helpful  
neutral   
not helpful 
other_______________________
2
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Section 3
If you are not currently regularly using a diabetes App, 
BUT HAVE USED ONE IN THE PAST:
Q3.1 What was the name of the primary App you were using? __________________
Q3.2 Why did you start using the App?
doctor’s/primary caregiver’s recommendation 
pharmacist’s recommendation    
friend’s recommendation     
Internet/blog recommendation    
health insurance suggestion  
clinical/academic evidence    
unplanned (e.g App Store)    
other?__________________ 
Q3.3 How long had you been using the App before stopping? (choose one)
One time to 1 day  
2 days -1 week   
1 week -1 month  
1 month- 3 months  
3 months- 6 months  
longer than 6 months 
Q3.3b How many times were you using this diabetes App in an average week?
1-2  
2-4 
4-6  
1x per day
More than 1x per day
Q3.4 While you were using this App did you find it helpful? (choose one)  
Very helpful   
somewhat helpful  
neutral   
not helpful at all 
Q3.5 If you did find the App helpful, in which ways? (Please check all that Apply)
logs/records for caregiver(e.g doctor)  
motivation     
diet/recipe support    
reminders/alarms    
medical advice/education   
data visualization/insight   
didn’t help     
other_______________________ 
Q3.6. Why did you stop using the App.? (choose one )
Fulfilled goal 
Didn’t help 
I couldn’t make it work 
App stopped working  
Too much work   
other_______________________
3
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Section 4
Diabetes Apps:
Q4.1 What is your opinion of the diabetes apps you have used?   
Q4.2 Please describe what kind of feelings you get before, during and after using a diabetes App?
before:
during:
after:
4
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Section 5
Non-Diabetes smartphone Apps :
Q5.1 Do you use any of these Apps every day?(choose as many as Apply)
Games  
Facebook   
Twitter  
Other Social networking
What‘sApp/Texting   
Health/Fitness    
Other________________________
Q5.2 What are your favorite non-diabetes Apps and how often do you use them in an average 
week?
Q5.3 What do you get from using these Apps?
Q5.4 Please describe what kind of feelings you get before, during and after using your favorite
non-diabetes Apps?
before:
during:
after:
5
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Section 6 
About you:
Year of Birth: ____________ 
Gender:   Male          Female
Type of Diabetes T1     T2       Gestational       Other___________
Year of Diagnosis___________
Q4.2 Would you like to receive the anonymized results of the survey?
 Yes, my email address is ___________________
 No
Q4.3 If there are any follow up questions, may I contact you by email or telephone? 
 Yes please do 
  Name(optional): ______________________________
   Email address(optional): _______________________ 
   Telephone /Mobile (optional): ____________________
 No, do not
That’s it ! Thanks for your help. 
I consent that the anonymous information gathered with this survey can be used for research on 
diabetes app usage. 
_______________________________________________________
Date/Signature
Additional comments:
6
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10.2.2 Chapter 5 User-Interaction study forms 
 
 
 
 
1		
Diabetes	App	Study	
	
The	following	survey	and	user	test	aims	to	understand	the	use	of	mobile	
phone	apps	primarily	designed	and	developed	for	diabetes	self-
management	
	
	
Participant	Consent	form		The	diabetes	app	study	is	being	conducted	by	Dmitri	Katz	(+49(0)177	494	4496,	dmitri.katz@my.open.ac.uk),	who	is	a	PhD	student	at	The	Open	University,	UK.	Dmitri	is	interested	in	improving	diabetes	care	by	investigating	how	mobile	phone	apps	developed	for	use	on	smart	phones	can	be	designed	to	improve	the	lives	of	people	with	diabetes.			There	are	no	known	risks	to	taking	part	in	this	research.	As	a	participant	in	this	study,	you	do	not	need	to	identify	yourself	and	all	information	will	be	anonymized.	If	you	choose	to	provide	any	identifying	information	this	data	will	be	stored	separately	from	your	answers	and	identified	only	by	a	unique	code	number.			There	will	be	video	recording	of	the	mobile	phone	interface,	your	voice	and	hands.	Your	face	will	at	no	time	be	visible	and	you	will	only	be	identified	by	a	unique	number,	i.e.	participant	#1.		If	you	do	choose	to	provide	contact	details	or	personal	information	this	data	will	be	stored	securely	in	accordance	with	the	UK	Data	Protection	Act	1988	and	the	relevant	European	Data	Protection	legislation.			If	you	have	any	questions	about	this	research,	please	contact	Dmitri	directly.	If	you	have	any	concerns	about	the	research	or	to	resign	yourself	and	data	from	the	study	please	contact,	Dr.	N.	Dalton	(+44	(0)7908	64	9005,	sheep.dalton	@	open.ac.uk)	who	is	supervising	Dmitri	through	his	graduate	studies.	Thank	you	for	your	time.	
	I	consent	that	the	anonymous	information	gathered	in	this	study	can	be	used	for	presentations,	journal	and	conference	presentations/papers	and	for	use	in	the	final	PhD	thesis.			Name:_____________________________																			Participant	I.D.____________		_______________________________________________________	Date/Signature 
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2		
Survey/Scenario of the diabetes app	
	In	order	to	understand	more	about	how	people	use	diabetes	mobile	phone	apps	you	will	be	asked	a	series	of	questions	relating	to	the	features,	preferences,	motivations	and	descriptions	of	popular	diabetes	apps.	This	study	aims	to	understand	how	best	to	display	diabetes	app	data	to	users,	and	it	is	not	the	requirement	of	the	study	for	you	to	know	and	understand	how	to	use	the	app	ahead	of	time.	You	will	be	asked	a	series	of	questions	before,	during	and	after	the	use	of	these	products.			We	are	trying	to	understand	more	about	how	people	relate	to	their	collected	health	data,	so	we	would	like	you	to	imagine	a	scenario	that	all	the	recorded	data	is	your	personal	data,	and	you	are	explaining	this	period	to	your	doctor.		Please	do	your	best	to	help,	and	talk	out	loud	about	what	you	think.	In	order	to	understand	the	process	better,	the	conversation,	the	smartphone	screen,	and	your	hands	will	be	recorded.	Your	face	will	at	no	time	be	visible,	as	we	are	measuring	the	performance	of	the	software,	not	the	user.	
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3		
Mobile	app	use	and	experience	general:	
	I	am	comfortable	using	a	smartphone.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		I	engage	readily	with	reading	graphs	e.g	in	newspapers,	presentations.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		I	enjoy	solving	puzzles.		Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		I	am	confident	that	I	can	troubleshoot	my	diabetes	logs	to	understand	problems.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		I	feel	comfortable	using	diabetes	apps		Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		I	am	in	general	satisfied	with	the	level	of	my	diabetes	control.		Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 			I	am	comfortable	using	smartphone	apps	in	general.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		I	have	used	self-tracking/logging	apps	(logging	weight,	exercise	or	diet	with	jawbone,	fitbit,	garmin,	strava,	my	fitness	pal,	etc.	)	for	purposes	other	than	diabetes	management.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 				
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If	you	have	used	a	diabetes	app,	it	was	difficult	to	understand	what	it	was		telling	you	about	your	diabetes.		Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 			I	don’t	like	using	maps	to	find	a	route,	and	would	rather	be	directed	with	a	navigator.		Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		
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5		
	
		
App	Test:	
	
There	will	be	a	series	of	questions	about	the	data	entered	into	the	app.	As	
you	are	answering	these	questions,	please	talk	about	what	you	are	thinking	
or	feeling.		Please	share	any	observations	about	the	app,	what	you	would	
like	to	know,	what	works	or	doesn’t.	
Look	at	data	on	each	app	from	July	16th	to	July	30th.	(go	through	each	app)	Functionality		1. What	do	you	see	about	this	period?	2. What	would	you	do	differently	based	on	this	data?	3. How	useful	is	this	app	for	helping	you	understand	this	diabetes	data?	Emotional	1. Talk	about	how	each	interface	makes	you	feel	about	being	diabetic	2. Please	look	at	July	28th,	what	happened	to	your	control	on	that	day?	How	do	you	feel	about	that	day?	3. Please	look	at	July	21st,	how	do	you	feel	reviewing	this	day?		
App	ratings	(cumulative)		desirable	and	undesirable	characteristics	(5	point	Likert)			1.	Diabetes	apps	are	motivating	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 	2.	Diabetes	apps	are	fun	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		3.	Diabetes	apps	are	boring	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		4.	Diabetes	apps	are	useful.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 		5.	Using		diabetes	apps	is	frustrating.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 	6.	Diabetes	apps	are	gimicky	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree	
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6		
	 	 	 	 	7.	Using	a	diabetes	app	makes	me	feel	guilty	about	my	diabetes	control.	Strongly	agree	 agree	 neutral	 disagree	 Strongly	disagree		 	 	 	 				
Personal	Preferences:	
	What	form	are	you	best	able	to	understand	information,	i.e.	charts,	sentences,	audio,	read,	etc.		Please	describe	your	feelings	and	motivations	of	using	the	diabetes	app.	Consider	and	explain	your	previous	experiences	of	using	diabetes	apps,	what	difficulties	you	had,	what	aspects	you	found	informative.		If	you	use	diabetes	apps,	are	there	particular	times	you	use	them	more	than	other	times?		Do	you	share	your	diabetes	data	with	other	people,	e.g	friends,	family,	partner,	doctor?				Why	do	you	share	this	information?	In	what	ways	does	it	help?		Have	you	ever	felt	any	stigma	or	negative	effects	from	sharing	your	data,	such	as	BG,	diet,	exercise,	or	other	information?	You	have	been	shown	several	apps,	please	explain	which	apps	you	find	the	best	and	which	the	worst.		Did	you	feel	one	app	in	particular	was	more	encouraging.		Was	any	app	more	discouraging	than	the	others?				
Demographic	data	
	
	1.	Year	of	Birth:	____________		Gender:			Male										Female		
2.	I	am	a	T1	diabetic___________	Year	of	Diagnosis___________	Profession:_______________________		
I	am	a	health	care	professional	or	caregiver	to	a	T1	diabetic_________	What	is	your	profession	or	relationship	to	diabetes?_________________________	
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3.	Which	diabetes	apps	have	you	tried	previously?	Do	you	use	graphical	charts	or	diagrams	in	your	work	life?	What	is	the	highest	level	of	education	you	have	completed?		4.	Do	you	use	now	or	have	you	ever	used	a	smart	phone	app	to	track	your	diabetes?		If	so	which:		5.	Length/frequency	of	using	an	app	for	tracking	diabetes?	Current	usage:	regular/irregular/stopped	Describe:			6.	What	type	of	phone	do	you	use?	Is	it	a	smart	phone?		7.	Do	you	use	a	web	or	desktop	interface	to	track	your	diabetes?		If	so	which:		8.	Why	do	you	use	the	particular	device,	i.e.	home	computer,	laptop,	smartphone,	smartwatch,	insulin	pump,	meter,	etc.?			Would	you	like	to	receive	the	anonymized	results	of	the	survey?		 Yes,	my	email	address	is	___________________		 No_________		If	there	are	any	follow	up	questions,	may	I	contact	you	by	email	or	telephone?			 Yes	please	do				 Name(optional):	______________________________				 Email	address(optional):	_______________________					 Telephone	/Mobile	(optional):	____________________		 No,	please	do	not	contact	me:___________________	
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10.2.3 Chapter 6:  FCR Survey forms 
 
 
 
 
 Page 1 of 1 
    
 
 
 
 
 
Online	survey	on	T1	diabetes	self-management		
This online survey is being conducted by Dmitri Katz, a PhD student at The Open University, UK. 
Dmitri is interested in improving diabetes care by investigating how people living with Type 1 
Diabetes make decisions about their diabetes management. We hope that the information collected 
will help guide designers in creating easier to understand ways of displaying personal health data. 
We will be asking about your opinions, thoughts and experiences, and will not give any advice on 
your current diabetes treatment.  You must be at least 18 years old, and under medical treatment 
for T1 diabetes. The questionnaire should take about 5-10 minutes to complete, and there are no 
known risks to taking part in this research. You do not need to identify yourself, but if you choose to 
provide an email address to receive the results of this research or to be contacted if there are any 
further questions, it will be stored separately from your answers that will be identified only by a 
code number. Only the principal university researchers will have access to this data. If you do choose 
to provide contact details or personally identifying information it will be stored securely in 
accordance with the UK Data Protection Act 1988 and relevant European Data Protection legislation. 
This research is in part being supported by a research grant from the European Research Council, the 
UK Engineering and Physical Sciences Research Council, and researchers from the Open University. 
You may choose to withdraw your data from the survey through email notification until the end of 
the collection period in July 2017. Once we have begun to analyze the data we will no longer be able 
to remove your answers. However, if you choose to submit an email address, this can be removed at 
any time upon your request. Please note that completion and submission of this questionnaire 
implies consent to your data being used for the academic research purposed, and your answers (in 
anonymized form) may be used or quoted in published academic literature. If you have any 
questions about this research, please contact Dmitri directly (+49 (0) 177 494 4496, 
dmitri.katz@open.ac.uk). If you have any concerns about the research you can contact Dmitri’s 
supervisor, Blaine Price (+44 (0)1908 653 701, b.a.price@open.ac.uk). Ethics approval for this survey 
was granted by The Open University Human Research Ethics Committee (HREC/2017/2524/Katz/1). 
Thank you for your time.  
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1.	What	is	your	age	in	years?	2.	What	is	your	identified	gender	3.	How	long	has	it	been	since	you	were	diagnosed	with	T1	diabetes?	4.		Which	specific	devices	do	you	currently	use	in	your	daily	or	near	daily	diabetes	management?	(i.e	insulin	pumps,	Blood	Glucose	meters,	insulin	pens,	fitness	trackers,	smartphone	apps,	etc.)	Please	include	model	names	and	numbers	if	you	know	them	such	as	Dexcom	G5,	Abbott	Libre,	Contour	Next,	or	Medtronic	530G.	5.	How	many	times	do	you	check	your	BG	values	on	a	normal	day?	(If	you	use	a	CGM	or	FGM	note	how	many	times	you	look	at	the	display	on	an	average	day.)	6.	How	many	shots	(boluses	or	manual	dosage	rate	adjustments,	if	you	are	a	pump	user)	do	you	normally	make	per	day?	7.	Imagine	that	it	is	time	for	you	to	take	an	insulin	dosage	for	a	meal.	You	check	your	blood	glucose	level,	and	as	you	expect	it	is	in	a	normal	range	(70-140	mg/dl	or	3.9-7.8	mmol/L).		Please	describe	the	factors	you	might	take	into	consideration	to	determine	how	much	insulin	to	take	for	this	meal.	8.	Please	try	and	remember	a	situation	where	you	had	a	serious	and	surprising	high	or	low	blood	glucose	value	(e.g.	despite	being	careful,	you	had	an	unexpected	dangerously	low	blood	sugar	on	an	airplane).		Please	describe	that	specific	situation,	and	your	thought	process	about	it.	Please	be	as	detailed	as	possible.	8b.	In	the	last	example	please	describe	how	you	managed	the	situation.	9.	Please	try	and	remember	a	time	that	you	had	done	something	that	had	caused	your	BG	level	to	be	out	of	ideal	range,	but	you	immediately	understood	why	(e.g.	eating	too	much	cake	at	a	birthday	party).	Please	describe	that	specific	situation,	and	your	thought	process	about	it.	Please	be	as	detailed	as	possible.	9b.	In	the	last	example	please	describe	how	you	managed	the	situation.	10.	Please	try	and	remember	a	situation	when	you	were	in	a	novel	or	unusual	situation	that	dramatically	affected	your	blood	glucose	level	(e.g.	arriving	in	a	different	time	zone,	becoming	distracted	by	unusual	circumstances	after	taking	a	shot,	miscalculating	an	insulin	dosage,	an	unusual	food,	etc.)	Please	describe	this	specific	situation,	and	your	thought	process	about	it.	Please	be	as	detailed	as	possible.	10b.In	the	last	example	please	describe	how	you	managed	the	situation.	11.	Is	your	diabetes	management	process	different	now	in	comparison	to	when	you	first	became	diabetic?	If	so,	please	explain	in	which	ways.	12.	If	you	use	a	CGM	or	Freestyle	Libre,	in	which	ways	has	it	changed	your	diabetes	management	process	as	opposed	to	using	strips?	Please	be	as	specific	as	possible.	13.	Please	check	your	blood	glucose,	and	record	the	value	in	the	space	below.	Describe	everything	that	comes	to	your	mind	and	what	factors	might	have	contributed	to	this	reading.	14.	Imagine	that	you	are	going	to	take	insulin	now	for	a	meal.		Given	your	current	BG	value,	please	describe	what	factors	you	would	take	into	consideration,	and	the	process	you	would	use	to	decide	on	an	appropriate	insulin	dosage.	15.	If	you	wish	to	receive	the	results	of	this	survey	please	enter	your	email	address.	You	will	not	be	contacted	for	any	commercial	offers	and	your	identity	will	be	kept	strictly	confidential.	(This	is	entirely	optional)	
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Application for assistance 
with research recruitment   
 
1. Classification of organisation  
Please indicate the type of organisation you are applying on behalf of: 
Not for profit organisation (i.e. University)   
NHS 
Commercial company 
Other   
x                                                              
   
   
   please specify: ________________________ 
Name of organisation The Open University, Milton Keynes 
 
 
2. Research and lead investigator details 
(PhD students must provide the details of a PhD supervisor) 
Title of research 
project/activity  
Questionnaire for investigating cognitive processes of T1 Diabetes Self-
Management 
Name and title of lead 
investigator  Mr. Blaine Price Position held Senior Lecturer 
Telephone number 01908 653701 Email Blaine.price@open.ac.uk 
Address School of Computing and Comms, The Open University, Milton Keynes, MK7 6AA 
 
 
3. Main point of contact for research participants (if different to above) 
Name and title Dmitri katz Position held PhD student 
Telephone number ++49 177 494 4496 Email Dmitri.katz@open.ac.uk 
Address Rigaerstr. 16, 10247 Berlin Germany 
 
 
4. Research funding 
Name(s) of funders/partners European Research Council, the UK Engineering and Physical Sciences Research Council 
Has this research been through a 
process of peer-review? Yes         No     
If yes, please provide brief details 3 PhD supervisors reviewed protocol 
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10.2.4 Chapter 7:  Wearables Study forms 
 
 
 
Diabetes(Monitoring(–(Patient(Information(Sheet(v2.0((18(Dec(2016( ( 1(
(  
 
 
A feasibility study to monitor lifestyle activities of 
people living with Type 1 Diabetes 
 
Patient Information Sheet  
(
We(would(like(to(invite(you(to(take(part(in(our(research(study.(Before(you(
decide(we(would(like(you(to(understand(why(the(research(is(being(done(
and(what(it(would(involve(for(you.(We(suggest(that(it(may(take(about(10(
minutes(to(read(thoroughly.(If,(after(reading(this(information(sheet,(you(
think(you(may(be(interested(in(taking(part(one(of(our(team(will(go(through(
the(sheet(with(you(via(telephone(and(answer(any(questions(you(have.(
(
You(have(been(selected(because(you(are(a(patient(living(with(Type(1(
diabetes.(At(this(stage(approximately(16L20(patients(are(expected(to(take(
part.(
(
(
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Diabetes(Monitoring(Participant(Informed(Consent(Form(Final(Version(2.0(18(Dec(2016(
3(copies(to(be(signed.(1(to(be(retained(by(patient,((
1(to(go(into(patient(notes(and(1(to(go(into(the(investigator(study(file.( Page 1 of 2(
  (
(
(
(
Patient(Identification(Number(for(this(trial:______________(
CONSENT'FORM(
Title(of(Project:(A(feasibility(study(to(monitor(lifestyle(activities(of(people(living(with(Type(1(Diabetes'
'Name(of(Researcher:(Dmitri(Katz((
Please(initial(all(boxes((
1. I(confirm(that(I(have(read(and(understand(the(information(sheet(dated(xxx'for(the(
above(study.((I(have(had(the(opportunity(to(consider(the(information,(ask(questions(
and(have(had(these(answered(satisfactorily.(
( ( (
2. I(understand(that(my(participation(is(voluntary(and(that(I(am(free(to(withdraw(at(any(
time(without(giving(any(reason,(without(my(medical(care(or(legal(rights(being(affected.(
I(understand(that(if(I(withdraw(during(the(study(I(may(be(asked(for(my(consent(to(use(
the(data(collected(to(that(point.(I(understand(that(if(I(withdraw(after(the(study(period(it(
may(not(be(possible(to(delete(my(anonymized(data(if(it(has(already(been(analysed(for(
publication.(
(
3. I(understand(that(relevant(sections(of(my(medical(notes(and(data(collected(during(the(
study,(may(be(looked(at(by(individuals(from(The'Open'University'from(regulatory(
authorities(or(from(the(NHS(Trust,(where(it(is(relevant(to(my(taking(part(in(this(
research.((I(give(permission(for(these(individuals(to(have(access(to(my(records.(
(
4. I(give(permission(for(the(research(team(to(send(me(study(related(text(messages(or(
emails,(or(for(a(relative(or(carer(to(receive(study(related(texts(or(emails(on(my(behalf.(
(
5. I(agree(to(my(GP(being(informed(of(my(participation(in(the(study.((
(
6. I(agree(to(return(the(continuous(glucose(monitor((delete(if(patient(has(own)(and(the(
sleep(monitor(to(the(researchers(once(my(participation(in(the(study(is(completed(
(
7. (I(agree(to(allow(the(researchers(to(use(audio(recordings(for(the(purpose(of(noteZ
taking.(
(
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Diabetes(Monitoring(Participant(Informed(Consent(Form(Final(Version(2.0(18(Dec(2016(
3(copies(to(be(signed.(1(to(be(retained(by(patient,((
1(to(go(into(patient(notes(and(1(to(go(into(the(investigator(study(file.( Page 2 of 2(
8. (Optional)(I(agree(to(being(contacted(for(an(additional(interview(at(a(later(time.(
(
9. I(agree(to(take(part(in(the(above(study.( ( ( (
(
( ( ( ( ( ( ( ( ( ( ( (
Name(of(Participant( ( ( Date( ( ( ( Signature(
((((((((((((((((((((((((((((((( ( (
(
( ( ( ( ( ( ( ( ( ( ( (
Name(of(Person( ( ( Date( ( ( ( Signature((
taking(consent.( (
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Diabetes(Monitoring((Intake(Survey(1.0(27November2016(
( Page 1 of 1(
    (
(
(
(
(
Intake'Survey'for'pilot'study'on'Diabetes(Monitoring:'
Participant'ID'number________'
'
1. Gender:___________(
2. Year(of(birth:(___________(
3. Year(of(diabetes(diagnosis:(___________(
4. Occupation:(________________________________(
5. Circle(the(insulin(therapy(you(are(using:(((((((((Pump((((((((((((Multiple(Dosage(Insulin((MDI)(
6. Average(number(insulin(injections(per(day:(___________(
7. Types(of(insulin(taken(daily:(___________(
8. Latest(A1C,(if(known:(___________(
9. Do(you(use(a(continuous(glucose(monitor,(if(so,(which?((YES((/((NO(
________________________________(
10. Do(you(currently(use(any(tracking(devices(or(apps,(if(so(which?(
_____________________________________________________________________(
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Diabetes(Monitoring((Participant(Introduction(1.0(27November2016(
( Page 1 of 1(
    (
(
(
(
(
Hello((_______________________,(
Before(we(get(started(I(want(to(tell(you(a(little(about(this(study.(We(are(investigating(how(the(
lifestyle(choices(you(make,(like(where(you(eat(or(when(you(exercise,(affects(your(diabetes(
management.(We(are(also(interested(in(how(you(feel(about(using(devices(like(smartphones(together(
with(health(devices,(which(will(be(important(in(developing(personal(health(systems(that(are(sensitive(
to(your(needs.(
In(order(to(do(this,(we(will(ask(you(to(install(an(app(on(your(phone,(wear(a(fitness(band,(and(use(a(
CGM((Continuous(Glucose(Monitor).((If(you(do(not(have(a(CGM,(we(will(supply(you(one(for(the(
duration(of(the(study,(though(we(may(need(you(to(return(the(CGM(meter(at(the(end(of(the(study.(
There(is(no(need(for(you(to(in(any(way(change(your(daily(routine,(and(in(fact(please(do(not(make(any(
changes(relating(to(your(diabetes(treatment(without(first(consulting(with(your(doctor.((We(are(not(
trying(to(change(your(behaviour,(we(just(want(to(learn(more(about(your(blood(glucose(patterns(in(
relation(to(your(activities.(
During(the(4Pweek(study(period(your(devices(will(be(recording(your(location,(exercise,(sleep,(and(
blood(glucose(level.((This(information(will(be(stored(anonymously,(and(your(identity(will(be(
protected.(We(request(that(you(do(your(best(to(keep(your(phone,(your(fitness(band,(and(your(CGM(
with(you(and(batteries(charged.(If(at(any(time(you(want(to(stop(using(one(or(more(of(the(devices,(
that(is(your(right,(and(there(will(be(no(penalties.(
At(the(end(of(the(study(period,(you(will(be(free(to(dePinstall(the(app(from(your(phone.(Please(return(
the(CGM(if(you(have(been(loaned(one.((You(may(keep(the(fitness(band(if(you(so(desire.(
We(would(now(like(to(ask(you(a(few(questions(about(diabetes(and(your(opinions(on(your(personal(
data.(For(convenience(sake,(if(it(is(ok(with(you,(we(would(like(to(record(audio(of(this(interview.(If(you(
do(not(wish(to,(we(can(just(record(the(information(by(hand.(
(
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Diabetes(Monitoring((Semi0Structured(Interview(Questions(2.0(21Dec2016(
( Page 1 of 2(
    (
(
(
(
(
Semi%structured,interviews,for,study,on,diabetes,lifestyle,correlations,
Before,Study,period:,
1. Can(you(tell(me(something(about(yourself?(
2. Have(you(used(any(exercise(tracking(devices,(if(so(which?(
3. Are(you(currently(satisfied(with(your(diabetes(management,(why(or(why(not?(
4. What(are(your(greatest(challenges(in(diabetes(management?(
5. Do(you(think(people(are(too(cautious(or(overly(easy(about(sharing(their(data?((
6. Do(you(share(your(diabetes(data,(if(so(who(with,(and(how(often?(
7. How(do(you(feel(about(sharing(your(personal(data(such(as:(
a. GPS(location?(
b. BG(values?(
c. How(often(and(where(you(sleep?(
d. When(and(how(you(exercise?(
e. Where(you(shop?(
f. Which(restaurants(you(go(to?(
g. Recreational(locations(and(activities?(
8. Would(your(opinions(in(the(previous(question(be(altered(if(you(were(assured(your(data(was(
properly(anonymized?(
9. How(do(you(feel(about(your(doctor(having(access(to(your(personal(data(such(as:(
a. CGM(values?(
b. Location?(
c. Exercise?(
d. Is(there(any(other(type(of(information(that(you(would(prefer(not(to(share(with(your(
doctor?(If(so,(without(giving(sensitive(details,(can(you(explain?(
10. How(do(you(feel(your(health(insurance(provider(having(access(to(your(personal(data(such:(
a. CGM(values?((
b. Location?(
c. Exercise?(
11. Can(you(share(any(circumstances(where(you(might(not(want(to(be(wearing(a(system(that(
tracks(your(health(and(other(personal(information?(If(so(what(might(you(do(in(such(times?(
12. Do(you(have(any(questions(or(concerns(about(this(study?,
,
, ,
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Diabetes(Monitoring((Semi0Structured(Interview(Questions(2.0(21Dec2016(
( Page 2 of 2(
Following,study,period:,
1. How(did(you(feel(about(wearing(tracking(devices?(
2. Are(you(currently(satisfied(with(your(diabetes(management?(Please(explain.(
3. If(you(stopped(using(any(of(the(devices,(which(ones(and(why?(
4. What(are(your(greatest(challenges(in(diabetes(management?(
5. Having(worn(these(devices(for(30(days(has(this(in(anyway(affected(how(you(feel(about(
tracking(and(sharing(your(personal(data?(
6. Did(the(wearing(of(data(tracking(devices(in(any(way(change(your(behaviors(or(awareness?(
7. How(was(wearing(the(fitness(band(during(the(study(period?(
8. How(did(your(feel(about(wearing(the(CGM(during(the(study(period?(
9. How(did(you(feel(about(sharing(your(personal(data(such(as:(
a. GPS(location?(
b. BG(values?(
c. How(often(and(where(you(sleep?(
d. When(and(how(you(exercise?(
e. Where(you(shop?(
f. Which(restaurants(you(go(to?(
g. Where(you(are(at(night?(
10. Do(you(think(the(sharing(of(your(personal(data(would(prevent(you(from(wearing(a(medical(or(
tracking(device(everyday?(
11. If(so,(what(assurances(would(make(a(difference?(
12. Do(you(feel(a(difference(between(your(data(being(accessed(by(a(person(or(an(automated(
system?(If(so,(in(which(ways?(
13. How(do(you(feel(about(your(doctor(having(access(to(your(personal(data(such(as:(
a. CGM(values?(
b. Location?(
c. Exercise?(
14. How(do(you(feel(about(How(do(you(feel(your(health(insurance(provider(having(access(to(
your(personal(data(such(having(access(to(your(personal(data(such(as:(
a. CGM(values?(
b. Location?(
c. Exercise?(
15. Is(it(important(to(you(that(you(control(access(to(your(personal(data?(If(so,(which(data(and(to(
whom?(
16. What(circumstances(might(change(your(attitudes(to(sharing(personal(data?(
17. What(assurances/risks(might(change(your(opinions(as(to(sharing(personal(data?(
18. Can(you(think(of(any(particular(times(or(circumstances(where(you(might(want(to(hide(your(
data(or(location?(If(so,(can(you(share(any(of(them?(
19. Do(you(have(any(questions(or(concerns(about(this(study?(
(
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10.2.5 Chapter 8: DUETS  study forms 
 
 
1		
DUETS	System	Analysis	Tool	
	
The	following	session	aims	to	better	understand	how	a	card-based	tool	can	
be	used	to	visualize	and	reflect	on	health	systems	in	order	to	assist	
developers	in	better	understanding	and	integrating	user	needs.		
	
Participant	Information	and	Consent	form		This	study	is	being	conducted	by	Dmitri	Katz	(+49(0)177	494	4496,	dmitri.katz@open.ac.uk),	who	is	a	PhD	student	at	The	Open	University,	UK.	Dmitri	is	interested	in	improving	health	care	by	investigating	how	stakeholder	opinions	and	needs	can	be	better	identified	and	integrated	into	product	development	processes.	It	will	involve	about	2	hours	of	your	time	but	you	can	choose	to	leave	at	any	time.	The	tasks	will	involve	considering	a	design	for	a	diabetes	support	system	using	usability	heuristics	and	paper-based	tools	to	reflect	on	the	potential	utility	of	the	product,	shortcomings,	and	ways	that	you	think	the	product	could	be	improved.	You	will	not	be	asked	to	share	any	of	your	personal	health	records,	medical	details,	experiences,	or	behaviors.		We	would	like	to	offer	you	an	Amazon	voucher	in	recognition	of	you	donating	your	valuable	time.			There	are	no	known	risks	to	taking	part	in	this	research.	As	a	participant	in	this	study,	you	do	not	need	to	identify	yourself	and	all	information	will	be	anonymized.	If	you	choose	to	provide	any	identifying	information	this	data	will	be	stored	separately	from	your	answers	and	identified	only	by	a	unique	code	number.	If	you	do	choose	to	provide	contact	details	or	personal	information	this	data	will	be	stored	securely	in	accordance	with	the	EU	General	Data	Protection	Regulation	(GDPR)	and	will	be	deleted	within	6	months	of	study	completion.	Your	participation	in	the	study	is	entirely	voluntary,	and	you	may	discontinue	at	any	time,	without	prejudice,	and	you	may	ask	to	have	your	data	deleted,	though	after	analysis	it	may	not	be	possible	to	delete	your	aggregated	and	anonymized	data.		If	you	have	any	questions	about	this	research,	please	contact	Dmitri	directly.	If	you	have	any	concerns	about	the	research	or	you	wish	to	delete	your	data	from	the	study	please	contact,	Prof.	Blaine	Price	(b.a.price	@	open.ac.uk)	who	is	supervising	Dmitri	through	his	graduate	studies.	Thank	you	for	your	time.	
	I	consent	to	participating	in	this	study	and	agree	that	the	anonymous	information	gathered	in	this	study	which	cannot	be	used	to	identify	me	may	be	used	for	academic	purposes.			Name:____________________________																			Participant	I.D.____________		_______________________________________________________	Date/Signature 
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Participant #                  Age                   Gender                      Date                  Profession 
 
 
Phase 1: Description of system  
Systems Concern (mark top 3)  
  
Ideas, modification, and new directions  
Phase 2: Reflection with heuristics  
Systems Concern (mark top 3) Heuristic # 
  
Ideas, modification, and new directions  
Phase 3: Reflection with Concerns cards  
Systems Concern (mark top 3) Card # 
  
Ideas, modification, and new directions  
Phase 4: Reflection with Concerns cards and System Cards  
Systems Concern (mark top 3) Card # 
  
Ideas, modification, and new directions  
Phase 5: Modify system with DUETS cards  
Systems Concern (mark top 3)  
  
Ideas, modification, and new directions  
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Thoughts, comments, suggestion on workshop: 
 
 
Thoughts, comments, suggestions on DUETS tool: 
 
Concerns cards in particular: 
 
Architecture cards in particular: 
 
 
DUETS cards are: I agree Somewhat 
agree 
neutral I somewhat 
disagree 
I disagree 
Fun to use      
Easy to understand      
Process provided guidance      
Information on cards useful      
Visual design is appealing      
Was easy to represent 
systems 
     
Had ideas I would not have 
had without cards 
     
Architecture cards were 
useful for understanding 
systems 
     
Concerns cards were useful 
for thinking about system 
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10.3 Appendix C: Results and other Outputs 
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10.3.1 Results from Chapter 4 diabetes app adoption  
(available for download at: https://figshare.com/articles/Supporting_Diabetes_Self-
Management_with_Ubiquitous_Computing_Technologies_A_User-Centered_Inquiry/7269398) 
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10.3.2 Results from Chapter 6 FCR 
Coding Scheme 
(available for download at: https://figshare.com/articles/Supporting_Diabetes_Self-
Management_with_Ubiquitous_Computing_Technologies_A_User-Centered_Inquiry/7269398) 
 
 
 
Table 1
type of 
model Habitual FCR Sensemaking
low cognitive demand medium cognitive demand high cognitive demand
Implicit, Eﬀortless Active  Engagement Explicit, Eﬀortful
frequent/continuous frequent occasional
Applying existing static, rule-based  
models
Adapting/ combining multiple 
existing models Problem solving /Hypothesis/Learning
Fixed discrete algorithms Fuzzy algorithms demanding or new algorithms
3 * 3 = 9 3.1* 2.9 ≈ 3 * 3 = 9 3.1 * 2.9 = 8.99
Reflexive/Reactive Improvisation/proactive Reflective or  Hypothetical thinking
Memorization Connecting Chunked memory Loading working memory
response to event navigation of event unexpected/hard to explain event
“If this, then that” “Some combination of this and that” “Could this cause that?”
A  reflexive responses, habitual 
behaviors, or a script activated  that 
allow for low cognitive demand 
execution of either a single or 
sequence of previously learned steps, 
models, or  forumulas? (e.g. for 
elevated BG take a correction shot of 
1 unit insulin per 50 mg/dl, drink 
water, test again in 1 hour.)
A combination of  models being 
adjusted and applied to  a  specific 
context with increased awareness 
of how factors aﬀect past, present, 
and future to  allow 'steering 
through' an extended time 
continuum.
A recognition of an unexplained event, 
discovery of a new pattern, cause and 
eﬀect analysis, explanation of what 
caused an event to occur, a learning 
process, with conscious creation or 
revision of specific model(s). (e.g.
insulin fixed Insulin to carb ratio insulin on board ( if not monitored by device) building models
bg correction factor insulin sensitivity in relation to a context
researching how  context changes 
insulin sensitivity
fixed insulin dosages waiting variable times before eating retrospective analysis of insulin eﬀect
changing individual insulin dosage 
in relation to multiple factors calculating new insulin/carb factors
micro-dosing for small changes experimenting to determine new fixed dosages
reducing insulin on board for 
specific contexts
series of small shots to deal with 
unusual situation
adjusting dosages according to 
trend anticipation
adjusting according anticipated 
length of meal
exercise set schedule engaging in variable exercise to for glycemic control
determining what eﬀect exercise had on 
outcome
x exercise has x eﬀect factoring in variable exercise eﬀects
past known exercise with set model anticipated future exercise to alter insulin dosages
dietary carb counting considering contextual eﬀect of carbs trying specific meals and learning eﬀect
same meals at same time Glycemic index of combined foods discovering glycemic index of diﬀerent foods through experimentation
Glycemic index if quantified Fat content delaying glucose response.
specific meals estimating cumulative eﬀect of absorption carbs vs fat vs. protein
predicting duration of meal
predicted time before meal
over correction for specfic context
Blood 
glucose fixed treatment for correction
variable corrections dependent on 
context
discovering how much a given amount 
of carbs raises BG
over eating for hypos/bouncing micro-dosing for small changes
15/15 rule (15 grams carb, wait 15 
minutes)
increasing testing frequency to 
observe results and adjust
 1
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drink water for hypers correcting as needed per context
reactive correction changing target BG according to context
setting fixed target BG seeking to stabilize rather than meet certain targets
Testing test before meals test as needed test before and after an action to learn its eﬀect
frequent watching of CGM for 
course corrections
habitual checking frequent checking/ frequentcy dependent on contect
checking to trouble shoot a specific 
problem
Context limiting contextual variables changing treatment according to context
analysis of how much a given 
termperature changes insulin 
requirement to form new dosages
temperature
weather
how much eﬀort is predicted to be 
put into diabetes management in 
given time period
accept device recommendation use device recomendation as one aspect of decision program device
Devices/ 
Interfaces bolus advisor
trends(graphs and  arrow on CGM/
rate of change)
reflecting on charts and graphs to 
change treatment regime
BG value on meter judging BG or average with context of situation
watching for change in direction of 
curve to trigger events
using average on meter to change 
habitual insulin therapy
change infusion set on schedule change infusion if it seems like a likely risk
trouble shoot that infusion set is to 
blame for problem through process of 
elimination
responsing to event with fixed plan using CGM to correct for predicted event graphs if used for retrospective analysis
graph if used to assess general 
tendency over time program bolus advisor
frequent looking for trends and 
patterns in CGM curves and 
adjusting accordingly
detailed examination of curves to modify 
habitual treatment
using arrow angle to adjust 
treatment
time set responses for given times time of day as factor to be considered with others
figuring out how time aﬀects diabetes 
management
BG level over recent past
projection to future possibilities
time of year
health changing insulin dosage for sickness
menstration cycle
factoring in eﬀect of other health 
conditions on control
general sense of wellness
Habitual FCR Sensemakingtype of model
 2
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FCR Online survey (n=192) results  
(data set available for download at: https://figshare.com/articles/Supporting_Diabetes_Self-
Management_with_Ubiquitous_Computing_Technologies_A_User-Centered_Inquiry/7269398) 
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10.3.3 Results from Chapter 7  Wearables study  
(data set available for download at: https://figshare.com/articles/Supporting_Diabetes_Self-
Management_with_Ubiquitous_Computing_Technologies_A_User-Centered_Inquiry/7269398) 
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Questions from Wearables study 
 
Q: Does your product in any way add to daily workload? If so, what rewards does the user 
receive to justify this time and effort? 
 
Q: Is the information collected by your system accessible to any stakeholder other than the 
primary user? If so what is your strategy for: 
-mitigating feelings of surveillance? 
-assisting the user in taking breaks from monitoring if they desire? 
-allowing them to control how data is presented? 
 
Q: How might your product or service create stigma in specific contexts? How might this 
stress be lessened? Is it possible to build for breaks in usage? 
 
Q: Does your product provide personal data to medical personal or other 3rd parties? If so: 
-what controls does the user have to manage when and which data is visible? 
-could such controls be modified quickly during an appointment to allow discussion of a 
specific topic? 
 
Q: Why should the user trust your product? What assurances can you promise, and how can 
you guarantee they will be followed? 
 
Q: Does your device or systems allow the user to adjust or alter components to meet their 
needs or preferences? If not, how is this justified? 
 
Q: Is your product transparent to how the data is being used? How do you keep the user 
informed and updated? 
 
Q: Is the information collected by your system visible to any stakeholder other than the 
primary user? If so, how do you: 
-Plan for monitoring pauses in sensitive contexts? 
-Plan for reengagement after pauses? 
-Allow user to control how and which data is shared?  
 
Q: Does your product or service make use of GPS data? 
-In which ways do you protect the user from vulnerability, such as being identified, or having 
that data associated with their medical data? 
 
Q: Does the proposed system have a system of consent which helps the user to easily control 
who, when, and for what purpose each of their different data types will be used? 
- If not, how do you justify this? 
-How could you implement such measures? 
 
Q: Does your business model involve using individual’s personal data for targeted marketing 
or use by 3rd parties?  If so, how do you protect the user from any harms that may result? 
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10.3.4 Results from Chapter 8 DUETS 
Following tables show simplified results from the study organized by stage and categorization. 
Color coding show which stage the concern was located by the other focus group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DUETS study 
First focus group: Concerns identified by Developers 
 
Stage Adoption & Util-
ity  
Emotional Im-
pacts 
Behaviors & Ac-
tions 
Cognition Consent & Con-
trol 
Stage 1 
Prior  
1a. Relevancy of 
information 
-Real-time BG 
availability 
-Recommendation 
risks 
-On device pro-
cessing for real-
time information  
-Insulin data  
-Personalization 
-User resistance to 
more apps 
-Information an-
noying 
-Historical data 
overwhelming 
-Excess notifica-
tion 
 
-Actionable infor-
mation 
 
 -Privacy concerns 
Stage 2 
heuris-
tics 
 
-Rewards systems 
-No user-input 
-Phone dependent 
-No user status  
-User interaction 
design  
-Technology vali-
dation 
-UI Design 
-Inaccurate notifi-
cations  
-Notification con-
text 
-Resistance to in-
creased diabetes 
engagement 
 
 
-Explaining 
technology 
-User educa-
tion 
 
-User privacy 
concerns due to 
misunderstanding 
product 
Stage 3 
Con-
cerns 
cards 
-Incorporate man-
ual feedback 6 
-How bad is man-
ual entry? 6 
-Cold start  
-Informing as to 
potential benefits  
-Doctor involve-
ment 
-No justification 
for no customiza-
tion 9 
-Further research 
on UI color  
-Stress related to 
potential adverse 
future events  
-No user-testing 
 
-Incorporating user 
algorithm training 
-System over-reli-
ance 
 
-Interference 
with auton-
omy 
-Guidance on 
recommenda-
tion effects 
-App not free-
standing 
 
-Validating out-
comes 
-Technology de-
pendent on de-
vice adoption 
-Increased atten-
tion to user 
-Discomfort with 
tracking 
 
Stage 4 
All 
cards 
“Providing accurate 
information given 
the lack of data, no 
user input, no user 
feedback” 
 
 
-Watch interface 
could cause 
stigma 
-Effects of non-fa-
vorable infor-
mation 
 -Triggering 
user’s existing 
knowledge 
-Misleading 
data presenta-
tions 
-Personal data us-
age by other par-
ties 
-User trust 
-Concealed 
stakeholders 
 Adoption & 
Utility  
Emotional 
Impacts 
Behaviors 
& Actions 
Cognition Consent & 
Control 
totals 
Developer focus group n=3, novel concerns located 
Prior  7 3 1 0 1 12 
heuristics 9 1  2 2 14 
Concerns 6 3 2 3 4 18 
DUETS 1 2  2 3 8 
totals 23 9 3 7 10 52 
Users focus group n=6, novel concerns located 
Prior  13 5 0 2 1 21 
heuristics 5 4 0 1 2 12 
Concerns 16 7 1 6 4 34 
DUETS 17 6 2 4 4 33 
totals 51 22 3 13 11 100 
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DUETS study 
Second focus group: Concerns identified by Users 
 
Stage Adoption & Utility  Emotional Impacts Behaviors 
& 
Actions 
Cognition Consent & 
Control 
Stage 1 
Prior  
-Notification frequency  
-Excess non-relevant information 
-Customization 
-Relevancy 
-Reliability 
-Quiet mode  
-Benefit/Effort ratio 
-Prediction 
-Additional parameters 
-System transparency  
-Detecting or learning behaviors 
-Medical certification 
-Integration with medical devices 
-Pre-existing App and 
device fatigue 
-Lack of trust in safety 
-Notifications annoying 
-Notification frequency 
annoying 
-System fatigue 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-Too much text to 
read 
-Suggestions too 
hard to understand 
 
 
 
 
 
 
 
 
 
 
-Data secu-
rity 
 
Stage 2 
heuris-
tics 
 
-Functionality that promote usage 
-Design  
-Progress visibility (feature) 
-Accuracy of information 
-Usability 
-Stigma from usage 
-Others annoyed by 
phone usage 
-UI emotionally over-
whelming  
-positive & motivating 
 -UI cognitively 
overwhelming 
- 
 
-Unclear 
what data is 
being used 
for 
-accidently 
sharing 
data on so-
cial media 
Stage 3 
concerns 
cards 
-Actionable information 
-Customizable type of assistance 
-Adaptively displayed data   
-Optional gamification only 
-Optional info /alerts  
-Display and explain status until 
sufficient data for prediction. 
-Rewards clinical or virtual?  
-False sensor readings excludable 
-Pre-existing CGM data integration  
-Integration with HCP software 
-Display uncertainty of detected ac-
tivities 
-Minimize workload 
-Contextual sensing for alarms 
-Ambiguity of messages 
-Convenient manual feedback 
-Not increasing diabetes manage-
ment time 
-Design should be non-
judgmental 
-Reconsider use of red 
-Privacy UI options  
-Non-visually coherent 
UI design  
-Current UI doesn’t 
support, just infor-
mation 
-Data looks fake 
-Blackbox inhibits trust 
 
-Clinical 
relevancy 
 
-Highlight flawed 
collected data 
-Focus or distrac-
tion? 
-Device malfunc-
tion could cause 
bad advice 
-Intuitive alerts 
-Goal of product 
unclear 
-Contextual display 
of retrospective 
data 
-Minimize usage of 
systems by design 
 
-Motives of 
developer 
-Transpar-
ency of 
profit and 
data 
--Independ-
ent usage 
-Access 
-Afforda-
bility 
 
Stage 4 
Con. 
Cards+ 
Archit. 
-Already using many apps-> high 
barriers to entry 
-Too complicated ->abandonment 
-A few days to a month to prove 
value 
-Must work right away if it uses 
retrospective data 
-Should function without GPS  
-Quiz at beginning for customiza-
tion (short) 
-Adjustable thresholds for hypo/hy-
per 
-Connecting with API’s like 
weather for novel insights 
-Customized by previous answers  
-Prompt data entry/outliers to assist 
medical appointments 
-Glanceable highlights 
-Insights for medical personal 
-Questions rather than statements 
-Stress detector function 
-Target specific group rather than 
broad appeal 
-Glanceable/hidden insight option 
-focus on watch interfaces rather 
than phone 
-Single annoying fea-
ture->abandonment 
-Stress from too many 
devices going off simul-
taneously  
-Machine simulating 
human annoying 
-Language must be 
carefully phrased 
-red only for actual 
emergency situations 
-Full transparency for 
trust 
 
 
-Specific 
behavior 
sugges-
tions 
-low dis-
tractions 
in emer-
gency sit-
uations 
 
-Separate reduced 
screens 
-graphs too compli-
cated 
-Help users under-
stand behavioral 
impacts 
-Training on how 
to use system 
 
-Hide loca-
tions option 
-Don’t 
nudge pur-
chasing 
-Sharing of 
data to cus-
tomizable 
for individ-
ual stake-
holders 
-Allow 
sharing of 
insights 
without ac-
tual data 
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DUETS Cards 
 
 
Functionality 
Concerns
 
01
To what extent does the 
system adjust or allow 
adjustment for individual 
preferences? 
How easy are such 
adjustments to locate and 
manipulate?
Functionality  
Concerns
 
02
Will this product be 
capable of delivering 
perceived value if the 
user fails to consistently 
manually enter data? 
If not, what rewards does 
the user receive for data 
entry? 
Functionality  
Concerns
 
03
Does this product depend 
on non-primary users 
such as doctors to accept 
this product? 
If so, how have you 
verified that they will be 
willing to do so?  
Functionality  
Concerns
 
04
Does the product in any 
way add to user daily 
workload?
If so, what indications are 
there that the benefits 
are sufficient for time 
invested?   
Functionality  
Concerns
 
05
Can the user gain 
benefits when they use 
product without having 
to have invested effort on 
previous occasions?
If not, how much effort 
will they need to invest, 
and why will the user do 
so? 
Functionality  
Concerns
 
06
How much effort per day 
will users have to invest in 
order to attain benefits? 
How is this request for 
user time justified?   
Functionality  
Concerns
 
07
Is this product meant for 
frequent usage? 
If so, can it support user 
needs without requiring 
significant cognitive effort? 
Functionality  
Concerns
 
08
If this product requires 
continual use to deliver 
benefits, how much effort 
does each use require? 
How can this be 
decreased?   
Functionality  
Concerns
 
09
Is this product meant as a 
daily usage tool?
If so, to what extent do 
benefits surpass required 
effort?     
Functionality 
Concerns
 
10
How useful for your 
user is the information 
presented?
What actual user problem 
does this information 
solve?     
Functionality  
Concerns
 
11
Does the system offer 
explicit actionable 
information? If not, why 
not?
Could the user be better 
served by more processed 
data?      
Functionality 
Concerns
 
12
If the system displays 
significant retrospective 
data, in what ways does 
this assist actual user 
needs? 
If less data were visible 
by default, would the user 
still be able to complete 
their task?      
Functionality  
Concerns
 
13
Are any extra elements 
such as sound effects? 
Can they be customized 
or turned off if they are 
intrusive?
If they add essential 
information, are there 
alternate ways for the 
user to receive this 
information?      
Functionality  
Concerns
 
14
Does the product assist 
with an actual user need? 
What is this need? 
How could it better meet 
this need?      
Functionality  
Concerns
 
15
Can the system offer 
benefits with a glance 
from the user?
If not, why not?    
Could it?  
Functionality  
Concerns
 
17
If there are elements such 
as gamification, are they 
appropriate to the context 
of use?
How can this be verified?  
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Functionality 
Concerns
 
19
Does your device or 
systems allow the user to 
alter, adjust, or exchange 
components to meet their 
needs or preferences?
If not, how is this justified? 
Functionality  
Concerns
 
       
Emotional Impacts
Concerns
 
20
Could this system or 
interface create feelings 
of stigma or vulnerability 
in specific situations? e.g. 
date, job interview, public 
space, etc. 
How could it be made 
more sensitive?
Emotional Impacts
Concerns
 
21
How does the interface 
display sensitive or unde-
sired data? 
Can it alert user to import-
ant situations, without 
creating undue stress?
Could this be improved?
Emotional Impacts
Concerns
 
22
Are design element col-
ors sensitive to the feel-
ings of the user? 
Has the use of alert col-
ors like red been properly 
tested for emotional re-
action from users?
Emotional Impacts
Concerns
 
23
Are the design choices 
such as color, sounds, 
and interface motivating 
or demotivating?
How has this been tested 
in a way appropriate to 
intended usage?
Emotional Impacts
Concerns
 
23
Have you adequately re-
searched how the infor-
mation or feedback you 
provide impacts your us-
ers emotionally?
What strategies do you 
have in place for deliv-
ering data in a way that 
minimizes undue stress?
Emotional Impacts
Concerns
 
Cognition
Concerns
 
24
Does the interface help to 
activate or jog the users’ 
existing knowledge? 
If not, how could this be 
improved?
Cognition
Concerns
 
If the system offers retro-
spective information, to 
what extent does such 
retrospection serve user 
needs?
Is this data always needed 
or just in specific cases?
25
Cognition
Concerns
 
Could information present-
ed give a false impression 
of actual data? (For exam-
ple, graphs that draw lines 
between data points, or 
averages that conceal de-
viation.)
26
Cognition
Concerns
 
If the user becomes con-
fused by the system, what 
means are in place to help 
them understand it?
27
Cognition
Concerns
 
Does the interface present 
all information needed for 
task simultaneously, e.g. a 
single screen? 
Why not?
Could it be changed to al-
low this to happen?
28
Cognition
Concerns
 
How much effort is re-
quired for the user to inter-
pret the interface?
Could the complexity be 
reduced without impairing 
essential functions?
29
Cognition
Concerns
 
In what ways does this 
interface help the user to 
question the habitual be-
haviors they do that might 
not be helpful?
30
Cognition
Concerns
 
Could this product add to 
confusion or delays in crit-
ical situations, such as with 
complicated interfaces, dis-
tracting, or overly engaging 
interfaces? 
If so, how is this risk justi-
fied?
31
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Cognition
Concerns
 
Could users become un-
necessarily dependent on 
this product for decisions? 
Would it be possible for this 
product to help the user to 
learn to not depend on it for 
decision making?
32
Cognition
Concerns
 
Does this product support 
in-the-moment decisions 
without undue effort?
33
Cognition
Concerns
 
Does this product help us-
ers to correct and adjust 
their decisions according to 
specific contextual need?
34 Concerns
 
Does this product help us-
ers to access knowledge 
they already possess in a 
fluid and flexible manner?
How could it do so?
Cognition
35
Concerns
 
Do interface elements as-
sist users in predicting the 
result of following the ad-
vice?
If not, could such function-
ality be integrated?
Cognition
36 Concerns
 
Does this product assist 
users in recognizing prob-
lems or unusual events? 
How does it assist them in 
understanding what is the 
problem?
How could it do this?
Cognition
38 Concerns
 
How does this product help 
users to question, explore, 
and test their assumptions? 
Could this process be bet-
ter supported?
Cognition
39 Concerns
 
In what ways does this 
product help users to 
identify and make sense 
of patterns?
How could such function-
ality be included?
Cognition
40
Concerns
 
In what ways does this 
product help users to 
form new ideas about 
how best to manage 
challenging situations? 
Cognition
41 Concerns
 Cognition
Concerns
 
Which aspects of the 
system are you most con-
cerned about? 
What would you change 
if you could?
Privacy & Security
42 Concerns
 
Does the proposed system 
have a system of consent 
which helps the user to 
easily control who, when, 
and for what purpose each 
of their different data will 
be used? 
If not, how do you justify 
this? 
How could such measures 
be implemented?
Privacy & Security
43
Concerns
 Privacy & Security
Concerns
 
Does your business model 
involve using individual’s 
personal data for targeted 
marketing or use by 3rd 
parties? 
If so, how do you protect 
the user from any harms 
that may result?
Privacy & Security
44 Concerns
 
Is the information collected 
by your system visible to any 
stakeholder other than the 
primary user? If so, how do 
you:
Enable user to pause moni-
toring in sensitive contexts?
Allow user to control which 
and how data is shared?
Privacy & Security
45 Concerns
 
Does your product provide 
user data to medical per-
sonal? If so:
-what controls does the 
user have to manage when 
and which data is visible?
-could such controls be 
modified quickly during an 
appointment to allow re-
view of specific data?
Privacy & Security
46
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Concerns
 
Does your product or ser-
vice make use of GPS data?
If so, in which ways do you 
protect the user from:
-identification
-linking  with medical data
-vulnerability
How could the user be bet-
ter protected?
Privacy & Security
47 Concerns
 
How transparent is the 
ways in which the user’s 
data is:
-being used?
-who has access?
How could you better in-
form the user?
Privacy & Security
48 Concerns
 
Why should the user trust 
your product?
What assurances can you 
promise? 
How can you guarantee 
they will be followed?
Privacy & Security
49 Concerns
 
How how much person-
al information is collected 
form the user?
Is there an imbalance in 
data collected and data re-
ceived? 
Is this data only being used 
to serve the user, or are 
there other purposes?
Privacy & Security
50
Concerns
 
Are there any stakeholders 
that the user is unaware 
of?
Are they receiving any data, 
anonymized or otherwise?
Do you think the user 
would be less likely to use 
this product if they were 
aware of this?
Privacy & Security
51 Concerns
 
Do you consider the patient 
the primary stakeholder? 
If not, how is this justified?
Privacy & Security
52 Concerns
 Privacy & Security
53 Concerns
 
Can the interface help us-
ers to react quickly in cru-
cial situations?
If so, in what ways could 
the system assist in the 
user becoming more inde-
pendent ?
Behavior & Action
54
Concerns
 
Does the system try to 
enforce a structure on the 
user, such as a set daily 
time schedule?
If so, how is this justified? 
Can it be easily custom-
ized?
Behavior & Action
55 Concerns
 
Does this product help us-
ers to act quickly in critical 
situations?
How could it better assist 
in such instances?
Behavior & Action
56 Concerns
 
Could this product interfere 
with the user engaging in 
necessary actions?
If so, how is this justified?
Behavior & Action
57 Concerns
 Behavior & Action
C-38
Devices
Notes
Smartphone
Dev-01 Devices
Notes
Smartwatch
Dev-02 Devices
Notes
Pad
Dev-03 Devices
Notes
Laptop
Dev-04
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Devices
Notes
Cloud Computing
Dev-05 Devices
Notes
Cloud Service
Dev-06 Devices
Notes
Cloud Documents
Dev-07 Devices
Notes
Cloud
Dev-08
Devices
Notes
IoT Health Device
Dev-09 Devices
Notes
Health Device
Dev-10 Devices
Notes
IoT Health Device
Dev-11 Devices
Notes
Network Data Base
Dev-12
Devices
Notes
Desktop Computer 
Dev-13 Devices
Notes
Fitness Band 
Dev-14 Devices
Notes
LAN Network
Dev-15 Devices
Notes
Networked Drive 
Dev-16
Devices
Notes
Local Drive 
Dev-17 Devices
Notes
Server Farm 
Dev-18 Devices
Notes
IoT medical device 
Dev-19 Devices
Notes
Dev-20
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Services
Notes
Medical Service
Ser-01 Services
Notes
Health Coaching
Ser-02 Services
Notes
Ser-03
Clinical Support
Services
Notes
Education
Ser-04
Services
Notes
Remote Monitoring
Ser-05 Services
Notes
Diagnosis
Ser-06 Services
Notes
Ser-07
Medical Evaluation
Services
Notes
Analytics
Ser-08
Services
Notes
Big Data Analytics
Ser-09 Services
Notes
Peer Support
Ser-10 Services
Notes
Ser-__ Stakeholder
Notes
SH-01
Patient
Stakeholder
Notes
Family
SH-02 Stakeholder
Notes
Friend
SH-03 Stakeholder
Notes
Parent
SH-04 Stakeholder
Notes
Co-Worker
SH-05
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Stakeholder
Notes
Medical Worker
SH-06 Company
Startup
Com-01
Notes
Company
Health Insurer
Com-02
Notes
Company
Tech Company
Com-03
Notes
Company
Care Provider
Com-04
Notes
Company
Corporation
Com-05
Notes
Company Com-__
Notes
Data
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Exercise
Step counts
Blood glucose
Behaviors
Locations
GPS
Insights
Records
Advice
Sleep
Goals
Peer support
Financial
Alerts
Encryption
Ads
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Goals
Habit Change
Social Interaction
Stress Reduction
More Exercise
Save Times
Coping
Emotional Support
Sell Product
Maximize Profit
Collect Data
Sell Service
Improve Health
Improve Diet
Improve Biomarker
Reduce Risk
Earn Money
Atr-02 Atr-03
Actions
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Analyze Data
Change Goal
Exercise
Eat/Drink
Sleep
Pressure
Encourage
Comment
Collect Data
Invitate
Adapt Algorithm
Reflect
Exercise
Sense
Read
Control Atr-04
Traits
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Health Condition
Proprietary
Secure
Vulnerable
Gender
Cognitive Disability
illness
Learning disability
Physical disability
Atr-05
Emotions
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Fear
Anger
Sadness
Joy
Disgust
Surprise
Trust
Anticpation
Suspicion
Shame
Envy
Love
Worry
Concern
Vulnerability
Stress
Atr-06
Responsibilities
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Financial
Emotional
Familial
Professional
Social
Monitoring
Household
Maintenance
Management
Recording
Coordination
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
Atr- _Atr-06
Sensors
GPS
Fingerprint 
Barometer
Three-axis gyro
Accelerometer
Proximity 
Ambient light 
Camera
Compass
Altimeter
Heart rate
Gyroscope
Ambient light
WiFi/ LTE
Attributes
D
at
a 
D
ire
ct
io
n
D
ata D
irection
